Principles of Bacterial Pathogenesis
This Page Intentionally Left Blank
Principles of Bacterial Pathogenesis EDITED...
280 downloads
2646 Views
50MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
Principles of Bacterial Pathogenesis
This Page Intentionally Left Blank
Principles of Bacterial Pathogenesis EDITED BY
Eduardo A. Groisman Howard Hughes Medical Institute Washington University School of Medicine Department of Molecular Microbiology St. Louis, Missouri
ACADEMIC PRESS San Diego London
Boston
New York
Sydney
Tokyo
Toronto
This book is printed on acid-free paper, (oo)
Copyright © 2001 by ACADEMIC PRESS
All Rights Reserved No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher Requests for permission to make copies of any part of the work should be mailed to: Permissions Department, Harcourt Inc., 6277 Sea Harbor Drive, Orlando, Florida 32887-6777
Academic Press a Harcourt Science and Technology Company 525 B Street, Suite 1900, San Diego, California 92101-4495, USA http://www.academicpress.com Academic Press Harcourt Place, 32 Jamestown Road, London NWl 7BY, UK http://www.academicpress.com
Library of Congress Catalog Card Number:
International Standard Book Number:
00-107418
0-12-304220-8
PRINTED IN UNITED STATES OF AMERICA 00 01 02 03 04 05 06 SB 9 8
7
6
5
Contents
Contributors Preface
xi XV
1. Evolution of Bacterial Pathogens HOWARD OCHMAN
I. II. III. IV. V. VI. VII. VIII. IX.
Introduction 2 The Genetic Basis of Virulence 2 Identification of Sequences Involved in Bacterial Pathogenesis 6 Recovery of Genes Contributing to Virulence 8 The Population Genetics of Pathogens 9 Studying Bacterial Population Genetics 10 The Organization of Genetic Diversity in Pathogenic Microorganisms Population Genetics of Representative Bacterial Pathogens 14 Conclusions 28 References 29
13
2. Germ Warfare: The Mechanisms of Virulence Factor Delivery JILL REISS HARPER AND THOMAS J. SILHAVY
I. II. III. IV. V VI. VII. VIII.
Introduction 43 The General Secretory Pathway 45 Autotransporters: Type V 47 Two-Step Secretion: Type II 49 ABC Transporters: Type I 52 Conjugal Transfer Systems: Type IV 55 Contact-Dependent Secretion: Type III 57 Concluding Remarks 61 References 61
vi
CONTENTS
3. Regulation of Virulence Gene Expression in Bacterial Pathogens CHARLES J. DORMAN AND STEPHEN G . J. SMITH
I. II. III. IV. V. VI. VII. VIII. IX. X. XL XII. XIII. XIV. XV. XVI. XVII. XVIII. XIX. XX. XXI. XXII.
Introduction 76 Transcription Initiation 77 Regulatory Protein Families 79 Covalent Modification of Transcription Factors 82 Regulatory Networks 86 The Oxidative Stress Response 87 The Modular Nature of Bacterial Regulatory Proteins 89 The Overlap between Genome Structure and Gene Regulation 92 Other Classes of Protein Regulators 94 DNA Structure and Gene Regulation 94 Stereotypical and Stochastic Events in the Control of Gene Expression The Switch Controlling Type 1 Fimbrial Expression in E. coli 101 Pap Pilus Gene Transcription 103 Contact-Dependent Gene Regulation 105 The Virulence Gene Regulatory Cascade of 5. y7exA2^n 106 A Thermometer Protein from the Salmonella Virulence Plasmid 109 Cell-Density-Dependent Regulation 110 Adaptive Mutation 114 Rare tRNAs and Translation Modulation 114 Protein Splicing 115 AntisenseRNA 115 Perspective 116 References 117
97
4. Strategies to Identify Bacterial Pathogenicity Factors ANDREW CAMILLI, D . SCOTT MERRELL, AND JOHN J. MEKALANOS
I. II. III. IV. V VI.
Introduction 134 Biochemical Strategies 135 Genetic Screens 149 Genetic Selections 159 Genomic Approaches 165 Concluding Remarks 169 References 170
5. Mechanisms of Bacterial Pathogenesis in Plants: Familiar Foes in a Foreign Kingdom JAMES R . ALFANO AND ALAN COLLMER
I. Introduction 180 II. An Overview of Bacterial Plant Pathogens and Plant Diseases 181 III. Tumorigenic Agrobacterium tumefaciens: Using the Type IV Secretion System to Transform the Host into a Factory for Bacterial Nutrients 186
CONTENTS
Vli
IV. Necrogenic, Stealth Pathogens: Parasites Strongly Dependent on the Hrp (Type III) Protein Secretion System 189 V. Necrogenic, Brute-Force Pathogens: Soft-Rotters Dependent on Type II Secretion of Pectic Enzymes 200 VI. Other Virulence Factors of Gram-Negative Plant Pathogens Compared with Those of Animal Pathogens 201 VII. Host Innate Immune Systems: Common Components in Pathogen Recognition and Defense Signaling 206 VIII. The R Gene Surveillance System: An Innate Immune System with Elaborate Recognition Specificity 207 IX. Pseudomonas aeruginosa: Dual-Kingdom Pathogenesis 209 X. Conclusions 210 References 211
6. Yersinia AoiFE P. BOYD AND GUY R . CORNELIS
I. II. III. IV. V. VI. VII.
Introduction 228 The Adhesive Factors 231 Iron Acquisition 236 Pathogenicity Islands 237 Yst Enterotoxin 238 The Yersinia Virulence Plasmid Conclusion 252 References 253
238
7. Molecular Pathogenesis of Salmonellae CHRISTINA A. SCHERER AND SAMUEL I. MILLER
I. II. III. IV. V. VI. VII. VIII. IX.
Introduction 266 History 266 Taxonomy 267 Epidemiology and Clinical Disease 268 Clinical Course and Basic Immunology 272 In Vitro Models of Salmonella Virulence 280 Virulence Factors 290 Antibiotic-Resistant Salmonellae 312 5a/mon^//<3-Based Vaccines 314 References 316
8. Shigellosis: From Disease Symptoms to Molecular and Cellular Pathogenesis PHILIPPE J. SANSONETTI, COUMARAN EGILE, AND CHRISTINE WENNERAS
I. Introduction 336 II. Bacteriology 337 III. The Somatic Antigen
338
viii
CONTENTS
IV. V. VI. VII. VIII. IX. X. XI. XII.
Epidemiology and Transmission 338 Disease Symptoms and Complications: Orientations for Future Research? Histopathology of Shigellosis: A Window on Pathogenesis 342 Animal Models: Strengths and Weaknesses 343 Cellular Models of Infection: The Contribution of Shigella to the Concept of Cellular Microbiology 344 Pathogenic Mechanisms: In Vitro Expression of the Invasive Phenotype Pathogenic Mechanisms: In Vivo Expression of the Invasive Phenotype Role of Chromosomally Encoded Genes in the Virulence of Shigella Conclusions 373 References 373
340
345 365 369
9. Pathogenic Escherichia coli JOSE L . PUENTE AND B . BRETT FINLAY
I. II. III. IV. V. VI. VII. VIII. IX. X.
Introduction 388 Enterotoxigenic E. coli (ETEC) 390 Enteroinvasive E. coli (EIEC) 396 Enteropathogenic E. coli (EPEC) 398 Enterohemorrhagic E. coli (EHEC) 408 Enteroaggregative £". CY?//(EAEC) 414 Diffusely Adhering E. coli (DAEC) 417 Uropathogenic £". C6>// 418 E. coli That Cause Sepsis and Meningitis 426 Conclusions 428 References 428
10. Molecular Basis of Vibrio cholerae Pathogenesis VICTOR J. DIRITA
I. II. III. IV. V. VI.
Introduction 457 Vibrio cholerae 458 Cholera 463 Molecular Mechanisms of Disease 465 Natural and Induced Immunity against Vibrio cholerae Infection Future Studies: The Past Is Prologue 493 References 495
\\. H. pylori Pathogenesis TIMOTHY L . COVER, DOUGLAS E . BERG, MARTIN J. BLASER, AND HARRY L . T. MOBLEY
I. II. III. IV. V.
Introduction 510 Epidemiology 510 Gastric Histology and Physiology 512 Clinical Diseases Associated with H. pylori Infection Microbiology 519
516
489
CONTENTS
VI. VII. VIII. IX. X. XI. XII.
ix
Genetic Diversity and Population Structure of H. pylori 521 Initial Gastric Colonization 524 Gastric Inflammation 529 Interactions of H. pylori with the Gastric Epithelium 531 Vacuolating Cytotoxin 532 Persistence of H. pylori Infection 536 Factors Influencing Development of Clinically Evident Disease References 542
12. Neisseria SCOTT D . GRAY-OWEN, CHRISTOPH DEHIO, THOMAS RUDEL, MICHAEL NAUMANN, AND THOMAS F. MEYER
I. II. III. IV. V. VI. VII. VIII. IX.
Introduction 559 Natural Competence for Transformation Surface Structures 567 Tissue Colonization 570 PorB31 586 IgAl Protease 590 Iron Acquisition in Vivo 592 Immune Response 594 Summary 599 References 600
566
13. Bordetella PEGGY A. COTTER AND JEFF F. MILLER
I. II. III. IV. V. VI. VII. VIII. IX.
Introduction 620 Respiratory Infections by B6>rj£'r6'//rt Species 621 Evolutionary Relationships among Bordetella Subspecies 624 Bordetella Virulence Factors 628 The Bordetella-Host Interaction 639 The BvgAS Sensory Transduction System 642 Phenotypic Modulation 646 Transcriptional Control of Bvg-Regulated Genes 640 The Role of Bvg-Mediated Signal Transduction in the Bordetella Life Cycle 654 References 658
14. Pathogenesis of Haemophilus influenzae Infections CHRISTOPH M . TANG, DEREK W . HOOD, AND E . RICHARD MOXON
I. II. III. IV. V.
Introduction 676 Population Biology 680 Molecular Determinants of Pathogenicity Pathogenesis 699 Conclusions 705 References 705
682
539
CONTENTS
15. Pathogenic Mechanisms in Streptococcal Diseases MICHAEL CAPARON
I. II. III. IV. V. VI. VII.
Introduction 717 Three Basic Mechanisms of Pathogenesis: Example of 5. pyogenes Steps Common to All Three Pathogenic Mechanisms 721 First Mechanism: Invasion and Multiplication in Tissue 728 Second Mechanism: Toxin-Mediated Disease 739 Third Mechanism: Immunopathological-Based Diseases 742 Concluding Remarks 743 References 743
719
16. Listeria monocytogenes HAFIDA FSIHI, PIERRE STEEPEN, AND PASCALE COSSART
I. General Overview of Listeria monocytogenes and Listeriosis II. Genetic Tools and Cell Biology Techniques to Study L. mono cytogenes Infection 755 III. Molecular Mechanisms for Entry and Spread of L. monocytogenes in Nonphagocytic Cells 758 IV. Regulation of L. monocytogenes Virulence Gene Expression V. Conclusion 787 References 787
Index
805
752
782
Contributors
Numbers in parentheses indicate the pages on which the authors' contributions begin.
(179), Department of Biological Sciences, University of Nevada, Las Vegas, Nevada 89154-4004
JAMES R. ALFANO
(509), Departments of Molecular Microbiology and Genetics, Washington University Medical School, St. Louis, Missouri 63110-1093
DOUGLAS E. BERG
J. BLASER (509), Department of Medicine, New York University School of Medicine, New York, New York 10016
MARTIN
AoiFE P. BOYD (227), Microbial Pathogenesis Unit, Universite Catholique de Louvain, ICP et Faculte de Medecine, Brussels 1200, Belgium (133), Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111
ANDREW CAMILLI
(717), Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110-1093
MICHAEL CAPARON
(179), Department of Plant Pathology, Cornell University, Ithaca, New York 14853-4203
ALAN COLLMER
(227), Microbial Pathogenesis Unit, Universite Catholique de Louvain, ICP et Faculte de Medecine, Brussels 1200, Belgium
GUY R. CORNELIS
(751), Unite de Interactions Bacteries-Cellules, Institut Pasteur, Paris, Cedex 15, 75724, France
PASCALE COSSART
A. COTTER (619), Department of Microbiology, Immunology, and Molecular Genetics, UCLA School of Medicine, Los Angeles, CA 90095-1747
PEGGY
(509), Department of Medicine and Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
TIMOTHY L. COVER
(559), Abteilung Infektionsbiologie, Max-Planck-Institut-fur Biologic, Tubingen 72076, Germany
CHRISTOPH DEHIO
XI
xii
CONTRIBUTORS
J. DIRITA (457), Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48109
VICTOR
J. DORMAN (75), Department of Microbiology, Moyne Institute of Preventive Medicine, Trinity College, Dublin 2, Ireland
CHARLES
COUMARAN EGILE (335), Unite de Pathogenic Microbienne Moleculaire & Unite INSERM 389, Institut Pasteur, 75724 Paris, Cedex 15, France B.
(387), Biotechnology Laboratory, and the Departments of Biochemistry & Molecular Biology and Microbiology & Immunology, University of British Columbia, Vancouver, BC V6TIZ3, Canada
BRETT FINLAY
(751), Unite des Interactions Bacteries-Cellules, Institut Pasteur, Paris, Cedex 15, 75724, France
HAFIDA FSIHI
(559), Department of Medical Genetics and Microbiology, University of Toronto, Toronto M5S 1A8, Canada
SCOTT D . GRAY-OWEN
(43), Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544
JILL REISS HARPER
DEREK W. HOOD (675), Molecular Infectious Diseases Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, 0X3 9DU, United Kingdom J. MEKALANOS (133), Department of Microbiology and Molecular Genetics, Shipley Institute of Medicine, Harvard Medical School, Boston, Massachusetts 02115
JOHN
D.
(133), Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111
SCOTT MERRELL
(559), Max-Planck-Institut fur Infektionsbiologie, Department of Molecular Biology, 10117 Berlin, Germany
THOMAS F. MEYER
(619), Department of Microbiology, Immunology, and Molecular Genetics, UCLA School of Medicine, Los Angeles, CA 90095-1747
JEFF F. MILLER
I. MILLER (265), Departments of Medicine and Microbiology, University of Washington, Seattle, Washington 98195
SAMUEL
(509), Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland 212011559
HARRY L.T. MOBLEY
E.
(675), Molecular Infectious Diseases Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, 0X3 9DU, United Kingdom
RICHARD MOXON
(559), Department of Molecular Biology, Max-Planck-Institut-fur Infektionsbiologie, Berlin 10117, Germany
MICHAEL NAUMANN
CONTRIBUTORS
Xili
(1), Department of Ecology and Evolutionary Biology, University of Arizona, Tucson, Arizona 85721
HOWARD OCHMAN
(387), Department of Molecular Microbiology, Instituto de Biotecnologia, Universidad Nacional Autonoma de Mexico, Cuemavaca 62210, Mexico
JOSE L. PUENTE
(559), Department of Molecular Biology, Max-Planck-Institutfiir Infektionsbiologie, Berlin 10117, Germany
THOMAS RUDEL
J. SANSONETTI (335), Unite de Pathogenic Microbienne Moleculaire & Unite INSERM 389, Institut Pasteur, 75724 Paris, Cedex 15, France
PHILIPPE
A. SCHERER (265), Departments of Medicine and Microbiology, University of Washington, Seattle, Washington 98195
CHRISTINA
J. SILHAVY (43), Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544
THOMAS
(75), Department of Microbiology, Moyne Institute of Preventive Medicine, Trinity College, Dublin 2, Ireland
STEPHEN G J . SMITH
(751), Unite des Interactions Bacteries-Cellules, Institut Pasteur, Paris, Cedex 15, 75724, France
PIERRE STEFFEN
(675), Molecular Infectious Diseases Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, 0X3 9DU, United Kingdom
CHRISTOPH M . TANG
(335), Department of Medical Microbiology and Immunology, University of Goteborg, S41345 Goteborg, Sweden
CHRISTINE WENNERAS
This Page Intentionally Left Blank
Preface
Infectious diseases are the leading cause of morbidity and mortality worldwide. While some of these infections are caused by eukaryotic parasites, bacterial pathogens continue to present a threat to the well-being of humans and animals both in the developing and developed worlds. The use of vaccines and antibiotics, together with changes in sanitary practices, has contributed to an important increase in the life span of humans in the last century. However, these significant improvements are now challenged by the appearance of microbes resistant to multiple antibiotics, the emergence of new bacterial pathogens, and the use of health care treatments that, while prolonging life, render individuals susceptible to opportunistic pathogens. Then, what can be done to sustain the improvements in health care developed during the last 100 years? Novel strategies are currendy being tested to prevent and/or treat bacterial infections. An increasing number of these strategies are based on our understanding of the mechanisms by which pathogenic microorganisms cause disease. This is possible due to exciting developments in the field of bacterial pathogenesis, which started some 20 years ago with the use of molecular genetics to investigate the microorganisms responsible for causing disease, and are now complemented with cell biological and biochemical approaches aimed at unraveling the consequences that infection by such microorganisms has on their hosts. We now have a basic understanding not only of the varied nature of virulence determinants but also of their origin and acquisition by pathogenic microbes. We appreciate that expression of virulence determinants is most often regulated in response to host signals and that microbes use different devices to deliver toxic products to host cells. These studies have revealed a set of principles that govern bacterial pathogenesis and, as the tide indicates, constitutes the subject matter of this book. The motivation for Principles in Bacterial Pathogenesis was twofold: first, to provide in-depth coverage of the best-characterized bacterial pathogens, with the goal of uncovering the salient features that these microbes have in common which allow them to conquer new niches and to circumvent host defense mechanisms, and, second, to group contributions by the world experts in bacterial pathogenesis
XV
XVI
PREFACE
in which they present a general discussion of the subject beyond the work performed in their own laboratories. This book is divided in two parts that comprise a total of 16 chapters, each of which can be read independent of the rest. The first part consists of five chapters, three of which discuss aspects of bacterial pathogenesis that are common to all pathogens: evolution, secretion, and regulation of virulence determinants. The fourth chapter presents a thorough description of the strategies currently used to identify virulence determinants. The fifth chapter discusses bacterial pathogens of plants, highlighting the similar mechanisms that bacterial pathogens of animal and plants employ when interacting with their respective hosts. These first 5 chapters serve as a general introduction to the 11 pathogen-based chapters that comprise the second part of the book. Each of the latter chapters provides a broad discussion of the best-understood human pathogens. In sum, while novel aspects of pathogenic organisms will continue to be discovered, a basic understanding of the principles governing bacterial pathogenesis will not only allow us to appreciate the sophisticated mechanisms used by microbes in their pathogenic lifestyle, but will also be essential in beginning to understand the plethora of information emerging from genomics, and to develop new rational approaches to the treatment and prevention of infectious diseases. Eduardo A. Groisman Department of Molecular Microbiology Howard Hughes Medical Institute Washington University School of Medicine St. Louis, Missouri
CHAPTER 1
Evolution of Bacterial Pathogens HOWARD OCHMAN
I. II. HI. IV. V. VI.
Introduction The Genetic Basis of Virulence Identification of Sequences Involved in Bacterial Pathogenesis Recovery of Genes Contributing to Virulence The Population Genetics of Pathogens Studying Bacterial Population Genetics A. Multilocus Enzyme Electrophoresis B. DNA Sequencing C. Multilocus Sequence Typing vn. The Organization of Genetic Diversity in Pathogenic Microorganisms VIII. Population Genetics of Representative Bacterial Pathogens A. Bordetella B. Borrelia C. Escherichia coli and Shigella D. Haemophilus E. Helicobacter F. Listeria G. Mycobacterium H. Neisseria I. Salmonella J. Staphylococcus K. Streptococcus L. Vibrio IX. Conclusions References
Principles of Bacterial Pathogenesis Copyright © 2001 by Academic Press All rights of reproduction in any form reserved. ISBN 0-12-304220-8
2 2 6 8 9 10 10 12 12 13 14 14 16 17 19 19 20 21 22 23 25 26 27 28 29
2
HOWARD OCHMAN
/. Introduction In what ways do pathogenic microorganisms differ from nonpathogenic forms? For an organism to be considered a pathogen, it must, during some phase of its life-cycle, advance disease and alter the health or behavior of another organism, that is, its host. Every organism can serve as a host for pathogens, and pathogens come into contact with a very large number of species; however, most pathogenic microorganisms are virulent to relatively few, and often only one, host species, and infection may cause disease in only a limited segment of the host population. So despite the wide range of mechanisms deployed by pathogens to disable their hosts (and to promote their own replication and transmission), there is one common theme: virulence depends upon the susceptibility of a host. Therefore, the identification of pathogens, the differences between pathogenic and nonpathogenic microorganisms, and the specific factors required for virulence must each be defined with regard to its relevance to the host. This chapter addresses two general issues about the evolution of microbial pathogenesis. First, we consider the differences between the genomes of pathogenic and nonpathogenic bacteria, the specific types of genes that contribute to the virulence phenotype, and the evolutionary history of these sequences in the genome of pathogens. Next, we discuss the molecular population genetics of microbial pathogens and the factors that govern the organization of genetic diversity within these populations. Because the origins and genetic bases of virulence influence the population structure of pathogens, these topics are interconnected and broadly relevant to the emergence, outbreak, control, and prevention of the diseases caused by microbial pathogens.
//. Thie Genetic Basis of Virulence One way to gain insight into the specific factors contributing to virulence has been to identify the genetic differences between pathogens and closely related nonpathogenic bacteria. In this regard, there are potentially four types of genetic events that might be responsible for the differences in pathogenic potential among related bacteria: (1) virulence as a result of genes specific to the pathogen; (2) virulence as a result of the absence of a suppressor locus in the pathogen; (3) virulence as a result of allelic differences between genes shared by the pathogen and nonpathogen; and (4) virulence as a result of the differential regulation of the same complement of genes in the pathogen and nonpathogen.
1.
VIRULENCE AS A RESULT OF SPECIES- OR STRAIN-SPECIFIC GENES
The most common approach to investigate virulence genes—on both analytical and technical grounds—has been to search for sequences that are restricted to
1.
THE EVOLUTION OF BACTERIAL PATHOGENS
3
pathogenic organisms. Virulence determinants are often acquired through horizontal transfer, which may explain why virulence traits are distributed sporadically among bacterial taxa (Fig. 1) or within some bacterial species (Fig. 2). In many bacterial species, there is an association between species-specific genes and virulence. Pathogenicity islands (or Pai)—i.e., segments of the chromosome that encode virulence genes and are absent from related nonpathogenic bacteria [1-3]—have been identified in pathogenic strains of E. coli [4-6], Shigella flexneri [7, 8, 24], Salmonella enterica [9], Yersinia pestis [10-12], Vibrio cholerae [13], Haemophilus influenzae [14, 15], Helicobacter pylori [16], and Staphylococcus aureus [17]. In each of these cases, a specific chromosomally encoded gene, or cluster of genes, has been implicated in the virulence of the microorganism, and the corresponding region was not present in avirulent strains or related species. Although it has long been known that species-specific regions confer traits that are unique to a bacterial species, the term "pathogenicity island" was first used to describe a DNA segment harbored by uropathogenic strains of E. coli [18]. Further characterization of pathogenicity islands revealed that many were situated at transfer RNA loci, which are commonly used as integration sites for foreign sequences [19]. For example, certain phages detected in E. coli, such as the retronphage (t)R73 [20] and the bacteriophage P4 [21] insert at, or near, tRNA genes, suggesting that pathogenicity islands are often transferred and acquired through phage-mediated events [1, 22]. The frequent insertion of foreign DNA sequences at tRNA genes is presumably due to the high degree of sequence conservation of tRNA genes across species. In fact, there is recurrent use of the
H:
Escherichia Shigella Salmonella Citrobacter Klebsiella Serratia Yersinia Proteus
Fig. 1 Phylogenetic relationships among enteric bacteria showing taxa that are normally capable of invading eukaryotic cells (denoted with darkened branches).
HOWARD OCHMAN
E. CO//K-12 ETEC0159:H4 EPEC0in:H12 ETEC078:Hn EIEC0n2:NM EPEC0m:H12 ECOR 5 EC0R6 ECOR 10 ECOR 14 (UTI)
-
ECOR27 ETEC0148:H28
EIEC0124:NM • Shigella flexneri Shigella boydii Shigella flexneri ETEC0159:H4 I ECOR 69 ' ECOR 30
LT ^
J ECOR 70 I ECOR 58 EIEC028:NM
ECOR 38
ECOR 61 ECOR 62 (UTI) ECOR 52 ECOR 64 (UTI) ECOR 59 ECOR 66 EPEC055:H6 Shigella sonnei I ECOR 50 (UTI) ^ 1 FPOR 4q ECOR 49
EHEC0157:H7 ECOR 37 Fig. 2 Relationships among commensal and pathogenic strains of Escliehchia coli and Shigella spp. based on nucleotide sequences of the gene encoding malate dehydrogenase (adapted with permission from Pupo et al. (1997) [56]). Abbreviations are as follows: UTI = urinary tract infection; EHEC = enterohemorrhagic E. coli; EIEC = enteroinvasive E. coli; EPEC = enteropathogenic E. coli; ETEC = enterotoxigenic E. coli. ECOR strains are from the E. coli reference collection [100], and the 0:H serotypes of pathogenic E. coli are noted.
tRNA^^^^ locus, which is targeted by (\>R\13 and as the integration site for several pathogenicity islands: Pai-1 of uropathogenic E. coli [4], the LEE island of enteropathogenic E. coli [23], the SHI-2 island of Shigella flexneri [8, 24], and the SPI-3 island of Salmonella enterica [25] each represent independent insertions of different virulence gene clusters into similar chromosomal locations. Flanking many pathogenicity islands there are signature sequences, such as short direct repeats, reminiscent of the integration of mobile elements (or even, in the case of Yersinia pestis, copies of the IS elements themselves) further attesting that these species- or strain-specific regions can be acquired laterally through a variety of transfer mechanisms. Although research on pathogenicity islands focuses on chromosomally encoded regions, genes involved in bacterial virulence are also carried on extrachromosomal elements that are maintained within the genome of pathogens. For example.
1.
THE EVOLUTION OF BACTERIAL PATHOGENS
5
many of the genes required for Shigella virulence reside on a 220-kb plasmid [26, 27], and, similarly, all virulent strains of Yersinia harbor a 70- to 75-kb plasmid that encodes proteins necessary for their antihost properties [28, 29]. In this regard, the acquisition of plasmid-borne antibiotic resistance genes will also allow previously sequestered pathogens to exploit new hosts. Other virulence determinants in these enteric species have been acquired by the organism in phage-mediated events. For example, the cytotoxins first characterized in Shigella are encoded on a bacteriophage that has subsequently been transferred to enterohemorrhagic strains of E. coli [30, 98]. In the case of Vibrio cholerae, two coordinately regulated factors contribute to virulence: cholera toxin, which is encoded by a filamentous bacteriophage (termed CTX(t)) related to the coliphage Ml3 [31], and the toxin-coregulated pili, which is encoded within a large pathogenicity island. This pathogenicity island of Vibrio cholera is in itself another filamentous bacteriophage [32], and this demonstrates a novel case where one horizontally acquired phage encodes the receptor for the products specified by a second phage, both of which are required for full virulence.
2.
VIRULENCE RESULTS FROM THE ABSENCE OF A SUPPRESSOR LOCUS
Similar to the mechanisms described above—whereby a microbe has acquired certain genes that render it virulent—it is also possible that the pathogen has either lost a gene encoding a product capable of diminishing its virulence potential, or that such a determinant was acquired by the related avirulent forms. An early example of a virulence suppressor in enteric bacteria is the surface protease OmpT, which is absent from the genomes of Shigella and enteroinvasive E. coli (EIEC). The presence of ompT results in attenuation of virulence because the encoded protease interferes with expression of the VirG protein, which is required for intercellular spread [33]. The ompT gtUQ is probably not ancestral to enteric bacteria: it is located within the 21-kb cryptic lambdoid phage, suggesting that avirulent strains of E. coli acquired ompT through horizontal gene transfer. In addition to lacking ompT, Shigellae are also devoid of genes whose products suppress virulence. Representatives of the four species of Shigella, as well as enteroinvasive strains of E. coli (Fig. 2), harbor deletions for the region containing cadA, which encodes lysine decarboxylase. When the cadA gene from an avirulent strain of E, coli was introduced into Shigella flexneri, the resulting strain was still able to invade cells in tissue culture, but did not exhibit the toxic effect that induces the fluid secretion normally associated with infection. In contrast to the situation where a microorganism gains genes that enhance its pathogenic potential (i.e., pathogenicity islands), these regions have been termed "black holes" to denote deletion of genes that reduce the pathogenic potential of an organism [34].
6
HOWARD OCHMAN
3.
VIRULENCE RESULTS FROM ALLELIC DIFFERENCES
BETWEEN HOMOLOGOUS GENES
Because pathogenic and nonpathogenic have often diverged in sequence, it is possible that the differences in pathogenic properties result from allelic variation in homologous genes due to nonsense or missense mutations. For example, point mutations in the fimH gene of E. coli can change the binding of fimbrial adhesins and confer increased virulence in the mouse urinary tract [35, 36].
4.
VIRULENCE RESULTS FROM THE DIFFERENTIAL REGULATION OF THE SAME COMPLEMENT OF GENES
In addition to genetic polymorphisms among bacterial strains and species, it is possible that the differences in pathogenic properties are caused by differential regulation of essentially the same set of genes. For example, the invasion gene complexes of S. enterica and S. flexneri are largely homologous, but controlled by very different environmental signals: invasion in S. enterica is regulated by oxygen tension [37], whereas the expression of virulence genes by Shigella is controlled by temperature [38]. The origin of virulence properties in many pathogenic species is likely to result from a combination of the factors presented above. For Shigella and enteroinvasive E. coli, it is clear that virulence is the result of the incorporation of a large virulence plasmid into a strain lacking the ompT gene and the deletion of cadA from their genomes. And while the virulence genes on the Shigella and EIEC plasmids are 99% identical, these species exhibit large differences in their median infective doses, which could be due to allelic variation or to differential regulation of homologous genes or to species-specific chromosomal genes. Also note that these types of genetic changes do not pertain to the analysis of most opportunistic or newly emerging pathogens. Because these microbes are displaced to nonstandard hosts, tissues or environments, the genes contributing to virulence are not preadapted to the host and are not likely to differ from the repertoire required for growth in their customary environments.
///. Identification of Sequences Invoived in Bacterial Pattiogenesis From the previous discussion, it is obvious that most of the differences in pathogenic potential among related bacteria are due to changes in gene content (mechanisms 1 and 2) rather than to changes in the ancestral genes themselves (mechanisms 3 and 4). Although the specific approach, as well as technical
1.
THE EVOLUTION OF BACTERIAL PATHOGENS
7
considerations, bias the identification of the particular genetic events and the recovery of genes involved in virulence (see below), the vast majority of traits that are unique to a species are encoded on segments of the genome that arose through horizontal transfer [39]. Stepwise mutational changes in existing genes only rarely confer novel functions, whereas traits encoded by acquired DNA will occasionally confer the ability to explore new hosts or environments and can have a large impact on bacterial evolution [40]. As a result, none of the phenotypic characteristics that distinguish E. coli from S. enterica are attributable to the divergence of homologous genes by mutation; instead, all of the species-specific traits derive from functions encoded by horizontally transferred genes (e.g., lactose utilization, citrate utilization, indole production) or from the loss of ancestral DNA (e.g., alkaline phosphatase) [39]. The broad association of species-specific traits with unique portions of the chromosome does not imply that all (or even the majority of) genes contributing to the virulence phenotype are restricted to pathogens and absent from the related nonpathogenic bacteria. The classification of genes as being involved in pathogenesis depends largely on the particular approach used to define and identify these factors [41]. The traditional approach to recognizing virulence determinants was purification of microbial products, which, upon introduction into a susceptible host, produced some of the symptoms advanced by the whole organism. This biochemical approach resulted in identification of a variety of factors, usually toxins, produced by several pathogens such as Vibrio cholerae and Clostridium botulinum. The classical bacterial genetics approach defines virulence genes as those that, on mutation, give rise to strains with median lethal doses (LD50) higher than that corresponding to the wild-type parent [42]. This interpretation of virulence includes all relevant loci—apart from those essential for growth under laboratory conditions—without assumptions about the precise role that particular virulence determinants play in the pathogenicity of the microorganism. The molecular genetic approach is used to isolate virulence genes based on their capacity to confer certain pathogenic properties on normally benign strains, such as E. coli. A prime example of this approach was the recovery of DNA segments contributing to the invasive character of Yersinia by selecting for clones that could render an E. coli laboratory strain capable of eliciting its uptake by epithelial cells [43]. Similarly, the introduction of a plasmid containing the LEE island into a laboratory isolate of E. coli creates strains that produce attachment and effacing lesions in host cells [23]. It is not surprising that these three strategies have led to the recovery of somewhat different subsets of genes involved in pathogenesis. However, if virulence is to be characterized in terms of the consequences of bacterial infection on the health of the host, the classical bacterial genetics approach—whose aim is to identify all genes that affect host fitness—provides the most comprehensive definition of virulence genes.
8
HOWARD OCHMAN
Given this perspective on bacterial pathogenicity, many of the "virulence" genes required for propagation of pathogens within a host would be identical to those required in commensal or benign interactions with hosts. In fact, the molecular genetic experiments, which attempt to convert nonpathogenic E. coli into pathogens, suggest that E. coli, as normal constituents of the human intestinal flora, already contain genes necessary for interaction with animal cells and are, thus, predisposed to become pathogens on acquisition of a particular virulence gene cluster. In addition, many of the genes implicated in Salmonella virulence are also present in nonpathogenic strains of E. coli [9]. These genes encode enzymes responsible for the biosynthesis of nutrients that are scarce within host tissues, transcriptional and posttranscriptional regulatory factors, proteins necessary for the repair of damaged DNA, and products necessary for defense against host microbicidal mechanisms. The presence of these genes in nonpathogenic species suggests that they promote survival within the nutritionally deprived and/or potentially lethal environments that microbes encounter inside and outside animal hosts.
IV. Recovery of Genes Contributing to Virulence Although the identification and isolation of virulence genes largely depends on how these genes are defined, many pathogens require genes that are absent from related nonpathogenic bacteria. Therefore, several researchers have applied molecular and genetic techniques to recover segments of the genome that are specific to particular bacterial lineages. These procedures yield anonymous DNA fragments and have been typically employed to obtain diagnostic probes for the identification of particular bacterial strains or species [44-49]. However, in a few cases, these techniques have been exploited to find new pathogen-specific genes having a potential role in virulence. A subtractive hybridization procedure [50] was used to recover DNA sequences present in an avian pathogenic strain of Escherichia coli but absent from a nonpathogenic laboratory strain of Escherichia coli K-12 [51]. The pathogen-specific sequences recovered by this method mapped to at least 12 positions in the chromosome. Subsequently, the phenotype of mutant strains harboring deletions for each of these unique fragments was tested, and two were found to contain genes required for virulence in avian hosts. Other studies have examined the unique DNA in the genome of pathogens, but have yet to directly assess the function of these sequences. For example, a subtractive hybridization procedure used to examine the differences in gene content among strains of Helicobacter pylori yielded 18 clones, several of which were presumed to have a role in the
1.
THE EVOLUTION OF BACTERIAL PATHOGENS
9
specific virulence characteristics of H. pylori strains [52]. Although genome subtraction and physical mapping techniques allow one to identify and clone the differences between two genomes, there is usually no rapid way to determine if these pathogen-specific sequences are indeed relevant to pathogenesis. A thorough review of the strategies used to identify virulence determinants is presented in the chapter by Camilli et al. in this book (see Chapter 4).
V. The Population Genetics of Pattiogens What is the genetic structure of pathogen populations, and how much genetic variation is present in these populations compared with that in related nonpathogenic microorganisms? Moreover, what is the apportionment of genetic diversity among pathogenic strains in relation to that in species at large? Although there are several genetic mechanisms by which microorganisms change their pathogenic potential, it has become evident that the bacteria responsible for disease outbreaks are distinct clones that are frequendy characterized by unique combinations of virulence genes or of alleles at virulence genes. The situation is not as clear for pathogenic species, principally because the classification of a pathogenic "species" is somewhat arbitrary, and historically reflects the ability of epidemiologists to classify strains. On one hand, pathogens have been overclassified—that is, they are typed into a multitude of genetically narrow groups or species—compared to nonpathogens. This is probably judicious, given the importance of assigning an identity of each isolate implicated in human disease. For example, based on serological characteristics, the Salmonellae were assorted into thousands of distinct species (now termed serovars), but a recent taxonomic revision based on DNA-DNA hybridization reclassified these strains into a single species. Salmonella enterica [53, 54]. Similarly, the Shigellae have traditionally been subdivided into four species—Shigella boydii, S.flexneri, S. dysenteriae, and S. sonnei—although the total amount of genetic variation within this genus is contained within E. coli [55-58]. The classification of Shigellae based on serologic and metabolic characteristics illustrates two additional points. First, the amount of diversity can vary widely among species: while Shigella sonnei consists a single genetically uniform clone, each of the other three species comprises a heterogeneous array of clones. Second, the classification of strains does not always reflect their true genetic similarities or relationships. As shown in Figure 2, certain strains of S. flexneri can be more closely related to S. boydii than to any other strains typed S. flexneri, and evidence from other studies have shown that Shigella boydii and S. dysenteriae have multiple origins from within E. coli [55-58].
10
HOWARD OCHMAN
In contrast to these enteric pathogens, the classification of strains into other pathogenic species is more liberal and diffuse, due, in part, to the inability to rapidly differentiate among isolates that display a diagnostic phenotype or produce a specific pathology in hosts. However, the subsequent analysis of such species using additional genetic and/or phenotypic markers often reveals the true nature of the diversity and the relationships among strains.
VL Studying Bacterial Popuiation Genetics Studies addressing the genetic structure of bacterial populations began relatively recently [59, 60] by evolutionary geneticists who had originally examined the amount and distribution of genetic variation among natural populations of eukaryotes. Bacteria, particularly E. coli and Salmonella, were an attractive group of organisms on account of their phenotypic diversity, haploid chromosomes, large populations sizes, short generation times, and ease of propagation and experimental manipulation. Hence, bacterial population genetic research was originated by population geneticists interested in bacteria, rather than by bacterial geneticists or medical microbiologists interested in population genetics. The information gathered by population geneticists has broad implications for medicine and epidemiology, and these studies typically go beyond the simple identification of strains and address questions pertaining to their genetic relationships and their levels of allelic diversity [61, 62]. Numerous molecular techniques—such as RAPDs, IS (and other repetitive element) fingerprinting, ribotyping, phage typing, macrorestriction mapping by pulsed-field gel electrophoresis, and plasmid profile analysis—have been applied to establish the identity of strains for the epidemiological purposes. But these methods typically do not supply the information necessary to establish the relationships among strains, infer the genetic structure of natural populations, or assess the relative roles of natural selection, random drift (i.e., the change in gene frequencies caused by the chance event of random sampling in small populations), new mutations, and horizontal gene transfer (including intragenic and intergenic recombination) on the organization of allelic diversity [63]. Once the evolutionary relationships of clones of a species is available, it is possible to examine the manner in which the total genetic diversity is apportioned with respect to host species, geographic populations, and the specific disease pathology. The following methods have been applied to establish the evolutionary relationships and genetic structure of bacterial populations.
A.
Muitilocus Enzyme Electrophoresis
Multilocus locus enzyme electrophoresis (or MLEE) has been the primary method used to assess genetic variation in bacterial populations [64]. The main advantage
1.
11
THE EVOLUTION OF BACTERIAL PATHOGENS
of this technique is that many genes can be readily examined in hundreds, if not thousands, of isolates. However, this method rehes on the discrimination of alleles of distinct electrophoretic mobilities—also called allozymes or electromorphs in this context—and, therefore, can detect only a portion of the sequence variation at a locus (Fig. 3). The key concept underlying the use of MLEE in population genetics is that the electromorphs can be direcdy equated with alleles of the corresponding structural gene and that electromorph profiles over the sample of different enzymes (frequently termed electrophoretic types or ETs) correspond to multilocus chromosomal genotypes [65]. The proteins assayed by this method are usually metabolic enzymes, such as those involved in glycolysis, which are expressed in all isolates of strains, and the allelic variation is unaffected by environmental conditions, including host, culture medium, or laboratory storage. Moreover, the allelic variation detected at these enzyme loci is selectively neutral, or nearly so, such that there is minimal convergence to the same allele through adaptive evolution [66-68]. Hence, this technique provides a rapid way to index the overall levels of genetic diversity at numerous loci throughout the chromo-
B
ISOLATE
Electrophoretic types (ETs) ET
ABCDEFGHI PGI
1
A
3
1
2
5
3
2
H
3
1
2
6
3
c D E F 6
2 2 2 2 2
1 1 1 1 1
3 3 3 3 3
2 2 2 2 2
1 1 1 1 1
4
B
1
1
4
4
2
5
I
2
1
1
1
1
3
G3P
AGO
IDE
PEP
PGI G3P ACO IDH PEP
1 2 3 4 5
Fig. 3 Multilocus enzyme electrophoresis (MLEE). (A) Supematants extracted from individual bacterial cultures (A-I) are extracted, electrophoresed through a support matrix, and selectively stained to detect the product of a specific enzyme locus (e.g., PGI). (B) Allelic variants (a.k.a. electromorphs) at each locus are numbered and cumulatively form the basis of the electrophoretic type (ET) of the isolate. (C) Relationships among isolates can be visualized as a dendrogram, constructed from a matrix of pairwise differences between the allelic profiles of the isolates. Reprinted with permission from and through the courtesy of Dr. Thomas Whittam.
12
HOWARD OCHMAN
some and to infer genetic relationships among strains. Because the number of alleles at a locus is fairly large in bacterial populations, we expect that recombination would, by chance, only rarely generate strains of identical multilocus chromosomal genotypes. Therefore, strains of the same ET are considered to be similar by descent and shared ancestry. Over the past two decades, MLEE has become established as the standard procedure for assessing genetic variation in bacterial populations and the one against which the discriminatory power of all other techniques is measured.
B.
DNA Sequencing
Although MLEE offers a rapid and inexpensive way to appraise the genetic variation in bacterial populations, many laboratories have turned to directly sequencing the genes specifying several of the enzymes originally indexed by MLEE or the genes encoding proteins involved in virulence. In contrast to MLEE, nucleotide sequencing offers a means of uncovering all of the allelic variation at a locus and detecting events of intragenic recombination. Moreover, nucleotide sequences are composed of discrete characters—i.e., the four bases—as opposed to MLEE, which can only provide the relative mobilities of electromorphs. This allows for the unambiguous identification of alleles, and for comparison and portability of data, from different studies and laboratories. Furthermore, the use of PCR to generate sequencing templates permits the analysis of noncultivable organisms. Although nucleotide sequencing provides the most complete information about the genetic variation and relationships among strains, it is still relatively cosdy and time consuming, especially for the analysis of variation at several loci in a large number of strains. And in many applications, the level of variation detected by MLEE has been sufficient to answer all but the subdest questions about the genetic diversity and structure of natural populadons.
C.
Multilocus Sequence l o p i n g
Maiden et al [69] have devised a method for the identification and typing of bacterial clones based on the determination of sequences of several gene fragments (Fig. 4). Multilocus sequence typing (MLST) exploits the advantages of nucleodde sequence data, but also constructs chromosomal genotypes, which can be used to detect intergenic recombination in the manner of MLEE, through an analysis of multiple chromosomally encoded loci [70]. In the initial application of MLST, the nucleodde sequences of PCR-amplified fragments from 11 housekeeping genes were obtained for more than 100 isolates oi Neisseria meningitis. For MLST, the gene fragments (i.e., alleles) are 400 to 500 nucleoddes in length—a convenient size for the direct automated sequencing of a DNA fragment
I.
13
THE EVOLUTION OF BACTERIAL PATHOGENS
Chromosomal DNA
Amplify -450-bp fragments of several (7-10) house-keeping genes
Sequence gene fragments on both strands
Compare sequences of each gene fragment with the known alleles at the locus
Assign alleles at the loci to give the allelic profile
Compare the allelic profile with those of isolates within a central database via the internet
Fig. 4 Multilocus sequence typing (MLST). The method for allocation of the allelic profile, or sequence type (ST), of a bacterial isolate is shown. As in MLEE, the relationships among isolates can be visualized as a dendrogram, constructed from a matrix of pairwise differences between the allelic profiles of the isolates. Reprinted with permission from Spratt (1999) [70].
with a single primer—and each unique combination of alleles over loci is referred to as a sequence type (ST). As the number of sequencing facilities increase, and the costs of DNA sequencing fall, MSLT is certain to become the method of choice for assessing variation in bacterial populations.
VIL The Orgonization of Genetic Diversity in Pattiogenic Microorganisms Early studies on microbial pathogens, particularly enteropathogenic E. coli [71, 72], suggested that very few clones, as identified by serotyping, were associated with disease outbreaks. Subsequent analysis using MLEE provided the first indication that the species E. coli as a whole was clonal, as evident from the repeated recovery of strains of the same chromosomal genotypes from different
14
HOWARD OCHMAN
times and geographic locations [60,73]. Three generalizations have emerged from the broad-scale application of MLEE to the study of common human pathogens [61, 63]. First, most species of bacteria are highly polymorphic for electrophoretically detectable alleles at each enzyme locus, such that a typical locus may have 10 to 20 electromorphs. Second, despite harboring large amounts of genetic variability, most bacterial species are clonal and consist of a relatively small number of genotypes. This implies that rates of recombination between genetically distinct clones, which would serve to generate new combinations of alleles over loci, must be very low. Finally, in most pathogenic species, only a very small proportion of clones promotes most of the disease worldwide (which indicates large differences in virulence among strains). Furthermore, the same clones that cause disease can be recovered over long periods of time.
VIIL Population Genetics of Representative Bacterial Pattiogens Having considered the connections among the molecular, genetic, and evolutionary perspectives on bacterial virulence, we can now turn our attention to the population genetic analysis of specific pathogens. Most of the information summarized below is based on data obtained through the application of MLEE; however, for several organisms, we can also integrate information on the relationships and diversity among strains, as achieved through the analysis of DNA sequences. The species are discussed in alphabetical order (with the exception of Shigella, which, based on its proper taxonomic position, is included within E. coli), and the key characteristics of their genetic variation and population structure are summarized in Table I.
A.
Bordetella
Bacteria belonging to the genus Bordetella are of primary importance in pediatric and veterinary medicine because of their ability to colonize the epithelium of the respiratory tract of a variety of vertebrate hosts, there causing bronchial and pulmonary pathology (see Chapter 13 herein, by Cotter and Miller). Based on phenotypic characteristics, the genus Bordetella nominally consists of four species: B. pertussis, an obligate human pathogen causing whooping cough, B. parapertussis, which has been isolated from humans and sheep, B. bronchiseptica, which is the etiologic agent of canine kennel cough, and B. avium, which causes respiratory disease in fowl. These four species have been further subdivided on the basis of serology and biotyping; however, evidence from MLEE indicates that
in
O
C
6^ •is
o
S -B
^
•6 £
d d
O
OO lO
'^ O m m o r^
( ^ Os 'd^ fS lO Tt Tt ON
o d d
m v^ \D
_
.
. _
r-oor-o
?3 a
-C2 ^
;^
CJ-"^
CO ^
(N Q
—' —« Tj-
0 o -^ c -^ 01 (N
r-iorsio—'
-
T
^ £ w
2S ^
ov
^
C C - C i l
»0 rf rf 00 (N — IT) r - O -^ r-i (N CM ^ ^
Ov »n r^< rr-i f<-, Tt -^ r f r*~j m
^ > X > ^
o»or-~rNir^
d> d> d> d: d: d d> d d> d>
\ iou-)Tt
Ov O r«-i
c lo (N -^ —I ^
-HooOrn
^ ^ ^ X X ? ^
*:
•o O C c -^ "^ £ ^ 2 ^3 Q.
m rsj O r- -^ m S rs —* 00 so
aNOv-)'Q„
::c :::
: ^ u -: -ii i o ^ •2 I "S E ^•5 1.5^:5 1 kj
-d
S
Si 2i C/5
3
JJ -a
15
o
i1 t^-
-c
o
u 4>
u X)
60 C
ito-
2^ 0
>
cd U
^ .«
.„"•
"^ co 3 > X)
o
^ S
i;o
H
'1
^ Si
8
E
o 1
3 C
o u
ui
E
li^ o a> c rt
^
3
c
C/5
CO
£
00
2i
£ bO O
c
i^ TD OJ
"o t^
C 1)
^
a.
"^. >.••6 U
'•B
o ' ^ =>o 5« 3 £
5^ ^ ^ -a
«:s
O
.2
^
c o
CO
§' ^
H- ^
.5^ E
tao
I-
° -a
i o
-1/35 ^
£ ^
^ O t - r » -
l.i
c
^ x: S o i^
(+_ .r' o
53 o p X
E Z
o
o *=>
^
r^i^H-O
16
HOWARD OCHMAN
from an evolutionary genetic standpoint B. pertussis and human isolates of B. parapertussis should be considered clones of B. bronchiseptica that adapted to the human host relatively recendy [74]. Furthermore, many electrophoredc types (ETs) within each species are strongly host adapted. For example, ETs 22 through 26 of B. parapertussis are confined to sheep, while B. parapertussis FT 28 and the four ETs of B. pertussis are only recovered from humans [75]. Although laboratory experiments have shown the Bordetellae to be naturally competent and capable of recombinadon, their populadon structure is predominandy clonal, with several of the same ETs recovered from different localises and at different dmes. While there is no evidence of gene exchange between distandy related strains, recombinadon occurs among some of the more closely related strains with broader host ranges [75].
B.
Borrelia
The spirochete Borrelia burgdorferi is the causal agent of Lyme disease and is transmitted to humans and animals by the bite of infective Ixodes dcks [76]. In humans, the clinical features of Lyme disease progress from a rash and flu-like symptoms to arthritis, cardids, and neurologic disorders; this pathology was first described in Europe several decades ago. Based on genetic criteria, strains from Europe, Asia, and the United States that were originally classified as Borrelia burgdorferi (sensu lato) were reassorted into a complex of at least four highly divergent species—B. burgdorferi (sensu stricto), B. garinii, B, afzelii, and B. japonica—and there are likely to be additional species in other geographic regions [77-79]. Among the ETs defined by MLEE, there were highly nonrandom associations of alleles over the chromosome (i.e., linkage disequilibrium), indicating a clonal population structure. All isolates from the United States (including the type strain from Shelter Island, New York isolated in 1982) and many from west-central Europe formed a monophyletic clade of lineages descended from a single common ancestor, which is presendy considered B. burgdorferi sensu stricto [77]. In addition, comparisons of the branching orders of phylogenetic trees based on the DNA sequences of two chromosomally encoded genes (fla and p93) and a plasmid-bome gene (ospA) provide no evidence of lateral gene transfer—again indicating that Borrelia burgdorferi (sensu lato) is strictly clonal—and that plasmid transfer between clones is very rare [80]. Recent analysis of the two outer surface lipoproteins encoded by ospA and ospC within Borrelia burgdorferi (sensu stricto) revealed a strong association between ospA and ospC alleles [81], despite the fact that these genes are encoded on separate plasmids. The ospC gene is highly variable, and even in local populations there are large numbers and high frequencies of divergent alleles, as expected if the diversity is maintained through some form of selection acting to maintain
1.
THE EVOLUTION OF BACTERIAL PATHOGENS
17
variation in the population. Furthermore, the geographic distribution of opaC alleles confirmed that Borrelia burgdorferi (sensu stricto) originated in the United States and only recendy spread to Europe [81],
C. Escherichia coli and Shigella Although typically a benign consdtuent of the mammalian intestinal flora, E. coli is occasionally an infecdous agent responsible for several human diseases. Unlike many of the pathogenic microbes discussed so far, most information on the evoludonary and population genetics of E. coli was obtained from studies of ''wild" strains from healthy hosts. And for the past 20 years, the genedc structure and level of variadon observed in these commensal populations of E, coli have served as the basis for interpreting results from pathogenic and nonpathogenic bacteria alike [82]. Given that the organization of genetic diversity is known for natural populations of E. coli isolated from a wide range of sources [83], we can begin to ask questions about the emergence of pathogenic strains and the extent of genetic variation in pathogenic strains of E. coli. Strains of E. coli have been tradidonally typed on the basis of polymorphism in their O (somatic), K (capsular) and H (flagellar) antigens [72, 84]. Despite more than 1000 combinadons of antigens of the O, K, and H groups, certain serotypes were repeatedly associated with certain diseases, providing the first indication that E. coli populadons were clonal [85, 86]. Enteropathogenic E. coli (EPEC) (see Chapter 9 herein, by Puente and Finlay) were first idendfied from outbreaks of infantile diarrhea in Great Britain nearly 50 years ago [87]. The EPEC strains constitute very few serotypes, many of which are represented by a single temporally stable, and geographically widespread, clone [88]. Based on MLEE, the EPEC strains form two clonal complexes, each possessing the plasmid-borne adherence phenotype and distandy related to other pathogenic E. coli [89]. In the early 1980s, there were several outbreaks of hemorrhagic colids associated to the rare E. coli serotype 0157:H7, the so-called Jack-in-the-Box strain [90, 91]. These isolates are serologically distinct from the EPEC strains, and over the past decade there have been numerous outbreaks of hemorrhagic colitis and hemolytic uremic syndrome in North America and Asia linked to a variety of foodstuffs [92-94]. The virulence characteristics of enterohemorrhagic E. coli 0157:H7 derive from several sources: strains produce one or more forms of Shiga cytotoxin, contain a 92-kb virulence plasmid (plus a 3.3-kb plasmid in Japanese strains) and harbor a 43-kb pathogenicity island conferring the ability to evoke attachment and effacing (A/E) lesions [95-98]. MLEE was used to determine the reladonships of enterohemorrhagic E. coli 0157:H7 isolates to one another and to other strains causing enteric infections. A majority of 0157:H7 strains belong to a clone complex that is only distantly
18
HOWARD OCHMAN
related to other Shiga-toxin-producing strains of E. coli or to other ETs of the 0 1 5 7 group causing enteric infections in animals [99]. The 0157:H7 clone is most closely related to strains 0 5 5 :H7, also capable of producing A/E lesions. The most hkely hypothesis for the origin of 0157:H7 is that it emerged from an 055:H7 progenitor after acquiring the phage-encoding Shiga toxins and plasmid-encoded adhesins through horizontal transfer [89]. An alternative approach to studying the evolutionary genetics of virulence in E. coli has been to examine the phylogenetic distribution of pathogenic strains in relation to the species as a whole. To index the degree of genetic diversity and relationships among strains from natural populations of E. coli, most researchers have relied on the ECOR collection, which includes 72 strains originally selected to encompass the range of genetic variation in the entire species [100]. Based on MLEE [101] and on the nucleotide sequences of several genes [102], the phylogeny of ECOR strains consists of four major subgroups (A, B l , B2, and D), and the characterization of the ECOR collection by most other techniques has yielded essentially the same groupings [83, 103]. From such studies, it is clear that pathogenic strains do not form a phylogenetically distinct group, nor do they have a single evolutionary origin within E. coli [56, 104, 105]. In addition, strains of E. coli are predisposed to become human pathogens on the disruption of chromosomal genes and/or the acquisition of additional plasmids, phages, or pathogenicity islands. Yet, some generalizations can be made: commensal strains of E. coli are principally within subgroups A and B1 (and these strains typically lack virulence determinants), whereas many of the genes associated with pathogenic isolates of E. coli are prevalent among ECOR strains in subgroups B2 and D [106, 107]. Despite the tendency for pathogens to be related to commensal strains in certain subgroups and the phylogenetic clustering of certain virulence-associated genes, there are pathogenic isolates in each of the E. coli subgroups. In a comprehensive analysis of the relationships between nonpathogenic (as represented by ECOR) and a variety of pathogenic strains of E. coli, analysis by MLEE and mdh (malate dehydrogenase) sequences shows that enteropathogenic (EPEC), enterotoxigenic (ETEC), enteroinvasive (EIEC), and enterohemorrhagic (EHEC) strains were distributed among the ECOR subgroups [56]. Shigella is the etiologic agent of bacillary dysentery and has long been known to be closely related to E. coli (see Chapter 8 herein, by Sansonetti et al). Although classified into a separate genus, the four subspecies of Shigella constitute lineages that actually fall within the range of variation detected in E. coli [55-58]. Strains of Shigella sonnei form a single clone that has remained virtually unchanged for at least the past 40 years [108], but each of the other Shigella species have multiple independent origins from within E. coli (Fig. 2). Based on genetic criteria, the Shigellae should not be considered species separate from E. coli, and, like other agents of enteric disease, they appear to be secondarily derived from commensal strains of E. coli.
1.
D.
THE EVOLUTION OF BACTERIAL PATHOGENS
19
Haemophilus
Isolates of Haemophilus influenzae have traditionally been serotyped on the basis of six chemically distinct polysaccharide capsule types, but many isolates are unencapsulated and, hence, untypable (see Chapter 14 herein, by Tang et al). These unencapsulated forms are generally noninvasive, but encapsulated strains are invasive; and, in particular, those expressing serotype b are the major agents of meningitis in children. There were originally few useful epidemiological markers for serotype b strains of H. influenzae because most isolates were of identical biotype. However, the application of MLEE to Haemophilus [109-111] provided the first genetic framework for studying the population structure and relationships among strains and species. Like several other pathogens, the population structure of//, influenzae is clonal, with certain ETs distributed worldwide and persisting over long periods of time [109, 112]. Among the encapsulated strains (serotypes a-f), there were two major phylogenetic divisions. Strains producing a and b capsules occur within each of these divisions, most probably as a result of transfer of the serotype-specific capsule genes between lineages [113, 114]. Although serotype a strains are rarely virulent, some have been implicated in cases of septicemia and meningitis. These isolates harbor a "virulence-enhancing" mutation usually detected in type b strains, providing additional evidence of horizontal transfer [115]. Although it was originally thought that unencapsulated forms of //. influenzae would simply represent a subset of the encapsulated strains that recendy lost the polysaccharide capsule, these nontypeable strains belonged to distinct clusters and are, as a group, much more genetically diverse than clones expressing capsuletype b [74, 116, 117]. In general, there is little relationship between ET and particular disease conditions; however, the nonencapsulated strains isolated from healthy carriers were distinct from those causing various diseases [118].
E.
Helicobacter
Nearly half the human population is colonized by Helicobacter pylori, but clinical symptoms, ranging in type from peptic ulcer to gastric carcinoma and lymphoma, manifest in only a very small proportion of those infected ([119]; see Chapter 11 herein, by Cover et al). Although host and environmental factors—such as blood type, cigarette smoking, and gender—affect the risk of gastric ailments [120, 121], strains of //. pylori causing disease contain genetic determinants not found in avirulent strains [16, 122]. As a result, strains have been classified into two groups (type I and type II) that differ in the presence of the cytotoxin-associated gene cagA, which is encoded on a pathogenicity island, and of the vacuolating cytotoxin tox, whose phenotype is controlled by expression of the vacA gene
20
HOWARD OCHMAN
[123]. Type I strains, which represent 60% of all isolates examined, are cagA'^/tox^ and are associated with duodenal and gastric ulceration, while type II strains are cagA~/iox~ and are largely asymptomatic [124-126]. The simple classification of H. pylori as type I or type II does not impart the true extent of genetic diversity within the species as a whole, or the degree of genetic differentiation among strains. Most typing methods can discriminate among isolates from different individuals [127], and minor genetic changes, arising from rearrangements occurring within a lineage, have been detected in samples from a single host [128]. The mean genetic diversity of H. pylori, as assessed by MLEE, exceeded that detected for any other bacterial species examined by this technique [129]. Moreover, the index of association (Z^) value between loci [130] did not differ significantly from zero, implying free recombination within natural populations of H. pylori. Such high levels of genetic exchange obscure the clonal descent and genealogical relationships among strains, and can also impede the use of certain therapies against this pathogen. As a step in the control and treatment of H. pylori infections, the sequence diversity at several virulence-associated loci has been investigated, often in an attempt to identify the association between sequence variants and disease pathology [131-133]. All loci examined display unusually high levels of genetic variability, and in some cases unique alleles have been formed through intragenic recombination [132, 134-137]. In an analysis of the partial nucleotide sequences from two flagellins, flaA and flaB, and from vacA, it was noted that the vast majority of H. pylori strains had unique sequences at all three loci and that approximately 20% of the nucleotide positions were polymorphic in different strains, due principally to changes at synonymous sites [138]. This pattern of substitutions, characterized by high levels of divergence at silent sites but very low levels at nonsynonymous sites, suggests that these genes are under strong selection. Moreover, analysis of these data confirms that recombination is so frequent within H. pylori that the alleles at different loci, as well as the polymorphisms within loci, are effectively at linkage equilibrium [138].
F.
Listeria
Among the species of this genus, only Listeria monocytogenes is commonly pathogenic for humans, causing several invasive diseases including septicemia, meningitis and meningoencephalitis (see Chapter 16 herein, by Fsihi et ai). L monocytogenes have been isolated from environmental sources and a wide variety of raw and processed foodstuffs, particularly dairy products, which has led to the application of numerous techniques for the detection, identification, and epidemiological tracing of strains [139-145]. Based of MLEE, strains of L monocytogenes belong to two major clusters [146-148], and the existence of two primary lineages has been confirmed by ribotyping [149], restriction mapping [150], and DNA sequencing [151]. One cluster contained strains serotyped as l/2a
1.
THE EVOLUTION OF BACTERIAL PATHOGENS
21
and l/2c, and the other included strains of serotypes l/2b, 3b, and 4b; and, except in a very few cases, each ET contained strains typed to only one serotype. Strains recovered from animals and humans were distributed into each of these phylogenetic groups, indicating that there is no genetic differentiation among strains infecting a variety of mammalian hosts. Subsequendy, on the basis of the DNA sequences of several genes, a third evolutionary lineage of L. monocytogenes has been defined [152, 153], and this group comprises strains recovered from animals, but not from humans. Several lines of evidence are consistent with the hypothesis that recombination of chromosomal genes is an infrequent event in natural populations of L monocytogenes. First, there is no overlap in the serotypes of isolates assigned to the two phylogenetic clusters. Second is the nonrandom association of alleles among ETs for many pairs of loci (i.e., linkage disequilibrium). Third is the finding that ETs are very stable, such that genetically indisdnguishable isolates have been recovered in widely separated geographic locations. Despite the large number of clones detected within L monocytogenes, clones typed as ETl have been implicated in disease outbreaks in California and Switzerland, suggesdng that this ET is either very abundant in the environment (or in foodstuffs), or highly pathogenic to humans [147].
G.
Mycobacterium
Despite a steady decline in the incidence of tuberculosis in the United States beginning in the 1950s, there has been an alarming increase in the number of individuals infected by Mycobacterium tuberculosis, and perhaps one-third of the world's population harbor this pathogen ([154]). In spite of this very large population size, the species as a whole displays almost no sequence variation, suggesting that all strains of M. tuberculosis shared a common ancestor an estimated 15,000 years ago [155]. Due to the close reladonships among strains, the epidemiological tracing of M. tuberculosis is typically based on RFLP analysis of a mobile genedc element, IS6J10, which is variable in its copy number and genomic location among strains [156, 157]. Analysis of more than two megabases of sequence data from a total of 26 loci has provided the first comprehensive view of the origin, ancestry, and genetic populadon structure of M. tuberculosis [158]. Unlike most bacterial species that gain antibiodc resistance genes through the acquisidon of plasmids or other elements, the vast majority (>95%) of sequence variation within this species is attributable to nonsynonymous substitutions or other mutations in chromosomal loci that confer resistance to antibiotics. Despite very low levels of neutral sequence variation—in fact, the M. tuberculosis species has the lowest level of nucleotide diversity of any bacterial pathogen—strains could be assigned to three genotypic groups based on combinations of polymorphisms at two sites: codon
22
HOWARD OCHMAN
463 in katG, and codon 95 in gyrA. (These two sites are not involved in antibiotic resistance and, hence, serve as useful genetic markers to examine the evolutionary history and relationships of strains.) All isolates of the predominandy nonhuman pathogens, M microti and M. bovis, and the human pathogen, M. africanum, have the same combination of polymorphisms characteristic of M. tuberculosis genotypic group 1, suggesdng that this genotypic group is ancestral to groups 2 and 3. Because the most ancient group is expected to contain the most variadon, this view of the relationships among the genotypic groups is further supported by the fact the genotypic group 1 contains the most variation in IS6100 copy numbers and in the nucleodde sequences at other loci [158]. Despite the low rate amount of nucleotide sequence diversity, the three genotypic groups of M. tuberculosis have diverged with respect to IS6110 copy numbers. \S6110 profiles can change reladvely rapidly, and in many cases isolates resampled after 90 days from the same patients displayed changes in IS6100 genotype, particularly among strains with greater numbers of these IS elements. And due to reladvely minor changes in the \S6110 fingerprint patterns of strains from single individuals, this variation could not have been produced by reinfecdon by a different strain [159].
H.
Neisseria
Due to the widespread and recurrent epidemics of meningococcal disease, there has been extensive work on the population biology of Neisseria meningitidis (see [160-163] for comprehensive reviews and Chapter 12 herein, by Meyer et al). In general, the variation among strains of Neisseria is generated through horizontal exchange, but epidemics are often caused by the spread of specific genedc variants, which results in clonal replacement. After their descent for a common ancestor, strains rapidly diversify through mutation and recombination [162]. A^. meningitidis are conventionally typed on the basis of capsular polysaccharides, and serogroups A, B, and C account for more than 90% of the cases of meningococcal disease worldwide ([164]). In an early study, it was demonstrated that the European epidemic of serogroup B disease that began in the 1970s was caused by a group of 22 very closely related clones, designated as the ET-5 complex, that have no close genedc relationship to other groups of clones [165]. Clones of the ET-5 complex were also the causative agents of later outbreaks in Africa, South America, Cuba, and the United States (where it was likely to have been introduced by Cuban immigrants). N. meningitidis is carried asymptomadcally in the upper respiratory tract by about 15% of the human population, and the clones isolated from carriers are only rarely represented among those causing disease, showing that certain complexes of clones have a low virulence potendal [166].
1.
THE EVOLUTION OF BACTERIAL PATHOGENS
23
Unlike most other serogroups of N. meningitidis, which are generally associated with endemic disease, isolates of serogroup A are unusual in that they may cause very large epidemics. Among the serogroup A organisms responsible for 23 epidemics between 1915 and 1983, there were 34 distinctive ETs constituting four clone complexes, each representing a group of related clones [167]. Most epidemics were caused by a single clone, and the same clone was responsible for concurrent epidemics in different countries. Clonal analysis has also demonstrated that serogroup A isolates are a restricted phylogenetic subpopulation of the species [168], which probably arose no more than a few hundred years ago [169]. Although recombination produces genetic variation within clone complexes, these results would indicate that only limited amounts of genetic exchange occur between phylogenetically unrelated strains of A^. meningitidis. Sequence analysis of meningococcal genes provides clear evidence that the evolution of N. meningitidis has been characterized by high levels of intra- and intergenic recombination, which is perhaps not surprising for a naturally transformable species. For example, allelic variants of the gene encoding adenylate kinase (adk), whose variation is regularly assayed by MLEE, have a mosaic structure produced by recombination between genes from different strains [170]. Moreover, within and among species of Neisseria, patterns of sequence divergence for adk, recA, aroE (shikimate dehydrogenase), and glnA (glutamine synthetase) are very different [171, 172], and the phylogenetic trees based on each of these genes are not congruent, as expected for species that undergo frequent recombination. Note that even in recombining species, such as A^. meningitidis, the epidemic increase of certain ETs can give the appearance of a clonal population structure despite high levels of gene exchange [130, 173].
I.
Salmonella
Under the original serotyping schemes of White [174] and Kauffman [175], the Salmonellae were assigned to nearly 3000 serotypes or serovars, with each considered a distinct species. However, based on the biotyping and molecular genetic evidence, all strains were subsequently typed as single species, S. enterica, which comprises eight subspecific groups (designated I, II, Ilia, Illb, IV, V, VI, and VII) [176, 177]. Hence, the nomenclature has changed such that Salmonella typhimurium would now be referred to as Salmonella enterica serovar Typhimurium or, simply, Typhimurium. Over 60% of the serotypes belong to subspecies I, including those strains causing >99% of the cases of human salmonellosis (see Chapter 7 herein, by Scherer and Miller). Due to its genetic relationships to the other subspecific groups, subspecies V has recently been reclassified as a separate species. Salmonella bongori [54], and MLEE as well as nucleotide sequence analysis of several genes have confirmed its divergent phylogenetic position [178, 179, 63, 180-182].
24
HOWARD OCHMAN
MLEE was originally used to investigate the allelic variation in genes in large samples of Salmonella [183-189]. The total genetic diversity in Salmonella, as assessed by MLEE, is among the highest reported for any bacterial species (Table I)—nearly twice that observed in E. coli. Clonal aspects of the genetic structure of S. enterica are well illustrated by the serovars Typhi and Paratyphi A, B, and C, all of which are agents of enteric fever in humans. MLEE analysis has demonstrated that there are no close relationships among these serovars, implying independent evolutionary derivation [187, 188]. Typhi is an unusually distinctive and homogenous serovar, and over 80% of the worldwide isolates are of a single ET (with a second ET comprising 16% of strains, all from West Africa). Paratyphi B consists of a large and heterogenous group of lineages that are closely related to Typhimurium. However, the ability of Paratyphi B to cause human enteric fever arose in a single globally distributed clone, and only recendy, since it is only weakly differentiated. The genetic variation and relationships among strains have also been assessed by the nucleotide sequencing of several housekeeping genes, including proline permease (putP) [178], glyceraldehyde-3-phosphate dehydrogenase (gapA) [190], malate dehydrogenase (mdh) [180], 6-phosphogluconate dehydrogenase (gnd) [179], isocitrate dehydrogenase (icd) [191], and isocitrate dehydrogenase kinase/phosphatase (aceK) [192]. For these five housekeeping genes, on average, about 16% of nucleotides and 5% of amino acids are polymorphic. With the exception of gnd, the level of sequence diversity is greater in S. enterica than in E. coli, which is attributable to the unusually high divergence of subspecies V {S. bongori) from the other subspecies. Comparisons of the individual trees based on the nucleotide sequences have revealed several cases in which the branching orders of lineages are not congruent. These disparities are due both to intragenic recombination events, which can involve regions ranging from six basepairs to more than 1 kb, and to the exchange of entire genes [63]. Notwithstanding low levels of recombination at some loci, the relationships among strains based on nucleotide sequences matched those established by DNA hybridization and MLEE. Based on these phylogenetic relationships, serovars that are exclusively or predominantly diphasic (subspecies I, II, Illb, and VI) cluster apart from the monophasic subspecies (Ilia, IV, V, and VII). This suggests that, following the divergence of S. enterica and E. coli from a common ancestor, E. coli evolved as an commensal of mammals while Salmonella remained associated with reptiles, which are still the primary hosts of the monophasic subspecies. Salmonella serovars are typically classified as either monophasic or diphasic based on their ability to produce one or two forms of flagellin. Subsequently, Salmonella evolved as an intracellular pathogen through the acquisition of several pathogenicity islands, which conferred the ability to invade host epithelial cells and circumvent host defenses. The diphasic condition originated in the lineage ancestral to subspecies I, II, Illb, and VI is a mechanism to further evade the host
1.
THE EVOLUTION OF BACTERIAL PATHOGENS
25
immune system and is likely to have assisted in the exploitation of birds and mammals of potential hosts [181]. This scenario is supported by the phylogenetic distribution of pathogenicity islands in Salmonella [193]. The SPI-1 island, which confers the ability to invade nonphagocytic host cells, was acquired very early in the evolution of Salmonella and is present in all subspecies, whereas the SPI-2 island, which is necessary for intracellular proliferation, is absent from Salmonella bongori, which were originally recovered from nonmammalian hosts. This suggests that the evolution of Salmonella as a pathogen has been marked by the acquisition and/or generation of several genes that facilitate interactions with the host [9, 194].
J.
Staphylococcus
The are two notable cases where MLEE has been applied to uncover the evolutionary history of infective strains of Staphylococcus aureus. The first involves strains of S. aureus causing toxic shock syndrome (TSS) in young, healthy menstruating women. Almost all strains of S. aureus recovered from TSS patients express a toxin (designated TSST-1) [195, 196], which is now known to be encoded as part of a 15-kb pathogenicity island present only in TSST-1 -positive strains [17]. The analysis of genetic variation in 315 isolates of S. aureus expressing TSST-1 revealed that toxin production occurs in association with chromosomal backgrounds representing the full breadth of genotypic diversity in the species as a whole, as might be expected for genes encoded on a mobile element [197]. But despite the diversity among strains expressing TSST-1, a single distinctive clone causes the majority of cases of toxic shock syndrome. It is not known whether the present-day distribution of the TSST-1 gene in S. aureus reflects an evolutionarily old association or the independent acquisition of the TSST-1 pathogenicity island by multiple strains. However, these results suggest that the particular clone causing TSS has properties conferring strong affinity for human cervicovaginal surfaces [197]. A second case where MLEE has provided insights into the nature of staphylococcal infections involved strains of S. aureus resistant to the antimicrobial agent methicillin. Soon after methicillin entered clinical use, there were several hospital outbreaks caused by methicillin-resistant S. aureus (MRSA), and these organisms have now achieved global distribution [198]. Methicillin resistance is conferred by the expression of a modified penicillin-binding protein encoded by the mec gene. MLEE was employed to determine the extent of genetic diversity of MRSA strains and the relationships among strains from temporally and geographically separated outbreaks [199, 200]. The mec gene is harbored by many divergent lineages of S. aureus and has spread through multiple episodes of horizontal transfer. Many of the MRSAs recovered from Europe and Africa soon after methicillin was introduced into clinical use in the 1960s were identified as the
26
HOWARD OCHMAN
same ET, suggesting that most early outbreaks were caused by dissemination of a single clone that had acquired the mec gene. However, the association of mec with genetically divergent strains contradicts the idea that all of the extant MRS As descended from a single methicillin-resistant clone [201].
K.
Streptococcus
A study on the diversity and population structure of Streptococcus pyogenes (Group A Streptococcus) was originally undertaken to determine the relationships among strains causing toxic-shock-like syndrome and other invasive diseases [202] (see Chapter 15 herein, by Caparon). Of the 108 strains analyzed by MLEE, there were 33 ETs; but nearly half of disease episodes (including more than 70% of the cases of toxic-shock-like syndrome) were caused by two related clones, designated ETl and ET2. The genetic structure of Streptococcus pyogenes has also been characterized with respect to the nucleotide sequence variation in several genes, including those encoding the scarlet fever exotoxin {speA) [202, 203], serotype M protein (emm) [204, 205] and complement inhibitor (sic) [206], streptokinase (ska) [205], pyrogenic enterotoxin B (speB) [205], C5a peptidase (scp) [205], superantigen SSA(ssa) [207], and hyaluronidase (hyl) [208]. In many cases, horizontal transfer and genetic exchange have contributed to the allelic diversity at these loci, and the phylogenies of strains produced from sequences of individual genes often do not match those based on MLEE. The level of polymorphism in the sic gene in M1 strains of Streptococcus greatly exceeds that observed at any other locus in this species. Moreover, virtually all nucleotide substitutions alter the amino acid sequence of the encoded protein, and all insertions and deletion are in frame [206]. Because the Sic protein functions to inhibit complement, this variability has been ascribed to selection acting to adapt this protein to host factors. Although it has long been known that certain genes of Streptococcus pneumoniae are subject to horizontal transfer and recombinational exchange [30, 209, 211], the population structure and genetic variation of this species has only recendy been assessed. Using MLST, the sequence diversity of strains of S. pneumoniae associated with disease was assessed by examining ~450-bp portions of seven housekeeping genes in nearly 300 isolates [212]. Despite relatively low levels of sequence variation, the numbers of alleles per locus ranged from 18 in aroE to 34 in xpt. Among the 143 STs, 34 contained more than one isolate and 12 included at least five invasive isolates. In 26 of the 34 STs containing multiple isolates, there was a perfect congruence between ST and serotype; however, strains of the same serotype could differ by as many as six of seven loci [212]. Moreover, there was evidence of recombination among loci, and the repeated recovery of identical isolates causing invasive disease in geographically distant regions suggests that certain STs define strains with increased capacity to cause disease.
1.
L.
THE EVOLUTION OF BACTERIAL PATHOGENS
27
Vibrio
Vibrio cholerae is a natural inhabitant of aquatic environments; however, some clones can cause severe diarrheal disease in humans (see Chapter 10 herein, by DiRita). Seven pandemics of cholera have been recorded since 1817, with the sixth pandemic subsiding in 1925 and the seventh beginning in Indonesia in 1961. Although V. cholerae, the causative agent of cholera, has been subdivided into nearly 200 serovars, the number of pathogenic serotypes is small, and all recorded pandemic and epidemic cases have been associated with the 01 serotype on a worldwide scale. Non-01 strains are more frequently isolated from environmental sources but have been implicated in cases of gastroenteritis, septicemia, and meningitis in humans. An outbreak of cholera in India that began in 1991 was caused by an 0139 strain. Toxigenic isolates of V. cholerae are also separated into Classical and El Tor types, which are differentiated on the basis of polymixin sensitivity, hemolysis and hemagglutination activity, phage resistance patterns, and the Voges-Proskauer reaction. The first six pandemics were thought to have originated from Classical strains, and the seventh from an El Tor strain. Based on MLEE, the seventh-pandemic clone is relatively homogenous worldwide. A large group of strains isolated over 30 years from several countries affected by the seventh pandemic constitute a single ET (ET3) [213-215], with isolates from Australia (ETl), the U.S. Gulf Coast (ET2), and Latin America (ET4) each representing a unique type. Among more recently isolated samples of V. cholerae from Latin America, ET4 was still prevalent, but about 10% of strains were of ET3, showing that the recent outbreaks of cholera in this region have originated from introduction of new toxigenic 01 strains. All seventh-pandemic clones have the same sequences for the asd (aspartatesemialdehyde dehydrogenase) gene and the ctxB (toxin) gene [216, 217], suggesting a single origin of this clone. The toxigenic 0139 strain is genetically closely related to the seventh-pandemic strains and presumably evolved from an early seventh-pandemic isolate [218]. But based on ribotyping, it was concluded that several clones, rather than one, caused the seventh pandemic, with one group of representing clones arising in 1961 and found only in Asia, and the other arising in 1966 and spreading worldwide [219]. However, the frequency of genetic exchange between rrn operons is high in seventh-pandemic clones—nine new ribotypes have been detected among 47 isolates sampled over a 33-year period [220]—and this degree of recombination could obscure the relationships among clones that are identified by this method. The original sequencing of asd in isolates of V. cholerae detected three homogeneous, but distantly related, clones representing the sixth-pandemic, seventh-pandemic, and U.S. Gulf Coast clones [218]. The subsequent sequencing of other loci [221] revealed virtually no variation in either the mdh (malate dehydrogenase) and hlyA (hemolysin) genes among sixth-pandemic, seventh-pandemic. Gulf Coast, and 0139 isolates, and these sequences were distinct from
28
HOWARD OCHMAN
environmental, nontoxigenic non-Ol strains. The frequent occurrence of identical gene sequences among pathogenic isolates suggests that these clones are indeed closely related, and that the variation observed at other loci, and in the nontoxigenic isolates, has been generated, in part, by recombination.
IX. Conclusions Infectious diseases caused by microbial pathogens—ranging from plague to tuberculosis—are among the world's leading causes of death. And while investigations into the molecular bases of virulence are underway for numerous bacterial pathogens, all but the most rudimentary information pertaining to the extent and organization of genetic variation, the factors contributing to allelic diversity, and the genetic structure of their populations is available for the majority of these microorganisms. Aside from identifying the forces shaping the extent and organization of genetic diversity in those microorganisms, these findings are also applicable to the choice of procedures used for identification, epidemiology, and control of bacterial pathogens. The identification and classification of a pathogenic species could potentially influence analysis of its genetic diversity and population structure (e.g., if serovars of Salmonella were each considered a separate species, as originally determined on the basis of serotyping, the amount of variation in each would be very different than that presently detected in populations of Salmonella enterica). In addition, the wide variety of mechanisms that generate differences in pathogenic potential among related bacteria will affect the origin of virulence and, hence, the apportionment of genetic diversity in natural populations. Despite these factors, several generalizations have emerged from the population genetic analysis of bacteria. Foremost is that most species of bacteria are highly variable but clonal and consist of relatively small numbers of genotypes. Moreover, only a small proportion of clones cause most of the disease worldwide, implying that there are large differences in virulence among strains. Among the most productive approaches for future research will be the analysis of variation in virulence-associated loci within populations of pathogens since these genes are likely to respond to selective pressures presented by the host. Not only do such studies provide information about the genetic structure of the populations and the factors that contribute to genetic diversity, but also they can identify polymorphisms associated with particular clinical symptoms or disease pathologies. Such analyses will be essential for understanding the endemic and epidemic spread of pathogenic organisms, and for the development of vaccines to abate their effects on human populations.
I.
THE EVOLUTION OF BACTERIAL PATHOGENS
29
References 1. Groisman, E. A., and Ochman, H. (1996). Pathogenicity islands: Bacterial evolution in quantum leaps. Ce//87, 791-794. 2. Lee, C. A. (1996). Pathogenicity islands and the evolution of bacterial pathogens. Infect. Agents Dis. 5, 1-7. 3. Hacker, J., Blum-Oehler, G., Muhldorfer. 1., and Tschape, H. (1997). Pathogenicity islands of virulent bacteria: Structure, function and impact on microbial evolution. Mol. Microbiol. 23, 1089-1097. 4. Blum, G., Ott, M., Lischewski, A.. Ritter. A.. Imrich. H., Tschape, H., and Hacker, J. (1994). Excision of large DNA regions termed pathogenicity islands from tRNA-specific loci in the chromosome of an Escherichia coli wild-type pathogen. Infect. Immiin. 62, 606-614. 5. McDaniel, T K., Jarvis, K. G.. Donnenberg, M. S.. and Kaper. J. B. (1995). A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. U.S.A. 28, 1664-1668. 6. Guyer, D. M., Kao, J.-S., and Mobley. L. T (1998). Genomic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: Distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and catheter associated bacteriuria and from fecal samples. Infect. Immiin. 66. 4411—4417. 7. Rajakamur, K. (1997). Use of a novel approach, termed island probing, identifies the Shigella flexneri she pathogenicity island which encodes a homolog of the immunoglobin A protease-like family of proteins. Infect. Inmmn. 65. 4606-4614. 8. Yokes, S. A., Reeves, S. A., ToiTes, A. G., and Payne. S. M. (1999). The aerobactin iron transport system genes in Shigella flexneri are present within a pathogenicity island. Mol. Microbiol. 33, 63-73. 9. Groisman, E. A., and Ochman, H. (1997). How Salmonella became a pathogen. Trends Microbiol. 5, 343-349. 10. Buchreiser, C., Brosch, R., Bach, S., Guiyoule. A., and Carniel. E. (1998). The high-pathogenicity island of Yersinia pseudotuberculosis can be inserted into any of the three chromosomal asn tRNA genes. Mol. Microbiol. 30, 965-978. 11. Buchreiser, C., Prentice, M., and Carniel. E. (1998). The 102-kilobase unstable region of F^rvm/c/ pestis comprises a high-pathogenicity island linked to a pigmentation segment which undergoes internal rearrangement. J. Bacteriol. 180. 2321-2329. 12. Schubert, S., Rakin, A., Karch, H.. Carniel E.. and Heesemann, J. (1998). Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans. Infect. Immun. 66. 480-485. 13. Karaolis, D. K., Johnson, J. A., Bailey, C. C. Boedeker, E. C. Kaper, J. B., and Reeves, P R. (1998). A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Proc. Natl. Acad. Sci. U.S.A. 95, 3134-3139. 14. Martin, K., Morlin, G., Smith, A.. Nordyke. A.. Eisenstark, A., and Golomb, M. (1998). The tryptophanase gene cluster of Haemophilus influenzae type b: Evidence for horizontal gene transfer. /. Bacteriol. 180, 107-118. 15. Mhlanga-Mutangadura, T, Morlin, G.. Smith. A. L., Eisenstark, A., and Golomb, M. (1998). Evolution of the major pilus gene cluster of Haemophilus influenzae. J. Bacteriol. 180, 4693-4703. 16. Censini, S., Lange, C, Xiang, Z., Crabtree. J. E., Ghiara, P.. Borodovsky, M., Rappuoli, R., and Covacci, A. (1996). cag, a pathogenicity island of Helicobacter pylori, encodes type 1-specific and disease associated virulence factors. Proc. Natl. Acad. Sci. U.S.A. 93, 14648-14653.
30
HOWARD OCHMAN
17. Lindsay, J. A., Ruzin, A., Ross, H. F., Kurepina, N., and Novick, R. P. (1998). The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol. Microbiol. 29, 527-543. 18. Hacker, J., Bender, L., Ott, M., Wingender, J., Lund, B., Marre, R., and Goebel, W. (1990). Deletions of chromosomal regions coding for fimbriae and hemolysins occur in vitro or in vivo in various extraintestinal Escherichia coli isolates. Microb. Pathogen. 8, 213-225. 19. Campbell, A. M. (1992). Chromosomal insertion sites for phages and plasmids. J. Bacteriol. 174, 7495-7499. 20. Inouye, S., Sunshine, M. G., Six, E. W., and Inouye, M. (1991). Retronphage phi R73: An E. coli phage that contains a retroelement and integrates into a tRNA gene. Science 252, 969-971. 21. Pierson III, L. S., and Kahn, M. L. (1987). Integration of satellite bacteriophage P4 in Escherichia coli. DNA sequences of the phage and host regions involved in site-specific recombination. / Mol. Biol. 196, 487-496. 22. Cheetham, B. F., and Katz, M. E. (1995). A role for bacteriophages in the evolution and transfer of bacterial virulence determinants. Mol. Microbiol. 18, 201-208. 23. McDaniel, T. K., and Kaper, J. B. (1997). A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. Mol. Microbiol. 23, 399-407. 24. Moss, J. E., Cardozo, T. J., Zychlinsky, A., and Groisman, E. A. (1999). The ^^/C-associated SHI-2 pathogenicity island of Shigella flexneri. Mol. Microbiol. 33, 74-83. 25. Blanc-Potard, A. B., and Groisman, E. A. (1997). The Salmonella selC locus contains a pathogenicity island mediating intramacrophage survival. EMBO. J. 16, 5376-5385. 26. Maurelli, A. T, Baudry, B., d'Hauteville, H., Hale, T. L., and Sansonetti, P J. (1985). Cloning of plasmid DNA sequences involved in invasion of HeLa cells by Shigella flexneri. Infect. Immun. 49, 164-171. 27. Sasakawa, C , Kamata, K., Sakai, T, Makino, S., Yamada, M., Okada, N., and Yoshikawa, M. (1988). Virulence-associated genetic regions comprising 31 kilobases of the 230-kilobase plasmid in Shigella flexneri 2a. J. Bacteriol. 170, 2480-2484. 28. Gemski, P., Lazere, J. R., Casey, T, and Wohlhieter, J. A. (1980). Presence of virulence-associated plasmid in Yersinia pseudotuberculosis. Infect. Immun. 28, 1044-1047. 29. Portnoy, D. A., Moseley, S. L., and Falkow, S. (1981). Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect. Immun. 31, 775-782. 30. Jackson, M. P, Neill, R. J., O'Brien, A. D., Holmes, R. K., and Newland, J. W. (1987). Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin-I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli. FEMS Microbiol. Lett. 44, 109-114. 31. Waldor, M. K., and Mekalanos, J. J. (1996). Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272, 1910-1914. 32. Karaolis, D. K., Somara, S., Maneval Jr., D. R., Johnson, J. A., and Kaper, J. B. (1999). A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Nature 399, 375-379. 33. Nakata, N., Tobe, T, Fukuda, I., Suzuki, T, Komatsu, K., Yoshikawa, M., and Sasakawa, C. (1993). The absence of a surface protease, OmpT, determines the intercellular spreading ability of Shigella: The relationship between the ompT and kcpA loci. Mol. Microbiol. 9, 459^68. 34. Maurelli, A. T., Fernandez, R. E., Bloch, C. A., Rode, C. K., and Fasano, A. (1998). "Black holes" and bacterial pathogenicity: A large genomic deletion that enhances the virulence of Shigella spp., and enteroinvasive Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 95, 3943-3948.
1.
THE EVOLUTION OF BACTERIAL PATHOGENS
31
35. Sokurenko, E. V., Chesnokova, V., Dykhuizen, D. E., Ofek. I., Wu. X. R., Krogfelt, K. A., Struve, C , Schembri, M. A., and Hasty, D. L. (1998). Pathogenic adaptation of Escherichia coli by natural variation of FimH adhesin. Pwc Natl. Acad. Sci. U.S.A. 95, 8922-8926. 36. Sokurenko, E. V., Hasty, D. L., and Dykhuizen, D. E. (1999). Pathoadaptive mutations: Gene loss and variation in bacterial pathogens. Trends Microbiol. 7, 191-195. 37. Lee, C. A., Jones, B. D., and Falkow, S. (1992). Identification of a Salmonella typhimurium invasion by selection for hyperinvasive mutants. Proc. Natl. Acad. Sci. U.S.A. 89, 1847-1851. 38. Hromockyj, A. E., and Maurelli, A. T. (1989). Identification of Shigella invasion genes by isolation of temperature-regulated inv::lacZ operon fusions. Infect. Immun. 57, 2963-2970. 39. Lawrence, J. G., and Ochman, H. (1998). Molecular archaeology of the Escherichia coli genome. Proc. Natl. Acad. Sci. U.S.A. 95, 9413-9417. 40. Lawrence, J. G. (1997). Selfish operons and speciation by gene transfer. Trends Microbiol. 5, 355-359. 41. Groisman, E. A., and Ochman, H. (1994). How to become a pathogen. Trends Microbiol. 2, 289-294. 42. Fields, R I., Swanson. R. V., Haidaris, C. G.. and Heffron, R (1986). Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc. Natl. Acad. Sci. U.S.A. 83,5189-5193. 43. Isberg, R. R., and Falkow, S. (1985). A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature 317, 262-264. 44. Darasse, A., Kotoujansky, A., and Berthau, Y. (1994). Isolation by genomic subtraction of DNA probes specific for Erwinia carotovora subsp. atroseptica. Appl. Environ. Microbiol. 60, 298-306. 45. Wu, F. M., and Muriana, P. M. (1995). Genomic subtraction in combination with PCR for enrichment of L/.v/^nV/ monocytogenes-^i^Q^c\f'\c sequences. Int. J. Food Microbiol. 11, 161-174. 46. Hughes, M. S., Beck, L. A., Skuce, R. A., and Neill S. D. (1997). Development of mycobacterial species-specific DNA probes by subtraction hybridization. EEMS Microbiol. Lett. 156, 31-36. 47. Kuflu, K. M., and Cuppels, D. A. (1997). Development of a diagnostic DNA probe for xanthomonads causing bacterial spot of peppers and tomatoes. Appl. Environ. Microbiol. 63, 4462^470. 48. Calia, K. E., Waldor, M. K., and Calderwood. S. B. (1998). Use of representational difference analysis to identify genomic differences between pathogenic strains of Vibrio cholerae. Infect. Immun. 66, 849-852. 49. Townsend, K. M., Frost, A. J., Lee, C. W., Papadimitriou, J. M., and Dawkins, H. J. (1998). Development of PCR assays for species- and type-specific identification of Pasteurella multocida isolates. / Clin. Microbiol. 36. 1096-1100. 50. Straus, D., and Ausubel, F. M. (1990). Genomic subtraction for cloning DNA corresponding to deletion mutations. Proc. Natl. Acad. Sci. U.S.A. 87, 1889-1893. 51. Brown, P. K., and Curtiss, R. (1996). Unique chromosomal regions associated with virulence of an avian pathogenic Escherichia coli strain. Proc. Natl. Acad. Sci. U.S.A. 93, 11149-11154. 52. Akopyants, N. S., Fradkov, A., Diatchenko, L., Hill J. E.. Siebert, P D., Lukyanov, S. A., Sverdlov, E. D., and Berg, D. E. (1998). PCR-based subtractive hybridization and differences in gene content among strains of Helicobacter pylori. Proc. Nad. Acad. Sci. U.S.A. 95, 13108-13113. 53. Le Minor, L., and M. Y. Popoff. (1987). Designation of Salmonella enterica sp. Nov., nom. Rev., as the type and only species of the genus Salmonella. Int. J. Syst. Bacteriol. 37, 465-468.
32
HOWARD OCHMAN
54. Reeves, M. W., Evins, G. M., Heiba, A. A., Plikaytis, B. D., and Farmer III, J. J. (1989). Clonal nature of Salmonella typhi and its genetic relatedness to other salmonellae as shown by multilocus enzyme electrophoresis, and proposal of Salmonella bongori comb. nov. J. Clin. Microbiol 27,313-320. 55. Ochman, H., Whittam, T. S., Caugant, D. A., and Selander, R. K. (1983). Enzyme polymorphism and genetic population structure in Escherichia coli and Shigella. J. Gen. Microbiol. 129, 2715-2726. 56. Pupo, G. M., Karaolis, D. K., Lan, R., and Reeves, R R. (1997). Evolutionary relationships among pathogenic and nonpathogenic Escherichia coli strains inferred from multilocus enzyme electrophoresis and mdh sequence studies. Infect. Immun. 65, 2685-2692. 57. Wang, R. F., Cao, W. W., and Cemiglia, C. E. (1997). Phylogenetic analysis and identification of Shigella spp. Mol. Cell. Probes 11, 427-432. 58. Rolland, K., Lambert-Zechovsky, N., Picard, B., and Denamur, E. (1998). Shigella and enteroinvasive Escherichia coli strains are derived from distinct ancestral strains of E. coli. Microbiology 144, 2667-2672. 59. Milkman, R. (1973). Electrophoretic variation in Escherichia coli from natural sources. Science 182, 1024-1026. 60. Selander, R. K., and Levin, B. R. (1980). Genetic diversity and structure in Escherichia coli populations. Science 210, 545-547. 61. Selander, R.K., and Musser, J. M. (1990). Population genetics of bacterial pathogenesis. In "Molecular Basis of Bacterial Pathogenesis," Vol. 11 (B. H. Iglewski and V. L. Clark, eds.), pp. 11-36. Academic Press, San Diego. 62. Musser, J. M. (1996). Molecular population genetic analysis of emerged bacterial pathogens: Selected insights. Emerg. Infect. Dis. 2, 1-17. 63. Selander, R. K., Li, J., Boyd, E. R, Wang, F-S., and Nelson, K. (1994). DNA sequence analysis of the genetic structure of populations of Salmonella enterica and Escherichia coli. In "Bacterial Diversity and Systematics" (F. G. Priest, A. Ramos-Cormenzana, and R. Tindall, eds.), pp. 17^9. Plenum, New York. 64. Selander, R. K., Caugant, D. A., Ochman, H., Musser, J. M., Gilmour, M. N., and Whittam, T. S. (1986). Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl. Environ. Microbiol. 51, 873-884. 65. Lewontin, R. C. (1974). "The Genetic Basis of Evolutionary Change." Columbia University Press, New York. 66. Kimura, M. (1983). "The Neutral Theory of Molecular Evolution." Cambridge University Press, London. 67. Whittam, T. S., Ochman, H., and Selander, R. K. (1983). Geographic components of linkage disequilibrium in natural populations of Escherichia coli. Mol. Biol. Evol. 1, 67-83. 68. Dykhuizen, D. E., de Framond, J., and Hartl, D. L. (1984). Selective neutrality of glucose-6phosphate dehydrogenase allozymes in Escherichia coli. Mol. Biol. Evol. 1, 162-170. 69. Maiden, M. C , Bygraves, J. A., Fell, E., Morelli, G., Russell, J. E., Urwin, R., Zhang, Q., Zurth, K., Caugant, D. A., Feavers, I. M., Achtman, M., and Spratt, B. G. (1998). Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. U.S.A. 95, 3140-3145. 70. Spratt, B. G. (1999). Multilocus sequence typing: Molecular typing of bacterial pathogens in an era of rapid DNA sequencing and the Internet. Curr Opin. Microbiol. 2, 312-316. 71. 0rskov, F, 0rskov, I., Evans Jr., D. J., Sack, R. B., Sack, D. A., and Wadstrom, T. (1976). Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med. Microbiol. Immunol. (Berlin) 162, 73-80.
I.
THE EVOLUTION OF BACTERIAL PATHOGENS
33
72. 0rskov, L, 0rskov, K, Jann, B., and Jann, K. (1977). Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacterial. Rev. 41, 667-710 73. Achtman, M., and Pluschke, G. (1986). Clonal analysis of descent and virulence among selected Escherichia coli. Annu. Rev. Microbiol. 40, 185-210. 74. Musser, J. M., Barenkamp, S. J., Granoff. D. M., and Selander, R. K. (1986). Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae. Infect. Immun. 52, 183-191. 75. van der Zee, A., Mooi, F, Van Embden, J., and Musser, J. (1997). Molecular evolution and host adaptation of Bordetella spp.: Phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences. J. Bacterial. 179, 6609-6617. 76. Steere, A. C., Grodzicki, R. L.. Kornblatt, A. N., Craft. J. E., Barbour, A. G., Burgdorfer, W., Schmid, G. P., Johnson, E., and Malawista. S. E. (1983). The spirochetal etiology of Lyme disease. New Engl. J. Med. 308, 733-740. 77. Boerlin, R, Peter, O., Bretz, A. G.. Postic. D.. Baranton. G., and Piffaretti, J. C. (1992). Population genetic analysis of Borrelia hurgdaiferi isolates by multilocus enzyme electrophoresis. Infect. Immun. 60, 1677-1683. 78. Balmelli, T, and Piffaretti, J. C. (1996). Analysis of the genetic polymorphism of Borrelia burgdorferi sensu lata by multilocus enzyme electrophoresis. Int. J. Syst. Bacterial. 46, 167-172. 79. Valsangiacomo, C, Balmelli, T, and Piffaretti. J. C. (1997). A phylogenetic analysis of Borrelia burgdorferi sensu lata based on sequence information from the hbb gene, coding for a histone-like protein. Int. J. Syst. Bacterial. 47. 1-10. 80. Dykhuizen, D. E., Polin, D. S., Dunn, J. J., Wilske. B.. Preac-Mursic, V., Dattwyler, R. J., and Luft, B. J. (1993). Borrelia burgdorferi is clonal: Implications for taxonomy and vaccine development. Prac. Natl. Acad. Sci. U.S.A. 90. 10163-10167. 81. Wang, I. N., Dykhuizen, D. E., Qiu, W., Dunn. J. J.. Bosler. E. M.. and Luft, B. J. (1999). Genetic diversity of aspC in a local population of Borrelia burgdaiferi sensu stricto. Genetics 151, 15-30. 82. Whittam, T. S. (1996). Genetic variation and evolutionary processes in natural populations of Escherichia coli. In ''Escherichia call and Salmonella^ Vol. 2 (F. C. Neidhardt, ed.), pp. 2708-2720. ASM, Washington, DC. 83. Selander, R. K., Musser, J. M., Caugant, D. A.. Gilmour. M. N., and Whittam, T S. (1987). Population genetics of pathogenic bacteria. Micrab. Pathogen. 3, 1-7. 84. Bettelheim, K. A. (1978). The source of "OH"" serotypes of Escherichia coli. J. Hyg. 80, 83-113. 85. 0rskov, F, and 0rskov, I. (1983). The clone concept in epidemiology, taxonomy, and evolution of the Enterobacteriaceae and other bacteria. J. Infect. Dis. 148, 346-357. 86. 0rskov, F, and 0rskov, I. (1992). Escherichia call serotyping and disease in man and animals. Can. J. Microbial 38, 699-704. 87. Levine, M. M., and Edelman, R. (1984). Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: Epidemiology and pathogenesis. Epidemiol. Rev. 6, 31-51. 88. 0rskov, F, Whittam, T. S., Cravioto, A., and 0rskov. I. (1990). Clonal relationships among classic enteropathogenic Escherichia call (EPEC) belonging to different O groups. J. Infect. Dis. 162,76-81. 89. Whittam, T. S., Wolfe, M. L., Wachsmuth, I. K.. 0rskov, F, 0rskov, I., and Wilson, R. A. (1993). Clonal relationships among Escherichia coli strains that cause hemorrhagic colitis and infantile diarrhea. Infect. Immun. 61, 1619-1629. 90. Riley, L. W., Remis, R. S., Helgerson, S. D.. McGee. H. B., Wells, J. G., Davis, B. R., Hebert, R. J., Olcott, E. S., Johnson, L. M.. Hargrett. N. T. Blake. P A., and Cohen, M. L. (1983). Hemorrhagic colitis associated with a rare Escherichia call serotype. A^^vv Engl. J. Med. 308, 681-685.
34
HOWARD OCHMAN
91. Boyce, T. G., Swerdlow, D. L., and Griffin, P. M. (1995). E. coli 0157:H7 and the hemolyticuremic syndrome. New Engl. J. Med. 333, 364-368. 92. Karmali, M. (1989). Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2, 15-38. 93. Besser, R. E., Lett, S. M., Weber, J. T., Doyle, M. P., Barrett, T. J., Wells, J. G., and Griffin, P. M. (1993). An outbreak of diarrhea and hemolytic uremic syndrome from Escherichia coli 0157:H7 in fresh-pressed apple cider. JAMA 269, 2217-2220. 94. Watanabe, Y., Ozasa, K., Mermin, J. H., Griffm, P. M., Masuda, K., Imashuku, S., and Sawada, T. (1999). Factory outbreak of Escherichia coliO\51:Hl Infection in Japan. Emerg. Infect. Dis. 5, 424-^28. 95. Burland, V., Shao, Y., Perna, N. T., Plunkett, G., Sofia, H. J., and Blattner, F. R. (1998). The complete DNA sequence and analysis of the large virulence plasmid of Escherichia coli 0157:H7. Nucleic Acids Res. 26, 4196-4204. 96. Makino, K., Ishii, K., Yasunaga, T., Hattori, M., Yokoyama, K., Yutsudo, C. H., Kubota, Y, Yamaichi, Y, lida, T, Yamamoto, K., Honda, T., Han, C. G., Ohtsubo, E., Kasamatsu, M., Hayashi, T., Kuhara, S., and Shinagawa, H. (1998). Complete nucleotide sequences of 93-kb and 3.3-kb plasmids of an enterohemorrhagic Escherichia coli 0157:H7 derived from Sakai outbreak. DNA Res. 5, 1-9. 97. Perna, N. T, Mayhew, G. F, Posfai, G., Elliott, S., Donnenberg, M. S., Kaper, J. B., and Blattner, F. R. (1998). Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli 0157:H7. Infect. Immiin. 66, 3810-3817. 98. Plunkett, G., Rose, D. J., Durfee, T. J., and Blattner, F R. (1999). Sequence of Shiga Toxin 2 Phage 933W from Escherichia coli 0157:H7: Shiga Toxin as a phage late-gene product. J. Bacteriol. 181, 1767-1778. 99. Whittam, T. S., Wachsmuth, I. K., and Wilson, R. A. (1988). Genetic evidence of clonal descent of Escherichia coli 0157:H7 associated with hemorrhagic colitis and hemolytic uremic syndrome. J. Infect. Dis. 157, 1124-1133. 100. Ochman, H., and Selander, R. K. (1984). Evidence for clonal population structure in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 81, 198-201. 101. Herzer, P. J., Inouye, M., and Whittam, T. S. (1990). Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J. Bacteriol. 172,6175-6181. 102. Lecointre, G., Rachdi, L., Darlu, P., and Denamur, E. (1998). Escherichia coli molecular phylogeny using the incongruence length difference test. Mol. Biol. Evol. 15, 1685-1695. 103. Arnold, C., Metherell, L., Willshaw, G., Maggs, A., and Stanley, J. (1999). Predictive fluorescent amplified-fragment length polymorphism analysis of Escherichia coli: High-resolution typing method with phylogenetic significance. J. Clin. Microbiol. 37, 1274-1279. 104. Wieler, L. H., McDaniel, T. K., Whittam, T. S., and Kaper, J. B. (1997). Insertion site of the locus of enterocyte effacement in enteropathogenic and enterohemorrhagic Escherichia coli differs in relation to the clonal phylogeny of the strains. FEMS Microbiol. Lett. 156, 49-53. 105. Bingen, E., Picard, B., Brahimi, N., Mathy, S., Desjardins, P, Elion, J., and Denamur, E. (1998). Phylogenetic analysis oiEscherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. J. Infect. Dis. Ill, 642-650. 106. Boyd, E. F, and Hartl, D. L. (1998). Chromosomal regions specific to pathogenic isolates of Escherichia coli have a phylogenetically clustered distribution. J. Bacteriol. 180, 1159-1165. 107. Picard, B., Garcia, J. S., Gouriou, S., Duriez, P., Brahimi, N., Bingen, E., Elion, J., and Denamur, E. (1999). The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect. Immun. 67, 546-553.
1.
THE EVOLUTION OF BACTERIAL PATHOGENS
35
108. Karaolis, D. K., Lan, R., and Reeves, R R. (1994). Sequence variation in Shigella sonnet (Sonnei), a pathogenic clone of Escherichia coli. over four continents and 41 years. J. Clin. Microbiol. 32, 796-802. 109. Musser, J. M., Granoff, D. M., Pattison, P. E., and Selander, R. K. (1985). A population genetic framework for the study of invasive diseases caused by serotype b strains of Haemophilus influenzae. Proc. Natl. Acad. Sci. U.S.A. 82, 5078-5082. 110. Porras, O., Caugant, D. A., Lagergard, T., and Svanborg-Eden, C. (1986). Application of multilocus enzyme gel electrophoresis to Haemophilus influenzae. Infect. Immun. 53, 71-78. 111. Caugant, D. A., Selander, R. K., and Olsen, I. (1990). Differentiation between Actinobacillus {Haemophilus) actinomycetemcomitans, Haemophilus aphrophilus and Haemophilus paraphrophilus by multilocus enzyme electrophoresis. J. Gen. Microbiol. 136, 2135-2141. 112. Musser, J. M., Kroll, J. S., Moxon, E. R., and Selander, R. K. (1988). Clonal population structure of encapsulated Haemophilus influenzae. Infect. Immun. 56, 1837-1845. 113. Musser, J. M., Kroll, J. S., Moxon, E. R., and Selander, R. K. (1988). Evolutionary genetics of encapsulated strains of Haemophilus influenz.ae. Proc. Natl. Acad. Sci. U.S.A. 85, 7758-7762. 114. Urwin, G., Musser, J. M., and Yuan, M. F. (1995). Clonal analysis of Haemophilus influenzae type b isolates in the United Kingdom. J. Med. Microbiol. 43, 45-49. 115. Kroll, J. S., Moxon, E. R., and Loynds, B. M. (1993). An ancestral mutation enhancing the fitness and increasing the virulence of Haemoplnlus influenzae type b. J. Infect. Dis. 168, 172-176. 116. Allan, I., Loeb, M. R., and Moxon, E. R. (1987). Limited genetic diversity of Haemophilus influenzae (type b). Microb. Pathogen. 2, 139-145. 117. Smith-Vaughan, H. C , Sriprakash, K. S., Leach, A. J.. Mathews, J. D., and Kemp, D. J. (1998). Low genetic diversity of Haemophilus influenz.ae type b compared to nonencapsulated H. influenzae in a population in which H. influenz.ae is highly endemic. Infect. Immun. 66, 3403-3409. 118. van Alphen, L., Caugant, D. A., Duim, B., O'Rourke, M., and Bowler, L. D. (1997). Differences in genetic diversity of nonencapsulated Haemophilus influenz.ae from various diseases. Microbiology U2>, 1423-1431. 119. Cover, T. L., and Blaser, M. J. (1996). Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: Pathogenesis and implications for eradication and prevention. Adv. Intern. Med. 41, 85-117. 120. Cover, T. L., Glupczynski, Y., Lage, A. P., Burette, A., Tummuru, M. K., Perez-Perez, G. L, and Blaser, M. J. (1995). Serologic detection of infection with cagA-i- Helicobacter pylori strains. J. Clin. Microbiol. 33, 1496-1500. 121. Atherton, J. C , Peek Jr., R. M., Tham, K. T., Cover, T. L., and Blaser, M. J. (1997). Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112, 92-99. 122. Covacci, A., Falkow, S., Berg, D. E., and Rappuoli, R. (1997). Did the inheritance of a pathogenicity island modify the virulence of Helicobacter pyloril Trends Microbiol. 5, 205-208. 123. Cover, T. L. (1996). The vacuolating cytotoxin of Helicobacter pylori. Mol. Microbiol. 20, 241-246. 124. Covacci, A., Censini, S., Bugnoli, M., Petracca, R., Burroni, D., Macchia, G., Massone, A., Papini, E., Xiang, Z., Figura, N., and Rappuoli, R. (1993). Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. U.S.A. 90. 5791-5795.
36
HOV/ARD OCHMAN
125. Xiang, Z., Censini, S., Bayeli, P. F, Telford, J. L., Figura, N., Rappuoli, R., and Covacci, A. (1995). Analysis of expression of CagA and Vac A virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect. Immun. 63, 94-98. 126. Weel, J. R, van der Hulst, R. W., Gerrits, Y., Roorda, R, Feller, M., Dankert, J., Tytgat, G. N., and van der Ende, A. (1996). The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, Sind Helicobacter pylori-related diseases. J. Infect. Dis. 173, 1171-1175. 127. Marshall, D. G., Dundon, W. G., Beesley, S. M., and Smyth, C. J. (1998). Helicobacter pylori—a conundrum of genetic diversity. Microbiology 144, 2925-2939. 128. Marshall, D. G., Chua, A., Keeling, R W., Sullivan, D. J., Coleman, D. C , and Smyth, C. J. (1995). Molecular analysis oi Helicobacter pylori populations in antral biopsies from individual patients using randomly amplified polymorphic DNA (RAPD) fingerprinting. FEMS Immunol. Med. Microbiol. 10, 317-323. 129. Go, M. R, Kapur, V., Graham, D. Y., and Musser, J. M. (1996). Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: Extensive allelic diversity and recombinational population structure. J. Bacteriol. 178, 3934-3938. 130. Maynard-Smith, J. N. H., O'Rourke, M., and Spratt, B. G. (1993). How clonal are bacteria? Proc. Natl. Acad. Sci. U.S.A. 90, 4384-4388. 131. Cover, T. L., Tummuru, M. K., Cao, R, Thompson, S. A., and Blaser, M. J. (1994). Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. / Biol. Chem. 269, 10566-10573. 132. Atherton, J. C , Cao, R, Reek Jr., R. M., Tummuru, M. K., Blaser, M. J., and Cover, T. L. (1995). Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270, \111\-\1111. 133. Yamaoka, Y, Kodama, T, Kita, M., Imanishi, J., Kashima, K., and Graham, D. Y. (1998). Relationship of vac A genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter 'i, 241-253. 134. Gamer, J. A., and Cover, T. L. (1995). Analysis of genetic diversity in cytotoxin-producing and non-cytotoxin-producing Helicobacter pylori strains. J. Infect. Dis. 172, 290-293. 135. Forbes, K. J., Fang, Z., and Pennington, T. H. (1995). Allelic variation in the Helicobacter pylori flagellin genes flaA and flaB: Its consequences for strain typing schemes and population structure. Epidemiol. Infect. 114, 257-266. 136. van der Ende, A., Rauws, E. A., Feller, M., Mulder, C. J., Tytgat, G. N., and Dankert, J. (1996). Heterogeneous Helicobacter pylori isolates from members of a family with a history of peptic ulcer disease. Gastroenterology 111, 638-647. 137. Cao, P., and Cover, T. L. (1997). High-level genetic diversity in the vapD chromosomal region of Helicobacter pylori. J. Bacteriol. 179, 2852-2856. 138. Suerbaum, S., Smith, J. M., Bapumia, K., Morelli, G., Smith, N. H., Kunstmann, E., Dyrek, I., and Achtman, M. (1998). Free recombination within Helicobacter pylori. Proc. Natl. Acad. Sci. U.S.A. 95, 12619-12624. 139. Bibb, W. R, GelHn, B. G., Weaver, R., Schwartz, B., Plikaytis, B. D., Reeves, M. W., Pinner, R. W., and Broome, C. V. (1990). Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Appl. Environ. Microbiol. 56, 2133-2141. 140. Boerlin, P., and Piffaretti, J. C. (1991). Typing of human, animal, food, and environmental isolates of Listeria monocytogenes by multilocus enzyme electrophoresis. Appl. Environ. Microbiol. 57, 1624-1629.
1.
THE EVOLUTION OF BACTERIAL PATHOGENS
37
141. Baloga, A. O., and Harlander, S. K. (1991). Comparison of methods for discrimination between strains of Listeria monocytogenes from epidemiological surveys. Appl. Environ. Microbiol. 57, 2324-2331. 142. Norrung, B., and Skovgaard, N. (1993). Application of multilocus enzyme electrophoresis in studies of the epidemiology of Listeria monocytogenes in Denmark. Apj?!. Environ. Microbiol. 59,2817-2822. 143. Avery, S. M., Hudson, J. A., and Buncic. S. (1996). Multilocus enzyme electrophoresis typing of New Zealand Listeria monocytogenes isolates. Int. J. Food Microbiol. 28, 351-359. 144. Caugant, D. A., Ashton, F. E., Bibb, W. P., Boerlin, P., Donachie, W., Low, C, Gilmour, A., Harvey, J., and Norrung, B. (1996). Multilocus enzyme electrophoresis for characterization of Listeria monocytogenes isolates: Results of an international comparative study. Int. J. Food Microbiol. 32, 301-311. 145. Louie, M., Jayaratne, P., Luchsinger, I., Devenish, J., Yao. J., Schlech, W., and Simor, A. (1996). Comparison of ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for molecular typing of Listeria monocytogenes. J. Clin. Microbiol. 34, 15-19. 146. Bibb, W. F, Schwartz, B., Gellin, B. G., Plikaytis, B. D., and Weaver, R. E. (1989). Analysis of Listeria monocytogenes by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Int. J. Food Microbiol. 8, 233-239. 147. Piffaretti, J. C , Kressebuch, H., Aeschbacher, M.. Bille, J., Bannerman, E., Musser, J. M., Selander, R. K., and Rocourt, J. (1989). Genetic characterization of clones of the bacterium Listeria monocytogenes causing epidemic disease. Proc. Natl. Acad. Sci. U.S.A. 86, 3818-3822. 148. Harvey, J., and Gilmour, A. (1994). Application of multilocus enzyme electrophoresis and restriction fragment length polymorphism analysis to the typing of Listeria monocytogenes strains isolated from raw milk, nondairy foods, and clinical and veterinary sources. Appl. Environ. Microbiol. 60, 1547-1553. 149. Graves, L. M., Swaminathan, B., Reeves. M. W.. Hunter, S. B.. Weaver, R. E., Plikaytis, B. D., and Schuchat, A. (1994). Comparison of ribotyping and multilocus enzyme electrophoresis for subtyping of Listeria monocytogenes isolates. J. Clin. Microbiol. 32, 2936-2943. 150. Vines, A., Reeves, M. W., Hunter, S., and Swaminathan, B. (1992). Restriction fragment length polymorphism in four virulence-associated genes of Listeria monocytogenes. Res. Microbiol. 143, 281-294. 151. Rasmussen, O. F., Beck, T., Olsen, J. E.. Dons, L., and Rossen, L. (1991). Listeria monocytogenes isolates can be classified into two major types according to the sequence of the listeriolysin gene. Infect. Immun. 59, 3945-3951. 152. Rasmussen, O. E, Skouboe, P., Dons. L.. Rossen, L.. and Olsen, J. E. (1995). Listeria monocytogenes exists in at least three evolutionary lines: Evidence from flagellin, invasive associated protein and listeriolysin O genes. Microbiology 141, 2053-2061. 153. Wiedmann, M., Bruce, J. L., Keating, C , Johnson, A. E., McDonough, P. L., and Batt, C. A. (1997). Ribotypes and virulence gene polymorphisms suggest three distinct Listeria monocytogenes lineages with differences in pathogenic potential. Infect. Immun. 65, 2707-2716. 154. Bloom, B. R., and Murray, C. J. L. (1992). Tuberculosis: Commentary on a reemergent killer. Science 251, 1055-1064. 155. Kapur, V., Whittam, T. S., and Musser, J. M. (1994). Is Mycobacterium tuberculosis 15,000 years old?y. Infect. Dis. 170, 1348-1349. 156. Cave, M. D., Eisenach, K. D., McDermott, P E, Bates, J. H., and Crawford, J. T. (1991). IS6110: Conservation of sequence in the Mycobacterium tuberculosis complex and its utilization in DNA fingerprinting. Mol. Cell. Probes 5, 73-80.
38
HOWARD OCHMAN
157. Yang, Z., Barnes, P. F, Chaves, R, Eisenach, K. D., Weis, S. E., Bates, J. H., and Cave, M. D. (1998). Diversity of DNA fingerprints of Mycobacterium tuberculosis isolates in the United States, y. Clin. Microbiol. 36, 1003-1007. 158. Sreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S., and Musser, J. M. (1997). Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionary recent global dissemination. Proc. Natl. Acad. Sci. U.S.A. 94, 9869-9874. 159. Yeh, R. W., Ponce de Leon, A., Agasino, C. B., Hahn, J. A., Daley, C. L., Hopewell, R C , and Small, P. M. (1998). Stability of Mycobacterium tuberculosis DNA genotypes. J. Infect. Dis. 177,1107-1111. 160. Achtman, M. (1995). Epidemic spread and antigenic variability of Neisseria meningitidis. Trends Microbiol. 3, 186-192. 161. Achtman, M. (1997). Microevolution and epidemic spread of serogroup A Neisseria meningitidis—a review. Gene 192, 135-140. 162. Achtman, M. (1998). Microevolution and epidemic spread of Neisseria meningitidis. Electrophoresis 19, 593-596. 163. Caugant, D. A. (1998). Population genetics and molecular epidemiology of Neisseria meningitidis. Apmis 106, 505-525. 164. Peltola, H. (1983). Meningococcal disease: Still with us. Rev. Infect. Dis. 5, 71-91. 165. Caugant, D. A., Froholm, L. O., Bovre, K., Holten, E., Frasch, C. E., Mocca, L. P., Zollinger, W. D., and Selander, R. K. (1986). Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc. Nat. Acad. Sci. U.S.A. 83, 4927^931. 166. Caugant, D. A., Kristiansen, B. E., Froholm, L. O., Bovre, K., and Selander, R. K. (1988). Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers. Infect. Immun. 56, 2060-2068. 167. Olyhoek, T., Crowe, B. A., and Achtman, M. (1987). Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983. Rev. Infect. Dis. 9, 665-692. 168. Caugant, D. A., Mocca, L. F, Frasch, C. E., Froholm, L. O., Zollinger, W. D., and Selander, R. K. (1987). Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J. Bacteriol. 169, 2781-2792. 169. Morelli, G., Malomy, B., Muller, K., Seller, A., Wang, J. F, del Valle, J., and Achtman, M. (1997). Clonal descent and microevolution of Neisseria meningitidis during 30 years of epidemic spread. Mol. Microbiol. 25, 1047-1064. 170. Feil, E., Carpenter, G., and Spratt, B. G. (1995). Electrophoretic variation in adenylate kinase of Neisseria meningitidis is due to inter- and intraspecies recombination. Proc. Natl. Acad. Sci. U.S.A. 92, 10535-10539. 171. Feil, E., Zhou, J., Maynard Smith, J., and Spratt, B. G. (1996). A comparison of the nucleotide sequences of the adk and recA genes of pathogenic and commensal Neisseria species: Evidence for extensive interspecies recombination within adk. J. Mol. Evol. 43, 631-640. 172. Zhou, J., Bowler, L. D., and Spratt, B. G. (1997). Interspecies recombination, and phylogenetic distortions, within the glutamine synthetase and shikimate dehydrogenase genes of Neisseria meningitidis and commensal Neisseria species. Mol. Microbiol. 23, 799-812. 173. Maynard-Smith, J., and Smith, N. H. (1998). Detecting recombination from gene trees. Mol. Biol. Evol. 15, 590-599. 174. White, P. B. (1926). Further studies on the Salmonella group. Med. Res. Spec. Rep. Counc. (Great Brittain) Sen 103, 3-160.
1.
THE EVOLUTION OF BACTERIAL PATHOGENS
39
175. Kauffman, F. (1966). "The Bacteriology of Enterobacteriaceae." Williams & Wilkins, Baltimore. 176. Crosa, J. H., Brenner, D. J., Ewing, W. H.. and Falkow, S. (1973). Molecular relationships among the salmonellae. J. Bactehol. 115. 307-315. 177. Le Minor, L., Veron, M., and Popoff, M. Y. (1982). Taxonomie de Salmonellae. Ann. Inst. Pasteur Microbiol. 133B, 223-243. 178. Nelson, K., and Selander, R. K. (1992). Evolutionary genetics of the proline permease gene iputP) and the control region of the proline utilization operon in populations of Salmonellae and Escherichia coli. J. Bacteriol. 174, 6886-6895. 179. Nelson, K., and Selander, R. K. (1994). Intergeneric transfer and recombination of the 6-phosphogluconate dehydrogenase gene {gnd) in enteric bacteria. Proc. Natl. Acad. Sci. U.S.A. 91, 10227-10231. 180. Boyd, E. F, Nelson, K., Wang, F-S., Whittam. T S.. and Selander. R. K. (1994). Molecular genetic basis of allelic polymorphism in malate dehydrogenase (nulh) in natural populations of Escherichia coli and Salmonella enterica. Proc. Natl. Acad. Sci. U.S.A. 91, 1280-1284. 181. Li, J., Ochman, H., Groisman, E. A., Boyd, E. F, Solomon, F, Nelson, K., and Selander, R. K. (1995). Relationship between evolutionary rate and cellular location among the Inv/Spa invasion proteins of Salmonella enterica. Proc. Natl. Acad. Sci. U.S.A. 92. 7252-7256. 182. Boyd, E. F, Wang, F-S., Whittam, T. S., and Selander. R. K. (1996). Molecular genetic relationships of the salmonellae. Appl. Environ. Microbiol. 62, 804-808. 183. Beltran, R, Musser, J. M., Helmuth, R.. Farmer III J. J., Frerichs, W. M., Wachsmuth, I. K., Ferris, K., McWhorter, A. C, Wells, J. G.. Cravioto, A., and Selander, R. K. (1988). Toward a population genetic analysis of Salmonella: Genetic diversity and relationships among strains of serotypes S. choleraesuis, S. derby, S. dublin, S. enteritidis, S. heidelberg, S. infantis, S. newport, and S. typhimiirium. Proc. Natl. Acad. Sci. U.S.A. 85, 7153-7151. 184. Beltran, R, Plock, S. A., Smith, N. H., Whittam. T S., Old. D. C., and Selander, R. K. (1991). Reference collection of strains of the Salmonella typhinuirium complex from natural populations. J. Gen. Microbiol. 137, 601-606. 185. Boyd, E. R, Wang, F-S., Beltran, P, Plock. S. A., Nelson, K., and Selander, R. K. (1993). Salmonella reference collection B (SARB): Strains of 37 serovars of subspecies I. J. Gen. Microbiol. 139, 1125-1132. 186. Li, J., Smith, N. H., Nelson, K., Crichton, P B.. Old, D. C., Whittam, T S., and Selander, R. K. (1993). Evolutionary origin and radiation of the avian-adapted non-motile salmonellae. J. Med. Microbiol. 38, 129-139. 187. Selander, R. K., Beltran, P, Smith, N. H., Barker, R. M., Crichton, P B., Old, D. C., Musser, J. M., and Whittam, T. S. (1990). Genetic population structure, clonal phylogeny, and pathogenicity oi Salmonella paratyphi B. Infect. Immim. 58, 1891-1901. 188. Selander, R. K., Beltran, P, Smith, N. H., Helmuth, R., Rubin, F A., Kopecko, D. J., Ferris, K., Tall, B. D., Cravioto, A., and Musser, J. M. (1990). Evolutionary genetic relationships of clones of Salmonella serovars that cause human typhoid and other enteric fevers. Infect. Immun. 58, 2262-2275. 189. Selander, R. K., Smith, N. H., Li, J., Beltran, P, Ferris, K., Kopecko, D. J., and Rubin, F A. (1992). Molecular evolutionary genetics of the cattle-adapted serovar Salmonella dublin. J. Bacteriol 174, 3587-3592. 190. Nelson, K., Whittam, T S., and Selander, R. K. (1991). Nucleotide polymorphism and evolution in the glyceraldehyde-3-phosphate dehydrogenase gene {gapA) in natural populations of Salmonella and Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 88, 6667-6671. 191. Wang, F. S., Whittam, T. S., and Selander, R. K. (1997). Evolutionary genetics of the isocitrate dehydrogenase gene (icd) in Escherichia coli and Salmonella enterica. J. Bacteriol. 179, 6551-6559.
40
HOWARD OCHMAN
192. Nelson, K., Wang, F. S., Boyd, E. R, and Selander, R. K. (1997). Size and sequence polymorphism in isocitrate dehydrogenase kinase/phosphatase gene (acek) and flanking regions in Salmonella enterica and Escherichia coli. Genetics 147, 1509-1520. 193. Ochman, H., and Groisman, E. A. (1996). Distribution of pathogenicity islands in Salmonella spp. Infect. Immun. 64, 5410-5412. 194. Baumler, A. J., Tsolis, R. M., Ficht, T. A., and Adams, L. G. (1998). Evolution of host adaptation in Salmonella enterica. Infect. Immun. 66, 4579-4587. 195. Bergdoll, M. S., Crass, B. A., Reiser, R. R, Robbins, R. N., and Davis, J. R (1981). A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1, 1017-1021. 196. Schlievert, R M., Shands, K. N., Dan, B. B., Schmid, G. R, and Nishimura, R. D. (1981). Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J. Infect. Dis. 143, 509-516. 197. Musser, J. M., Schlievert, R M., Chow, A. W., Ewan, R, Kreiswirth, B. N., Rosdahl, V. T., Naidu, A. S., Witte, W., and Selander, R. K. (1990). A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc. Natl. Acad. Sci. U.S.A. 87, 225-229. 198. Grubb, W. B. (1990). Molecular epidemiology of methicillin-resistant Staphylococcus aureus. In "Molecular Biology of the Staphylococci" (R. Novick and R. A. Skurray, eds.), pp. 595-606. VCH, New York. 199. Musser, J. M., and Selander, R. K. (1990). Brazilian purpuric fever: Evolutionary genetic relationships of the case clone of Haemophilus influenzae biogroup aegyptius to encapsulated strains of Haemophilus influenzae. J. Infect. Dis. 161, 130-133. 200. Musser, J. M., and Kapur, V. (1992). Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: Association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination. / Clin. Microbiol. 30, 2058-2063. 201. Kreiswirth, B., Komblum, J., Arbeit, R. D., Eisner, W., Maslow, J. N., McGeer, A., Low, D. E., and Novick, R. P. (1993). Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science 259, 227-230. 202. Musser, J. M., Hauser, A. R., Kim, M. H., Schliever, R M., Nelson, K., and Selander, R. K. (1991). Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: Clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. U.S.A. 88, 26682672. 203. Nelson, K., Schlievert, R M., Selander, R. K., and Musser, J. M. (1991). Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J. Exp. Med. 174, 1271-1274. 204. Whatmore, A. M., Kapur, V., Sullivan, D. J., Musser, J. M., and Kehoe, M. A. (1994). Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci. Molec. Microbiol. 14, 619-631. 205. Musser, J. M., Kapur, V., Szeto, J., Pan, X., Swanson, D. S., and Martin, D. R. (1995). Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype Ml protein: Recent intercontinental spread of a subclone causing episodes of invasive disease. Infect. Immun. 63, 994-1003. 206. Stockbauer, K. E., Grigsby, D., Pan, X., Fu, Y.-X., Perea Mejia, L. M., Cravioto, A., and Musser, J. M. (1998). Hypervariability generated by natural selection in an extracellular complementinhibiting protein of serotype Ml strains of gvou^ \ Streptococcus. Proc. Natl. Acad. Sci. U.S.A. 95,3128-3133.
1.
THE EVOLUTION OF BACTERIAL PATHOGENS
41
207. Reda, K. B., Kapur, V., Goela, D., Lamphear, J. G., Musser, J. M., and Rich, R. R. (1996). Phylogenetic distribution of streptococcal superantigen SSA allelic variants provides evidence for horizontal transfer of ssa within Streptococcus pyogenes. Infect. Immun. 64, 1161-1165. 208. Marciel, A. M., Kapur, V., and Musser, J. M. (1997). Molecular population genetic analysis of a Streptococcus pyogenes bacteriophage-encoded hyaluronidase gene: Recombination contributes to allelic variation. Microb. Pathogen. 22. 209-217. 209. Dowson, C. G., Hutchison, A., Brannigan, J. A., George, R. C , Hansman, D., Linares, J., Tomasz, A., Maynard Smith, J., and Spratt, B. G. (1989). Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc. Natl. Acad. Sci. U.S.A. 86, 8842-8846. 210. Dowson, C. G., Hutchison, A., Woodford, N., Johnson, A. R, George, R. C., and Spratt, B. G. (1990). Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proc. Natl. Acad. Sci. U.S.A. 87, 5858-5862. 211. Coffey, T. J., Enright, M. C., Daniels, M., Morona, J. K., Morona, R., Hryniewicz, W., Paton, J. C., and Spratt, B. G. (1998). Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae. Molec. Microbiol. 27, 73-83. 212. Enright, M. C., and Spratt, B. G. (1998). Amultilocus sequence typing scheme for Streptococcus pneumoniae: Identification of clones associated with serious invasive disease. Microbiology 144, 3049-3060. 213. Wachsmuth, I. K., Evins, G. M., Fields, R I., Olsvik, O., Popovic, T., Bopp, C. A., Wells, J. G., Carrillo, C, and Blake, P. A. (1993). The molecular epidemiology of cholera in Latin America. y. Infect. Dis. 161, 621-626. 214. Evins, G. M., Cameron, D. N., Wells, J. G., Greene, K. D., Popovic, T, Giono-Cerezo, S., Wachsmuth, L K., and Tauxe, R. V. (1995). The emerging diversity of the electrophoretic types of Vibrio cholerae in the Western Hemisphere. J. Infect. Dis. 172, 173-179. 215. Beltran, P, Delgado, G., Navarro, A., Trujillo, F., Selander, R. K., and Cravioto, A. (1999). Genetic diversity and population structure of Vibrio cholerae. J. Clin. Microbiol. 37, 581-590. 216. Olsvik, O., Wahlberg, J., Petterson, B., Uhlen, M., Popovic, T, Wachsmuth, L K., and Fields, P. L (1993). Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae 01 strains. J. Clin. Microbiol. 31, 22-25. 217. KaraoHs, D. K., Lan, R., and Reeves, P. R. (1995). The sixth and seventh cholera pandemics are due to independent clones separately derived from environmental, nontoxigenic, non-01 Vibrio cholerae. J. Bacteriol. Ill, 3191-3198. 218. Karaolis, D. K., Lan, R., and Reeves, P. R. (1994). Molecular evolution of the seventh-pandemic clone of Vibrio cholerae and its relationship to other pandemic and epidemic V. cholerae isolates. /. Bacteriol 176, 6199-6206. 219. Koblavi, S., Grimont, F, and Grimont, P A. (1990). Clonal diversity of Vibrio cholerae 01 evidenced by rRNA gene restriction patterns. Res. Microbiol. 141, 645-657. 220. Lan, R., and Reeves, P. R. (1998). Recombination between rRNA operons created most of the ribotype variation observed in the seventh pandemic clone of Vibrio cholerae. Microbiology 144, 1213-1221. 221. Byun, R., Elbourne, L. D., Lan, R., and Reeves, P. R. (1999). Evolutionary relationships of pathogenic clones of Vibrio cholerae by sequence analysis of four housekeeping genes. Infect. Immun. 67, 1116-1124.
This Page Intentionally Left Blank
CHAPTER 2
Germ Warfare: The Mechanisms of Virulence Factor Delivery JILL REISS HARPER THOMAS J. SILHAVY
I. II. III. IV. V. VI. VII. VIII.
Introduction The General Secretory Pathway Autotransporters: Type V Two-Step Secretion: Type II ABC Transporters: Type I Conjugal Transfer Systems: Type IV Contact-Dependent Secretion: Type III Concluding Remarks References
43 45 47 49 52 55 57 61 61
/. Introduction Pathogenic bacteria synthesize a diverse array of virulence determinants. These virulence proteins, which comprise the arsenal of bacterial weapons, have a wide variety of activities that require them to be targeted to specific locations. For example, proteins involved in attachment of the bacterium to the host cell must be localized to the bacterial surface, some bacterial toxins are secreted into surrounding fluids, and others are injected directly into the cytoplasm of the eukaryotic host cell. Thus, in pathogenic bacteria secretion itself is a virulence determinant; without the means to selectively target proteins, these bacteria are harmless.
Principles of Bacterial Pathogenesis Copyright © 2001 by Academic Press All rights of reproduction in any form reserved. ISBN 0-12-304220-8
A^
44
JILL REISS HARPER AND THOMAS J. SILHAVY
The problem of targeting proteins to their correct location is not unique to pathogenic bacteria. All cells have subcellular compartments that are bound by lipid bilayers, and it is essential that each of these compartments contain a characteristic set of proteins. To maintain this organization, cells have specific mechanisms to target proteins from their site of synthesis in the cytoplasm to each noncytoplasmic location. This targeting, of course, requires the movement of proteins into and across the lipid bilayers. In most cases, proteins destined to leave the cytoplasm are tagged with a signal sequence at the amino terminus that serves to target them to the cellular secretion (Sec) machinery that includes a heterotrimeric complex of integral membrane proteins. Signal sequences and the components of this heterotrimeric complex have been conserved in all three domains of life [1]. While bacterial cells are not as complex as their eukaryotic counterparts, they do exhibit some compartmentalization. If we consider lipid bilayers to be compartments, then Gram-positive bacteria have three destinations to which proteins can be targeted: the cytoplasm, the membrane, and the extracellular environment. Gram-negative bacteria, on the other hand, can target proteins to five distinct locations: the cytoplasm, the inner membrane, the periplasm, the outer membrane, and the extracellular environment. In Gram-positive bacteria, the Sec machinery is sufficient for targeting to the extracellular environment since the secreted proteins must pass through only one lipid bilayer. The outer membrane of Gram-negative bacteria complicates protein secretion to the extracellular environment. At least five different mechanisms, termed Types I through V, appear to be conserved among the Gram-negative bacteria. (Unfortunately, this nomenclature is confusing and incomplete because it does not include the mechanisms responsible for secretion of certain colicins [2] and the process of pilus assembly [3], for which there is currendy no name. Nonetheless, this nomenclature system has caught on and will be used in this chapter.) The various Gram-negative secretion systems can be divided into those that utilize the Sec machinery for translocation across the inner membrane (Sec-dependent) and those that do not (Sec-independent). The Sec-dependent secretion systems include Types II and V. The Type II system involves a two-step mechanism in which proteins are first targeted to the periplasm by the Sec machinery and then secreted from the cell by a complex reaction requiring a dozen or so additional proteins. The Type V systems, also called the autotransporters, utilize the normal pathway for outer membrane targeting. Autoproteolysis releases a secreted protein domain into the environment. The Sec-independent secretion systems include Types I, III, and IV. The Type I systems utilize a complex of three proteins that span both the inner and outer membranes, and they secrete proteins directly into the media. The Type IV systems are not well characterized at this time; they appear to be closely related to systems used for the conjugal transfer of DNA from one bacterium to another. The Type III systems are fascinating
2.
GERM WARFARE
45
devices that actually allow injection of bacterial proteins directly into the cytoplasm of the host cell. Sometimes they are called "contact-dependent" to reflect this capacity for injection. Altogether these systems provide a wide range of options for bacterial protein secretion and will be the focus of this chapter.
//. The General Secretory Pathway Protein export from the cytoplasm is a conserved pathway that was discovered and characterized in the Gram-negative bacterium Escherichia coli. As noted above, many proteins destined for noncytoplasmic locations are synthesized with a signal sequence that targets them for translocation. This amino-terminal signal is later cleaved during the export process [4]. The function of signal sequences was first demonstrated using gene fusions in which the amino-terminal end of an exported protein such as LamB, the receptor for bacteriophage X, is fused to the cytoplasmic enzyme (3-galactosidase, or LacZ (reviewed in [5]). Strains carrying gene fusions of this type exhibit several novel phenotypes that can be exploited to obtain mutations that alter the secretion process. First, LacZ is meant to fold in the cytoplasm; if it is located somewhere else, it folds improperly and exhibits no activity. Second, the attempted secretion of large amounts of LacZ lethally jams the secretion machinery. The original LamB signal sequence mutations were isolated as suppressors of this deadly jamming. Furthermore, these signal sequence mutations increased LacZ activity because they prevented enzyme export from the cytoplasm [6]. Further analysis of many signal sequences from both prokaryotic and eukaryotic proteins has shown that they consist of about 15-26 amino acids. There is no conserved sequence, but they do possess common features [7]. They contain a stretch of 10-12 hydrophobic amino acids preceded by one or two positively charged residues and followed at the carboxy-terminal end by a cleavage site for leader peptidase, which removes the signal sequence from the preprotein to yield the mature protein. This run of hydrophobic residues resembles a transmembrane domain. Mutations that block signal sequence processing do not prevent translocation, but leave the mutant precursor protein tethered to the inner membrane with the amino terminus of the signal sequence facing the cytoplasm [8]. To catalyze insertion into and translocation across the inner membrane, E. coli has a set of proteins—the Sec proteins—that were identified using two complementary genetic approaches. In one approach, suppressors of signal sequence mutations were selected based on their ability to restore localization of a mutant precursor protein. The genes identified by this approach were called/?r/ for protein localization [9]. In the complementary approach, mutations were sought that increased the LacZ activity of an exported fusion protein and simultaneously
46
JILL REISS HARPER AND THOMAS J. SILHAVY
conferred a conditional lethal phenotype. Genes identified in this way were termed sec for secretion [10]. Subsequent molecular analysis revealed that three of the sec genes were also/7r/ genes: secA/prlD [10, 11], secE/prlG [12, 13], and secY/prlA [9, 12, 14]. It is these three proteins that form the essential core of the secretion machinery; protein translocation can be reconstituted in vitro with only Sec A, SecE, and SecY [15, 16]. Later genetic experiments identified three additional nonessential sec genes—secB [17], secD [18], and secF [19]—and biochemical studies added two others—secG [16, 20] and jo/C [21]. Interestingly, prl alleles of secG were identified in 1997 [22]. Biochemical approaches have elucidated the role of the Sec proteins in protein export from the cytoplasm [23]. The Sec machinery is comprised of soluble cytoplasmic proteins and peripheral and integral cytoplasmic membrane proteins (Fig. 1, see color plate). In order to be exported from the cytoplasm, a protein must first be recognized by the secretion machinery. Multiple, partially redundant mechanisms ensure the accuracy of precursor recognition. In the cytoplasm, SecA binds signal sequences directly [24]. The secretion-specific chaperone SecB binds to the mature portions of exported proteins such as LamB or MalE [25, 26] and maintains them in an unfolded, export-competent state [27-31]. This contributes to recognition because SecB also binds SecA [32, 33]. SecA functions as a dimer to direct the precursor to the membrane and energize the translocation reaction [34]. The complex of SecA, precursor protein, and SecB interacts on the cytoplasmic face of the heterotrimeric SecYEG complex in the inner membrane. The SecYEG complex, based on studies with its eukaryotic counterparts, likely forms a protein-conducting channel through the inner membrane [35-37]. Binding of ATP then induces a change in the structure of SecA that allows it to insert into the inner membrane [38]. Once SecA enters the membrane, SecB is released into the cytoplasm and the precursor is partially translocated through the SecYEG complex [39]. This translocation allows access of signal peptidase to the precursor, and signal peptidase then cleaves the signal peptide. SecD, SecF, and YajC seem to stabilize the membrane-bound form of SecA [40]. ATP hydrolysis causes SecA to release the partially translocated precursor and deinsert from the membrane. Additional ATP binding and hydrolysis by SecA will repeat the insertion/deinsertion process to catalyze the progressive threading of the translocating protein through the inner membrane [40-42]. Translocation may also continue using energy from the proton-motive force in a step that is poorly characterized. E. coli possesses another mechanism for targeting proteins to the secretion apparatus in the inner membrane—SRP, or Signal Recognition Particle. This targeting factor is a diminutive version of its eukaryotic counterpart. Prokaryotic SRP contains a protein, Ffh, that is homologous to eukaryotic SRP54, the subunit that recognizes the signal peptide, and an RNA, 4.5S RNA, that resembles eukaryotic 7S RNA. E. coli also has a protein, FtsY, that is similar to the a subunit of the mammalian SRP receptor. These proteins are functional in targeting; the
2. GERM WARFARE
47
bacterial proteins can replace their eukaryotic counterparts in vitro [43]. Genetic analysis of secB mutants and ffh-dtp\eied strains argues that there may be two separate subsets of exported proteins in E. coli—those targeted by SecB and those targeted by Ffh [44, 45]. Alternatively, or in addition, prokaryotic SRP may function in the insertion of inner membrane proteins [46-48]. As noted above, components of the secretion machinery such as signal sequences, SecYEG, and SRP are conserved throughout biology. SecA is found only in eubacteria and chloroplasts [1]. Apparently, eukaryotes use a different mechanism to energize translocation. SecB has only been found in the family Enterobacteriaccae [ 1 ].
///. Autotransporters: Type V The simplest of the Sec-dependent secretion systems are the Type V systems, also known as the autotransporters [49]. The prototype of these is the IgA protease from M gonorrhoeae [50], which has been studied extensively for quite some time because the proteolysis of IgA by IgA protease is a major contributor to virulence. Other examples of autotransporters include the immunoglobulin A (IgA) protease from Haemophilus influenzae [51], the serine protease from Serratia marcescens [52], and the vacuolating cytotoxin VacA from Helicobacter pylori [53]. Autotransporters are first exported to the outer membrane, where a proteolytic event releases the final product into the medium (Fig. 2, see color plate) [54]. The secreted protein is first expressed in the cytoplasm as a large multidomain protein consisting of an amino-terminal Sec-dependent signal sequence, the 106-kD mature portion of the protein, a 30-amino-acid y-protein, a 15-kD secreted a-protein, and a 45-kD carboxy-terminal (J-protein, which remains inserted in the outer membrane [55]. The amino-terminal signal sequence targets the protein for translocation from the cytoplasm by the Sec machinery. Concomitant with translocation across this membrane, the signal peptide is cleaved and the remainder of the protein is released into the periplasm. The carboxy-terminal p-domain is targeted to the outer membrane, where it forms a P-barrel pore or channel through which the rest of the protein can pass in its unfolded state through the outer membrane onto the cell surface. The protein then undergoes autoproteolysis to cleave the (J-domain from the rest of the protein. The (J-protein remains in the outer membrane, while the mature, a-, and y-domains are released into the extracellular environment. Subsequent autoproteolytic cleavages release the mature protein from the small a- and y-proteins [56]. Their function is unknown; however, they could play a role as chaperones.
48
JILL REISS HARPER AND THOMAS J. SILHAVY
The signals that direct the secretion of IgA protease are twofold: first, the presence of an amino-terminal signal sequence to direct export from the cytoplasm via the Sec machinery and, second, the presence of the (i-domain for secretion from the periplasm across the outer membrane [57]. The P-domain contains the information necessary for insertion into the outer membrane, and this insertion is sufficient for the rest of the protein to pass onto the surface. The information in the ^-domain responsible for targeting to the outer membrane has been reduced to a minimal "core" region that retains the ability to translocate a passenger protein across the outer membrane. This core is conserved among the carboxy-terminal regions of the IgA p-domains of several species. Based on structural predictions, the p-core resembles the p-barrel motif conserved among Gram-negative outer membrane proteins, and presumably all of these proteins share a common mechanism for outer membrane insertion [56]. However, this important process remains poorly characterized. Little was known about the secretion of autotransporters until the discovery that IgA protease itself is the only protein, aside from the Sec machinery, required for its secretion into the extracellular environment. The key experiment was the isolation of a DNA fragment from A^. gonorrhoeae that allowed secretion of active IgA protease when expressed in Escherichia coli [58]. Because E. coli does not usually secrete proteins into the extracellular environment, this indicated that all the components for secretion were present on the plasmid. Sequencing revealed that the cloned fragment contained a single gene coding for a protein significantly larger than the secreted, active form of IgA protease. Subsequent work demonstrated that the mature IgA protease, a-protein, and p-protein are the result of autoproteolytic processing at cleavage sites similar to those on host proteins that are the target of IgA protease [55, 57]. Other important work has shown that fusion proteins consisting of a signal sequence, the Vibrio cholerae toxin B subunit, and the IgA p-domain are efficiently secreted by E. coli, demonstrating that the signal sequence and the p-domain are sufficient for secretion. This work also shows that sequences translocated through the p-domain are generally in an unfolded state and that the translocation occurs in a linear fashion [59]. That the passenger proteins are translocated through the p-core in their unfolded state is further supported by the lack of cysteines, and therefore disulfide bonds, in the translocated portions of the autotransporters. Disulfide bonds would presumably introduce structures that cannot pass through the P-core pore [60]. Work with S. marcescens serine protease has demonstrated that, at least for this IgA protease-like protein, part of the carboxy-terminal p-domain plays the role of a chaperone and assists in folding of the mature enzyme once located on the surface [61]. Other work involves the development of systems to facilitate kinetic and structural studies of autotransporter secretion [62].
2. GERM WARFARE
49
The simplicity of these systems is striking, especially in contrast to other systems we will discuss. Accordingly, these autotransporters have implications for biotechnology, and many are being examined for their potential ability to secrete heterologous proteins from E. coli.
IV. Two-step Secretion: Type II The Type II secretion systems provide a commonly used mechanism for the extracellular secretion of proteins from Gram-negative bacteria. The pal system of Klebsiella oxytoca is the founding member of this diverse family. This system directs the secretion of pullulanase, a starch-debranching enzyme. Pullulanase is a lipoprotein that is exported to the periplasm by Sec-dependent means, targeted to the outer membrane, and then secreted by a complex mechanism requiring more than a dozen other proteins [63]. Examples of Type II secretion systems include the out systems of Envinia dvysanthemi and Erwinia cawtovora [64, 65], the xcp system of Pseudomonas aeruginosa [66], exe from Aeromonas hydrophila [67], xps from Xanthomonas campestris [68], and eps from Vibrio cholerae [69]. Type II systems also show similarities to systems that catalyze biogenesis of type IV pili, assembly of filamentous phages, and competence for DNA uptake [70-72]. The Type II secretion systems consist of about 12-14 proteins that are encoded by a cluster of genes [72, 73] (Fig. 3, see color plate). Although there is no direct evidence to support it, one model suggests that some of the components of the Type II systems form a pilus-like structure in the envelope [71, 74, 75]. The presence of several proteins—PulG, H, I, and J—that have homology to type IV pilin subunits led to this suggestion. These proteins, the pseudopilins, contain consensus prepilin peptidase cleavage sites and are processed by the PulO protein, which is homologous to the PilD/XcpA prepilin peptidase involved in the biogenesis of type IV pili [76]. PilD/XcpA is a multifunctional protein from P. aeruginosa that processes and A^-methylates the subunits of the type IV pilus and also the components of the apparatus that secretes alkaline phosphatase, phospholipase C, elastase, and exotoxin A [77-83]. The purpose of this processing is not yet known; it does not seem to be involved in pseudopilin complex formation or in relocalization of the pseudopilins [73]. Furthermore, the pseudopilins in K. oxytoca have been shown to localize to the cytoplasmic membrane, which may not lend well to their role in a pilus-like complex [84]. Nonetheless, it would seem that the role of the O protein is to process the components of the pilus-like structure so that they can assemble properly. The pilus-like structure is thought to guide secreted proteins in their folded conformation to the secretin PulD, located in the outer membrane. The secretins
50
JILL REISS HARPER AND THOMAS J. SILHAVY
are a conserved family of proteins that form pores in the outer membrane large enough to allow secreted proteins to pass into the surrounding medium [85-87]. Support for the PulD protein forming a pore in the outer membrane comes from its sequence similarity to gpIV, a filamentous phage protein, and PilQ proteins, involved in type IV pilus assembly [88]. It has been suggested that this similarity reflects similar mechanisms at work in the filamentous phage type IV pili, and Type II secretion systems. Indeed, PulD protein forms large stable complexes in the outer membrane that are similar to complexes formed by the gpIV and PilQ proteins [87, 89, 90]. The gpIV protein forms pores [91], and one of the PulD-like proteins, XcpQ from P. aeruginosa, has been shown to form multimeric ring complexes in the outer membrane that could also serve as pores [92]. PulD targeting requires the activity of PulS, a lipoprotein that is also found in the outer membrane [93]. PulS also acts as a chaperone to protect PulD from degradation [87, 94]. Additional components required for secretion include PulC, F, K, L, M, and N, all of which are located in the inner membrane and have unknown functions [84, 93, 95, 96]. The final component required for secretion is PulE, a cytoplasmic protein with a putative nucleotide-binding motif [96, 97]. PulE associates with the inner membrane only in the presence of the other Pul proteins [97]. The specific protein with which PulE interacts is unknown, but in V. cholerae the PulE homolog EpsE interacts with the PulL homolog EpsL [98]. The obvious role for PulE, because of its nucleotide-binding site, would be to act, along with the proton-motive force, as the energizer for the process of secretion. PulE could also play a role in signaling [98]. In any event, ATP binding by PulE is essential for secretion [97]. Perhaps the most surprising feature of the current model is that, with the exception of PulD, PulS, and PulE, all of the Type II components are found in the inner membrane [72]. Why a system that targets proteins from the periplasm through the outer membrane needs so many cytoplasmic membrane proteins and one cytoplasmic protein is not understood. Like Type IV autotransporters, secretion via Type II systems requires the presence of a classical signal peptide recognized by the Sec machinery and cleaved by signal peptidase I in most cases, or signal peptidase II in the case of lipoproteins like K. oxytoca pullulanase. This signal, of course, is necessary and sufficient to get the secreted protein into the periplasm. What is the signal that distinguishes a protein to be secreted via the Type II system from any other periplasmic protein? One approach to this question has been deletion analysis of secreted proteins to analyze the regions necessary and sufficient for secretion. From this work in P. aeruginosa, it appears that the first 30 amino acids of exotoxin A play an important role in extracellular secretion [99, 100]. There also seems to be a second secretion signal located in the carboxy terminus of the protein [100]. Another strategy has implemented the use of
2. GERM WARFARE
51
reporter fusions to proteins such as p-lactamase. The secretion of these fusion proteins is surprisingly resistant to large internal deletions [101, 102]. Two regions, each of about 80 amino acids and separated by about 600 amino acids, have been identified as putative extracellular targeting signals in pullulanase [102]. In exotoxin A of f! aeruginosa, the signal has been localized to amino acids 60-120 in the amino-terminal end of the protein [101]. Based on the ambiguity of these results, it seems unlikely that all Type II secretion systems will recognize a common stretch of amino acid sequence like the Sec machinery does. It is more likely that a combination of specific sequences and conformational information targets secreted proteins such as pullulanase to the Type II secretion machinery [103]. Some evidence already supports the idea that these proteins must be folded into a certain conformation in order to be secreted [104-109]. It seems likely that proper folding of the protein allows regions that are far apart in the primary sequence to come together and form a signal patch that is then recognized by the secretion machinery [103]. The history of concept development with the Type II secretion systems is interesting and informative (reviewed in [73]). It had been established that a large number of proteins secreted by Gram-negative bacteria were synthesized with classical signal peptides at their amino termini. However, viable mutants had been isolated in several species that were defective in the secretion of proteins to the extracellular surroundings. Presumably, the genes identified were specifically involved in the process of extracellular protein secretion (e.g., [110, 111-114]); this secretion system could not be essential. Based on the simplicity of certain systems, such as the recendy identified autotransporters, it was originally thought that few cellular components would be required for export across the outer membrane [73]. The discovery of the extremely complicated Type II systems was, therefore, quite surprising. The breakthrough occurred with the examination of pullulanase secretion. Previous attempts to express pullulanase in E. coli resulted in accumulation of enzyme in the membranes [115]. Finally, a large 23-kb DNA fragment from Klebsiella oxytoca was cloned that supported pullulanase secretion in E. coli [116]. Subsequent work showed that the cloned fragment contained 14 genes—pulC, D, E, F, G, //, /, y, K, L, M, A^, O, and S—that are required for the secretion of pullulanase [84, 117, 95, 96]. In the meantime, genes involved in the secretion of proteins in several pathogenic species were shown to be homologous to several of the pul genes [64, 66, 81]. Surprisingly, a functional secretion system that is homologous to the Pul system has been identified in E. coli K-12, which historically had not been thought to actively secrete proteins into the environment [118-120]. Understanding how all of these components interact to catalyze protein secretion will not be easy. It seems likely that all of these components make up
52
JILL REISS HARPER AND THOMAS J. SILHAVY
a macromolecular machine. The isolation or visualization of such a machine would be an important advance.
V. ABC Transporters: Type I At least in terms of number of components, the Type I, or ABC, transporter systems are quite simple. In these systems, only three proteins are required for Sec-independent secretion. Examples of the proteins secreted by the Type I secretion systems include a-hemolysin from Escherichia coli, Proteus vulgaris, and Morganella morganii [121]; leukotoxin from Pasteurella haemolytica [122]; metalloprotease from Serratia marcescens [123]; alkaline protease from Pseudomonas aeruginosa [124]; and proteases A, B, and C from Erwinia chrysanthemi [125]. As their name implies, these systems include a component that is a member of the ATP-binding cassette, or ABC, family of transporter proteins (reviewed in [2]). ABC transporters are found in all organisms from bacteria to mammals and function in the import and export of a diverse array of molecules. This family of proteins can be subdivided into three groups—the bacterial importers, the eukaryotic transporters, and the bacterial exporters [2]—with the bacterial exporters comprising the largest subfamily. The first bacterial exporter to be identified was the transporter for the a-hemolysin secreted by uropathogenic E. coli (reviewed in [2]; see also Wandersman, 1996), and this system remains the paradigm. The Type I systems secrete proteins and other substrates via a mechanism in which transfer across both the inner and outer membranes occurs in a single step [126, 127] (Fig. 4, see color plate). The most surprising feature of these systems is that secretion across both the inner and outer membranes requires only three proteins. These components include an ABC transporter, a membrane fusion protein, or accessory factor, and an outer membrane component. The secreted protein, while still in the cytoplasm, is recognized by and binds to the ABC protein via a carboxy-terminal signal. Substrate binding inhibits the ATPase activity of the ABC protein [128] and promotes interaction of the ABC protein with the membrane fusion protein. This interaction then stimulates interaction of the membrane fusion protein with the outer membrane component, so that the secretion apparatus is assembled in an ordered fashion [129,130]. The mechanism by which the substrate passes from the cytoplasm to the environment is not clear. The most likely scenario is that the complex of the ABC protein, membrane fusion protein, and outer membrane factor forms a channel through which the proteins pass, in one step, from the cytoplasm to the external medium. This model, of course, depends on the pore-forming ability of the outer membrane factor, which is still under debate.
2. GERM WARFARE
53
The ABC transporter—HlyB, in the case of E. coli a-hemolysin—contains an ATP-binding domain that is homologous to ATP-binding cassettes found in many types of proteins in organisms from bacteria to mammals [131, 132]. These ATP-binding cassettes are absolutely required for secretion; mutations that block ATPase activity also block hemolysin secretion [128, 133]. These transporter proteins reside in the inner membrane [134] with the ABC cassette in the cytoplasmic carboxy-terminal domain of the protein. The transmembrane domain of HlyB does not perform any other functions other than the anchoring of HlyB. Replacement of the HlyB transmembrane domain with another unrelated domain does not affect secretion of hemolysin [135]. Several lines of evidence demonstrate that the ABC transporter proteins are also responsible for substrate specificity. Hybrid ABC transporter systems comprised of components from different bacteria tend to secrete ABC cognates [129]. In addition, mutations in the signal sequence of a-hemolysin have been used to identify compensatory mutations in the cytoplasmic domain of HlyB that alter the substrate specificity of the system [136]. Indeed, it is the recognition and binding of the substrate by the ABC transporter that promotes interactions between the ABC transporter and the other two components [130]. The second component of the Type I secretion systems is known as the membrane fusion protein, or accessory factor [2, 137]. These proteins share a common predicted topology consisting of an amino-terminal domain anchored in the inner membrane, a periplasm-spanning domain, and a (3-barrel carboxy-terminal domain that is thought to span the outer membrane [138, 139]. The predicted topology of these proteins is supported by fractionation studies. HlyD fractionates to both the inner and outer membranes, while truncated HlyD, missing its carboxy-terminal 10 amino acids, fractionates only to the inner membrane [140]. The third component of the a-hemolysin-like systems is the outer membrane factor, which in the a-hemolysin system is TolC. TolC is unusual because the structural gene is unlinked, and the protein performs other important functions in E. coli [141, 142]. Demonstration of TolC involvement in a-hemolysin secretion was an important advance that clarified a very confusing situation [143]. TolC and other members of the membrane fusion protein family are thought to form a pore in the outer membrane through which the secreted substrates pass into the external milieu, but the evidence for their pore-forming abilities is limited [144-146]. Structural characterization of TolC has demonstrated that the protein exists as a trimer in the outer membrane with extensive (3-barrel structures [145, 146]. The carboxy-terminal domain of TolC protrudes into the periplasm and most likely contacts the other components, thus providing a bridge between the inner and outer membranes [146]. Proteins secreted by the ABC transporters, of course, lack signal sequences [147, 148]. The first insight into the nature of the signal was that the carboxy-terminal 23-kDa fragment of the 107-kDa HlyA is secreted [126, 149], Gene fusion
54
JILL REISS HARPER AND THOMAS J. SILHAVY
approaches further dehneated the portion of the carboxy terminus that is necessary and sufficient for hemolysin secretion to the last 48-60 amino acids [150-155]. Other members of this family show similar carboxy-terminal signal peptides [156-159]. Attempts have been made to identify individual amino acids within this signal, but none emerged [160,161]. In addition to possible "contact" residues [160], these carboxy-terminal sequences may have other structural features that are important in the recognition of the secretion machinery. An extended amphipathic helix as well as other structural features is found in the carboxy-terminal regions of many of the proteins secreted via Type I mechanisms [155]. Yet another region just upstream of the carboxy terminus may play a role in signal recognition as well. This region, which consists of a glycine-rich GGXGXD sequence that is repeated up to 36 times, is found in all types of cytotoxic proteins secreted by the ABC transporters [162]. This repeated sequence is clearly important for secretion, and may function as an internal chaperone to keep the secretion signal exposed [163, 164]. The cloning and sequencing of the chromosomal hemolysin gene cluster helped establish the novelty of the secretion system for a-hemolysin [165]. The hemolysin, HlyA, has no signal peptide, indicating that secretion is independent of the Sec machinery [147], and the sequence of HlyB revealed features of an ABC transporter [2, 138, 166]. As noted above, the third component of the a-hemolysin secretion system, the outer membrane protein TolC, was not identified until several years later [143]. In the meantime, other proteins from numerous bacteria were found that are secreted by similar systems. For example, the hemolysins from Proteus vulgaris, Proteus mirabilis, and Morganella morganii have gene clusters homologous to the E. coli hly cluster, and mutations in the secretion factors for these hemolysins can be complemented by the homologous E. coli genes [121]. Type I systems are also involved in the secretion of Pasteurella haemolytica leukotoxin [167], Erwinia chrysanthemi proteases [125], and Serratia marcescens Has A heme-binding protein [168]. The presence of a large number of Type I secretion systems that are highly homologous to one another has expedited the characterization of these systems. Characterization of other Type I systems such as the Has system in Serratia marcescens has provided important new information. HasA is an extracellular heme-binding protein. Perhaps the most surprising result is that interfering with SecB [169] can prevent HasA secretion. This provides the first example of SecB function in a different secretion system, and it suggests that proteins secreted by Type I systems must be maintained in an unfolded state. Further study of Type I systems may provide a means to attenuate the virulence of organisms that possess them. In addition, these systems have been demonstrated to be an efficient method of delivering antigens, such as the p67 sporozoite antigen of Theileria parva, for vaccination purposes [170-172].
2.
GERM WARFARE
55
W. Conjugal Transfer Systems: Type IV Type IV secretion systems are used by the plant pathogen Agwbacterium tumefaciens for the transfer of oncogenic T-DNA and proteins to plants, and certain Type IV components are used by Bordetella pertussis for the secretion of pertussis toxin (reviewed in [173]). Based on sequence homologies, these secretion systems appear to be novel adaptations of the conjugal transfer system used for the horizontal transfer of plasmids. Identification of a similar type of system in Legionella pneumophila [174, 175] and of homologs in the pathogenicity island of Helicobacter pylori (reviewed in [176-178]) demonstrate that the Type IV systems may be more widespread than originally thought. The conjugal transfer systems in Gram-negative bacteria, which include the F plasmids and the IncN plasmids, are well characterized. These plasmids carry the tra genes, which are required for plasmid transfer into another bacterium. Over the years, it has become clear that the mechanism of T-DNA transfer in A. tumefaciens is quite similar to the mechanism of conjugal plasmid transfer in Gram-negative bacteria (reviewed in [173]). The ways in which the DNA is processed prior to transfer are similar [179-181]. Finally, sequence analysis has demonstrated that the virB genes from A. tumefaciens show striking similarity to the tra genes from the IncN, IncP, and other conjugative plasmids [182-184] and that the tra genes most likely encode the proteins that form the DNA-channeling pore in the outer membrane [185, 186]. It is reasonable that a system for transferring DNA between bacteria might evolve into a system for delivering bacterial DNA into host cells. More surprising, however, was the discovery that these conjugal transfer systems have also been adapted to promote the secretion of proteins, such as the Bordetella pertussis toxin. This finding makes more sense, though, if we look at DNA transport systems as systems that are designed to transport proteins. The DNA merely "hitches" a ride with the protein as the protein gets transported into the recipient cell, regardless of whether the recipient is another bacterium or a plant or animal host cell. Evidence for this model comes from early experiments that demonstrated that some A. tumefaciens proteins can be transported by themselves into plant cells. At least two proteins, VirE2 and VirD2, are secreted along with the T-DNA as a complex, the T-complex, into the recipient plant cells. Mixed infections of plant cells with one bacterial strain deleted for T-DNA and one mutant for the virulence protein VirE2 result in tumorigenesis in the host plant, indicating that the protein can be transported into the plant in the absence of the T-DNA [187]. This tumorigenesis is, however, dependent on the presence of the virB operon, which encodes the transport apparatus, and VirD2, which binds the T-DNA. These results indicate that the VirE2 protein forms complexes with the T-DNA once both are in the plant. This is further supported by the observation that plants with a virEl transgene undergo tumorigenesis when infected with a
56
JILL REISS HARPER AND THOMAS J. SILHAVY
normally avirulent virE2 mutant strain [188]. In addition, VirF, which is also required for virulence, has been shown by similar experiments to be exported into plant cells independent of T-DNA [189]. The mechanism of protein transport from Agrobacterium tumefaciens is not yet clear. VirD4 and 11 different proteins encoded by the virB operon are required for transport of the T-complex and are proposed to form a pilus-like transport apparatus through which the proteins and DNA can pass (Fig. 5, see color plate). The VirB proteins have been fairly well characterized as to their subcellular locations (reviewed in [176]). The proteins appear to form a macromolecular complex that traverses the entire bacterial envelope, leading to the exterior of the cell. This huge complex is most likely a channel that allows secreted proteins to pass from the cytoplasm to the surface of the cell. Starting from the outside, this macromolecular complex is comprised of VirB9 and its companion lipoprotein VirB7. These two proteins form the bulk of the structure that spans the outer membrane and periplasm. VirB6, which is the main integral inner membrane protein, and several other proteins, VirB3, VirB8, and VirB 10, which are associated with the inner membrane, are proposed to form the channel through which the T-complex passes across the inner membrane. In addition, three ATPases, VirD4, VirB 11, and VirB4, are associated with the inner membrane and provide energy for both assembly of the transport complex and secretion of the T-complex. The final component, the VirBl protein, resides in at least two locations in the cell. First, it is located in the large complex between the two membranes. Second, it is cleaved and exported to the surface. VirBl has homology to transglycosylases and has been proposed to bore holes in the peptidoglycan layer and allow pilus assembly to occur. For quite some time, the idea of a pilus-like structure, much like the conjugative F pili encoded by a subset of the tra genes, has been favored as a mechanism of T-complex transport from the bacterial surface to the interior of the plant cell. Until recendy, however, there was no evidence to support this hypothesis. Lai and Kado have now shown that VirB2 actually does form pilus-like structures [190], with VirB5 suggested to be a minor pilin subunit. The signal that directs the VirE2, VirD2, and VirF proteins to the secretion apparatus is not currently known. These proteins do not contain the amino-terminal signal sequences that are recognized by the Sec machinery. Thus, the Type IV systems appear to be Sec-independent. However, pertussis toxin subunits, which may be secreted by a similar mechanism, are synthesized with classical signal sequences and are secreted to the periplasm by Sec-dependent mechanisms. Thus, while it is true that the B. pertussis Ptl proteins, which comprise the pertussis toxin secretion apparatus, are homologous to the Tra and Vir proteins of conjugal plasmid and T-DNA transfer systems, the actual mechanisms of toxin secretion and DNA secretion may be very different. Indeed, some of the proteins that are absolutely required for DNA transfer in the Tra and Vir systems are absent from
2. GERM WARFARE
57
the Ptl system. The Ptl proteins are probably responsible for secreting the pertussis toxin from the periplasm, while the Tra and Vir proteins are transferring molecules from the cytoplasm [173]. Perhaps characterization of the Legionella and Helicobacter Type IV systems will provide answers to this dilemma.
VIL Contact-Dependent Secretion: Type III Like the Type I systems, the Type III systems secrete proteins via a Sec-independent mechanism. However, these systems are much more complicated than the three-component ABC transporter systems. The Type III systems, which are sometimes called contact-dependent secretion systems, allow not only secretion but also injection of virulence factors directly into the cytosol of eukaryotic host cells. Type III systems are known in animal pathogens such as Yersinia pestis and other Yersiniae, Shigella flexneri, and Salmonella typhinnirium, as well as plant pathogens such as Pseudomonas syringae and Erwinia species, and they will likely be found elsewhere. Since the Yersinia Ysc system is the best characterized of these systems, it will be our primary focus. For more detailed discussions see [191]. Yersinia secretes a collection of virulence proteins that are inappropriately called Yops (yersinia outer proteins) for historical reasons. While these Yops were known to be essential for virulence for some time, their site of action has been elusive for several reasons (reviewed in [192]). For one, the Yops are not secreted under conditions in which Ca^^ is present at the millimolar levels; the absence of Ca^+ stimulates Yops secretion into the media. This observation was exploited to identify mutants that are secretion defective, and the genes identified were called ysc (Yop secretion) [193]. The Ysc proteins mediate Yop secretion in a Sec-independent manner despite the presence of YscC, a homolog of the Type II outer membrane secretin PulD [193]. Homologs of the Ysc proteins have been found in many pathogenic bacteria such as Salmonella typhimurium (the Inv/Spa proteins). Shigella flexneri (the Mxi/Spa proteins), and Pseudomonas solanacearum (the Hrp proteins) [194-199]. This is not the whole picture, though. Another set of observations complicates the story. The secreted Yops aggregate terribly in the extracellular medium, and adding them direcdy to eukaryotic cells has no cytotoxic effects. The real breakthrough in characterization of Yersinia secretion came with the observation that the cytotoxic effect of YopE is dependent on the presence of YopD protein. However, this requirement for YopD can be circumvented by direct microinjection of YopE into HeLa cells [200]. Yops must require both secretion out of the bacteria and injection or translocation into the host cell to exert their toxicity. This
58
JILL REISS HARPER AND THOMAS J. SILHAVY
translocation of Yops is mediated by a subset of the Yops, YopD and YopB. This was further supported by two key experiments. In the first, YopE was shown by microscopy to be injected into the host cell in a YopD-dependent manner [201]. Second, a reporter gene (Cya) was fused to YopE, and the enzymatic activity of this hybrid protein was used to demonstrate YopB- and YopD-dependent injection into host cells [202]. Thus, the process of Yop injection occurs in two steps: secretion out of the bacterium and translocation into the eukaryotic host. These two steps require greater than 20 proteins to transfer toxins direcdy from pathogen to host (Fig. 6, see color plate). This direct transfer requires that the cell coregulate secretion and translocation. The bacterial cell senses contact with the host cell via the YopN protein. YopN (LcrE) appears to remain on the surface of the bacterial cell, where it plugs the secretion pore [201, 203, 204]. The TyeA protein, identified in 1998, may also play a role similar to that of YopN; it also localizes to the bacterial cell surface and seems to function in the negative regulation of secretion [205]. When the bacterium contacts a host cell or Ca^"*^ is removed, the secretion channel is unplugged. In Yersiniae, this allows the secretion of factors that negatively regulate the expression of Yops and toxin synthesis commences. It seems that Yersinia might also have a plug on the cytoplasmic side of the secretion apparatus. LcrG may function as a cytoplasmic YopN, with LcrV acting as its inhibitor [206, 207]. In other systems, such as Shigella Ipa secretion, the secreted toxins accumulate in the bacterial cytoplasm prior to the stimulation of secretion by contact with host cells. In the absence of Ca^"^, the fully folded Yops are secreted from the bacterial cytoplasm to the exterior of the cell, where they are retained on the surface or released into the external environment. Secretion probably occurs through a channel-like complex that traverses the entire bacterial envelope. LcrD and its homologs in other organisms function as the channel through the inner membrane [191, 208]. As mentioned earlier, YscC and related proteins show homology to the outer membrane secretins (PulD) from the Type II systems [193]. They localize to the outer membrane [197, 209] and form ringlike multimers through which the Yops could pass [209]. YscJ is a lipoprotein [193] and may function to bridge between the inner and outer membranes. Passage through the inner and outer membranes is likely energized by the cytoplasmic ATPase YscN [210]. Despite this progress, there remain many essential Ysc proteins about which little is known. YscD, J, Q, R, S, T, and U are inner membrane proteins that show homology to the components of the flagellar export apparatus [191, 193, 211]. Accordingly, these proteins, as well as YscO and YscG, are probably part of a macromolecular machine that spans the bacterial envelope [193, 211, 212]. Little is known about the components YscF, I, K, L, and P, except that the F, I, K, and L proteins may be cytoplasmic [191]. The next step, translocation, is facilitated by the formation of a translocator through which the effector Yops are injected into the eukaryotic cell. YopB and
2. GERM WARFARE
59
YopD are thought to form a channel through which the effector Yops can enter the host cytosol. Indeed, these proteins look like transmembrane proteins in contrast to most Yops, which are soluble proteins [213]. Furthermore, YopB has been shown to exhibit a pore-forming hemolytic activity consistent with its role as the pore [214]. More recent evidence, however, suggests that YopD is translocated into the cytosol of the host, which seems inconsistent with its role in forming the translocation pore [215]; the role for YopD in the translocation is, therefore, unclear at this time. LcrV, mentioned earlier as having a role in regulation of secretion, may also have an important role in the translocation process. LcrV has been shown to facilitate the secretion of YopB and YopD and, therefore, may be important for assembhng the translocation machinery [207, 216]. Similarly, TyeA appears to have dual roles since it has been found to participate in translocation in a subset of the Yops [205]. Another factor that is important in translocation of proteins into the host cytosol is YopK. Mutants defective in yopK exhibit an increased cytotoxicity resulting from increased levels of translocated YopE, while overexpression of YopK causes decreased translocation [217]. YopK is not translocated but remains associated with the bacteria from which it is secreted, which supports the hypothesis that YopK acts as a modulator of translocation by negatively controlling the size of the pore through an association with the pore-forming proteins [217]. Another group of proteins important in translocation of Yops into host cells is the chaperones (reviewed in [218]). These chaperones, several of which have been identified, are bacterial cytoplasmic proteins that demonstrate specificity for one or two substrates and are usually named Syc for specific Yop chaperone. SycE, also called YerA, acts as a chaperone for YopE; it binds but does not target YopE to the secretion machinery in the inner membrane [219, 220]. Unlike general chaperones, SycE and the other Syc chaperones bind to a specific sequence on the target protein, and these sequences coincide with the domain required for efficient translocation into eukaryotic cells [221]. The implication is that by binding to these translocation domains the Syc proteins prevent premature interaction of their respective Yops with components of the translocator, YopB and YopD [221]. The Type III chaperones include SycE, SycH (for YopH), SycD (for YopD), and YscB (for YopN) [218, 222]. In Salmonella typhimurium, the Type III secretion system involved in eukaryotic cell invasion has been isolated and visualized [223]. These "needle complexes" clearly resemble the flagellar basal body, and this strengthens the idea that the two systems have a common ancestor [223]. Undoubtedly, the isolation of similar macromolecular structures from organisms with other Type III systems will be forthcoming. Yops were isolated from culture supernatants in the early 1980s [224-226], and later work revealed the genes encoding the Yops and hinted at the mechanism of their regulation [227, 228]. Further examination of the sequence information
60
JILL REISS HARPER AND THOMAS J. SILHAVY
available for the Yops showed that these proteins do not contain typical Sec-dependent amino-terminal signal sequences, nor do they contain the carboxyterminal signals required for secretion by the Sec-independent Type I secretion systems, which was the only known Sec-independent secretion mechanism at the time [229-232]. The use of gene fusion technology narrowed down the Type III signal sequence to the amino-terminal 48 amino acids of the YopH protein; this sequence, fused to a reporter protein, directed the secretion of the reporter by the Yersinia export system [232]. Later studies with other yo/?//and v6>/7£'gene fusions located the signal for secretion in the amino-terminal 11-17 amino acids of the Yops, while the signal for translocation into the eukaryotic cytoplasm requires at least the first 50-70 amino acids [233, 234]. This suggests that the Yops contain several domains—a secretion domain, a translocation domain, and an effector domain [233]. Surprisingly, the secretion domains show very little similarity at the amino acid level [231, 233, 234]. A gene fusion approach reported in 1997 provided insight into the signal recognized by the Ysc secretion machinery [235]. As expected, hybrid proteins containing the first 15 amino acids of YopN fused to neomycin phosphotransferase are efficiendy secreted. Single point mutations that alter any of the YopN amino acids cause no significant reduction in the secretion of the fusion protein. Very unexpected, however, was the observation that frameshift mutations, which alter the entire YopN sequence, have little effect either. These results imply that the signal for Yop secretion lies in the mRNA and that Yop secretion may be coupled with translation [235]. Future work is necessary to determine the nature of the mRNA signal for Yop secretion and to identify the factors that recognize this signal. However, these striking findings present a paradox. Remember that many of the Yops require a cytoplasmic Syc chaperone to be translocated. If, in fact, Yop secretion occurs cotranslationally, there should be no protein in the cytoplasm for the Syc proteins to bind. One possible explanation for these two very different signals is that perhaps Yersinia switches between the signals during different stages of pathogenicity. The mRNA signal facilitates YopE secretion under conditions of Ca^"^ deprivation, yet YopE, in addition to having its first 15 codons intact, must bind to its cognate chaperone, SycE, for translocation into eukaryotic cells [236]. Perhaps secretion into the medium requires different signals than translocation, and Yersinia uses different modes of substrate recognition for these processes. It will be interesting to see if knowledge gained from the Yersinia system applies generally to all Type III systems. For example, is the mRNA signal universal? Does this apply even to flagellar subunits? Certain mechanistic steps must be conserved because selected components from one system can be exchanged with the homologous components from another system [237-240]. Obviously, the characterization of these secretion systems have important clinical applications, but these systems, which so efficiendy inject proteins, also have important biotechnological implications for the delivery of proteins to eukaryodc
2. GERM WARFARE
61
cells, such as their utility as antigen delivery systems for vaccine development [241].
VIIL Concluding Remarks At first glance, the five mechanisms for protein secretion that are conserved among Gram-negative bacteria appear quite diverse. Some work independently of the Sec apparatus—Types 11 and V—and some do not—Types I, III, and IV. The various systems require anywhere from one special component in the case of the autotransporters, to 20 or more components, in the case of the contact-dependent secretion systems. Despite this diversity, however, at least two major themes are emerging. First, whether it is a secretin such as PulD or other proteins such as the P-protein domain of the autotransporters, these secretion systems all possess a putative pore-forming protein that allows passage of the secreted substrate through the outer membrane. Mounting evidence supports a channel for the signal-sequence directed passage of proteins through the bacterial cytoplasmic membrane (SecYEG) or the endoplasmic reticular membrane of eukaryotic cells (the Sec61p complex), and YopBD seems to form a channel that allows Yop passage into the eukaryotic cytosol. Mother Nature seems to have a favored solution to the barrier problem posed by lipid bilayers. Second, we predict that the multiple components of complex secretion systems form a macromolecular machine that spans the Gram-negative cell envelope, and that such structures will likely resemble surface structures such as pili or flagella. This is most strikingly demonstrated by the Type III secretion system in Salmonella. In this case "needle complexes" have been isolated, visualized, and shown to resemble the flagellar basal body. We anticipate that similar techniques applied to the other systems will be fruitful as well.
References 1. PohlSchroder, M., Prinz. W. A.. Hartmann. E.. and Beckwith. J. (1997). Protein translocation in the three domains of life: Variations on a theme. Cell 91, 563-566. 2. Path, M. J., and Kolter, R. (1993). ABC Transporters: Bacterial exporters. Microbiol. Rev. SI, 995-1017. 3. Thanassi, D. G., Saulino, E. T., and Hultgren, S. J. (1998). The chaperone/usher pathway: A major terminal branch of the general secretory pathway. Ciirr. Opiii. Microbiol. 1, 223-231. 4. Blobel, G., and Dobberstein, B. (1975). Transfer of proteins across membranes, I: Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membranebound ribosomes of murine myeloma. J. Cell. Biol. 67. 835-851. 5. Bieker, K. L., Phillips, G. J., and Silhavy, T. J. (1990). The sec and prl genes of Escherichia coli. J. Bioenerg. Biomemb. 22, 291-310. 6. Emr, S. D., Schwartz, M., and Silhavy. T. J. (1978). Mutations altering the cellular localization of the phage lambda receptor, an Escherichia coli outer membrane protein. Proc. Natl. Acad. Sci. U.S.A. 75, 5802-5806.
62
JILL REISS HARPER AND THOMAS J. SILHAVY
7. von Heijne, G. (1985). Signal sequences. The limits of variation. J. Mol Biol 184, 99-105. 8. Fikes, J. D., and Bassford, P. J. J. (1987). Export of unprocessed precursor maltose-binding protein to the periplasm of Escherichia coli cells. J. Bacteriol 169, 2352-2359. 9. Emr, S. D., Hanley-Way, S., and Silhavy, T. J. (1981). Suppressor mutations that restore export of a protein with a defective signal sequence. Cell 23, 79-88. 10. Oliver, D., and Beckwith, J. (1981). E. coli mutant pleiotropically defective in the export of secreted proteins. Cell 25, 2765-2772. 11. Fikes, J. D., and Bassford, P. J. J. (1989). Novel secA alleles improve export of maltose-binding protein synthesized with a defective signal peptide. J. Bacteriol. 171, 402^09. 12. Riggs, P. D., Derman, A. I., and Beckwith, J. (1988). A mutation affecting the regulation of a secA-lacZ fusion defines a new sec gene. Genetics 118, 571-579. 13. Stader, J., Gansheroff, L. J., and Silhavy, T. J. (1989). New suppressors of signal-sequence mutations, prlG, are linked tightly to the secE gene of Escherichia coli. Genes Dev. 3, 1045-1052. 14. Ito, K., Wittekind, M., Nomura, M., Shiba, K., Yura, T, Miura, A., and Nashimoto, H. (1983). A temperature-sensitive mutant of E. coli exhibiting slow processing of exported proteins. Cell 32, 789-797. 15. Akimaru, J., Matsuyama, S., Tokuda, H., and Mizushima, S. (1991). Reconstitution of a protein translocation system containing purified SecY, SecE, and SecA from Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 88, 6545-6549. 16. Brundage, L., Hendrick, J. P, Schiebel, E., Driessen, A. J. M., and Wickner, W. (1990). The purified E. coli integral membrane protein SecY/E is sufficient for reconstitution of SecA-dependent precursor protein translocation. Cell 62, 649-657. 17. Kumamoto, C. A., and Beckwith, J. (1983). Mutations in a new gene, secB, cause defective protein localization in Escherichia coli. J. Bacteriol. 154, 253-260. 18. Gardel, C., Benson, S., Hunt, J., Michaelis, S., and Beckwith, J. (1987). secD, a new gene involved in protein export in Escherichia coli. J. Bacteriol. 169, 1286-1290. 19. Gardel, C., Johnson, K., Jacq, A., and Beckwith, J. (1990). The secD locus of E. coli codes for two membrane proteins required for protein export. EMBO J. 9, 3209-3216. 20. Nishiyama, K. I., Hanada, M., and Tokuda, H. (1994). Disruption of the gene encoding pl2(SecG) reveals the direct involvement and important function of SecG in the protein translocation of Escherichia coli at low temperature. EMBO J. 13, 3272-3277. 21. Duong, P., and Wickner, W. (1997). Distinct catalytic roles of the Sec YE, SecG, and SecDFyajC subunits of the preprotein translocase. EMBO J. 16, 2756-2768. 22. Bost, S., and Belin, D. (1997). prl mutations in the Escherichia coli secG gene. J. Biol. Chem. 272, 4087^093. 23. Duong, R, Eichler, J., Price, A., Leonard, M. R., and Wickner, W. (1997). Biogenesis of the Gram-negative bacterial envelope. Cell 91, 567-573. 24. Cunningham, K., and Wickner, W. (1989). Specific recognition of the leader region of precursor proteins is required for the activation of translocation ATPase of Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 86, 8630-8634. 25. Gannon, P. M., Li, P., and Kumamoto, C. A. (1989). The mature portion of Escherichia coli maltose-binding protein (MBP) determines the dependence of MBP on SecB for export. J. Bacteriol. 171, 813-818. 26. Randall, L. L., Topping, T. B., and Hardy, S. J. S. (1990). No specific recognition of leader peptide by SecB, a chaperone involved in protein export. Science 248, 860-863. 27. Collier, D. N., Bankaitis, V., Weiss, J. B., and Bassford, P J. (1988). The antifolding activity of SecB promotes the export of the E. coli maltose-binding protein. Cell 53, 273-283.
2.
GERM WARFARE
63
28. Kusters, R., deVrije, T., Breukink, E., and deKruijff, B. (1989). SecB stabilizes a translocationcompetent state of purified prePhoE protein. / Biol. Chem. 264, 20827-20830. 29. Lecker, S. H., Driessen, A. J. M., and Wickner. W. (1990). ProOmpA contains secondary and tertiary structure prior to translocation and is shielded from aggregation by association with SecB protein. EMBO J. 9, 2309-2314. 30. Randall, L. L., Topping, T. B., and Hardy. S. J. S. (1994). The basis of recognition of non-native structure by the chaperone SecB. In "The Biology of Heat Shock Proteins and Molecular Chaperones" (R. I. Morimoto, A. Tissieres. and C. Georgopoulos, eds.), pp. 285-298. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 31. Smith, V. R, Hardy, S. J., and Randall, L. L. (1997). Determination of the binding frame of the chaperone SecB within the physiological ligand oligopeptide-binding protein. Protein Sci. 6, 1746-1755. 32. Hartl, E-U., Lecker, S., Schiebel, E., Hendrick, J. P, and Wickner, W. (1990). The binding cascade of SecB to SecA to SecY/E mediates preprotein targeting to the E. coli membrane. Cell 63, 269-279. 33. den Blaauwen, T, Terpetschnig, E., Lakowicz, J. R., and Driessen, A. J. (1997). Interaction of SecB with soluble SecA. FEBS Lett. 416. 35-38. 34. Driessen, A. J. (1993). SecA, the peripheral subunit of the Escherichia coli presursor protein translocase, is functional as a dimer. Biochemistry 32. 13190-13197. 35. Hanein, D., Matlack, K. E., Jungnickel. B.. Plath, K., Kalies, K. U., Miller, K. R., Rapoport, T. A., and Akey, C. W. (1996). Oligomeric rings of the Sec61p complex induced by ligands required for protein translocation. Cell 87, 721-732. 36. Hamman, B. D., Chen, J. C, Johnson, E. E., and Johnson, A. E. (1997). The aqueous pore through the translocon has a diameter of 40-60 A during cotranslational protein translocation at the ER membrane. Cell 89, 535-544. 37. Beckmann, R., Bubeck, D., Grassucci, R.. Penczek, P., Verschoor, A., Blobel, G., and Frank, J. (1997). Alignment of conduits for the nascent polypeptide chains in the ribosome-Sec61 complex. Science 278, 2123-2126. 38. Economou, A., and Wickner, W. (1994). SecA promotes preprotein translocation by undergoing ATP-driven cycles of membrane insertion and deinsertion. Cell 78, 835-843. 39. Eekkes, P., van der Does, C , and Driessen. A. J. (1997). The molecular chaperone SecB is released from the carboxy terminus of SecA during initiation of precursor protein translocation. EMBO J. 16,6105-6113. 40. Duong, E, and Wickner, W. (1997). The SecDFyajC domain of preprotein translocase controls preprotein movement by regulating SecA membrane cycling. EMBO J. 16, 4871-4879. 41. Driessen, A. J., Eekkes, P, and van der Wolk. J. P W. (1998). The Sec system. Cum Opin. Microbiol. 1, 216-222. 42. Economou, A. (1998). Bacterial preprotein translocase: Mechanism and conformational dynamics of a processive enzyme. Mol. Microbiol. 27, 511-518. 43. Powers, T, and Walter, P. (1997). Co-translational protein targeting catalyzed by the Escherichia coli signal recognition particle and its receptor. EMBO J. 16, 4880^886. 44. Kumamoto, C. A., and Beckwith, J. (1985). Evidence for specificity at an early step in protein export in Escherichia coli. J. Bacteriol. 163, 267-274. 45. Phillips, G. J., and Silhavy, T. J. (1992). The E. coli ffh gene is necessary for viability and efficient protein export. Nature 359, 144-146. 46. de Gier, J. W., Mansournia, P., Valent, Q. A., Phillips, G. J., Luirink, J., and von Heijne, G. (1996). Assembly of a cytoplasmic membrane protein in Escherichia coli is dependent on the signal recognition particle. FEBS Lett. 399, 307-309.
64
JILL REISS HARPER AND THOMAS J. SILHAVY
47. Ulbrandt, N. D., Newitt, J. A., and Bernstein, H. D. (1997). The E. coli signal recognition particle is required for the insertion of a subset of inner membrane proteins. Cell 88, 187-196. 48. Valent, Q. A., Scotti, P. A., High, S., de Gier, J. W., von Heijne, G., Lentzen, G., Wintermeyer, W., Oudega, B., and Luirink, J. (1998). The Escherichia coli SRP and SecB targeting pathways converge at the translocon. EMBO J. 17, 2504-2512. 49. Klauser, T, Pohlner, J., and Meyer, T. F. (1993). The secretion pathway of IgA protease-type proteins in Gram-negative bacteria. Bioessays 15, 799-805. 50. Koomey, J. M., and Falkow, S. (1984). Nucleotide sequence homology between the immunoglobulin Al protease genes of Neisseria gonorrhoeae. Neisseria meningitidis, and Haemophilus influenzae. Infect. Immun. 43, 101-107. 51. Poulsen, K., Brandt, J., Hjorth, J. R, Thogersen, H. C , and Kilian, M. (1989). Cloning and sequencing of the immunoglobulin Al protease gene (iga) of Haemophilus influenzae serotype b. Infect. Immun. 57, 3097-3105. 52. Yanagida, N., Uozimi, T, and Beppu, T. (1986). Specific excretion of Serratia marcescens protease through the outer membrane of Escherichia coli. J. Bacteriol. 166, 937-944. 53. Schmitt, W., and Haas, R. (1994). Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: Structural similarities with the IgA protease type of exported protein. Mol. Microbiol. 12,307-319. 54. Henderson, I. R., Navarro-Garcia, P., and Nataro, J. P. (1998). The great escape: Structure and function of the autotransporter proteins. Trends Microbiol. 6, 370-378. 55. Pohlner, J., Halter, R., and Meyer, T. F. (1987). Neisseria gonorrhoeae IgA protease. Secretion and implications for pathogenesis. Antonie Van Leeuwenhoek 53, 479^84. 56. Klauser, T., Kramer, J., Otzelberger, K., Pohlner, J., and Meyer, T. F. (1993). Characterization of the Neisseria IgA beta-core: The essential unit for outer membrane targeting and extracellular protein secretion. J. Mol. Biol. 234, 579-593. 57. Pohlner, J., Halter, R., Beyreuther, K., and Meyer, T F. (1987). Gene structure and extracellular secretion on Neisseria gonorrhoeae IgA protease. Nature 325, 458^62. 58. Halter, R., Pohlner, J., and Meyer, T F. (1984). IgA protease of Neisseria gonorrhoeae: Isolation and characterization of the gene and its extracellular product. EMBO J. 3, 1595-1601. 59. Klauser, T., Pohlner, J., and Meyer, T. F. (1992). Selective extracellular release of cholera toxin B subunit by Escherichia coli: Dissection of Neisseria IgA beta-mediated outer membrane transport. EMBO J. 11, 2327-2335. 60. Jose, J., Jahnig, F, and Meyer, T. F. (1995). Common structural features of IgAl protease-like outer membrane protein autotransporters. Mol. Microbiol. 18, 378-380. 61. Ohnishi, Y., and Horinouchi, S. (1996). Extracellular production of a Serratia marcescens serine protease in Escherichia coli. Biosci. Biotechnol. Biochem. 60, 1551-1558. 62. Strauss, A., Pohlner, J., Klauser, T, and Meyer, T. F. (1995). C-terminal glycine-histidine tagging of the outer membrane protein IgA beta of Neisseria gonorrhoeae. FEMS Microbiol. Lett. Ill, 249-254. 63. Pugsley, A. P., Chapon, C , and Schwartz, M. (1986). Extracellular puUulanase of Klebsiella pneumoniae is a lipoprotein. J. Bacteriol. 166, 1083-1088. 64. He, S. Y, Lindeberg, M., Chatterjee, A. K., and Collmer, A. (1991). Cloned Erwinia chrysanthemi out genes enable Escherichia coli to selectively secrete a diverse family of heterologous proteins to its milieu. Proc. Natl. Acad. Sci. U.S.A. 88, 1079-1083. 65. Reeves, P. J., Whitcombe, D., Wharam, S., Gibson, M., Allison, G., Bunce, N., Barallon, R., Douglas, P, Mulholland, V., Stevens, S., Walker, D., and Salmond, G. P C. (1993). Molecular cloning and characterization of 13 out genes from Erwinia carotovora subspecies carotovora: Genes encoding members of a general secretion pathway (GSP) widespread in gram-negative bacteria. Mol. Microbiol. 8, 443-456.
2.
GERM WARFARE
65
66. Filloux, A., Bally, M., Ball. G., Akrim. M.. Tommassen. J., and Lazdunski, A. (1990). Protein secretion in Gram-negative bacteria: Transport across the outer membrane involves common mechanisms in different bacteria. EMBO J. 9, 4323^329. 67. Howard, S. P., Critch, J., and Bedi. A. (1993). Isolation and analysis of eight exe genes and their involvement in extracellular protein secretion and outer membrane assembly in Aewmonas hydrophila. J. Bacterial. 175, 6695-6703. 68. Dums, F., Dow, J. M., and Daniels, M. J. (1991). Structural characterization of protein secretion genes of the bacterial phytopathogenX<://zr/?<';/»c;/z<:/.s campestris pathovar campesths: Relatedness to secretion systems of other gram-negative bacteria. Mol Gen. Genet. 229, 357-364. 69. Sandkvist, M., Michel, L. O., Hough. L. P., Morales. V. M., Bagdasarian, M., Koomey, M., DiRita, V. J., and Bagdasarian, M. (1997). General secretion pathway {eps) genes required for toxin secretion and outer membrane biogenesis in Vibrio cholerae. J. Bacteriol. 179, 6994-7003. 70. Whitchurch, C. B., Hobbs, M.. Livingston. S. P. Krishnapillai. V.. and Mattick, J. S. (1991). Characterization of a Pseiidomonas aeruginosa twitching motility gene and evidence for a specialised protein export system widespread in eubacteria. Gene 101, 33-44. 71. Hobbs, M., and Mattick, J. S. (1993). Common components in the assembly of type 4 fimbriae, DNA transfer systems, filamentous phage and protein-secretion apparatus: A general system for the formation of surface-associated protein complexes. Mol. Microbiol. 10, 233-243. 72. Russel, M. (1998). Macromolecular assembly and secretion across the bacterial cell envelope: Type II protein secretion systems. /. Mol. Biol. 279. 485^99. 73. Pugsley, A. P. (1993). The complete general secretory pathway in Gram-negative bacteria. Microbiol. Rev. 57, 50-108. 74. Pugsley, A. P., and Possot. O. (1993). The general secretory pathway of Klebsiella oxytoca: No evidence for relocalization or assembly of pilin-like PulG protein into a multiprotein complex. Mol. Microbiol. 10, 665-674. 75. Pugsley, A. P. (1996). Multimers of the precursor of a type IV pilin-like component of the general secretory pathway are unrelated to pili. Mol. Microbiol. 9. 295-308. 76. Pugsley, A. P., and Dupuy, B. (1992). An enzyme with type IV prepilin peptidase activity is required to process components of the general extracellular protein secretion pathway of Klebsiella oxytoca. Mol. Microbiol. 6, 751-760. 77. Nunn, D., Bergman. S., and Lory. S. (1990). Products of three accessory genes, pilB, pilC, and pilD, are required for biogenesis of Pseudonionas aeruginosa pili. J. Bacteriol. Ill, 2911-2919. 78. Strom. M. S., Nunn, D., and Lory, S. (1991). Multiple roles of the pilus biogenesis protein PilD: Involvement of PilD in excretion of enzymes from Pseudomonas aeruginosa. J. Bacteriol. 173, 1175-1180. 79. Nunn, D. N., and Lory, S. (1991). Product of the Pseudomonas aeruginosa gene pilD is a prepilin leader peptidase. Proc. Natl. Acad. Sci. U.S.A. 88. 3281-3285. 80. Nunn, D. N., and Lory, S. (1992). Components of the protein-excretion apparatus of Pseudomonas aeruginosa are processed by the type IV prepilin peptidase. Proc. Natl. Acad. Sci. U.S.A. 89,47-51. 81. Bally, M., Ball, G., Badere. A., and Lazdunski. A. (1991). Protein secretion in Pseudomonas aeruginosa: The xcpA gene encodes an integral inner membrane protein homologous to Klebsiella pneumoniae secretion function protein PulO. J. Bacteriol. 173, 479-486. 82. Bally, M., Filloux, A., Akrim, M., Ball. G., Lazdunski. A., and Tommassen. J. (1992). Protein secretion in Pseudomonas aeruginosa: Characterization of seven xcp genes and processing of secretory apparatus components by prepilin peptidase. Mol. Microbiol. 6, 1121-1131. 83. Nunn, D. N., and Lory, S. (1993). Cleavage, methylation, and localization of the Pseudomonas aeruginosa export proteins XcpT. -U, -V. and -W. J. Bacteriol. 175, 4375-4382.
66
JILL REISS HARPER AND THOMAS J. SILHAVY
84. Reyss, I., and Pugsley, A. R (1990). Five additional genes in the pulC-0 operon of the Gram-negative bacterium Klebsiella oxytoca UNF5023 which are required for pullulanase secretion. Mol Gen. Genet. 222, 176-184. 85. Genin, S., and Boucher, C. A. (1994). A superfamily of proteins involved in different secretion pathways in Gram-negative bacteria: Modular structure and specificity of the A^-terminal domain. Mol. Gen. Genet. 243, 112-118. 86. Russel, M. (1994). Phage assembly: A paradigm for bacterial virulence factor export? Science 265, 612-614. 87. Hardie, K. R., Lory, S., and Pugsley, A. P. (1996). Insertion of an outer membrane protein in Escherichia coli requires a chaperone-like protein. EMBO J. 15, 978-988. 88. Martin, P R., Hobbs, M., Free, P D., Jeske, Y, and Mattick, J. S. (1993). Characterization of pilQ, a new gene required for the biogenesis of type 4 fimbriae in Pseudomonas aeruginosa. Mol. Microbiol. 9, 857-868. 89. Drake, S. L., and Koomey, M. (1995). The product of the pilQ gene is essential for biogenesis of type-IV pili in Neisseria gonorrheae. Mol. Microbiol. 18, 975-986. 90. Linderoth, N. A., Model, P., and Russel, M. (1996). Essential role of a sodium dodecyl sulfate-resistant protein IV multimer in assembly-export of filamentous phage. J. Bacteriol. 178, 1962-1970. 91. Linderoth, N. A., Simon, M. N., and Russel, M. (1997). The filamentous phage pIV multimer visualized by scanning transmission electron microscopy. Science 278, 1635-1638. 92. Bitter, W., Koster, M., Latijnhouwers, M., de Cock, H., and Tommassen, J. (1998). Formation of oligomeric rings by XcpQ and PilQ, which are involved in protein transport across the outer membrane oi Pseudomonas aeruginosa. Mol. Microbiol. 27, 209-219. 93. d'Enfert, C , Reyss, I., Wandersman, C , and Pugsley, A. P. (1989). Protein secretion by gram-negative bacteria. Characterization of two membrane proteins required for pullulanase secretion by Escherichia coli K-12. J. Biol. Ghent. 264, 17462-17468. 94. Hardie, K. R., Seydel, A., and Guilvout, I. (1996). The secretin-specific, chaperone-like protein of the general secretory pathway: Separation of proteolytic protection and piloting functions. Mol. Microbiol. 22, 967-976. 95. Pugsley, A. P., and Reyss, I. (1990). Five genes at the 3' end of the Klebsiella pneumoniae pulC operon are required for pullulanase secretion. Mol. Microbiol. 4, 365-379. 96. Possot, O., d'Enfert, C , Reyss, I., and Pugsley, A. P. (1992). Pullulanase secretion in Escherichia coli K-12 requires a cytoplasmic protein and a putative polytopic cytoplasmic membrane protein. Mol. Microbiol. 6, 95-105. 97. Possot, O., and Pugsley, A. P. (1994). Molecular characterization of PulE, a protein required for pullulanase secretion. Mol. Microbiol. 12, 287-299. 98. Sandkvist, M., Bagdasarian, M., Howard, S. P., and DiRita, V. J. (1995). Interaction between the autokinase EpsE and EpsL in the cytoplasmic membrane is required for extracellular secretion in Vibrio cholerae. EMBO J. 14, 1664-1673. 99. Hamood, A. N., Olson, J. C , Vincent, T. S., and Iglewski, B. H. (1989). Regions of toxin A involved in toxin A excretion in Pseudomonas aeruginosa. J. Bacteriol. 171, 1817-1824. 100. McVay, C. S., and Hamood, A. N. (1995). Toxin A secretion in Pseudomonas aeruginosa: The role of the first 30 amino acids of the mature toxin. Mol. Gen. Genet. 249, 515-525. 101. Lu, H. M., and Lory, S. (1996). A specific targeting domain in mature exotoxin A is required for its extracellular secretion from Pseudomonas aeruginosa. EMBO J. 15, 429^36. 102. Sauvonnet, N., and Pugsley, A. P. (1996). Identification of two regions of Klebsiella oxytoca pullulanase that together are capable of promoting beta-lactamase secretion by the general secretory pathway. Mol. Microbiol. 22, 1-7.
2.
GERM WARFARE
67
103. Pugsley, A., Francetic, O., Possot, O. M., Sauvonnet, N., and Hardie, K. R. (1997). Recent progress and future directions in studies of the main terminal branch of the general secretory pathway in Gram-negative bacteria—a review. Gene 192, 13-19. 104. Hirst, T. R., and Holmgren, J. (1987). Conformation of protein secreted across bacterial outer membranes: A study of enterotoxin translocation from Vibrio cholerae. Proc. Natl. Acad. Sci. U.S.A. 84,7418-7422. 105. Pugsley, A. P., Poquet, I., and Kornacker, M. G. (1991). Two distinct steps in pullulanase secretion by Escherichia coli K12. Mol. Microbiol. 5, 865-873. 106. Pugsley, A. P. (1992). Translocation of a folded protein across the outer membrane via the general secretory pathway in Escherichia coli. Proc. Natl. Acad. Sci U.S.A. 89, 12058-12062. 107. Py, B., Chippaux, M., and Barras, F. (1993). Mutagenesis of cellulase EGZ for studying the general protein secretory pathway in Erwinia chrysanthemi. Mol. Microbiol. 7, 785-793. 108. Hardie, K. R., Schulze, A., Parker, M. W., and Buckley, J. T (1995). Vibrio spp. secret proaerolysin as a folded dimer without the need for disulphide bond formation. Mol. Microbiol. 17, 1035-1044. 109. Braun, P., Tommassen, J., and Filloux, A. (1996). Role of the propeptide in folding and secretion of elastase of Pseudomnas aeruginosa. Mol. Microbiol. 19, 3199-3211. 110. Andro, T, Chambost, J.-P., Kotoujansky, A., Cattaneo, J.. Bertheau, Y., Barras, F., van Gijsegem, F., and Coleno, A. (1984). Mutants of Erwinia chrysanthemi defective in secretion of pectinase and cellulase. / Bacteriol. 160, 1199-1203. 111. Gray, G. L., and Vasil, M. L. (1981). Isolation and genetic characterization of toxin-deficient mutants of Pseudomonas aeruginosa PAO. J. Bacteriol. 147, 275-281. 112. Howard, S. P., and Buckley, J. T (1983). Intracellular accumulation of extracellular proteins by pleiotropic export mutants of Aeromonas hydrophila. J. Bacteriol. 154, 413-418. 113. Kornacker, M. G., Boyd, A., Pugsley, A. P., and Plastow, G. S. (1989). A new regulatory locus of the maltose regulon in Klebsiella pneumoniae identified by the study of pullulanase secretion mutants. J. Gen. Microbiol. 135, 397-408. 114. Wretlind, B., and Pavlovkis, O. R. (1984). Genetic mapping and characterization of Pseudomonas aeruginosa mutants defective in the formation of extracellular proteins. J. Bacteriol. 158, 801-808. 115. Michaelis, S., Chapon, C., d'Enfert, C., Pugsley, A. P, and Schwartz, M. (1985). Characterization and expression of the structural gene for pullulanase, a maltose-inducible secreted protein of Klebsiella pneumoniae. J. Bacteriol. 164, 633-638. 116. d'Enfert, C , Ryter, A., and Pugsley, A. P. (1987). Cloning and expression in Escherichia coli of the Klebsiella pneumoniae genes for production, surface localization and secretion of the lipoprotein pullulanase. EMBO J. 6, 3531-3538. 117. d'Enfert, C , and Pugsley, A. P. (1989). Klebsiella pneumoniae pulS gene encodes an outer membrane lipoprotein required for pullulanase secretion. J. Bacteriol. 171, 3673-3679. 118. Whitchurch, C. B., and Mattick, J. S. (1994). Escherichia coli contains a set of genes homologous to those involved in protein secretion, DNA uptake and the assembly of type-4 fimbriae in other bacteria. Gene 150, 9-15. 119. Stojiljkovic, I., Schonherr, R., and Kusters, J. G. (1995). Identification of the hopG gene, a component of Escherichia coli K-12 type II export system, and its conservation among different pathogenic Escherichia coli and Shigella isolates. /. Bacteriol. Ill, 1892-1895. 120. Francetic, O., and Pugsley, A. P. (1996). The cryptic general secretory pathway (gsp) operon of Escherichia coli K-12 encodes functional proteins. J. Bacteriol. 178, 3544-3549.
68
JILL REISS HARPER AND THOMAS J. SILHAVY
121. Koronakis, V., Cross, M., Senior, B., Koronakis, E., and Hughes, C. (1987). The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli. J. Bacteriol 169, 1509-1515. 122. Chang, Y. F., Young, R., Moulds, T. L., and Struck, D. K. (1989). Secretion of the Pasteurella leukotoxin by Escherichia coli. FEMS Microbiol. Lett. 51, 169-73. 123. Letoffe, S., Ghigo, J. M., and Wandersman, C. (1993). Identification of two components of the Serratia marcescens metalloprotease transporter: Protease SM secretion in Escherichia coli is TolC dependent. J. Bacteriol. 175, 7321-7328. 124. Duong, F., Lazdunski, A., Cami, B., and Murgier, M. (1992). Sequence of a cluster of genes controlling synthesis and secretion of alkaline protease in Pseudomonas aeruginosa: Relationships to other secretory pathways. Gene 121, 47-54. 125. Letoffe, S., Delepelaire, R, and Wandersman, C. (1990). Protease secretion by Erwinia chrysanthemi: The specific secretion functions are analogous to those of Escherichia coli alpha-hemolysin. EMBO J. 9, 1375-1382. 126. Gray, L., Mackman, N., Nicaud, J. M., and Holland, I. B. (1986). The carboxy-terminal region of haemolysin 2001 is required for secretion of the toxin from Escherichia coli. Mol. Gen. Genet. 205, 127-133. 127. Oropeza-Wekerle, R. L., Speth, W., Imhof, B., Gentschev, I., and Goebel, W. (1990). Translocation and compartmentalization of Escherichia coli hemolysin (HlyA). J. Bacteriol. Ill, 3711-3717. 128. Delepelaire, P. (1994). PrtD, the integral membrane ATP-binding cassette component of the Erwinia chrysanthemi metalloprotease secretion system, exhibits a secretion signal-regulated ATPase activity. J. Biol. Chem. 269, 27952-27957. 129. Binet, R., and Wandersman, C. (1995). Protein secretion by hybrid bacterial ABC-transporters: Specific functions of the membrane ATPase and the membrane fusion protein. EMBO J. 14, 2298-2306. 130. Letoffe, S., Delepelaire, P., and Wandersman, C. (1996). Protein secretion in Gram-negative bacteria: Assembly of the three components of ABC protein-mediated exporters is ordered and promoted by substrate binding. EMBO J. 15, 5804-5811. 131. Gerlach, J. H., Endicott, J. A., Juranka, P. F, Henderson, G., Sarangi, F, Deuchars, K. L., and Ling, V. (1986). Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature 324, 485-489. 132. Koronakis, V., Koronakis, E., and Hughes, C. (1988). Comparison of the haemolysin secretion protein HlyB from Proteus vulgaris and Escherichia coli: Site-directed mutagenesis causing impairment of export function. Mol. Gen. Genet. 213, 551-555. 133. Koronakis, E., Hughes, C , Milisav, I., and Koronakis, V. (1995). Protein exporter function and in vitro ATPase activity are correlated in ABC-domain mutants of HlyB. Mol. Microbiol. 16, 87-96. 134. Mackman, N., Nicaud, J. M., Gray, L., and Holland, I. B. (1986). Secretion of haemolysin by Escherichia coli. Curr Top. Microbiol. Immunol. 125, 159-181. 135. Thomas, W. D. J., Wagner, S. P., and Welch, R. A. (1992). A heterologous membrane protein domain fused to the C-terminal ATP-binding domain of HlyB can export Escherichia coli hemolysin. J. Bacteriol. 174, 6771-6779. 136. Zhang, F, Sheps, J. A., and Ling, V. (1993). Complementation of transport-deficient mutants of Escherichia coli alpha-hemolysin by second-site mutations in the transporter hemolysin B. / Biol. Chem. 268, 19889-19895.
2.
GERM WARFARE
69
137. Dinh, T., Paulsen, 1. T., and Saier, M. H. J. J. (1994). A family of extracytoplasmic proteins that allow transport of large molecules across the outer membranes of Gram-negative bacteria. J. Bacterial. 176, 3825-3831. 138. Mackman, N., Nicaud, J. M.. Gray, L., and Holland. I. B. (1985). Genetical and functional organisation of the Escherichia coli haemolysin determinant 2001. Mol. Gen. Genet. 201, 282-288. 139. Delepelaire, P., and Wandersman. C. (1991). Characterization, localization and transmembrane organization of the three proteins necessary for protease secretion by the Gram-negative bacterium Erwinia chrysantheuii. Mol. Microbiol. 5. 2427-2434. 140. Schulein, R., Gentschev, I., Mollenkops. J. J., and Goebel. W. (1992). A topological model for the haemolysin translocator protein HlyD. Mol. Gen. Genet. 234, 155-163. 141. Morona, R., and Reeves, P. (1982). The tolC locus of Escherichia coli affects the expression of three major outer membrane proteins. J. Bacteriol. 150. 1016-1023. 142. Hiraga, S., Niki, H., Ogura. T.. Ichinose, C. Mori. H.. Ezaki, B., and Jaffe, A. (1989). Chromosomal partitioning in Escherichia coli: Novel mutants producing anucleate cells. J. Bacteriol. Ill, 1496-1505. 143. Wandersman, C, and Delepelaire, P. (1990). TolC. an Escherichia coli outer membrane protein required for hemolysin secretion. Proc. Natl. Acad. Sci. U.S.A. 87, 4776-4780. 144. Morona, R., Manning. P. A., and Reeves. P. (1983). Identification and characterization of the TolC protein, an outer membrane protein from Escherichia coli. J. Bacteriol. 153, 693-699. 145. Benz, R., Maier, E., and Gentschev. I. (1993). TolC of Eshcerichia coli functions as an outer membrane channel. Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis. 278, 187-196. 146. Koronakis, V., Li, J.. Koronakis. E., and Stauffer, K. (1997). Structure of TolC, the outer membrane component of the bacterial type I efflux system, derived from two-dimensional crystals. Mol. Microbiol. 23, 617-626. 147. Felmlee, T., Pellett, S., Lee, E. Y.. and Welch. R. A. (1985). Escherichia coli hemolysin is released extracellularly without cleavage of a signal peptide. /. Bacteriol. 163, 88-93. 148. Delepelaire, P., and Wandersman. C. (1989). Protease secretion by Erwinia chrysanthemi: Proteases B and C are synthesized and secreted as zynogens without a signal peptide. J. Biol. Chem. leA, 9083-9089. 149. Nicaud, J. M., Mackman, N., Gray, L., and Holland. I. B. (1986). The C-terminal, 23 kDa peptide of £. coli haemolysin 2001 contains all the information necessary for its secretion by the haemolysin (HlyA) export machinery. EEBS Lett. 204, 331-335. 150. Mackman, N., Baker, K., Gray, L., Haigh. R., Nicaud. J. M.. and Holland, L B. (1987). Release of a chimeric protein into the medium from Escherichia coli using the C-terminal secretion signal of haemolysin. EMBO J. 6, 2835-2841. 151. Gray, L., Baker, K., Kenny, B., Mackman. N.. Haigh. R.. and Holland, I. B. (1989). A novel C-terminal signal sequence targets Escherichia coli haemolysin directly to the medium. J. Cell Sci. Siippl. 11, 45-57. 152. Hess, J., Gentschev, L, Goebel, W.. and Jarchau. T. (1990). Analysis of the haemolysin secretion system by PhoA-HlyA fusion proteins. Mol. Gen. Genet. 224. 201-208. 153. Kenny, B., Haigh, R., and Holland. I. B. (1991). Analysis of the haemolysin transport process through the secretion from Escherichia coli of PCM. CAT. or beta-galactosidase fused to the Hly C-terminal signal sequence. Mol. Microbiol. 5. 2557-2568. 154. Koronakis, V., Koronakis, E.. and Hughes. C. (1989). Isolation and analysis of the C-terminal signal directing export oi Escherichia coli hemolysin protein across both bacterial membranes. EMBO J. 8.595-605.
70
JILL REISS HARPER AND THOMAS J. SILHAVY
155. Stanley, P., Koronakis, V., and Hughes, C. (1991). Mutational analysis supports a role for multiple structural features in the C-terminal secretion signal of Escherichia coli hemolysin. Mol Microbiol 5, 2391-2403. 156. Delepelaire, P., and Wandersman, C. (1990). Protein secretion in Gram-negative bacteria: The extracellular metalloprotease B from Erwinia chrysanthemi contains a C-terminal secretion signal analogous to that of Escherichia coli alpha-hemolysin. J. Biol Chem. 265, 17118-17125. 157. Ghigo, J. M., and Wandersman, C. (1992). Cloning, nucleotide sequence and characterization of the gene encoding the Erwinia chrysanthemi B374 metal loprotease secreted via a C-terminal secretion signal. Mol Gen. Genet. 236, 135-144. 158. Ghigo, J. M., and Wandersman, C. (1992). A fourth metalloprotease gene in Erwinia chrysanthemi. Res. Microbiol 143, 857-867. 159. Letoffe, S., Delepelaire, P., and Wandersman, C. (1991). Cloning and expression in Escherichia coli of the Serratia marcescens metalloprotease gene: Secretion of the protease from E. coli in the presence of the Erwinia chrysanthemi protease secretion functions. J. Bacteriol 173, 2160-2166. 160. Kenny, B., Taylor, S., and Holland, I. B. (1992). Identification of individual amino acids required for secretion within the haemolysin (HlyA) C-terminal targeting region. Mol Microbiol 6, 1477-1489. 161. Kenny, B., Chervaux, C , and Holland, I. B. (1994). Evidence that residues -15 to -A6 of the haemolysin secretion signal are involved in early steps in secretion, leading to recognition of the translocator. Mol Microbiol 11, 99-109. 162. Welch, R. A. (1991). Pore-forming cytolysins of Gram-negative bacteria. Mol. Microbiol 60, 101-124. 163. Letoffe, S., and Wandersman, C. (1992). Secretion of CyaA-PrtB and HlyA-PrtB fusion proteins in Escherichia coli: Involvement of glycine-rich repeat domains of Erwinia chrysanthemi protease B. J. Bacteriol 174, 4920-4927. 164. Binet, R., Letoffe, S., Ghigo, J. M., Delepelaire, P, and Wandersman, C. (1997). Protein secretion by Gram-negative bacterial ABC exporters—a review. Gene 192, 7-11. 165. Felmlee, T., Pellett, S., and Welch, R. A. (1985). Nucleotide sequence of an Escherichia coli chromosomal hemolysin. J. Bacteriol 163, 94-105. 166. Nicaud, J. M., Mackman, N., Gray, L., and Holland, I. B. (1985). Characterisation of HlyC and mechanism of activation and secretion of haemolysin from E. coli 2001. FEBS Lett. 187, 339-344. 167. Strathdee, C. A., and Lo, R. Y. (1989). Cloning, nucleotide sequence, and characterizatioin of genes encoding the secretion function of Pasteurella haemolytica leukotoxin determinant. J. Bacteriol 111, 916-928. 168. Letoffe, S., Ghigo, J. M., and Wandersman, C. (1994). Secretion of the Serratia marcescens HasA protein by an ABC transporter. J. Bacteriol 176, 5372-5377. 169. Delepelaire, P., and Wandersman, C. (1998). The SecB chaperone is involved in the secretion of the Serratia marcescens HasA protein through an ABC transporter. EMBO J. 17, 936-944. 170. Gentschev, I., Deitrich, G., Mollenkopf, H. J., Sokolovic, Z., Hess, J., Kaufmann, S. H., and Goebel, W. (1997). The Escherichia coli hemolysin secretion apparatus—a versatile antigen delivery system in attenuated Salmonella. Behring Inst. Mitt. 98, 103-113. 171. Hess, J., Miko, D., Gentschev, I., Dietrich, G., Goebel, W., Mollenkopf, H. J., Ladel, C , and Kaufmann, S. H. (1997). Modulation of antigen display by attenuated Salmonella typhimurium strains and its impact on protective immunity against listeriosis. Behring Inst. Mitt. 98, 160-171.
2.
GERM WARFARE
71
172. Gentschev, I., Glaser, I., Goebel, W., McKeever, D. J.. Musoke, A., and Heussler, V. T. (1998). Delivery of the p67 sporozoite antigen of Theileria pcuya by using recombinant Salmonella dublin: Secretion of the product enhances specific antibody responses in cattle. Infect. Immiin. 66, 2060-2064. 173. Winans, S. C , Burns, D. L., and Christie. P. J. (1996). Adaptation of a conjugal transfer system for the export of pathogenic molecules. Trends Microbiol. 4, 64-68. 174. Segal, G., Purcell, M., and Shuman, H. A. (1998). Host cell killing and bacterial conjugation require overlapping sets of genes within a 22-kb region of the Legionella pneumophila genome. Proc. Natl. Acad. Sci. U.S.A. 95, 1669-74. 175. Vogel, J. P., Andrews, H. L., Wong, S. K., and Isberg, R. R. (1998). Conjugative transfer by the virulence system of Legionella pneumophila. Science 279, 873-876. 176. Christie, P. J. (1997). Agrobacterium tumefaciens T-complex transport apparatus: A paradigm for a new family of multifunctional transporters in eubacteria. J. Bacteriol. 179, 3085-3094. 177. Censini, S., Lange, C , Xiang, Z., Crabtree, J. E., Ghiara, P., Borodovsky, M., Rappuoli, R., and Covacci, A. (1996). cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. U.S.A. 86, 9677-9681. 178. Tummuru, M. K. R., Sharma, S. A., and Blaser, M. J. (1995). Helicobacter pylori picB, a homologue of Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol. Microbiol. 18. 867-876. 179. Pansegrau, W., Schoumacher, F., Hohn, B., and Lanka, E. (1993). Site-specific cleavage and joining of single-stranded DNA by VirD2 protein of Agrobacterium tumefaciens Ti plasmids: Analogy to bacterial conjugation. Proc. Natl. Acad. Sci. U.S.A. 90, 11538-11542. 180. Pansegrau, W., Schroder, W., and Lanka, E. (1993). Relaxase (Tral) of IncP alpha plasmid RP4 catalyzes a site-specific cleaving-joining reaction of single-stranded DNA. Proc. Nad. Acad. Sci. U.S.A. 90, 2925-2929. 181. Waters, V. L., Hirata, K. H., Pansegrau, W.. Lanka. E., and Guiney, D. G. (1991). Sequence identity in the nick regions of IncP plasmid transfer origins and T-DNA borders of Agrobacterium Ti plasmids. Proc. Natl. Acad. Sci. U.S.A. 88, 1456-1460. 182. Lessl, M., Balzer, D., Pansegrau, W.. and Lanka, E. (1992). Sequence similarities between the RP4 Tra2 and the Ti VirB region strongly support the conjugation model for T-DNA transfer. J. Biol. Chem. 267, 20471-20480. 183. Shirasu, K., Koulolikova-Nicola, Z., Hohn, B., and Kado, C. I. (1994). An inner-membrane associated virulence protein essential for T-DNA transfer from Agrobacterium tumefaciens to plants exhibits ATPase activity and similarities to conjugative transfer genes. Mol. Microbiol. 11,581-588. 184. Pohlman, R. F., Genetti, H. D., and Winans. S. C. (1994). Common ancestry between IncN conjugal transfer genes and macromolecular export systems of plant and animal pathogens. Mol. Microbiol. 14, 655-668. 185. Ward, J. E., Akiyoshi, D. E., Regier, D.. Datta, A., Gordon, M. P, and Nester, E. W. (1988). Characterization of the virB operon from an Agrobacterium tumefaciens Ti plasmid. /. Biol. Chem. 263,5804-5814. 186. Thompson, D. V., Melchers, L. S., Idler. K. B.. Schilperoort, R. A., and Hooykaas, P J. (1988). Analysis of the complete nucleotide sequence on the Agrobacterium tumefaciens virB operon. Nucleic Acids Res. 16, 4621-4636. 187. Otten, L., De Greve, H., Leemans, J., Hain, R., Hooykaas, P, and Schell, J. (1984). Restoration of virulence of vir region mutants of Agrobacterium tumefaciens strain B6S3 by coinfection with normal and mutsint Agrobacterium strains. Mol. Gen. Genet. 195, 159-163. 188. Citovsky, V., Zupan, J., Warnick, D., and Zambryski, P. (1992). Nuclear localization of Agrobacterium VirE2 protein in plant cells. Science 256, 1802-1805.
72
JILL REISS HARPER AND THOMAS J. SILHAVY
189. Regensburg-Tuink, A. J. G., and Hooykaas, R J. J. (1993). Transgenic N. glauca plants expressing bacterial virulence gene virF are converted into hosts for nopaline strains of A. tumefaciens. Nature 363, 69-1 \. 190. Lai, E. M., and Kado, C. I. (1998). Processed VirB2 is the major subunit of the promiscuous pilus of Agrobacterium tumefaciens. J. Bacterial. 180, 2711-2717. 191. Hueck, C. J. (1998). Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Rev. 62, 379-433. 192. Cornelis, G. R., and Wolf-Watz, H. (1997). The Yersinia Yop virulon: A bacterial system for subverting eukaryotic cells. Mol. Microbiol. 23, 861-867. 193. Michiels, T., Vanooteghem, J.-C., Lambert deRouvroit, C., China, B., Gustin, A., Boudry, R, and Cornelis, G. (1991). Analysis of virC, an operon involved in the secretion of Yop proteins by Yersinia enterocolitica. J. Bacteriol. 173, 4994-5009. 194. Galan, J. E., Ginocchio, C , and Costeas, P. (1992). Molecular and functional characterization of the Salmonella invasion gene invA: Homology of InvA to members of a new protein family. J. Bacteriol. 174, 4338-4349. 195. Allaoui, A., Sansonetti, P. J., and Parsot, C. (1992). MxiJ, a lipoprotein involved in secretion of Shigella Ipa invasins, is homologous to YscJ, a secretion factor of the Yersinia Yop proteins. J. Bacteriol. 174, 7661-7669. 196. Venkatesan, M. M., Buysse, J., and Oaks, E. V. (1992). Surface presentation of Shigella flexneri invasion plasmid antigens requires the products of the spa locus. J. Bacteriol. 174, 1990-2001. 197. Allaoui, A., Sansonetti, P. J., and Parsot, C. (1993). MxiD, an outer membrane protein necessary for the secretion of the Shigella flexneri Ipa invasins. Mol. Microbiol. 7, 59-68. 198. Bergman, T, Erickson, K., Galyov, E., Persson, C , and Wolf-Watz, H. (1994). The IcrB (yscN/U) gene cluster of Yersinia pseudotuberculosis is involved in Yop secretion and shows high homology to the spa gene clusters of Shigella flexneri and Salmonella typhimurium. J. Bacteriol. 176,2619-2626. 199. Huang, H. C , Lin, R. H., Chang, C. J., Collmer, A., and Deng, W. L. (1995). The complete hrp gene cluster of Pseudomonas syringae pv. syringae 61 includes two blocks of genes required for harpin Pss secretion that are arranged colinearly with Yersinia ysc homologs. Mol. Plant Microbe Interact. 8, 733-746. 200. Rosqvist, R., Forsberg, A., and Wolf-Watz, H. (1991). Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect. Immun. 59, 4562-4569. 201. Rosqvist, R., Magnusson, K. E., and Wolf-Watz, H. (1994). Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J. 13, 964-972. 202. Sory, M.-P, and Cornelis, G. R. (1994). Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol. Microbiol. 14, 583-594. 203. Forsberg, A., Viitanen, A. M., Skurnik, M., and Wolf-Watz, H. (1991). The surface-located YopN protein is involved in calcium signal transduction in Yersinia pseudotuberculosis. Mol. Microbiol. 5, 977-986. 204. Persson, C , Nordfelth, R., Holmstrom, A., Hakansson, S., Rosqvist, R., and Wolf-Watz, H. (1995). Cell-surface-bound Yersinia translocate the protein tyrosine phosphatase YopH by a polarized mechanism into the target cell. Mol. Microbiol. 18, 135-150. 205. Iriarte, M., Sory, M.-P, Boland, A., Boyd, A. P, Mills, S. D., Lambermont, I., and Cornelis, G. R. (1998). TyeA, a protein involved in control of Yop release and in translocation of Yersinia Yop effectors. EMBO J. 17, 1907-1918.
2.
GERM WARFARE
73
206. Nilles, M. L., Williams, A. W., Skrzypek, E., and Straley, S. C. (1997). Yersinia pestis LcrV forms a stable complex with LcrG and may have a secretion-related regulatory role in the low-Ca-^ response, y. Bacterial. 179, 1307-1316. 207. Nilles, M. L., Fields, K. A., and Straley, S. C. (1998). The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG. J. Bacterial. 180,3410-3420. 208. Piano, G. V., Barve, S. S., and Straley, S. C. (1991). LcrD. a membrane-bound regulator of the Yersinia pestis low-calcium response. / Bacterial. 173, 7293-7303. 209. Koster, M., Bitter, W., de Cock, H., Allaoui, A., Cornelis, G. R., and Tommassen, J. (1997). The outer membrane component, YscC, of the Yop secretion machinery of Yersinia enterocalitica forms a ring-shaped multimeric complex. Mol. Microbiol. 26, 789-797. 210. Woestyn, S., Allaoui, A., Wattiau, P., and Cornelis, G. R. (1994). YscN, the putative energizer of the Yersinia Yop secretion machinery. J. Bacterial. 176, 1561-1569. 211. Piano, G. V., and Straley, S. C. (1995). Mutations in yscC. yscD, and >\srG prevent high-level expression and secretion of V antigen and Yops in Yersinia pestis. J. Bacterial. Ill, 3843-3854. 212. Payne, P. L., and Straley, S. C. (1998). YscO of Yersinia pestis is a mobile core component of the Yop secretion system. J. Bacterial. 180, 3882-3890. 213. Hakansson, S., Bergman, T., Vanooteghem, J. C, Cornelis, G., and Wolf-Watz, H. (1993). YopB and YopD constitute a novel class of Yersinia Yop proteins. Infect. Innniin. 61, 71-80. 214. Hakansson, S., Schesser, K., Persson, C, Galyov, E. E., Rosqvist, R., Homble, P., and Wolf-Watz, H. (1996). The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. EMBO J. 15, 5812-5823. 215. Francis, M. S., and Wolf-Watz, H. (1998). YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: Evidence of a structural domain necessary for translocation. Mol. Microbiol. 29, 799-813. 216. Sarker, M. R., Neyt, C, Stainier, 1., and Cornelis, G. R. (1998). The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD. J. Bacterial. 180, 1207-1214. 217. Holmstrom, A., Pettersson, J., Rosqvist, R., Hakansson, S., Tafazoli, R, Fallman, M., Magnusson, K.-E., Wolf-Watz, H., and Forsberg, A. (1997). YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane. Mol. Microbiol. 24, 73-91. 218. Wattiau, P., Woestyn, S., and Cornelis, G. R. (1996). Customized secretion chaperones in pathogenic bacteria. Mol. Microbiol. 20, 255-262. 219. Wattiau, P., and Cornelis, G. R. (1993). SycE, a chaperone-like protein of Yersinia enterocalitica involved in the secretion of YopE. Mol. Microbiol. 8, 123-131. 220. Frithz-Lindsten, E., Rosqvist, R., Johansson, L., and Forsberg, A. (1995). The chaperone-like protein YerAof Yersinia pseudotuberculosis stabilizes YopE in the cytoplasm but is dispensable for targeting to the secretion loci. Mol. Microbiol. 16, 635-647. 221. Woestyn, S., Sory, M.-P, Boland, A., Lequenne, O.. and Cornelis, G. R. (1996). The cytosolic SycE and SycH chaperones of Yersinia protect the region of YopE and YopH involved in translocation across eukaryotic cell membranes. Mol. Microbiol. 20, 1261-1271. 222. Jackson, M. W., Day, J. B., and Piano, G. V. (1998). YscB of Yersinia pestis functions as a specific chaperone for YopN. J. Bacterial. 180. 4912-4921. 223. Kubori, T, Matsushima, Y, Nakamura, D., Uralil. J., Lara-Tejero, M., Sukhan, A., Galan, J. E., and Aizawa, S.-I. (1998). Supramolecular structure of the Salmonella typhinmriiun Type III protein secretion system. Science 280, 602-605.
74
JILL REISS HARPER AND THOMAS J. SILHAVY
224. Portnoy, D. A., Moseley, D. A., and Falkow, S. (1981). Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect. Immun. 31, 775-782. 225. Straley, S. C , and Brubaker, R. R. (1981). Cytoplasmic and membrane proteins of yersiniae cultivated under conditions simulating mammalian intracellular environment. Proc. Natl Acad. Sci. U.S.A. 78, 1224-1228. 226. Bolin, I., Portnoy, D. A., and Wolf-Watz, H. (1985). Expression of the temperature-inducible outer membrane proteins of yersiniae. Infect. Immun. 37, 506-512. 227. Comelis, G., Vanooteghem, J.-C, and Sluiters, C. (1987). Transcription of the yop regulon from Y. enterocolitica requires trans acting pYV and chromosomal genes. Microb. Pathogen. 2, 367-379. 228. Mulder, B., Michiels, T., and Comelis, G. (1989). Identification of additional virulence determinants on the pYVe plasmid of Yersinia enterocolitica. Infect. Immun. 57, 2534-2541. 229. Forsberg, A., and Wolf-Watz, H. (1988). The virulence protein Yop5 of Yersinia pseudotuberculosis is regulated at transcriptional level by plasmid pIBl-encoded trans-diCimg elements controlled by temperature and calcium. Mol. Microbiol. 2, 121-133. 230. Michiels, T., and Comelis, G. (1988). Nucleotide sequence and transcription analysis of yop51 from Yersinia enterocolitica W22703. Microb. Pathogen. 5, 449^59. 231. Michiels, T., Wattiau, P, Brasseur, R., Ruysschaert, J.-M., and Comelis, G. (1990). Secretion of Yop proteins by Yersiniae. Infect. Immun. 58, 2840-2849. 232. Michiels, T., and Comelis, G. (1991). Secretion of hybrid proteins by the Yersinia Yop export system./ Bacteriol. 173, 1677-1685. 233. Sory, M.-P, Boland, A., Lambermont, I., and Comelis, G. R. (1995). Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach. Proc. Natl. Acad. Sci. U.S.A. 92, 11998-12002. 234. Schesser, K., Frithz-Lindsten, E., and Wolf-Watz, H. (1996). Delineation and mutational analysis of the Yersinia pseudotuberculosis YopE domains which mediate translocation across bacterial and eukaryotic cellular membranes. J. Bacteriol. 178, 7227-7233. 235. Anderson, D. M., and Schneewind, O. (1997). An mRNA signal for the type III secretion of Yop proteins by Yersinia enterocolitica. Science 278, 1140-1143. 236. Lee, V. T., Anderson, D. M., and Schneewind, O. (1998). Targeting of Yersinia Yop proteins into the cytosol of HeLa cells: One-step translocation of YopE across bacterial and eukaryotic membranes is dependent on SycE chaperone. Mol. Microbiol. 28, 593-601. 237. Groisman, E. A., and Ochman, H. (1993). Cognate gene clusters govem invasion of host epithelial cells by Salmonella typhimurium and Shigella flexneri. EMBO J. 12, 3779-87. 238. Hermant, D., Menard, R., Arricau, N., Parsot, C , and Popoff, M. Y (1995). Functional conservation of the Salmonella and Shigella effectors of entry into epithelial cells. Mol. Microbiol. 17, 781-9. 239. Ginocchio, C. C , and Galan, J. E. (1995). Functional conservation among members of the Salmonella typhimurium InvA family of proteins. Infect. Immun. 63, 729-732. 240. Rosqvist, R., Hakansson, S., Forsberg, A., and Wolf-Watz, H. (1995). Functional conservation of the secretion and translocation machinery for vimlence proteins of yersiniae, salmonellae, and shigellae. EMBO J. 14, 4187-4195. 241. Russmann, H., Shams, H., Poblete, E, Fu, Y, Galan, J. E., and Donis, R. O. (1998). Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281, 565-568.
CHAPTER 3
Regulation of Virulence Gene Expression in Bacterial Pathogens CHARLES J. DORM AN STEPHEN G. J. SMITH
I. II. III. IV. V. VI. VII. VIII. IX. X. XL XII. XIII. XIV. XV. XVI. XVII. XVIII. XIX. XX. XXI. XXII.
Introduction Transcription Initiation Regulatory Protein Families Covalent Modification of Transcription Factors Regulatory Networks The Oxidative Stress Response The Modular Nature of Bacterial Regulatory Proteins The Overlap between Genome Structure and Gene Regulation Other Classes of Protein Regulators DNA Structure and Gene Regulation Stereotypical and Stochastic Events in the Control of Gene Expression The Switch Controlling Type 1 Fimbrial Expression in E. coli Pap Pilus Gene Transcription Contact-Dependent Gene Regulation The Virulence Gene Regulatory Cascade of S. flexneri A Thermometer Protein from the Salmonella Virulence Plasmid Cell-Density-Dependent Regulation Adaptive Mutation Rare tRNAs and Translation Modulation Protein Splicing AntisenseRNA Perspective References
Principles of Bacterial Pathogenesis Copyright © 2001 by Academic Press All rights of reproduction in any form reserved. ISBN 0-12-304220-8
'7C
76 77 79 82 86 87 89 92 94 94 97 101 103 105 106 109 110 114 114 115 115 116 117
76
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
/. Introduction As with other bacterial genes, the expression of most virulence genes seems to be regulated. This is usually rationalized as a mechanism that avoids inappropriate expression of virulence traits while ensuring their rapid expression when they are required. It implies that bacteria have the means to know when to express the genes and when not to. Consequently, those wishing to understand the control of gene expression must consider both the mechanisms of gene regulation and the means by which bacteria interpret their internal and external environments. Most of the pioneering work on bacterial gene regulation was carried out in Escherichia coli K-12 and its near relatives, using as model systems genes coding for carbohydrate utilization and other traits with no obvious role in bacterial virulence. Nevertheless, the lessons learned from these studies have proved to be extremely valuable and in many cases are applicable to virulence genes. In general terms, genes can be regulated positively (activated) or negatively (repressed), and in E. coli repression seems to be the chief method by which gene expression is controlled [1]. Genes can be regulated at transcription or translation, or posttranslationally. Regulation at the transcriptional level, and in particular at the level of transcriptional initiation, is the most efficient method for the obvious reason that it is better to control a complex process at its point of origin rather than further downstream. It is clear that bacteria have invested heavily in transcriptional control mechanisms, and many of these are emerging as control elements in virulence genes. Thinking about bacterial gene regulation has been influenced very strongly by the operon model, in which a dedicated regulatory protein controls simultaneously the expression of a number of sequential genes that are transcribed as a polycistronic message. The operon represents a simple mechanism for coordination of gene expression, and this concept is critical for useful insights into the means by which the transcriptional profile of the entire cell is modulated as the bacterium experiences environmental change. Grouping several operons or individual genes under the command of a common regulatory protein produces a regulon, with all of the members being coregulated in response to a common signal (Fig. 1). Allowing regulon members to belong to more than one regulon produces a networking of regulons, with genes responding to distinct, yet overlapping signals. The challenge of understanding the complexities of these higher levels of coordination is emerging as a key issue in the new era of microbiology that follows determination of the genome sequences of many bacteria. It is within this regulatory complex that virulence genes are located. Many possess dedicated regulators and also display sensitivity to regulatory inputs that are shared with many of the ''housekeeping" genes of the cell. For this reason, an appreciation of bacterial gene regulatory mechanisms in general is a prerequisite for understanding how virulence gene expression is controlled.
3.
REGULATION OF VIRULENCE GENE EXF^RESSION IN BACTERIAL PATHOGENS
77
•^..^;^2^i f-^:s^-.Wi4^m'M~
Fig, 1 Coordinated control of transcription. Four separate genetic loci are shown that respond to a common stimulus. The stimulus acts through two unrelated regulatory proteins, RegA and RegB. This grouping is referred to as a stimulon. Proteins RegA and RegB both control their own regulons of genes by binding to an operator sequence near the promoter (P). In the case of RegA, the regulon consists of independent gene 1, and operon I. which is composed of three cotranscribed genes. In the case of RegB, the regulon consists of operons 2 and 3. composed of two and three cotranscribed genes, respectively. The stimulon shown here consists of all of the genes responding to the stimulus, a total of nine genes.
//. Transcription Initiation The first step in transcription involves recognition and binding of the promoter DNA by RNA polymerase (Fig. 2). The ''standard" bacterial promoter consists of four elements whose locations are given with respect to the transcription start site, + 1. These are the -10 and -35 boxes to which the sigma factor of RNA polymerase binds, the spacer between these boxes, and a recently discovered UP element, which consists of an AT-rich sequence in the region ^ 0 to -60 [2, 3]. For recognition by sigma-70, the ideal sequences for the -10 and -35 boxes are TATAAT and TTGACA, respectively, and the ideal length of the spacer is 17 bp. In general, promoter strength is a function of similarity to these ideal sequences and this spacer length. Differences in the structure of the promoter result in different basal levels of expression. Regulatory features can be imposed to increase or decrease expression with respect to the intrinsic, basal level. Promoter selection is influenced strongly by the type of sigma factor carried by RNA
78
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
A+T-rich UP element
17 bp spacer TGN motif
Fig. 2 RNA polymerase and a sigma-70-dependent promoter. The key elements of the promoter are shown, and consist of the A+T-rich UP element extending from ^ 0 to -60, the -35 and -10 canonical sequences, the 17-bp spacer, and the transcription start site at position +1. The TGN motif, lying immediately to the left of the -10 box, is also shown. The five protein subunits of RNA polymerase are alpha (two copies), beta, beta prime, and sigma. The sigma factor contacts the promoter at the -10 and -35 boxes, while the alpha subunits contact the promoter via their carboxy-terminal domains (CTDs). These domains also contact transcription factors bound upstream of the promoter, while other regulatory protein contacts can be made on polymerase at the beta and the sigma subunits (see text). Alpha NTD represents the amino terminal domain of this protein.
polymerase. Sigma-70 (RpoD) recognizes most bacterial promoters, while other sigma factors such as sigma-32 (RpoH, heat shock), sigma-38 (RpoS, stress and stationary phase), or sigma-54 (RpoN, nitrogen limitation) direct polymerase to other promoters. Selection is made on the basis of the DNA sequence of the promoter. Thus, a requirement by a group of genes for a particular form of RNA polymerase represents a level of transcriptional networking; one can speak of heat shock genes, stationary phase genes, nitrogen-regulated genes, etc. Recruitment of RNA polymerase to the promoter may depend on factors additional to the DNA sequence of the sigma factor recognition motif [4]. These factors may include upstream and downstream DNA sequences, and regulatory proteins. The involvement of regulatory proteins provides a further level of coordinated control, since copies of the same protein may operate at multiple promoters in the genome. Interactions between RNA polymerase and transcription factors usually involve protein-protein contact [5]. Within RNA polymerase, contact is usually made with the carboxy-terminal domain of the alpha subunit or with the sigma-70 subunit, although contact with the P' subunit can also occur [5, 6] (Fig. 2). The nature of the contact depends on the type of regulatory protein and the distance its binding site lies upstream of the promoter. Transcription activator proteins assist RNA polymerase with the formation of an open complex in which the DNA helix at the promoter melts (see below). Some repressor proteins can act by preventing successful transcriptional initiation and elongation through direct allosteric interaction with RNA polymerase; they may achieve
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
79
similar results by altering the local structure of the DNA at the promoter. Other repressor proteins can act simply by interfering sterically with the ability of polymerase to bind to the promoter. In this way, the processes of both closed- and open-complex formation can be regulated positively and negatively, although not every promoter displays each type of regulation [7]. Transcription factors can act on polymerase by recruiting it to the promoter, and the well-characterized cyclic-AMP receptor (CRP) protein works in this way. Recruitment assists polymerase in establishing a closed complex, but it can also play a key role in assisting isomerization to an open complex. Thus, CRP works to recruit RNA polymerase to the lac promoter [8], but it both recruits polymerase and drives formation of an open complex at the gal promoter [9]. In contrast, the unrelated transcription factor NtrC is not involved in recruitment; it instead acts on prebound polymerase. This ATP-dependent enhancer-binding transcription factor activates bacterial promoters recognized by the RpoN (sigma-54) form of RNA polymerase, and it exerts its effect at a distance through DNA looping [10, 11] (Fig. 3). In addition to its much-studied role as a transcription activator, CRP also has the ability to act as a transcription repressor; for example, it can repress the cya gene, encoding adenylate cyclase [12]. It can also exert effects beyond the family of sigma-70-dependent promoters with which it is usually associated; for example, CRP has been shown recently to be able to repress the sigma-54-dependent dctA promoter from Rhizobium meliloti [13]. After an open complex has been created, the template strand can begin to direct polymerization of the transcript. The binding of the initiating NTP can stabilize the open complex. For example, ATP is the initiating NTP in the PI promoter of the rrnB ribosomal RNA gene in E. coli, and the availability of ATP controls the stability of the open complex at this promoter. In this way, the size of the ATP pool, which is determined by the metabolic activity of the cell and is a function of growth rate, dictates the rate at which the rniB PI promoter functions, and hence the rate of synthesis of stable RNA. This provides a mechanistic link between stable RNA synthesis and growth rate [14].
///. Regulatory Protein Families Bacterial transcription factors are usually classified by amino acid sequence comparison with prototypic members of families of DNA-binding proteins, such as the LysR-like and AraC-like protein families [15, 16]. The most common DNA-binding motif in prokaryotic transcription factors is the helix-turn-helix (HTH) structure, and this is utilized by both the AraC and LysR families. A strong correlation has been reported between the position of the HTH motif, and the function of the protein. In repressors, the HTH is usually associated with the amino terminus, while it occurs in the carboxy terminus in activators; the LysR family forms a distinct group with a repressor-like HTH location. The functional significance of the HTH location remains obscure and may simply reflect the evolutionary origins of the proteins [17].
80
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
sigiiia*54 form of RNA polymerase bound to promoter
|>hospho-NtrC uligomer
.|4<>
.24
408
-12
clos^ complex
enhancer
DMA loop
+ATP
iiiRNA
open complex
Fig. 3 DNA looping and NtrC-dependent transcription initiation. The phospliorylated NtrC protein forms an oligomeric structure at an upstream enhancer sequence between positions -108 and -140. RNA polymerase containing sigma-54 is bound to the promoter in a closed complex, DNA looping allows physical contact to occur between NtrC and the bound polymerase, and ATP consumption accompanies isomerization of the closed to an open transcription complex. The sigma factor is lost from the polymerase once transcription is initiated.
Environmental sensing by members of these families often occurs through binding of specific ligands. For example, the LysR protein binds diaminopimelate, a component of the bacterial cell wall [18], while AraC binds arabinose [19]. Ligand binding alters the behavior of these proteins in terms of their interaction with the genes they control. It is believed that the change in protein conformation that results from ligand binding is responsible for conversion of the transcription factor to an active form, either as an activator or repressor [20]. This model of gene regulation in response to a chemical signal is appealing, not least because it is easy to understand. Less accessible are mechanisms by which changes in the physical environment act through such proteins to alter transcription, since no chemical signal may
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
81
be apparent. For example, the SpvR protein of Salmonella typhimurium and related serovars is an LysR-like positive regulator of plasmid-linked spv virulence genes [21-23]. The spv genes are induced during infection of mice, and they are required for full virulence and establishment of a systemic infection [24-26]. Yet, how SpvR detects and transmits to the spv promoters signals associated with adaptation to the environments encountered during mouse infection is still unclear. In some cases, LysR-like proteins have been found to exhibit a two-stage activation of gene promoters. The first stage involves binding of one protein dimer to a promoter-distal high-affinity binding site, and the second involves the recruitment of another protein dimer to a second, lower-affinity promoter-proximal binding site. This second stage may be cofactor dependent and involve a ligand-induced conformational change in the protein-DNA complex that allows transcription to be initiated [27, 28]. Although the SpvR protein interacts with the promoter of the spv structural genes in a way that is consistent with this two-stage model [23], no ligand has been identified that is responsible for its activation of ^/j>v transcription as the bacterium enters the stationary phase of growth. On the other hand, the involvement of the RpoS sigma factor at the SpvR-activated promoters may fulfill the regulatory requirements that ligand-binding normally achieves at sigma-70-dependent promoters controlled by other LysR-like proteins. The AraC-like VirF proteins of enteroinvasive E. coli (EIEC, [29]) and Shigella flexneri [30], both of which regulate homologous sets of invasion genes located on a high-molecular-weight virulence plasmid, the related protein of the same name found in Yersinia species that regulates plasmid-encoded yop virulence gene expression [31], and the VirF homologs Rns [32] and CfaD/CfaR [33] from enterotoxigenic E. coli that control adhesin expression, all activate virulence gene expression in response to increases in temperature. By analogy with AraC, these are probably homodimeric proteins. No ligand has been identified as being required for this process to occur, and, in most cases, few details are available on the mechanism by which activation is achieved in response to the thermal signal. Another important family of transcription factors is related to the proteins CRP and FNR. CRP binds cAMP and functions as a broad-domain regulator of gene expression in bacteria, while FNR has a redox-sensitive iron-binding center and controls expression of many genes under anaerobic conditions. Significandy, from the point of view of the theme of this volume, the cAMP-CRP protein is required by S. typhimurium for virulence in mice [34]. It also contributes to virulence gene regulation in Vibrio cholerae, where it is involved in repression of the genes coding for cholera toxin and the toxin-coregulated pilus [35]. In contrast, the FNR protein is not required by S. typhimurium for mouse virulence [36]. The CRP/FNR family is growing and now includes the dimeric PrfA protein, a major regulator of virulence gene expression in the facultative intracellular pathogen Listeria monocytogenes. In L. monocytogenes, PrfA regulates virulence gene transcription in response to temperature, and once again this regulatory protein does not appear to require a ligand for activadon [37]. The Fur protein is responsible for regulating many genes concerned with iron metabolism in bacteria, and it is highly conserved from species to species. Bacterial
82
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
pathogens of mammalian hosts usually find that available iron levels are extremely low, and they have evolved regulatory circuits that respond to iron concentrations and use these to control the expression of genes that can assist the bacteria in iron acquisition. In addition to iron-uptake systems, bacteria use Fur or a related ironregulatory protein to control the expression of toxin and hemolysin genes. Examples include the Fur-regulated bacteriophage-encoded shiga-like toxin of some pathogenic strains of £. coli, and the DtxR-regulated bacteriophage-encoded diphtheria toxin of Corynebacterium diphtheria [38, 39]. In S. typhimurium, an intact fur locus is required for virulence in mice and for resistance to acid pH stress [40]. On binding Fe^"^, these proteins become proficient for binding at specific operator sequences associated with the promoters they control. In the case of Fur, the binding sites are termed "iron boxes". Fur and its relatives normally act as transcription repressors [41]. As with the AraC and LysR families, the CRP/FNRlike proteins and the iron regulator proteins are active as dimers. This is a general feature of transcription factors in prokaryotes, as it is in eukaryotes. These proteins recognize and bind to specific operator sequences, and these frequently display dyad symmetry (hence the dimeric nature of the proteins). The possession of the appropriate operator sequence by a gene admits it to membership of the regulon controlled by the regulatory protein that binds to that sequence.
IV. Covalent Modification of Transcription Factors Protein phosphorylation is now recognized as an important mechanism by which transcription factor activity in bacteria is modulated in response to environmental cues. The usual arrangement involves an environmental sensor protein with histidine protein autokinase activity that becomes phosphorylated in response to a signal or group of signals. The phosphorylated sensor serves as a substrate, or phosphate donor, for a second protein that elicits a response. This second protein is called a response regulator. In addition to its kinase activity, the sensor often possesses a phosphatase activity that can dephosphorylate the response regulator. These "two-component" regulatory protein partnerships are found in many bacteria, and the chemistry of the phosphorylation and dephosphorylation reactions seems to be highly conserved among members of the family. Many, but by no means all, of the histidine protein kinase sensor proteins are associated with the cytoplasmic membrane, where extracellular domains are believed to be involved in signal reception. Two-component systems regulate environmental responses by the bacterium usually, but not exclusively, at the level of transcription. An exception to the transcriptional response mode involves the use of the phosphotransfer systems in controlling swimming behavior in enteric bacteria [42]. Examples in which the details of two-component regulation have been elucidated most clearly include control of OmpC and OmpF porin expression in E. coli and 5. typhimurium by the EnvZ/OmpR partnership, and the control of nitrogen assimilation in enteric bacteria by the NtrB/NtrC proteins (Fig. 4).
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
83
—C)yter oienibiane-
iicnv-- dnd oihc? tncinbct^ oi the
Ssgtna-54 dependent promoter ol',i?l«4 gene and oilier members of the NtrC reaiilon
Fig. 4 The EnvZ/OmpR and NtrB/NtrC two-component regulatory systems. The EnvZ histidine protein kinase is shown associated with the cytoplasmic membrane, where it detects changes in osmotic pressure. The NtrB histidine protein kinase is a cytosolic protein, and it responds to changes in the level of combined nitrogen in the cell. Both kinases become phosphorylated in response to their cognate signals at conserved histidine residues within the carboxy-terminal domains. Their response regulator partners then remove the phosphates, becoming phosphorylated on aspartate residues within their amino-terminal domains. Phosphorylated OmpR and NtrC are then proficient enough to activate transcription of genes possessing the appropriate binding sites at their promoters for these proteins. Each response regulator has a DNA-binding motif within its carboxy terminal domain. C = carboxy terminus; N = amino terminus.
Two-component regulatory systems, with their distinctive phospho-relay mechanism, are at the heart of several virulence gene networks. These include the PhoP/PhoQ system in S. typhimiiriunu which plays a critical role in survival of the bacterium in macrophages, and the OmpR/EnvZ system, which is crucial for successful infection of mice by the same bacterium using the oral route. Initially, neither of these two-component regulatory systems was linked to the control of virulence genes [43^5]. Now each is seen as a component of a complex regulatory network that includes factors playing a direct role in bacterial virulence. The PhoP/PhoQ system is central to the virulence of S. typhimurium
84
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
[46, 47], while the OmpR/EnvZ system has been shown to influence virulence in Salmonella and Shigella [48, 49]. The PhoQ protein is a membrane-associated histidine protein kinase, while PhoP is a transcription regulator that is involved in activating some genes (collectively called pag, for PhoP-activated genes) and repressing others (prg, PhoP-repressed genes) (Fig. 5). The periplasmically located sensing domain of PhoQ responds to magnesium ions, and the magnesium concentration has a profound modulatory influence on the whole PhoQ/PhoP regulon [50, 51]. The divalent cations bind to an acidic cluster in the sensing domain of the PhoQ protein and apparently lock it into a conformation that cannot signal. This occurs without affecting the oligomeric state of the protein [52, 53]. Following the identification of PhoP/PhoQ as a regulator of virulence genes in S. typhimurium [47], it was discovered that it interacts with a second two-component system to exert a further layer of control on virulence gene transcription [54, 55]. ThtpmrAB locus encodes a two-component system that mediates resistance to the peptide antibiotic polymyxin B and modifications to lipopolysaccharide (LPS). This locus forms an operon with the PhoP-activated gene pagB (also called pmrC), giving PhoP a role in pmrAB gene activation [54] (Fig. 5). PmrB is probably involved in sensing pH. The PmrA protein is the response regulator, and it is in turn responsible for the expression of several genes known to be activated by PhoP This PmrA-mediated activation of pag genes is dependent on the PhoP/PhoQ proteins for induction in response to Mg^"^ limitation but not for pH-mediated induction [55], Despite the overlap between the two systems, PhoP/PhoQ has a domain of influence that is distinct from that of PmrA/PmrB. For example, the PhoP-dependent resistance of S. typhimurium to the NP-1 defensin peptide is not affected by PmrA/PmrB [54]. Thus, the PhoP/PhoQPmrA/PmrB cascade provides a nice illustration of the way in which two phospho-relay systems can be networked. It has been proposed that this network has evolved to assist S. typhimurium to adapt to low Mg^"^ environments, such as that within the phagolysosome of macrophages. Here, S. typhimurium may be forced to use the Mg^^ from its own LPS, with PmrA-dependent modifications allowing the bacterium to maintain LPS integrity [56]. Networking of the type illustrated by PhoP/PhoQ and PmrA/PmrB is distinct from the concept of crosstalk, in which the histidine protein kinase of one partnership can phosphorylate the response regulator of another. While examples of such crosstalk have emerged from work with purified systems in vitro [57, 58], the in vivo significance of crosstalk may not be very great, and in vivo crosstalk of this type may even be detrimental [59]. The role of OmpR/EnvZ in controlling the invasive phenotype of S. flexneri is not well characterized. There are no data showing a direct role for OmpR in the control of specific virulence genes, and it seems likely that OmpR acts indirectly on the invasion genes through its ability to modulate the porin profile of the cell [60]. In S. typhimurium, porin control is a large part of the contribution of OmpR/EnvZ to virulence [61], but other factors are also involved. S. typhimurium
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
85
FmrA*l*
kesi^hiiHH- tii c;itionic
Modilk-alioii ofl IN
pmrii
pm? \
puiiH
Fig. 5 The PhoP/PhoQ-PmrA/PmrB regulatory cascade in S. typhimuriiim. The PmrB and PhoQ proteins are located in the cytoplasmic membrane, where they detect environmental signals and transmit them to their regulons via their cognate response regulators. PmrA and PhoP, respectively. The response regulators are activated by phosphorylation, and PhoP has a role in the positive control of the genes that code for PmrA and PmrB. making them members of the pag (PhoP-activated gene) regulon. C = carboxy terminus: N = amino terminus: prg = PhoP-repressed gene. A possible role for PmrB in pH sensing is indicated by "pH?".
86
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
mutants deficient in OmpR protein expression cannot induce filament formation in HeLa cells [62]. This indicates that OmpR and EnvZ are required for filament induction while the bacterium is inside host cells. This defect is independent of the OmpR-controlled porins, and may reflect a direct role for OmpR in controlling the S. typhimurium genes responsible for filament induction [62]. The ompR locus is also required for Salmonella-pvomoiQd apoptosis of macrophages [63]. OmpR is also involved in controlling interactions between different S. typhimurium cells. This aggregative phenotype involves the agf locus (known as csg in E. coli) coding for curli fimbriae and its normal expression is OmpR-dependent. This locus is also subject to control by the sigma-38 form of RNA polymerase and by the histone-like protein H-NS (see below) [64]. In Salmonella typhi, a pathogen of humans, the EnvZ/OmpR system is required for expression of the Vi polysaccharide; OmpC and OmpF porin expression is also controlled by EnvZ/OmpR in this pathogen [65]. Evidence now points to the use of tyrosine protein phosphorylation in E. coli as a mechanism for achieving pleiotropic effects on gene expression. A gene called typA, which codes for a protein subject to tyrosine phosphorylation, is required for the normal expression of the H-NS nucleoid-associated protein and other proteins [66]. The S. typhimurium equivalent of typA is called bipA, and this gene has been associated with pathogenesis [67]. Further research is required to assess the importance of this form of posttranslational protein modification for global control of bacterial gene expression and virulence.
V. Regulatory Networks Networking of genes and operons is in part a reflection of the distribution of transcription factor-binding sites (operators) throughout the bacterial genome. It also permits overlaps to occur between regulons. For example, the spv virulence genes already referred to depend on the LysR-like protein SpvR for their activation (see the preceding). They also depend on the sigma-38 form of RNA polymerase [68, 69]. Thus, they belong to a large group of coregulated genes (those dependent on sigma-38) and to a much more exclusive group (those controlled by SpvR, i.e., spvR itself and the spvABCD operon). The lac operon of E. coli is repressed by the Lad repressor, a protein with no other known function in the cell. In contrast, the lac operon is activated by the cAMP-CRP complex, which also regulates expression of very many other promoters in the cell. Included in this group is the araBAD operon, which is under the control of the AraC protein. Thus, lac and ara both belong to the cAMP-CRP regulon, while retaining individual regulatory features imposed by the locally acting Lad and AraC proteins, respectively. Among virulence genes, membership of complex regulatory networks is proving to be very common.
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
87
The OmpR/EnvZ and NtrB/NtrC two-component systems also provide examples of overlap with other regulatory pathways in the cell. The OmpR/EnvZ-dependent OmpC and OmpF control pathway is governed primarily by changes in osmolarity, linking regulation of the ompC and ompF genes to other osmotically sensitive genes in the cell, such as the proU operon that encodes an uptake system for compatible solutes required to survive osmotic shock. However, the EnvZ/OmpR two-component system does not control proU, indicating that ompC, ompF, and proU do not constitute a regulon [70]. Instead, these are part of a stimulon, that is, a group of genes influenced by the same environmental signal not necessarily acting through a common regulatory protein. The NtrB/NtrC system controls transcription of the gene coding for glutamine synthetase, and this gene possesses a promoter recognized by the alternative sigma factor, sigma-54 [42]. Thus, this NtrB/NtrC-dependent gene is networked with other sigma-54-dependent genes.
W. The Oxidative Stress Response The networking concept is illustrated nicely by the response of bacteria to oxidative stress. This stress arises when molecular oxygen undergoes reduction to form toxic products such as hydrogen peroxide and superoxide radicals, and these are processed to harmless products by catalase and superoxide dismutase, respectively. In E. coli, there are three forms of superoxide dismutase (CuZnSod in the periplasm, and the cytoplasmically located MnSod and FeSod) and two catalases, HPI, encoded by katG, and the starvation-induced HPII, encoded by the katE gene [71]. The expression of genes encoding factors protective of cells undergoing oxidative stress involves several regulatory proteins. The SoxR and SoxS proteins are two of these, and they control the expression of approximately 10 genes involved in responding to superoxide-generating agents. SoxS is an AraC-like protein that regulates target genes (including sod A, the gene for MnSod), while SoxR is related to the metal-binding mercury regulator MerR, and is both a repressor and activator of transcription. The SoxR protein is homodimeric, and each monomer possesses a redox-sensitive [2Fe-2S] cluster [72]. Oxidation and reduction of this redox center activates or represses SoxR activity as a transcription factor, respectively. SoxR binds to a single regulatory site between the divergently transcribed soxR and soxS genes. This site lies in the unusually long (19 bp) spacer between the -10 and -35 boxes of the soxS promoter, and just downstream of the soxR promoter. Here it represses soxR transcription, whether stimulated by oxidative stress or not. However, on stimulation, SoxR stimulates soxS transcription by more than 30-fold by altering the local conformation of the
88
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
DNA in a way that compensates for the nonstandard length of the spacer element [73, 74]. In addition to SoxR and SoxS, several proteins control sodA expression: this gene is under positive control of the Fnr anaerobic regulator, and under negative control of the ArcA/ArcB aerobic respiration two-component regulatory system and the Fur iron regulatory protein [71, 75]. Therefore, the multiplicity of inputs at the sodA promoter provides an example of the complexity of transcriptional regulatory networking in bacteria. Interestingly, SoxRS has also been found to crossregulate OmpF porin expression in E. coli. This involves SoxRS-mediated activation of the micF antisense RNA, which blocks translation of the ompF mRNA [76]. In this way, the SoxRS system can influence the diffusion of small hydrophilic molecules across the outer membrane of the cell. The case of micF is even more relevant to the topic of networking when one realizes that it is also controlled negatively by the leucine-responsive regulatory protein (LRP) and the nucleoid-associated protein H-NS [77, 78]. These two pleiotropic regulators are discussed in more detail in what follows. The OxyR protein of E. coli and related organisms belongs to the LysR family of transcription regulators, and it activates, among others, the genes coding for HPI catalase and the Dps DNA-binding protein, both of which protect the cell from hydrogen peroxide damage, and it regulates its own gene negatively [79]. Both HPI and Dps are also under the positive transcriptional control of the RpoS sigma factor, making their genes simultaneously members of both the OxyR and RpoS regulons [80, 81]. OxyR is regulated by oxidative stress posttranslationally. It is bound to its operator sites both in the active and the inactive configuration, and it is both the sensor of the signal and regulator of the response. OxyR is activated on oxidation through the formation of a disulfide bond, and it is inactivated when reduced by glutaredoxin, an enzyme whose gene is under OxyR control [82]. OxyR is also responsive to nitrosative stress due to exposure of the bacterium to 5-nitrosothiols [83]. These compounds are found in high concentrations in infectious and inflammatory sites, leading to speculation that OxyR may assist in pathogenesis by helping the bacterium to adapt to 5-nitrosothiols as well as to oxidative stress [83, 84]. Nevertheless, oxyR null mutants of S. typhimurium are fully virulent in Balb/C mice [85]. The oxyS gene lies upstream of oxyR, and the genes are transcribed divergently and coregulated. The product of oxyS is a stable and abundant 109-nucleotide RNA that is induced by oxidative stress in an OxyR-dependent manner and has pleiotropic effects in the cell [86]. One of its functions is to inhibit RpoS in exponentially growing cells undergoing oxidative stress. In stationary phase cells, OxyR is not activated by oxidative stress, and it is thought that RpoS can induce transcription of the katG (HPII catalase) and dps genes to protect the cell in the absence of OxyR activation [86]. In this way, the oxyS small RNA contributes to integration of the oxidative and stationary phase regulons.
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
89
VIL The Modular Nature of Bacterial Regulatory Proteins The two-component systems provide a clear illustration that bacterial regulatory proteins are composed of modules and have been adapted to perform specific functions. In the case of the EnvZ/OmpR pair, EnvZ has an environmental signal-sensing domain in its amino terminus and a signal-transmission domain in its carboxy terminus. The two are divided by a transmembrane domain, which may also function in signaling. The OmpR protein has a signal receiver domain in its amino terminus and a DNA-binding domain in its carboxy terminus. In EnvZ, the signal transmitter is centered around the histidine residue that becomes phosphorylated in response to environmental signals (in this case, an increase in periplasm osmolarity) (Fig. 4). In OmpR, the signal-receiver domain has at its core the aspartic acid residue that will be phosphorylated by EnvZ. These transmitter and receiver domains are found in all examples of the two-component family studied to date. Despite this strong conservation of structure and function, the different family members do very different jobs in the cell. This diversity reflects variety in the structure and function of the signal-reception domains of the histidine protein kinases, and in the regulatory domains of the response regulators. The modular nature of the proteins is confirmed by the results of domain-swapping experiments. By fusing the signal-reception domain of the Tar chemotaxis receptor protein to the signal-transmitter domain of EnvZ, a hybrid protein, Tazl, was generated. Tazl responds to the presence or absence of aspartate (a trait of Tar but not EnvZ) but not to osmolarity (an EnvZ trait), and it regulates porin gene expression in response to aspartate [87]. Some histidine protein kinases possess signal-receiver domains in their carboxy termini. Examples include the BvgS protein of the whooping cough bacterium Bordetella pertussis and the VirA protein of the plant pathogen Agrobacterium tumefaciens [88, 89] (Fig. 6). It is possible that the addition of this module allows signaling to the response regulator proteins to be damped. Thus, signal-receiver domains can be attached to response regulators to modulate a biological function (DNA binding in the case of the Bordetella and Agrobacterium systems), or they can be added to the signal transmitters to modulate signal-to-noise discrimination and signal amplification. The B. pertussis BvgS protein possesses a further module at its carboxy terminus that resembles a transmitter domain, and it seems that both signal transmitter and the receiver domain must be phosphorylated before phosphotransfer to the DNA-binding BvgA response regulator is possible [90] (Fig. 6). Sensor proteins with both transmitter and receiver domains are involved in cell-density-dependent gene regulation (sometimes called quorum sensing) in the marine bacterium Vibrio harveyii (see the below). Here, the bacterium responds to two autoinducers called HAI-1 and HAI-2 through specific interactions with
90
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
N
N TMl
peoplasmic domain
TM! periplasmic domain
TM2
Imker
kjfiase
TM2 linker
iHl kinase domain
domain
receiver domain
D
VirA hislidine prolein kinase of Agrohavterlum
receiver domain
carboxyterminal domain
iHl
D
H
tumefat tens
BvgS histidine protein kinase of Bordetelki pertmsis
Fig. 6 The modular nature of histidine protein kinases and response regulators. The proteins illustrated are Wrkirom Agrobacteriiim tumefaciens (left) and BvgS from Bordetellapertussis (right). Both proteins are associated with the cytoplasmic membrane, and each has two transmembrane sequences (TMl and TM2). The histidines at which the proteins are phosphorylated in the kinase domains are represented by H; BvgS also has such a domain in its carboxy terminus (see text). The aspartate residues that receive phosphate groups are represented by D within the receiver domains. C = carboxy terminal; N = amino terminal.
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
91
the membrane-located sensor proteins LuxN and LuxQ, respectively. Once phosphorylated, these proteins transfer the signal to the DNA-binding protein LuxO, which then activates genes coding for bioluminescence [91]. The response regulators also display a modular structure. For example, proteins that are not involved in phosphotransfer regulatory relationships have been described as having DNA-binding domains similar to that of OmpR. The ToxR protein regulator of cholera toxin gene expression in V. cholerae is one such protein. It is unusual in being a membrane-located DNA-binding protein [92]. Its OmpR-like DNA-binding domain is located in the amino terminus. In contrast, the corresponding domain is located within the carboxy terminus of OmpR. The DNA-binding domain of OmpR is the founding member of a new class of DNA-binding motifs. Called winged-helix-turn-helix transcription factors, OmpR and its relatives bind DNA and interact productively with RNA polymerase [93]. Presumably, ToxR interacts with the transcription machinery in V. cholerae through a similar mechanism, with the proviso that this protein is tethered to the cytoplasmic membrane. ToxR also differs from OmpR in forming heteromeric complexes with the cytoplasmic membrane protein ToxS [94]. Another protein exhibiting similarity to the DNA-binding domain of the OmpR family of transcription factors is the HilA protein of S. typhimurium [95]. Like ToxR, the HilA protein has its DNA-binding domain within its amino terminus. However, this is not a membrane-associated DNA-binding protein. The hilA gene lies within a pathogenicity island, and its product activates transcription of invasion genes located in the same island [95]. Expression of invasion genes is under environmental control, and HilA is believed to play a role in the activation of invasion genes in response to environmental cues. HilA is under the transcriptional control of the SirA (i.e., UvrY) protein, which is a response regulator of the two-component family [96]. Yet, both the sensor responsible for SirA phosphorylation and the signal that controls its phosphorylation remain unknown. ToxR is not unique in being a membrane-associated transcription factor. The CadC protein of E. coli is involved in pH and lysine signaling, and it is a membrane-located DNA-binding protein with an OmpR-type DNA-binding domain [97]. Interestingly, ToxR-regulated genes also respond to pH [92]. Thus, protein modularization has permitted the OmpR winged-helix-turn-helix DNAbinding domain to be utilized in several different settings to influence the expression of both virulence and housekeeping functions in a variety of bacterial species. The MviA protein of S. typhimuhiim (also called RssB and SprE in E. coli) shows homology to response regulators, but only at its amino terminus [98]. The carboxy terminus does not resemble any known DNA-binding motif. This raises the possibility that a signal-reception module common to response regulators has been employed to modulate the activity of MviA in processes other than DNA binding. The MviA protein influences the stability of the RpoS sigma factor, probably by modulating the susceptibility of RpoS to degradation by the ClpXP protease [99-101]. This is consistent with the known role of the mviA gene as a determinant of S. typhimurium virulence in mice [98]. This theme of protein
92
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
modularization will be revisited in the discussion of the nucleoid-associated proteins H-NS and StpA (see below).
VIIL The Overlap between Genome Structure and Gene Regulation Many of the elements that impose structure on the bacterial genome are emerging as regulators of gene expression. While the bacterial nucleoid lacks the highly organized structure of eukaryotic nucleosomes, there is a degree of structure, and this is imposed partly by the histone-like proteins [102]. Protein H-NS is of particular interest because of the number of virulence systems in which it plays a part. When H-NS influences transcription, it usually acts as a repressor. It forms higher-order multimers on DNA but is not thought to bind a ligand or undergo covalent modification. An example of H-NS as a repressor of virulence gene expression may be found in S. typhimurium, where it regulates spv virulence gene expression [103], or in S.flexneri, where it regulates invasion gene expression [60]. H-NS is a 15.6-kDa polypeptide present in about 18,000 copies per cell. It does not have a consensus sequence for its binding site in DNA; instead it seems to bind to particular structures, especially those showing DNA curvature. H-NS can itself influence the structure of DNA by its ability to constrain supercoils. In this way it can contribute to the compaction of the nucleoid that is essential for its efficient packaging within the confines of the bacterial cell [104, 105]. In E. coli and at least some related organisms, H-NS is partnered by the StpA protein (see below). This protein is 58% identical to H-NS in its amino acid sequence but is present in only about 200 copies per cell. It differs from H-NS in having a strong RNA-binding activity, and it serves a chaperone function in group I intron splicing reactions [106, 103, 108]. These two proteins crossregulate each other's genes negatively [109], and in rich growth media stpA transcription is confined to a narrow window in exponential phase [110]. Like H-NS, StpA can form homomeric higher-order structures. In addition, the proteins can form heteromeric structures with one another, and this may allow a primitive form of regulation if the heteromeric and homomeric structures have distinct biological functions (see below). This is in contrast to the "conventional" transcription factors such as the AraC-, LysR-, CRP-, and FNR-like proteins, which form only homodimers. H-NS and StpA each consist of two domains, connected by a linker sequence [106]. Genetic analyses and protein crosslinking studies show that the amino-terminal domains of these proteins are required for oligomerization, while the carboxy-terminal domains have DNA-binding activity [111-115], and in the case of StpA, RNA-modulating activity [106]. Thus, H-NS and StpA have a modular
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
93
Structure, and individual modules have now been discovered to form components of proteins otherwise unrelated to these two. For example, the pMKlOl plasmidencoded KorB regulatory protein consists of two H-NS-like DNA-binding domains arranged in tandem, while the MdbA protein from plasmid p24-2 has an H-NS-related amino terminus linked to a carboxy-terminal domain with no relationship to H-NS [106]. This raises the possibility that the MdbA protein may form heteromeric complexes with H-NS or StpA, modulating the activities of these proteins as a result. The LEE pathogenicity island of enteropathogenic E. coli (EPEC) encodes an H-NS-like protein [116]. This protein, encoded by Orfl within the pathogenicity island, possesses an H-NS-like DNA-binding domain. The distribution of H-NS-like proteins among bacteria is variable. E. coli and its close relatives Klebsiella pneumoniae, S. flexneri, S. typhimurium, and Serratia marcescens, and the plant pathogen Envinia chrysanthemi all possess an H-NS homolog, as does B. pertussis, Proteus vulgaris, Pseudomonas aeruginosa, and Yersinia enterocolitica [105, 117-122]. The stpA gene has been cloned from E. coli, and S. typhimurium and been detected in E. chrysanthemi and S. flexneri [107, 123, 124]. There is no evidence for either gene in Aeromonas, Bacillus, Clostridium, or Listeria species [105]. The complete genome sequence of Haemophilus influenzae has revealed only one gene coding for an H-NS-like protein [125]. The HU protein of E. coli forms homo- and heterodimers from its alpha and beta subunits. It is an abundant histone-like protein and contributes to both structural and regulatory processes in the genome. HU does not have a consensus DNA sequence for binding; instead, it appears to be a general DNA-binding protein. It is closely related to integration host factor IHF, which in E. coli forms heterodimers exclusively from its alpha and beta subunits [126]. IHF binds to a consensus DNA sequence and can bend DNA by angles up to 180° [127]. This bending activity is central to its biological function, and it plays both structural and regulatory roles in the cell. It can perform the role of a transcription factor and has been shown to influence virulence gene transcription in Neisseria gonorrhoeae, where it controls expression of the pilE pilin gene, and in S. flexneri, where it controls transcription of dedicated virulence gene regulators [128-130]. Like HU, it does not bind a low-molecular-weight ligand. The factor for inversion stimulation, or FIS, is another protein with histone-like properties. FIS forms homodimers exclusively and is involved in both the determination of local nucleoid structure and gene regulation. It plays an important role in site-specific inversions of DNA and in transcriptional activation of stable RNA promoters [131-133]. It can also act as a repressor of transcription [134, 135]. Part of its activity derives from an ability to modulate the transitions in DNA structure that arise as a result of changes in the growth phase of the culture [136]. FIS does not bind a low-molecular-weight ligand, but its concentration is high in cells in the early exponential phase and very low in the stationary phase of growth. This allows FIS to influence gene expression and other genetic events in response to
94
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
growth phase. In contrast, IHF levels are higher in the stationary than in the exponential phase of growth, while HU forms heterodimers mainly in mid-exponential phase, with homodimers occurring outside of this range. These fluctuations in histone-like protein availability and oligomeric state allow this group of proteins to modulate the gene expression profile of the cell in a very dynamic manner. Several genes are influenced by more than one of these proteins, allowing for quite complex regulatory patterns to be achieved. These include the genes coding for the histone-like proteins themselves. For example, H-NS is encoded by the hns gene and its transcription is repressed by H-NS and StpA but activated by PIS. Crossregulation of this form ties the genes of the cell together in tight regulatory networks.
IX. other Classes of Protein Regulators The cAMP-CRP protein might be regarded as lying between the histone-like proteins and conventional transcription regulators. It binds to a well-conserved consensus DNA sequence, is active as a homodimer, and binds a low-molecularweight ligand (cAMP). In addition, it alters DNA structure at the binding site, by bending the DNA by angles of approximately 90°. Another example of such a difficult-to-classify protein is LRP, the leucine-responsive regulatory protein [137]. This DNA-binding protein has a consensus binding site (albeit a rather degenerate one), is active as a homodimer, can bend DNA, and has a ligand-binding capacity. Interestingly, it responds to several nonpolar amino acid ligands (L-leucine, L-alanine, L-valine, and L-isoleucine), and its activity can be potentiated, antagonized, or unaffected by this ligand interaction. The nature of the ligand effect seems to be determined by the system being regulated by LRP. Thus, this protein is a sophisticated control element capable of influencing both DNA structure and gene expression, and doing so in a manner that can link it to amino acid metabolism. The LRP protein is a very prominent regulator of adhesin gene expression in E. coli, as are cAMP-CRP, IHF and H-NS (see below).
X. DNA Structure and Gene Regulation Since promoter function is likely to be influenced by local DNA structure, the influence of DNA structuring elements such as the histone-like proteins is perhaps unsurprising. In addition, one must take account of factors directly influencing the flexibility of the DNA, and the facility with which it may form an open
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
95
transcription complex. Negative supercoiling increases the free energy of the DNA and can assist in isomerization of a closed to an open complex. Environmental stimuli such as osmotic stress can alter the supercoiling level of the DNA, and this can modulate the efficiency of transcription initiation of many genes (see below). In this way, supercoiling variations represent a crude form of regulation, upon which more specific regulatory factors can be superimposed. Supercoiling is controlled by topoisomerases, with DNA gyrase (unique to prokaryotes) introducing negative supercoils while DNA topoisomerase I removes them. Some relaxing activity is also provided by DNA topoisomerases III and IV [138-140]. DNA gyrase is an ATP-dependent enzyme, and this dependency links its activity to the [ATP]/[ADP] ratio in the cell, and hence to metabolic activity. In this way, changes in environmental parameters such as osmolarity, temperature, oxygen availability, and pH, as well as growth phase, which alter the [ATP]/[ADP] ratio, can influence the degree to which bacterial DNA is supercoiled [141-147]. It is well established that transcriptional activity can alter the level of supercoiling of plasmids, and this is likely to be true of the chromosome [148]. These are usually short-range effects caused by perturbation of local DNA topology by the movement of RNA polymerase. The movement through DNA of other complexes, such as the DNA replication machinery, exerts similar effects. This movement can introduce simultaneously positive and negative supercoils into DNA, and these are then relaxed by DNA gyrase and topoisomerase I, respectively [149-151] (Fig. 7). Sensitivity to variations in DNA supercoiling is a function of the promoter sequence and, in many cases, is strongly context-dependent. The normal pattern involves activation by increases in negative supercoiling (or underwinding of the DNA duplex). However, there are examples of promoters that are inhibited by negative supercoiling, and which require a relaxed template for activation. The gyrA and gyrB genes, encoding the subunits of gyrase, have promoters of this type [138]. Since increased negative supercoiling enhances the efficiency of DNA unwinding, the mechanism of supercoiling-driven promoter activation is easy to understand. The mechanism by which DNA relaxation assists promoter activation is less clear. The G-C content of a promoter might be expected to influence the facility with which it can be opened, and hence make it susceptible to the influence of changes in DNA structure, such as supercoiling, that modulate DNA strand separation. Mutations that increase the number of G-C basepairs in a promoter can make it more difficult to melt, and this can be overcome by increased negative supercoiling of the DNA [152]. The G-C-rich discriminator region of stable RNA promoters such as the S. typhimuriwn hisR. a tRNA operon, makes the promoter a member of the stringently controlled regulon. These are genes controlled in response to the alarmones guanosine tetra- and pentaphosphate, and they are only expressed at high levels when the cell is growing rapidly [153]. The G-C-rich discriminator also imposes a well-characterized sensitivity to DNA supercoiling
96
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
highly neijalivel)' %up^r^ml^
Fig. 7 Creation of two domains of supercoiling during transcription. A plasmid with two converging transcription units is divided into domains of relaxed and highly negatively supercoiled DNA when the genes are expressed. Dashed arrows show the directions the transcription complexes (TCs) will take on initiation. Coupled transcription and translation helps to establish the differentially supercoiled domains. Anchoring the ends of the DNA to nonrotatable supports, preventing supercoils from escaping by rotational diffusion, would achieve similar results in the case of single transcription units (see text).
on the promoter [154]. Thus, the nucleotide composition of the promoter can make a major contribution to its sensitivity to changes in DNA supercoiling. It has been suggested that the length of the spacer between the -10 and -35 boxes of the promoter might impose a sensitivity to DNA twist [155]. In one case where this has been carefully investigated, that of the proU promoter of S. typhimurium, which has a 16-bp spacer, DNA twist does not seem to be an issue in the supercoiling response. Instead, supercoiling imparts greater flexibility to the promoter DNA, presumably favoring productive interactions with RNA polymerase [156, 157]. In addition to supercoiling, other aspects of DNA structure contribute to control of gene expression. DNA cruciform extrusion contributes to the complex regulation of the bgl locus in E. coli, which also involves a H-NS protein, DNA gyrase,
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
97
and cAMP-CRP [158]. Loop formation promotes long-range interactions in the DNA, such as contact between regulatory proteins bound to remote sites and RNA polymerase at promoters [159, 160]. This type of action-at-a-distance is central to regulation of transcription by proteins such as the enhancer-binder NtrC [11] (Fig. 3). Such interactions are influenced by the intrinsic flexibility of the DNA, a feature that can be modulated by supercoiling. DNA curvature, a property determined by the base sequence of the DNA, can also influence long-range interactions [161, 162], and serve as a recognition site for the binding of proteins such as H-NS [105] (see above). Protein-induced DNA bending can serve a function similar to curvature, with the added benefit that, because the alteration in the trajectory of the DNA is protein dependent, it can be regulated by the availability of the protein and the accessibiHty of its binding site [163]. IHF is an excellent example of a protein that performs such a reversible DNA bending function, promoting long-range interactions in the genome [127].
XL Stereotypical and Stoctiastic Events in ttie Controi of Gene Expression The individual members of a clonal population of bacteria in a homogeneous environment might be expected to respond identically to a newly perceived stimulus. For example, if a pure culture of E. coli K-12 is subjected to a sudden drop in temperature, one might anticipate that the cold shock-inducible genes will be activated in every cell to a similar level. This is an example of a stereotypical response at the level of the gene to environmental stress. Tools for analyzing the expression of a given gene in individual cells within the population (as opposed to aggregate measurements of the entire population) have only become available recently, and there is little hard information on just how uniform such stereotypical responses are through the population. Nevertheless, data from studies of the survival of bacteria under stress indicate that in apparently homogeneous populations some cells are more prepared than others to deal with the environmental assault. Presumably, some of this inequality reflects variation at the level of the gene in the population, and may be influenced by the existence of microenvironments that alter gene expression sufficiently to give some population members an advantage (or place them at a disadvantage) in comparison with their apparendy identical neighbors. It may also reflect the operation of mutagenic processes within the population (see below). Variation could be achieved by exerting conventional gene regulatory mechanisms to differing extents in different cells of a clonal population. A role for microenvironmental influences is easy to imagine in such a scenario. For example, in a static liquid culture, cells at the liquid-air interface would experience a
98
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
different set of external stimuli to those within the body of the liquid. Thus, the gene expression profile of the interfacial cells will differ from those in the bulk liquid environment. Cells moving between these environments might display a third profile of gene expression, and so on for each subcategory of environment that may exist in this apparently homogeneous world. Of course, the environments encountered by bacterial pathogens during infection are much more complex than those experienced during laboratory growth and probably result in a very wide range of variation in the levels to which particular genes are expressed in the infecting population. In addition to conventional gene regulatory mechanisms, bacterial cells also possess the means to generate phenotypic diversity through altering the structure of the genome. These alterations can be extremely modest, as in methylation of a critical residue at a regulatory motif in the DNA, or more extensive, involving rearrangements of large stretches of DNA [164, 165]. Processes of this type that operate in a reversible manner are described as genetic switches. This distinguishes them from mutations, that is, small or large changes to the genome that are irreversible, or that reverse very rarely. An example of a reversible mutation is the insertion in a gene of a transposable element that subsequently leaves by precise excision, restoring gene function to normal. Genetic switches underlie the process of phase variation, in which a gene can exist in an expressed or nonexpressed state, with the state varying from cell to cell in the population. Switching between states can appear random, and phase variation is often regarded as an example of a stochastic genetic process. However, in some of the better-studied examples, clear roles are emerging for environmental stimuli in determining the rates at which such switches operate, and even in determining the directionality of the switch (i.e., favoring one phase or the other). Furthermore, regulatory features are being discovered that control the operation of the switch, and these may be under environmental control. Thus, these switches may not operate so randomly after all. Examples of genetic switches controlling phase and antigenic variation include inversion systems where a promoter is alternately connected and disconnected from the gene it transcribes, e.g., the fim switch controlling type 1 fimbrial expression in E. coli (Fig. 8) [166]; the tfp inversion system controlling adhesin expression in Moraxella lacunata [167]; shutde systems that move portions of genes into and out of expression sites in the genome, using an archive of silent gene copies as a source of alternative versions of a gene (such as the RecA-dependent pilus variation in N. gonorrhoeae [168]; Fig. 9); small RecA-independent sequence deletions or additions that involve slipped-strand mispairing among short directly repeated DNA sequences, altering the reading frame of genes coding for surface-expressed proteins (e.g., the opacity protein genes of A^. gonorrhoeae and A^. meningitidis', [169, 170]); the lipopolysaccharide loci of //. influenzae [171] (Fig. 10); alterations in the number of residues making up polymeric repeats that change the transcription or translation of the gene affected. This mechanism can influence transcription by altering the spacing of the elements of the gene
3.
99
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
JimB
fimA
fmit SM3^]-4_
P llll^sili'l
T
shvsLL}
ON phase
fill'MU 2
mu
f
I IN \ imri'sioii CIIM- CO sitr-spritlH rrcomhiinilion ;«t Ikl and IKk
I
nil- Mie I
IRI
^S-C^
f/rr phase
F/g. ^ The switch controUing expression of type 1 fimbriae in Escherichia coli. ThtfimA gene codes for the major subunit of type 1 fimbriae, and its promoter is carried on a 314-bp segment of invertible DNA (the//m switch). GQUtsfimB and fimE encode recombinases for inverting the switch between ON and OFF phases. In the ON phase, the /•//??A promoter (PfimA) is directed toward the fimA gene; in the OFF phase, it is directed away. In the expanded views of the switch, binding sites for the recombinases are shown, and these overlap the inverted repeats IRL and IRR, which undergo recombination during DNA inversion. Also shown are binding sites for the accessory proteins integration host factor (IHF, two sites) and the leucine responsive regulatory protein (LRP, three sites).
100
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
pilE gene mciy
nic5
mc4
mc3
riic6
mc5
nic4
inc3
m^ m^ w^ w^ w^mmm wk
pits (silent)
met
I RecrA-ciepcndent homologous recombinaiiDO
s
/ii7£ gene mc6
rTic5
riic4
iiii-3
2gg% W^
inc I
~m^
w/A w/A mmmk mc6
riicS
iiic4
mc3
rtw I
pUS {silent)
- Highly cufiscTvcd srt|yeiiceh
*iod
- Highly variable sec|yeri€es
F/g. 9 RecA-dependent pilin gene antigenic variation in Neisseria gonorrhoeae. The structures of the pilE pilin gene, and a silent gene, pilS, are shown. The coding sequence of the gene is composed of highly conserved and variable regions, the latter called minicassettes (MCs). RecA-dependent reciprocal recombination between the conserved sequences (represented by the crossovers to the left of mc4 and the right of mc2 in the figure) permits genetic information from the silent locus to be shuttled into the expressed locus. The result is a novel pilE gene sequence, coding for a new form of the PilE pilin protein.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
N
(CTCTT)n
N
(CTCTT)9
101
full-length protein
N
(CTCTT)7or8 C out-of-frame; premature termination
Fig. 10 Phase variation in the opacity protein genes of N. gonorrhoeae and N. meningitidis. The opa genes have pentameric repeats of CTCTT within the region coding for the amino-terminal domain of the protein. Variations in the numbers of these repeats result in phase variation due to the effects on the reading frame of losing or gaining repeats. Repeat numbers vary during DNA replication as a result of slipped-strand mispairing, and this may involve the transient creation of novel DNA structures (see text).
promoter (e.g., the hifA and hifB genes of H. influenzae that encode the major subunit protein and the chaperone protein required for fimbrial expression [172]; Fig. 11), by altering the spacing between a promoter and an adjacent regulatory protein-binding site (such as in the case of the //Vn genes of B. pertussis [173]; Fig. 11), or it can alter the reading frame of the gene, interfering with its translation (e.g., iht pi IC pilus assembly gene of N. gonorrhoeae [174]; Fig. 11), the ope outer membrane protein gene of N. meningitidis [175], or the bvgS virulence gene of B. pertussis [176]). Switches of such diversity operate via a number of molecular mechanisms. All involve changes to the structure of the genome, and the rate at which these changes occur can be modulated by several factors. Examples of modulatory influences include the formation of unusual DNA structures, such as triple-stranded H-DNA, or the influence of transcription in the case of neisserial opa genes [177, 178]. These can serve to integrate the operation of the switch with other processes occurring in the genome, and may overrule its apparently random mode of operation.
XIL The Switch Controlling Type 7 Fimbrial Expression in E. coli The genetic switch controlling expression of type 1 fimbrial gene expression in E. coli is proving to be a very valuable guide to the principles by which a random genetic event can be brought under control and, perhaps, made to operate according to a program. The switch consists of a promoter carried within a short
102
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
H, mfluenme fimbriae
•10
hifA
-m (TA)«, ICI
-35
hifB
N. gommrh^eae pUC gene ATG
Gu
!Vfi»t
Oly4
ATG
Gil
Mel
preifi«tiif«
ternifiiatioii
oatHjf-ftnpiiiie
B. pertussis fimbrial gene phase variation iriiiiMrriptltifi factor biiidlftg site
promoler etemrnt fuRclioiiiii prcMittii^r
-|Miiy»C>
I
ddifN^ «ii€ or titort C n^idtte^ traiiscrt|itta«i tmUw binding site
promoter etement -polyC-
J
non^fttticlloiid promoter
Fig. 7/ Phase variation based on homopolymeric DNA tracts. Top: the spacer common to the promoters of the hi/A and hifB genes of H. influenzae contains a poly-TA tract. Loss of TA dinucleotide repeats results in a reduction in promoter efficiency or complete inactivation. Center: the coding region of the pilC gene of A^. gonorrhoeae includes a poly-G tract. Loss of a G residue from this tract results in a shift in the reading frame of the gene and premature termination of translation. Bottom: the spacer between the promoter and binding site for a positive regulator in iht fimS gene of Bordetella pertussis contains a poly-C tract. Loss of C residues from this tract alters the spacing between these elements and makes the promoter nonfunctional.
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
103
stretch of invertible chromosomal DNA. The promoter is required for transcription of the//mA gene, encoding the type 1 fimbrial subunit. The invertible element is flanked by 9-bp inverted repeats, and these form part of the binding sites for the site-specific recombinases that operate the switch. These proteins, FimB and FimE, are encoded by nearby genes {finiB and fimE, respectively), and are members of the integrase family of recombinases [179, 180]. They are very closely related, and show 48% identity in amino acid sequence. The FimB protein can invert the switch in both directions with approximately equal efficiency, whereas the FimE protein has a marked tendency to turn the switch off. Therefore, the switch is subject to directional bias, depending on which recombinase is acting at the inverted repeats at any time. The FimB and FimE recombinases do not act alone. They have requirements for two accessory proteins, IHF and LRP, both of which have been described earlier herein. The IHF protein binds to two sites, one in the switch and one just outside [181] (Fig. 8). The site within the switch is bifunctional since it is also required for operation of the fimA promoter. Without occupancy of this internal site by IHF, the switch ceases to function and the power of the promoter is reduced sevenfold [179]. The contribution of IHF to operation of the switch seems to be architectural; it probably promotes interactions between the inverted repeats and their associated recombinases that are favorable for recombination. A similar role has been described for LRP, which has three binding sites within the switch [182]. LRP interaction with the switch is enhanced by leucine, isoleucine, valine, and alanine, linking switch operation to nonpolar amino acid pools in the cell. The switch is also subject to modulation by H-NS. This protein binds to and represses the promoters of the recombinase genes and may also interact with the switch direcdy, retarding the rate of inversion. The latter possibility is consistent with the preference of H-NS for curved DNA since the fim switch includes DNA elements displaying a strong potential for curvature. In addition to the influences of two recombinases and three accessory proteins, the fim switch is also highly sensitive to the degree of supercoiling of its DNA. Departures from optimal levels of supercoiling can either inactivate the switch (too supercoiled), or cause it to become heavily biased toward one outcome (too relaxed) [183]. All of these influences serve to constrain the freedom of the switch to operate randomly. Instead, it seems to display several dependencies simultaneously. These may serve to direct the switch in ways that benefit the cell during its interacdons with a host, or while it is in a free-living state.
XIII. Pap Pilus Gene Transcription Pap pili assist uropathogenic E. coli in attachment to uroepithelial cells [184]. The pili are expressed at 37°C but not at 23°C, and are subject to phase variadon at the higher temperatures [185]. It has been suggested that low temperature is a cue that the bacteria are outside the host, and so it is unnecessary to express the pili [186]. The control of transcription and phase variation in the pap system is complex and multifactorial. Similar circuitry governs expression of the E. coli F1845 and S pili.
104
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
encoded by the daa and sfa operons, respectively [187]. Phase variation is a function of the differential methylation by the Dam methylase of two GATC sites in the pap regulatory region called GATC-I and GATC-II [188] (Fig. 12). This methylation, involving just two basepairs, represents the modification to the genome that underlies phase variation in the pap system. In Phase-ON cells, GATC-I is unmethylated while GATC-II is methylated; the converse is true in Phase-OFF cells [ 189]. Methylation at these sites is blocked by the LRP protein. In Phase-OFF cells LRP binds cooperatively to three sites (LRP sites 1, 2, and 3) in the pap regulatory region and so blocks methylation of GATC-II (which is part of LRP site 2). In Phase-OFF cells, GATC-I remains available for methylation by Dam. Methylation of GATC-I reduces the affinity of LRP for sites 4 and 5. Failure of LRP to bind at sites 4 and 5 prevents/7(3/?^/transcription, locking cells in the OFF phase until after the next round of DNA replication [188, 190]. The Papl protein collaborates with LRP to block methylation of GATC-I. The proteins form a complex that has enhanced LRP affinity for sites 4 and 5 at GATC-I. Shifting LRP binding to GATC-I frees GATC-II for methylation by the Dam methylase. The LRP protein is a transcription activator when bound to GATC-I but is a repressor when bound to GATC-II [191, 192] (Fig. 12). Transcription of papl is activated by the PapB protein, and the cAMP-CRP complex activates both papB and papl, with cAMP-CRP playing the role of an
^ papB
C^ P papi
1
papA
pupH
binding siie
I •
4
LRP binding sites 5 6 1 2
GATC4
r impBA
3
I
GATC*II
Fig. 12 Phase-variable control oipap gene expression in E. coli. The pap regulatory sequences lying between the divergently transcribed papl and papB genes are shown. In the enlargement, the locations of the six binding sites for LRP, together with the cAMP-CRP-binding sites are shown. The two sites subject to Dam-mediated DNA methylation, GATC-I and GATC-II, are also illustrated, and these are associated with LRP sites 5 and 2, respectively. The promoters for the papl and papBA transcription units are at the borders of the enlarged area.
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
105
antirepressor [193-195]. The nucleoid-associated protein H-NS is involved in thermoregulation of pap gene expression, where it acts as a repressor of transcription at low temperatures [196]. The binding of H-NS to the pap regulatory sequences containing the GATC-I and GATC-II sites prevents methylation, although the mechanism by which this occurs is not understood [186]. Thus, the regulation of pap gene expression occurs at many levels. On top of phase variation, expression of pap responds to the metabolic state of the cell (via cAMP-CRP) and to temperature via a mechanism that involves H-NS.
XIV. Contact'Dependent Gene Regulation The pap genes of uropathogenic E. coli have been implicated in a form of gene activation that is triggered by contact with the host. Induction requires the presence of the PapG adhesin protein that recognizes a specific carbohydrate receptor on uroepithelial cells, and the presence of this receptor. Among the targets of the induction is barA (or airS), a gene required for production of siderophores (iron-chelators) and their receptors, and without which E. coli cannot grow in urine. BarA/AirS shows homology to histidine protein kinases, raising the possibility that it senses Pap-mediated contact and transmits the signal to virulence genes via an unidentified response regulator [197]. In the human and rodent pathogens Yersinia pseudotuberculosis (which causes adenitis and septicaemia), Y. enterocolitica (gastrointestinal infections), and Y. pestis (bubonic plague), contact with host cells results in export of a bacterial transcriptional repressor, allowing previously repressed virulence genes on a plasmid to become activated [198, 199]. The repressor is the LcrQ protein (equivalent to the 57% identical YscMl and YscM2 proteins in K enterocolitica, encoded by closely related genes [200]), and is exported from the bacterial cytosol into the external medium via a plasmid-encoded type III secretion system that is triggered by host-microbe interaction. Plasmid-linked yop virulence genes that are subject to LcrQ repression are then transcribed. LcrQ is more accurately described as an anti-activator, since it inhibits the ability of the LcrF protein to activate yop gene transcription. (LcrF, called VirF in Y. enterocolitica, is an AraC-like transcription factor that responds to temperature.) The LcrQ protein has not been shown to bind to yop DNA, and it may exert its negative regulatory effects indirecdy [198, 201]. This regulatory mechanism is reminiscent of one employed in the control of flagellar biosynthesis in S. typhimurium. There, the counterpart of LcrQ is an anti-sigma factor called FlgM, which is secreted via the type III secretion system used to assemble flagellae and an integral component of the flagellum [202].
106
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
XV. The Virulence Gene Regulatory Cascade of S. flexneri S. flexneri causes bacillary dysentery in humans, and is a facultative intracellular pathogen. The bacteria enter and replicate within the cells of the colonic epithelium, and move between cells. The process involves M-cell entry, basolateral invasion of epithelia, actin-dependent intra- and intercellular movement, and macrophage killing. The genes required for expression of the pathogenic phenotype are located on a high-molecular-weight plasmid. They occupy 31 kb and consist of ipa genes coding for secreted proteins needed for invasion of host cells, the mxi and spa genes encoding components of a type III secretion system required for Ipa protein secretion [203, 204], and regulatory elements that govern the expression of the virulence factors (see below). The S. flexneri virulence gene regulatory system illustrates many points that are of general relevance in bacterial pathogens (Fig. 13). The key genes are grouped in operons under the collective control of a regulatory protein. The specific regulators and all of the structural genes are located on a plasmid, but chromosomally encoded proteins with wide-ranging effects in the cell also influence expression of the virulence genes. Gene expression is under tight control and responds to particular environmental influences. In the S. flexneri system, a considerable amount of molecular detail is available [60], and a very similar system is found in enteroinvasive E. coli (EIEC) [29, 205]. The control regime takes the form of a cascade, at the top of which is an AraC-like protein called VirF. This plasmid-encoded protein binds to and activates transcription of a gene coding for a subordinate regulator called VirB [206]. This protein is presumed to have DNA-binding activity (it shows homology to DNA-binding proteins involved in plasmid maintenance) and is required for transcriptional activation of the structural genes. These are organized in large, divergendy transcribed operons (Fig. 13). The virB regulatory region is the key control element in the cascade. It seems to be occupied by the VirF protein under both activated and nonactivated conditions. Activation requires a temperature of 37°C and physiological levels of osmolarity, together with a pH of 7.4 [207-209]. The pH control is exerted positively via the CpxA/CpxR two-component regulatory system, and CpxR has been shown to bind directly to the upstream region of the v/rFgene [210]. The organization of the genes into a regulatory cascade allows for very tight control of expression coupled with rapid activation of the system once appropriate environmental signals are received. The cascade displays a gearing effect in which the gene at the top, virF, is regulated over only a twofold range, while the next gene, virB, is controlled over a 10-fold range, and the structural genes at the bottom of the cascade experience a 100-fold range of regulation. Control of virF expression is loose at the level of transcription, while virB is more tightly
3.
107
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
i
.^
\ii r II %s
\irl
WW
\)\\-
-'ihni:
i 17^/^
w w Fig. 13 The virulence gene regulatory cascade of Shii^ella flexueri. The virulence regulon occupies approximately 33 kb of a 230-kb virulence plasmid. Large gaps between genes have been deleted for convenience, and are represented by short diagonal lines through the genetic map shown in the center of the figure. The virF and virB genes are illustrated in more detail at the top and bottom of the figure, respectively. Positive regulatory inputs are represented by downward vertical arrows above, and negative influences by T-shaped symbols below the promoter regions. See text for details.
controlled, with the structural genes being under the tightest control of all [211]. This regime seems to ensure that energetically wasteful expression of the structural genes under inappropriate conditions is avoided while allowing for sufficient expression of the regulatory proteins under nonpermissive conditions to facilitate a rapid activation of the structural genes when inducing conditions
108
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
arise. The system also has the capacity to permit fine-tuning of individual structural operon promoters once activation has occurred [211]. The virB promoter provides one of the clearest examples of a role for DNA supercoiling in the environmental activation of a virulence gene [212, 213]. Although the VirF protein is required absolutely for virB promoter activation, no activation occurs at 30°C (i.e., in the absence of a thermal signal) unless the level of supercoiling of the virB promoter is increased by artificial means [213]. Since increases in temperature cause a general increase in negative supercoiling in bacterial DNA, the simplest interpretation of these data is that the change in DNA structure resulting from a transition to growth at 37°C helps either to drive open complex formation or to improve the interaction between bound VirF and RNA polymerase, or both. It is also a possibility that the multimerization of VirF on DNA may be driven by DNA structural changes at the binding site. Other AraC-like proteins, such as the E. coli MelR protein, display DNA-dependent multimer formation that results in a change in their biological activities [214]. The dependence of the virB promoter on DNA structure for activation is also consistent with a requirement for a normal complement of DNA topoisomerases in the cell [212, 215, 216]. In addition, the promoter is repressed by the H-NS nucleoid-associated protein and requires the IHF protein for full activity in stationary phase [118, 130, 212]. Both H-NS and IHF contact the virB regulatory sequences directly. H-NS levels in the cell are maintained at a near-constant value of about 20,000 copies per cell [217], except in cold-shock, when the level increases by about three- to fourfold [218, 219]. One of the tasks of VirF may be to overcome the repression imposed by H-NS at the virB promoter, a task it carries out in collaboration with thermally induced increases in the negative supercoiling of the DNA [60, 220]. As cells enter stationary phase, their DNA becomes relaxed, a situation that would inhibit supercoiling-dependent promoters such as that of the virB gene [141]. The function of IHF in stationary phase may be to offset this negative effect by maintaining the virB promoter in an active conformation [130]. The virF gene is under posttranscriptional control and provides a good example of the power of translational regulation to influence the expression of a virulence gene regulon. Mutations in the miaA gene, coding for the tRNA A^-isopentyladenosine (i^ A37) synthetase, which is required for the synthesis of the modified nucleoside 2-methyl-A^-isopentyladenosine, a component of tRNA, have a negative effect on the translation of virF mRNA, and hence on the expression of the other genes in the regulatory cascade [221]. Normal expression of the virF gene also requires a functional tgt gene (called vacC in S. flexneri) that codes for tRNA-guanine transglycosylase, required for the synthesis of modified bases in tRNA. Mutations in tgt {vacC) interfere negatively with translation of virF mRNA, and hence with expression of the virulence genes that depend on VirF [222]. The location of the S. flexneri virulence genes on a plasmid is also significant. In EIEC, this plasmid has been shown to integrate at a specific location on the chromosome. This integration event is accompanied by shutting down of vim-
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
109
lence gene expression, caused by an H-NS-dependent repression of virB transcription [223]. The plasmid also displays significant instability, being lost from the cell when expression of the virulence genes is induced. The instability depends on the functioning of the virF and virB genes and suggests that expression of the structural gene operons makes the plasmid difficult to maintain [224]. The virulence genes are also prone to inactivation by insertion sequences and to DNA rearrangements. Inactivation of virF and virB prevents virulence gene expression and stabilizes the plasmid, although the significance of this in vitro observation is not understood fully. In the case of insertion sequence mutations, these may reverse precisely in the future, restoring virulence gene expression. Thus, the inactivating mutations may serve as a means of ensuring that the plasmids are maintained in the absence of selective pressure [224]. The S. flexneri virulence gene control network also illustrates the point that both specific and general regulators of gene expression can contribute to control of expression of a particular phenotype. In this case, the phenotype is invasiveness, and the specific control elements (VirF and VirB) are encoded by the virulence plasmid, while the general control elements (H-NS, IHF, the DNA topoisomerases, and the tRNA modification systems) are encoded by the chromosome. The general regulatory elements key the virulence genes into the global gene expression program of the cell, while the specific elements operate at a local level to optimize and fine-tune virulence gene expression.
XVL A Thermometer Protein from ttie Salmonella Virulence Plasmid The tlpA gene on the large virulence plasmid of S. typhimiiriiim encodes an autoregulatory repressor protein called TlpA [225]. This protein responds to changes in temperature by shifting ixom an inactive unfolded monomer to an active folded coiled-coil dimeric protein. Its ability to bind to the tlpA gene promoter and repress it is a function of the intracellular concentration of TlpA (which influences protein-protein interactions) and the thermally determined stmcture of the protein. At 22°C, the promoter is repressed, and derepression occurs as the temperature increases. The shift in the structure of the protein is reversible; in other words, TlpA does not become denatured permanently by increases in temperature. No accessory proteins are required for TlpA action at the tlpA promoter, and thermally induced changes in DNA conformation do not appear to be an issue. It will be interesting to see if more examples of this type of regulatory protein emerge in the future. It has been pointed out that a DNA sequence motif characteristic of the tipA promoter is found in several virulence genes, including spvA on the plasmid, and the PhoP/PhoQ-regulated genes prgH
110
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
and pagC on the chromosome [225]. It will be important to determine which genes, if any, in addition to tlpA are under the control of the TlpA protein.
XVII. CelI'Density'Dependent Regulation Although bacteria are unicellular, they can collaborate to perform certain functions, some of which are of benefit to pathogens during infection of a host. At the heart of these processes Hes a mechanism by which the bacteria sense their own population density. Various forms of bacterial group behavior are regulated by small diffusible self-produced regulatory molecules. Individually, bacteria are incapable of producing the signal in sufficient quantities to elicit a response, but as a population increases in density a critical threshold is crossed and signaling results in a response, usually at the level of transcription, that alters bacterial behavior [226-228]. Early research on cell-density-dependent regulation focused on the bioluminescent phenotype in certain marine bacteria, such as Photobacterium fischeri (formerly Vibrio fischeri). When free-living, and at a low culture density, these bacteria do not emit light. When the population density increases, as during growth in the specialized light organ of the fish with which they have a symbiotic relationship, the bacteria become bioluminescent and emit a blue-green light. This is caused by accumulation of a low-molecular-weight A^-acyl-L-homoserine lactone (AHL) that is synthesized by the bacteria, and sensed by the population. The particular AHL made by P. fischeri is A^-(3-oxo)-hexanoyl-L-homoserine lactone (OHHL). The sensor/regulator is the autoregulatory membrane-associated LuxR protein, and, on binding OHHL, this activates transcription of the bioluminescence genes, which are organized as an operon on the bacterial chromosome (Fig. 14). Also in this operon is the gene for Luxl, which is involved in production of OHHL. Thus, upregulation of the lux operon involves increased transcription of the gene for signal production. It is proposed that downregulation occurs because the LuxR protein is unstable and is subject to rapid turnover by the Lon protease [228]. The population-density-dependent system used by another marine bacterium, V harveyii, has already been discussed in the context of the modular nature of bacterial regulatory proteins (see above). Here, the signal-reception and -transmission system is of the type used by the "two-component" regulators and is based on a phosphotransfer mechanism [91]. Among Gram-negative pathogens, cell-density-dependent regulation based on AHL signaling has been characterized in P aeruginosa, where two systems operate to control expression of a wide array of virulence genes. One system is composed of LasI, a signal generator, and LasR, a response regulator, and is sensitive to A^-(3-oxo)-dodecanoyl-L-homoserine lactone (OdDHL). This controls
3.
11]
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
An\ iteiisih iiiliiiiv
±J
LELJ.
•J^ : .... \
'iih
''oi
;uM
Hiuli dcriMU ciilliire
/
• • • hixi^
'u^i s a . H ; ..
HIOI.UMINESCENCE \
"\J-^V \ .
Fig. 14 Cell-density-dependent gene regulation in Photohactehiim {Vibrio) fischeri. Expression of lux genes is controlled by a diffusible autoinducer (OHHL, see text for details). This is in low concentrations at low culture densities, and the luxICDABEG operon is expressed at a basal level. Autoinducer is synthesized by the Luxl protein, and no single cell can produce enough to induce bioluminescence. At high culture densities, autoinducer levels are sufficient to activate luxICDABEG transcription. This occurs via the LuxR sensor protein, which also acts a repressor of its own gene.
112
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
the expression of alkaline protease, elastase, exotoxin A, exoenzyme S, neuraminidase, and hemolysin. The second system is composed of VsmI (or Rhll), a signal generator, and VsmR (or RhlR), a response regulator. It is sensitive to A^-butanoyl-L-homoserine lactone (BHL), and controls expression of chitinase, elastase, hydrogen cyanide, pyocyanin, rhamnolipid, lectins, staphylolytic activity, hemolysin, and alkaline protease [229, 230]. Cell-density-dependent regulation also contributes to the ability of P. aeruginosa to form biofilms, an important feature of the pathogen in colonization of catheters, and in growth in the lungs of cystic fibrosis patients [231]. Interestingly, the RhlR protein and the BHL signal are required for activation of the rpoS gene, encoding the sigma-38 component of RNA polymerase [232]. This points to a very wide network of effects exerted by this cell-density-dependent regulatory system in the cell, extending beyond dedicated virulence genes to include genes involved in general adaptation by the cell to changes in growth phase and environmental composition. Detailed information on cell-density-dependent regulation and bacterial virulence is also available for the Gram-negative plant pathogens A. tumefaciens, Erwinia carotovora, and Erwinia stewartii [233]. In A. tumefaciens, the cause of crown gall tumors in plants, A^-(3-oxooctonoyl)-L-homoserine lactone (OOHL) regulates transfer of the tumor-inducing plasmid from one bacterial cell to another by conjugation. In E. carotovora, OHHL regulates production of carbapenem antibiotics. It also regulates the expression of the virulence factors protease, cellulase, and pectinase in the same organism, and exopolysaccharide production in E. stewartii [233]. In the case of E. carotovora, OHHL coordinates the expression of an antimicrobial agent (the carbapenem antibiotic) and the expression of three virulence factors required for successful aggression against a plant host. This may be a way in which the pathogen can eliminate bacterial competitors while ensuring that it undertakes an attack on the host only when the bacterial population is of sufficient size. Among Gram-positive bacteria, similar population density regulatory strategies are in use, albeit with different types of signaling molecules. Typically, a complex phenotype is controlled by a two-component regulatory system that responds to a peptide signal. In the case of Staphylococcus aureus, several virulence traits are controlled by the accessory gene regulatory (agr) locus. In the laboratory, as the culture enters the late exponential phase of growth, agr coordinates repression of cell-surface-associated factors (e.g., protein A, fibronectin binding protein, and coagulase) and induction of secreted components (such as alpha toxin, betahemolysin, toxic-shock syndrome toxin, enterotoxin, lipases, and proteases). The signal is an 8-amino acid peptide called AgrD, which is derived from a 45-amino acid precursor. AgrD production requires AgrB, with which it is translationally coupled. These factors are translated from RNAII (Fig. 15). Transcribed divergently from RNAII is RNAIII, and this is under positive transcriptional control. The AgrD pheromone is one of three signals that activates RNAIII production; the others are the genetic loci sar, xpr, and the RNAIII-activating protein, or RAP [234-237].
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
113
Fig. 15 The Agr regulatory system of Staphylococcus aureus. The effector molecule of the agr locus is RNAIII. It is under the control of the AgrD pheromone. whose synthesis requires the agrB and agrD genes. The agrA and agrC genes code for a two-component signal transduction system that responds to AgrD levels. AgrA-P probably operates on the <:/^i,'/- locus indirectly.
The AgrD peptide binds to a histidine protein kinase encoded by the agrC gene, leading to phosphorylation of the AgrA response regulator [238]. Direct evidence that AgrA is a DNA-binding protein is lacking, but it may exert its effect through interaction with SarA, which has been shown to bind to the RNAIII promoter [239]. Once expressed, RNAIII can influence either transcription or translation of the genes it controls. The mechanisms by which RNAIII influences transcription, positively or negatively, remain obscure. It can facilitate translation of the alpha toxin by binding to mRNA and inhibiting formation of a stem-loop that sequesters the ribosome-binding site [240]. In this way, it performs a function that is the opposite of an antisense RNA. Cell-density sensing systems in Gram-positive bacteria control several properties, including plasmid transfer in Entewcoccus faecalis\ expression of the competence phenotype in Streptococcus pneumoniae, S. sanguis, and Bacillus subtilis; nisin production in Lactobacillus lactis; and antibiotic production in Streptomyces griseus. With the exception of the actinomycete S. griseus, where a y-butyrolactone is used, all of these population-densitydependent regulatory systems involve signaling peptides, and several require two-component systems to transduce the signal [224].
114
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
XVIIL Adoptive Mutation When a population of bacteria is subjected to environmental stress, a subpopulation undergoes hypermutation, allowing novel genetic combinations to emerge that result in bacteria that are more fit in the stressful environment [241-243]. This capacity to bring forth improved strains under stress operates in parallel with the conventional regulatory mechanisms that have evolved to enhance the survivability of every cell in the population. Regulation operates (almost) universally in the population and is reversible; the hypermutable state operates in a subpopulation, and its products cannot revert easily to their previous genetic state. In the main, the subject of adaptive mutation has been treated as a laboratory phenomenon. In part, this reflects the model systems that have been used to study it. Typically, these have been mutations in carbohydrate utilization operons in E. coli [244-246]. The concept of adaptive mutation in relation to infection and the microevolution of a population of bacteria in association with the host deserves to receive detailed attention [247]. This is a difficult research topic and needs more work. Results from one study indicate that mutator strains occur at a very high frequency (over 1 %) in populations of pathogenic E. coli and Salmonella species [248]. The mutators are defective in methyl-directed mismatch repair, typically a defect in the mutS gene, allowing rapid genetic variation to generate derivatives with enhanced virulence characteristics and antibiotic resistance. Presumably, these strains have been selected for by the environments in which these pathogens live. Under laboratory growth conditions, such mutator strains are destined for extinction, but in the wild they clearly have an advantage and so are maintained in the population at a high frequency.
XiX, Rote tRNAs ond Tronslotion Modulotion It has been suggested that there is a bias toward the use of rare codons in genes for regulatory proteins [249], although there seems to be litde evidence to support this view [250]. Instead, it seems that codon usage is a passive reflection of accumulation of random mutations rather than a mechanism for modulation of gene expression. Rare codon bias and its associated slow translation rates do not necessarily lead to lower levels of gene expression [251]. Strong modulation requires a coincidence of rare codon usage with sites prone to mishaps in translation. An important site for such events is the ribosome-binding site [252-254]. When rare codons are grouped near here, strong negative effects on gene expression may result due to premature termination of translation or queuing of ribosomes [255-259]. Elsewhere in the gene, the use of rare codons can result in frameshifting and premature termination and decoupling of transcription and translation. Such effects are subsidiary to slow translation of the rare codons, and can be overcome by increasing expression of the rare tRNA species [256, 259].
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
115
The integrase protein of bacteriophage lambda is subject to translational modulation by the rare arginine codons AG A and AGG [260]. This protein is the site-specific recombinase that allows lambda to enter and leave the E. coli chromosome at the lambda attachment site, and it is related to the recombinases that operate the //m switch in E. coli [179, 180] (see above). Here, the FimB recombinase has also been found to be subject to modulation by a rare codon, in this case a leucine codon that is decoded by the product of the leuX gene. The fimB gene ofE. coli K-12 contains five of these codons, and the levels of the leuX gene product are thought to govern the rate at which fimB mRNA is translated, thus creating a dependency on the leiiX gene for normal expression of type 1 fimbriae [261]. The leuX gene can be inactivated, with concomitant loss of type 1 fimbrial expression, in uropathogenic E. coli that undergo deletion of their copy of the Pai II pathogenicity island. This island is inserted immediately adjacent to the leuX locus, and it deletes at a high frequency. Disruption of the leuX sequence appears to be a result of the deletion event [262]. This relationship between//mi5 and leuX is more accurately described as one of dependency rather than a regulatory one.
XX. Protein Splicing Protein splicing represents an unusual form of regulation. A small number of bacterial genes, including some from pathogens, code for proteins that must undergo splicing in order to become active [263]. By analogy with RNA splicing, one refers to "inteins" and "exeins" when describing the spliced and flanking structures, respectively. Examples include the RecA proteins of Mycobacterium tuberculosis and Mycobacterium leprae, and the GyrA protein of some mycobacteria [263, 264]. In each case, a single "intein" insertion resides within the protein, and this must be excised for the protein to become active. Excision is thought to be by an autocatalytic mechanism and proceeds via a branched protein intermediate [265]. Work with the 440-amino acid RecA intein of M. tuberculosis shows that this is a mobile genetic element that invaded the recA gene using a site-specific endonuclease activity [266]. The process by which an intein invades an intein-less gene with an appropriate insertion site is referred to as "intein homing" [263].
XXI. AntisenseRNA Antisense RNA is so called because its sequence is complementary to that of the transcript of the gene it is regulating. Regulation by antisense RNA is widely used in bacteria, especially by plasmids and phage [267, 268]. There are some instances of chromosomal gene regulation by this mechanism, and some of them involve genes with a proven role in pathogenesis. For example, the crp gene is inhibited at the level of transcription by an antisense RNA species called tic that complexes
116
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
with the 5' end of crp mRNA [269]. Upstream of the ompC gene, and transcribed on the opposite strand, is a gene for the m/cFantisense RNA. This molecule shows complementarity to the 5' end of ompF mRNA, and it can complex with this to inhibit translation. It is thought that micF contributes to the shutting down of ompF gene expression in response to temperature increases that favor expression of the OmpC porin [270]. Sensitivity to micF aho extends the range of regulatory inputs influencing ompF gene expression. In addition to the direct inputs of the OmpR response regulator partner of the EnvZ histidine protein kinase, OmpF is also controlled (via micF) by LRP, H-NS and SoxRS [76-78]. In this way, micF may be regarded as an integrator of regulatory circuits in the cell.
XXIL Perspective Our understanding of gene regulation in bacteria has reached a very high level. Much of our information has been obtained from experiments with bacteria grown under laboratory conditions, often involving highly focused investigations of individual genes or operons. This approach has carried us a long way. The complexity of the regulatory circuits in use by bacteria can seem daunting at times, and certainly exposes the naivete of the view that bacteria are "simple" organisms. However, despite the current breadth of knowledge and the depth of understanding of many aspects of the regulatory processes in prokaryotes, for those interested in bacterial pathogens and their interactions with the host and with the external environment, the present levels of knowledge and understanding remain insufficient. At the time of this writing, the prokaryotic gene regulation field is in a state of flux due to the explosion of new knowledge from whole genome projects [271]. These projects provide us with catalogues of the genes in cells but tell us little about the manner in which expression of the genetic information is controlled. Nevertheless, because of the predictive power of genomics, many new regulatory proteins and other control elements are being discovered, and these must be fitted into the current gene regulation circuit diagrams. This process will require much experimental work. Knowledge of virulence gene regulation is being expanded through the application of recent technologies such as signature-tagged mutagenesis [25] and in vivo expression technology [24], the use of reporters such as the green fluorescent protein [272], and the exploitation of DNA chip technology [273]. These give a more true-to-life impression of which genes are important to bacteria during infection of the host, or for survival in tissue culture. They also provide important insights into what are the key signals provided by the host environment for gene control in pathogens. By combining the data from such studies with information from whole genome sequences, a more integrated view of bacterial gene regulatory circuits is in prospect.
3.
REGLILATION OF VIRULENCE GENE EXPRESSION IN B ACTERIAE PATHOGENS
117
A renewed awareness of the importance of mutation (changes in the DNA sequence of the genes in the cell) to bacterial adaptation to the host is likely to be an essential component of a truly holistic view of the gene expression options available to the pathogen [231]. An important task for the immediate future will be to determine the mechanisms by which environmental changes can influence molecular processes that lead to sequence diversity within apparently clonal populations of bacteria [274]. This information must then be integrated with knowledge of "conventionaf gene regulation to give a more complete picture of the bacterial cell in action during infection. It will also be important to extend understanding at the molecular level beyond the individual bacterial cell, to take account of the role of intercellular signaling in the successful establishment of an infection. This movement is already underway in the field of cell-density-dependent regulation, and illustrates the importance of appreciating that the bacterium is not simply an entity within an environment, but is itself a component of that environment. It seems that the future of this very reductionist, molecular field must include many elements that have been regarded traditionally as aspects of ecology. This is a strong indication that molecular biology in prokaryotes is becoming truly integrative.
Acknowledgments This work was supported by grants from the WeUcome Trust and the European Union.
References 1. Graila, J. D.. and Collado-Vides. J. (1996). Organization and tunetion of transcriptional regulatory elements. In "Escherichia coli and ScdnioiiclUr. Cellular and Molecular Biology"" (F C. Neidhardt. R. Curtiss III. J. L. higraham. E. C. C. Lin. K. Brooks Low. B. Magasanik. W. S. Reznikoff, M. Riley. M. Schaechter. and H. E. Umbarger. eds.). 2nd ed.. pp. 1232-1245. American Society for Microbiology Press. Washington. DC. 2. deHaseth. R L., Zupancic. M. L.. and Record. XL T. (1998). RNA polymerase-promoter interactions: The comings and goings of RNA polymerase. ./. Bcicteriol. 180. 3019-3025. 3. Ross, W.. Gosink, K. K.. Salomon. J.. Igarashi. K.. Zou. C . Ishihama. A.. Severinov, K.. and Course, R. L. (1993). A third recognition element in bacterial promoters: DNA binding by the alpha subunit of RNA polymerase. Science 262. 1407-1413. 4. Ptashne. M., and Gann. A. (1997). Transcriptional acti\ation by recruitment. Nature 386, 569-577. 5. Hochschild. A., and Dove. S. L. (1998). Protein-protein contacts that activate and repress prokaryotic transcription. Cell 92. 597-600. 6. Miller. A., Wood. D.. Ebright. R. H.. and Rothman-Denes. L. B. (1997). RNA polymerase p' subunit: A target of DNA binding-independent activation. Science 275. 1655-1657. 7. Choy, H., and Adhya. S. (1996). Negative control. /// "Escherichia coli and Salmonella: Cellular and Molecular Biology*" (R C. Neidhardt. R. Curtiss 111. J. L. Ingraham. E. C. C. Lin, K. Brooks Low, B. Magasanik, W. S. Reznikoff. M. Rile\. .M. Schaechter. and H. E. Umbarger, eds.). 2nd ed., pp. 1287-1299. American Society for Microbiology Press. Washington. DC.
118
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
8. Malan, T. P., Kolb, A., Buc, H., and McClure, W. R. (1982). Mechanism of CRP^AMP activation of the lac operon transcription initiation activation of the PI promoter. J. Mol. Biol. 180, 881-909. 9. Bell, A., Gaston, K., Williams, R., Chapman, K., Kolb, A., Buc, H., Minchin, S., Williams, J., and Busby, S. (1990). Mutations that alter the ability of the Escherichia coli cyclic AMP receptor protein to activate transcription. Nucleic Acids Res. 18, 7243-7250. 10. Wedel, A., and Kustu, S. (1995). The bacterial enhancer-binding protein NTRC is a molecular machine: ATP hydrolysis is coupled to transcriptional activation. Genes Dev. 9, 2042-2052. 11. Wyman, C , Rombel, I., North, A. K., Bustamante, C , and Kustu, S. (1997). Unusual oligomerization required for activity of NtrC, a bacterial enhancer-binding protein. Science 275, 1658-1661. 12. Aiba, H. (1985). Transcription of the Escherichia coli adenylate cyclase gene is negatively regulated by cAMP-cAMP receptor protein. Nucleic Acids Res. 10, 1345-1361. 13. Wang, Y. P, Kolb, A., Buck, M., Wen, J., O'Gara, F., and Buc, H. (1998). CRP interacts with promoter-bound sigma-54 RNA polymerase and blocks transcriptional activation of the dctA promoter. EMBO J. 17, 786-796. 14. Gaal, T, Bartlett, M. S., Ross, W., Turnborough Jr., C. L., and Course, R. L. (1997). NTP concentration as a regulator of transcription initiation: Control of rRNA synthesis in bacteria. Science 278, 2092-2097. 15. Gallegos, M.-T, Schleif, R., Bairoch, A., Hoffmann, K., and Ramos, J. L. (1997). The AraC/XylS family of transcriptional regulators. Microbiol. Mol. Biol. Rev. 61, 393^10. 16. Schell, M. A. (1993). Molecular biology of the LysR family of transcriptional regulators. Annu. Rev. Microbiol. 47, 597-626. 17. Perez-Rueda, E., Gralla, J. D., and CoUado-Vides, J. (1998). Genomic position analyses and the transcription machinery. J. Mol. Biol. 275, 165-170. 18. Stragier, P., Danos, O., and Patte, J. (1983). Regulation of diaminopimelate decarboxylase synthesis in Escherichia coli. J. Mol. Biol. 168, 307-350. 19. Schleif, R. (1969). An L-arabinose-binding protein and arabinose permeation in Escherichia coli. J. Mol. Biol. 46, 185-196. 20. Saviola, B., Seabold, R., and Schleif, R. F. (1998). Arm-domain interactions in AraC. J. Mol. Biol. 278, 539-548. 21. Fang, F. C , Krause, M., Roudier, C , Fierer, J., and Guiney, D. G. (1991). Growth regulation of a Salmonella plasmid gene essential for virulence. J. Bacteriol. 173, 6783-6789. 22. Pullinger, G. D., Baird, G. D., Williamson, C. M., and Lax, A. J. (1989). Nucleotide sequence of a plasmid gene involved in the virulence of salmonellas. Nucleic Acids Res. 17, 7983. 23. Sheehan, B. J., and Dorman, C. J. (1998). In vivo analysis of the interactions of the LysR-like regulator SpvR with the operator sequences of the spvA and spvR virulence genes of Salmonella typhimurium. Mol. Microbiol. 30, 91-105. 24. Heitoff, D. M., Conner, C. P, Hanna, P C , Julio, S. M., Hentschel, U., and Mahan, M. J. (1997). Bacterial infection as assessed by in vitro gene expression. Proc. Natl. Acad. Sci. U.S.A. 94, 934-939. 25. Hensel, M. Shea, J. E., Gleeson, C , Jones, M. D., Dalton, E., and Holden, D. W (1995). Simultaneous identification of bacterial virulence genes by negative selection. Science 269, 400-403. 26. Libby, S. J., Adams, L. G., Ficht, T. A., Allen, C , Whitford, H. A., Buchmeier, N. A., Bossie, S., and Guiney, D. G. (1997). The spv genes on the Salmonella dublin virulence plasmid are required for severe enteritis and systemic infection in the natural host. Infect. Immun. 65, 1786-1792.
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
119
27. Carmel, O., Rahav-Manor, O., Dover. N., Shaanan, B., and Padan, E. (1997). The Na+-specific interaction between the LysR-type regulator, NhaR. and the iihciA gene encoding the NaVH+ antiporter of Escherichia coli. EMBO J. 16. 5922-5929. 28. Rhee, K. Y., Senaer, D. P., and Hatfield, G. W. (1998). Activation of gene expression by a ligand-induced conformational change of a protein-DNA complex. J. Biol. Chem. 273, 11257-11266. 29. Dagberg, B., and Uhlin, B. E. (1992). Regulation of virulence-associated genes in enteroinvasive Escherichia coli. J. Bacteriol. 174, 7606-7612. 30. Sakai, T., Sasakawa, C., Makino, S., and Yoshikawa, M. (1986). DNA sequence and product analysis of the v/rF locus responsible for Congo red binding and cell invasion in Shigellaflexneri 2a. Infect. Immim. 54, 395-402. 31. Cornells, G. R., Sluiters, C, Lambert de Rouvroit, C, and Michiels, T. (1989). Homology between VirP, the transcriptional activator of the Yersinia virulence regulon, and AraC, the Escherichia coli arabinose operon regulator. J. Bacteriol. Ill, 254-262. 32. Caron, J., Coffield, L. M., and Scott, J. R. (1989). A plasmid-encoded regulatory gene, rns, required for expression of the CSl and CS2 adhesins of enterotoxigenic Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 86, 963-967. 33. Savelkoul, P H. M., Wilshaw, G. A., McConnell, M. M.. Smith, H. R., Hamers, A. M., van der Zeijst, B. A. M., and Gaastra, W. (1990). Expression of CFA/I fimbriae is positively regulated. Microb. Pathogen. 8, 91-99. 34. Curtiss, R., and Kelly, S. M. (1987). Salmonella typhimuriiim deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immim. 55, 3035-3043. 35. Skorupski, K., and Taylor, R. K. (1997). Cyclic AMP and its receptor protein negatively regulate the coordinate expression of cholera toxin and toxin-coregulated pilus in Vibrio cholerae. Proc. Natl. Acad. Sci. U.S.A. 94, 265-270. 36. Dorman, C. J., and Dougan, G. Unpublished data. 37. Lampidis, R., Gross, R., Sokolovic, Z., Goebel, W., and Kreft, J. (1994). The virulence regulator protein of Listeria ivanovii is highly homologous to PrfA from Listeria monocytogenes and both belong to the Crp-Fnr family of transcription regulators. Mol. Microbiol. 13, 141-151. 38. Calderwood, S. B., and Mekalanos. J. J. (1987). Iron regulation of shigaTike toxin expression in Escherichia coli is mediated by iht fur locus. J. Bacteriol. 169, 4759-4764. 39. Schmitt, M. P., and Holmes, R. K. (1993). Analysis of diphtheria toxin repressor operator interactions and characterization of a mutant repressor with decreased binding activity for divalent metals. Mol. Microbiol. 9, 173-181. 40. Riesenberg-Wilmes, M. R., Bearson, B., Foster, J. W.. and Curtiss III, R. (1996). Role of the acid tolerance response in virulence of Salmonella typhimurium. Infect. Immim. 64, 1085-1092. 41. Neilands, J. B. (1990). Molecular biology and regulation of iron acquisition by Escherichia coli K-12. In "Molecular Basis of Bacterial Pathogenesis'' (B. H. Iglewski and V. L. Clark, eds.), pp. 205-223. Academic Press, San Diego. 42. Stock, J. B., Ninfa, A. J., and Stock, A. M. (1989). Protein phosphorylation and regulation of adaptive responses in bacteria. Microbiol. Rev. 53, 450-490. 43. Hall, M. N., and Silhavy, T. J. (1981). Genetic analysis of the ompB locus in Escherichia coli K-12. J. Mol. Biol. 151, 1-15. 44. Kier, L. D., Weppleman, R. M., and Ames. B. N. (1977). Regulation of two phosphatases and a cyclic phosphodiesterase of Salmonella typhimurium. J. Bacteriol. 130, 420-428. 45. Kier, L. D., Weppleman, R. M., and Ames, B. N. (1979). Regulation of nonspecific acid phosphatase in Salmonella: phoN and phoP genes. J. Bacteriol. 138, 155-161.
120
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
46. Fields, P. I., Groisman, E. A., and Heffron, F. (1989). A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells. Science 243, 1059-1062. 47. Miller, S. I., Kukral, A. M., and Mekalanos, J. J. (1989). A two-component regulatory system (phoP phoQ) controls Salmonella typhimuhum virulence. Pwc Natl. Acad. Sci. U.S.A. 86, 5054-5058. 48. Bernardini, M. L., Fontaine, A., and Sansonetti, P. J. (1990). The two-component regulatory system OmpR-EnvZ controls virulence of Shigella fle.xneri. J. Bacteriol. 172, 6274-6281. 49. Dorman, C. J., Chatfield, S., Higgins, C. F, Hay ward, C., and Dougan, G. (1989). Characterization of porin and ompR mutants of a virulent strain of Salmonella typhimuhum: ompR mutants are attenuated in vivo. Infect. Imnnm. 57, 2136-2140. 50. Garcia Vescovi, E., Soncini, F. C , and Groisman, E. A. (1996). Mg-^ as an extracellular signal: Environmental regulation of Salmonella typhimurium. Cell 84, 165-174. 51. Groisman, E. A. (1998). The ins and outs of virulence gene expression: Mg-^ as a regulatory signal. BioEssays 20, 96-101. 52. Waldburger, C. D., and Sauer, R. T (1996). Signal detection by the PhoQ sensor-transmitter: Characterization of the sensor domain and a response-impaired mutant that identifies ligandbinding determinants. J. Biol. Chem. Ill, 26630-26636. 53. Garcia Vescovi, E., Ayala, Y. M., Di Cera. E., and Groisman, E. A. (1997). Characterization of the bacterial sensor protein PhoQ. Evidence for distinct binding sites for Mg-^ and Ca-^. J. Biol. Chem. 272, 1440-1443. 54. Gunn, J. S., and Miller, S. I. (1996). PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J. Bacteriol. 178, 6857-6864. 55. Soncini, F. C , and Groisman, E. A. (1996). Two-component regulatory systems can interact to process multiple environmental signals. J. Bacteriol. 178, 6796-6801. 56. Groisman, E. A., Kayser, J., and Soncini, F. C. (1997). Regulation of polymyxin resistance and adaptation to low-Mg-^ environments. J. Bacteriol. 179, 7040-7045. 57. Igo, M. M., Ninfa, A. J., and Silhavy, T. J. (1989). A bacterial environmental sensor that functions as a protein kinase and stimulates transcriptional activation. Genes Dev. 3, 598-605. 58. Ninfa, A. J., Ninfa, E. G., Lupas, A. N., Stock, A., Magasanik, B., and Stock, J. (1988). Crosstalk between bacterial chemotaxis signal transduction proteins and regulators of transcription of the Ntr regulon: Evidence that nitrogen assimilation and chemotaxis are controlled by a common phosphotransfer mechanism. Proc. Natl. Acad. Sci. U.S.A. 85, 5492-5496. 59. Parkinson, J. S. (1995). Genetic approaches for signaling pathways and proteins. In "Two-Component Signal Transduction" (J. A. Hoch and T. J. Silhavy, eds.), pp 9-23. American Society for Microbiology Press, Washington, DC. 60. Dorman, C. J., and Porter, M. E. (1998). The Shigella flexneri virulence gene regulatory cascade: A paradigm of bacterial gene control mechanisms. Mol. Microbiol 29, 677-684. 61. Chatfield, S. N., Dorman, C. J., Hayward, C , and Dougan, G. (1991). Role of 6>m/7/?-dependent genes in Salmonella typhimurium virulence: Mutants defective in both OmpC and OmpF are attenuated in vivo. Infect. Immun. 59, 449-452. 62. Mills, S. D., Ruschkowski, S. R., Stein, M. A., and Finlay, B. B. (1998). Trafficking of porin-deficient Salmonella typhimurium mutants inside HeLa cells: ompR and envZ mutants are defective for the formation of Salmonella-induced filaments. Infect. Immun. 66, 1806-1811. 63. Lindgren, S. W., Stojiljkovic, I,, and Heffron, F. (1996). Macrophage killing is an essential virulence mechanism of Salmonella typhimurium. Proc. Natl. Acad. Sci. U.S.A. 93, 4197-4201.
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
121
64. Romling. U., Sierralta. W. D.. Eriksson. K.. and Normark, S. (1998). Multicellular and aggregative behaviour of Sahuotiella txphimnriiun strains is controlled by mutations in the agf'D promoter. Mol. Microbiol. 28. 249-264. 65. Pickard, D., Li, J., Roberts. M.. Maskell. D.. Hone. D.. Levine. M.. Dougan. G., and Chatfield, S. (1994). Characterization of defined oinpR mutants of Salmonella typhi: onipR is involved in the regulation of Vi polysaccharide expression. Infecf. linmiui. 62. 3984-3993. 66. Freestone, P., Trinei, M.. Clarke. S. C . Nystrom. T.. and Norris. V. (1998). Tyrosine phosphorylation in Escherichia coli. J. Mol. Biol. 219. 1045-1051. 67. Qi, S.-Y., Li, Y.. Szyroki. A.. Giles. L G.. Moir. A., and O'Connor. C. D. (1995). Salmonella typhimiirium responses to a bacterial protein from human neutrophils. Mol. Microbiol. 17, 523-531. 68. Chen. C.-Y, Buchmeier. N. A.. Libby, S.. Fang. F C. Krause. M.. and Guiney, D. G. (1995). Central regulatory role for the RpoS sigma factor in expression of Salmonella diiblin plasmid virulence genes. J. Bacterial. 111. 5303-5309. 69. Kowarz, L.. Coynault. C, Robbe-Saule. V.. and Norel. F (1994). The Salmonella typhimnriwn katF {rpoS) gene: Cloning, nucleotide sequence, and regulation of spvR and spvABCD virulence plasmid genes. J. Bacteriol. 176. 6852-6860. 70. Csonka, L. N.. and Hanson, A. D. (1991). Prokaryotic osmoregulation: Genetics and physiology. Anmi. Rev. Microbiol. 45, 569-606. 71. Lynch, A. S.. and Lin, E. C. C. (1996). Responses to molecular oxygen. In "Escherichia coli and Salmonella: Cellular and Molecular Biology" (F. C. Neidhardt, R. Curtiss IH, J. L. Ingraham, E. C. C. Lin, K. Brooks Low. B. Magasanik. W. S. Reznikoff, M. Riley, M. Schaechter. and H. E. Umbarger. eds.). 2nd ed.. pp. 1526-1538. American Society for Microbiology Press, Washington. DC. 72. Ding, H., and Demple. B. (1997). In vivo kinetics of a redox-regulated transcriptional switch. Proc. Natl. Acad. Sci. U.S.A. 94. 8445-8449. 73. Hidalgo, E.. and Demple, B. (1997). Spacing of promoter elements regulates the basal expression of the soxS gene and converts SoxR from a transcriptional activator into a repressor. EMBO J. 16. 1056-1065. 74. Hidalgo, E., Leautaud, V.. and Demple. B. (1998). The redox-regulated SoxR protein acts from a single DNA site as a repressor and an allosteric activator. EMBO J. 17. 2629-2636. 75. Tardat, B., and Touati. D. (1993). Iron and oxygen regulation of Escherichia coli MnSOD expression: Competition between the global regulators Fur and ArcA for binding to DNA. Mol. Microbiol. 9, 53-63. 76. Chou, J. H.. Greenberg. J. T., and Demple. B. (1993). Posttranscriptional repression of Escherichia coli OmpF protein in response to redox stress: Positive control of the /?z/rf antisense RNAby the so.xRS locus. J. Bacteriol. 175. 1026-1031. 77. Ferrario. M., Ernsting. B. R.. Borst. D. W.. Wiese. D. E.. Blumenthal. R. M., and Matthews, R. G. (1995). The leucine-responsive regulatory protein of Escherichia coli negatively regulates transcription of ompC and micE and positively regulates translation of ompF. J. Bacteriol. 177, 103-113. 78. Suzuki, T., Ueguchi, C . and Mizuno. T. (1996). H-NS regulates OmpF expression through micE antisense RNA in Escherichia coli. J. Bacteriol. 178. 3650-3653. 79. Christman, M. F, Morgan. R. W., Jacobson. F S.. and Ames. B. N. (1985). Positive control of a regulon for defenses against oxidative stress and some heat shock proteins in Salmonella typhimurium. Cell 41, 753-762.
122
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
80. Altuvia, S., Almiron, M., Huisman, G., Kolter, R., and Storz, G. (1994). The dps promoter is activated by OxyR during growth and by IHF and a' during stationary phase. Mol. Microbiol. 13, 265-272. 81. Ivanova, A., Miller, C , Glinsky, G., and Eisenstark, A. (1994). Role of rpoS (katF) in ox>'/?-independent regulation of hydroperoxidase I in Escherichia coli. Mol. Microbiol. 12, 571-578. 82. Zheng, M., Aslund, F., and Storz, G. (1998). Activation of the OxyR transcription factor by reversible disulfide bond formation. Science 279, 1718-1721. 83. Hausladen, A., Privalle, C. T., Keng, T., DeAngelo, J., and Stamler, J. S. (1996). Nitrosative stress: Activation of the transcription factor OxyR. Cell 86, 719-729. 84. Gaston, B., Reilly, J., Drazen, J. M., Fackler, J., Ramdev, R, Arnelle, D., Mullins, M., Sugarbaker, D. J., Chee, C, Singel, D. J., Loscalzo, J., and Stamler, J. S. (1993). Endogenous nitrogen oxides and bronchodilator 5-nitrosothiols in human airways. Proc. Natl. Acad. Sci. U.S.A. 90, 10957-10961. 85. Groisman, E. A. personal communication. 86. Altuvia, S., Weinstein-Fischer, D., Zhang, A., Postow, L., and Storz, G. (1997). A small, stable RNA induced by oxidative stress: Role as a pleiotropic regulator and antimutator. Cell 90,43-53, 87. Utsumi, R., Brisette, R. E., Rampersaud, A., Forst, S. A., Oosawa, K., and Inouye, M. (1989). Activation of bacterial porin gene expression by a chimeric signal transducer in response to aspartate. Science 245, 1246-1249. 88. Chang, C.-H., and Winans, S. C. (1992). Functional roles assigned to the periplasmic, linker, and receiver domains of the Agrobacterium tumefaciens VirA protein. J. Bacteriol. 174, 7033-7039. 89. Uhl, M. A., and Miller, J. F. (1994). Autophosphorylation and phosphotransfer in the Bordetella pertussis BvgAS signal transduction cascade. Proc. Natl. Acad. Sci. U.S.A. 91, 1163-1167. 90. Uhl, M. A., and Miller, J. F. (1995). Bordetella pertussis BvgAS virulence control system. In "Two-Component Signal Transduction" (J. A. Hoch and T. J. Silhavy, eds.), pp. 333-349. American Society for Microbiology Press, Washington, DC. 91. Bassler, B., Wright, M., and Silverman, M. (1994). Sequence and function of luxO, a negative regulator of luminescence in Vibrio harx'eyii. Mol. Microbiol. 12, 403^12. 92. Miller, V. L., Taylor, R. K., and Mekalanos, J. J. (1987). Cholera toxin transcriptional activator ToxR is a transmembrane DNA binding protein. Cell 48, 271-279. 93. Martinez-Hackert, E., and Stock, A. M. (1997). Structural relationships in the OmpR family of winged-helix transcription factors. J. Mol. Biol. 269, 301-312. 94. Ottemann, K. M., and Mekalanos, J. J. (1996). The ToxR protein of Vibrio cholerae forms homodimers and heterodimers. / Bacteriol. 178, 156-162. 95. Bajaj, V., Hwang, C , and Lee, C. A. (1995). hilA is a novel ompR/toxR family member that activates the expression of Salmonella typhimurium invasion genes. Mol. Microbiol. 18, 715-727. 96. Johnson, C , Pegues, D. A., Hueck, C. J., Lee, A., and Miller, S. I. (1996). Transcriptional activation of Salmonella typhimurium invasion genes by a member of the phosphorylated response-regulator superfamily. Mol. Microbiol. 22, 715-727. 97. Dell, C. L., Neely, M. N., and Olsen, E. R. (1994). Altered pH and lysine signalling mutants of cadC, a gene encoding a membrane-bound transcriptional activator of the Escherichia coli cadBA operon. Mol. Microbiol. 14, 7-16.
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
123
98. Benjamin Jr., W. H., Wu, X., and Swords. W. E. (1996). The predicted amino acid sequence of the Salmonella typhimiihwn virulence gene mviA^ strongly indicates that MviA is a regulator protein of a previously unknown S. typlniuuriwn response regulator family. Infect. Immun. 64, 2365-2367. 99. Muffler, A., Fischer, D., Altuvia, S., Storz. G., and Hengge-Aronis, R. (1996). The response regulator RssB controls stability of the a' subunit of RN A polymerase in Escherichia coli. EMBO J. 15, 1333-1339. 100. Pratt, L. A., and Silhavy, T. J. (1996). The response regulator SprE controls the stability of RpoS. Pwc. Natl. Acad. Sci. U.S.A. 93, 2488-2492. 101. Zhou, Y., and Gottesman, S. (1998). Regulation of proteolysis of the stationary phase sigma factor RpoS. J. Bacteriol. 180, 1154-1158. 102. Pettijohn, D. E. (1996). The nucleoid. In "Escherichia coli and Salmonella: Cellular and Molecular Biology"" (F. C. Neidhardt, R. Curtiss III J. L. Ingraham, E. C. C. Lin, K. Brooks Low, B. Magasanik, W. S. Reznikoff, M. Riley. M. Schaechter, and H. E. Umbarger, eds.), 2nd ed., pp. 158-166. American Society for Microbiology Press. Washington, DC. 103. Robbe-Saule, V., Schaeffer, E, Kowarz. L.. and Norel. E (1997). Relationships between H-NS, sigma S, SpvR and growth phase in the control of spvR, the regulatory gene of the Salmonella cliiblin virulence plasmid. Mol. Gen. Genet. 256, 333-347. 104. Atlung, T., and Ingmer, H. (1997). H-NS: A modulator of environmentally regulated gene expression. Mol. Microbiol. 24. 7-17. 105. Ussery, D. W., Hinton, J. C. D.. Jordi. B. J. A. M., Granum. R E., Seirafi, A., Stephen, R. J., Tupper, A. E., Berridge, G., Sidebotham, J. M.. and Higgins. C. E. (1994). The chromatin-associated protein H-NS. Biochimie 76, 968-980. 106. Cusick, M. E., and Belfort, M. (1998). Domain structure and RNA annealing activity of the Escherichia coli regulatory protein StpA. Mol. Microbiol. 28, 847-857. 107. Zhang, A., and Belfort, M. (1992). Nucleotide sequence of a newly identified Escherichia coli gene, stpA, encoding an H-NS-like protein. Nucleic Acids Res. 20. 6735. 108. Zhang, A., Derbyshire, V., Galloway Salvo. J. L.. and Belfort, M. (1995). E. coli protein StpA stimulates self-splicing by promoting RNA assembly in vitro. RNA 1, 783-793. 109. Zhang, A., Rimsky, S., Reaban, M. E.. Buc, H., and Belfort. M. (1996). Escherichia coli protein analogs StpA and H-NS: Regulatory loops, similar and disparate effects on nucleic acid dynamics. EMBO J. 15, 1340-1349. 110. Eree, A., and Dorman, C. J. (1997). The Escherichia coli stpA gene is transiently expressed during growth in rich medium and is induced in minimal medium and by stress conditions. J. Bacteriol. 179,909-918. 111. Eree, A., Williams, R. M., and Dorman. C. J. (1998). The StpA protein functions as a molecular adapter to mediate repression of the bgl operon by truncated H-NS in Escherichia coli. J. Bacteriol. 180, 994-997. 112. Spurio, R., Ealconi, M., Brandi, A., Pon. C. L.. and Gualerzi. C. O. (1997). The oligomeric structure of nucleoid protein H-NS is necessary for recognition of intrinsically curved DNA and for DNA bending. EMBO J. 16, 795-805. 113. Ueguchi, C , Suzuki, T., Yoshida. T., Tanaka. K., and Mizuno, T. (1996). Systematic mutational analysis revealing the functional domain organization of Escherichia coli nucleoid protein H-NS. J. Mol. Biol. 263. 149-162. 114. Ueguchi, C, Seto, C, Suzuki. T. and Mizuno. T. (1997). Clarification of the dimerization domain and its functional significance for the Escherichia coli nucleoid protein H-NS. J. Mol. Biol. 274. 145-151.
124
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
115. Williams, R. M., Rimsky, S., and Buc, H. (1996). Probing the structure, function, and interactions of the Escherichia coli H-NS and StpA proteins by using dominant negative derivatives. J. Bacterioi 178, 4335-4343. 116. Elliot, S. J., Wainwright, L. A., McDaniel, T. K., Jarvis, K. G., Deng, Y., Lai, L.-C., MacNamara, B., Donnenberg, M. S., and Kapen J. B. (1998). The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol. Microbiol. 28, 1 ^ . 117. Goyard, S., and Bertin, R (1997). Characterization of BpH3, an H-NS-like protein in Bordetella pertussis. Mol. Microbiol. 24, 815-823. 118. Hromockyj, A. E., Tucker, S. C, and Maurelli, A. T (1992). Temperature regulation oi Shigella virulence: Identification of the repressor gene virR, an analogue of hus, and partial complementation by tyrosyl transfer RNA (tRNA,'>^). Mol. Microbiol. 6, 2113-2124. 119. Hulton, C. S. J., Seirafi, A., Hinton, J. C. D., Sidebotham, J. M., Waddell, L., Pavitt, G. D., Owen-Hughes, T, Spasskey, A., Buc, H., and Higgins, C. F. (1990). Histone-like protein HI (H-NS), DNA supercoiling and gene expression in bacteria. Cell 63, 631-642. 120. La Teana, A., Falconi, M., Scarlato, V., Lammi, M., and Ron, C. L. (1989). Characterization of the structural genes for the DNA-binding protein H-NS in Enterobacteriaceae. EEBS Letts. 244, 34-38. 121. Marsh, M., and Hillyard, D. R. (1990). Nucleotide sequence oi hns encoding the DNA-binding protein H-NS of Salmonella typhimiiriiim. Nucleic Acids Res. 18, 3397. 122. Ron, C. L., Calogero, R. A., and Gualerzi. C. O. (1988). Identification, cloning, nucleotide sequence and chromosomal map location of /z/?.v, the structural gene for Escherichia coli DNA-binding protein H-NS. Mol. Gen. Genet. 111. 199-202. 123. Sonnenfield, J. M., Raupach, B., Falkow. S., Higgins, C. R, and Hinton, J. C. D. (1997). Genbank Database Accession No. AF009363. 124. Free, A., and Dorman, C. J. Unpublished data. 125. Fleischmann, R. D., Adams, M. D., White, O., Clayton, R. A., Kirkness, E. F, Kerlavage, A. R., Bult, C. J., Tomb, J.-F., Dougherty, B. A., Merrick, J. M., McKenney, K., Sutton, G., FitzHugh, W, Fields, C. A., Gocayne, J. D., Scott, J. D., Shirley, R., Liu, L.-I., Glodek, A., Kelley, J. M., Weidman, J. R, Phillips, C. A., Spriggs, T, Hedblom, E., Cotton, M. D., Utterback, T. R., Hanna, M. C , Nguyen, D. T, Saudek, D. M., Brandon, R. C , Fine, L. D., Fritchman, J. L., Fuhrmann, J. L., Geoghagen, N. S. M., Gnehm, C. L., McDonald, L. A., Small, K. V., Eraser, C. M., Smith, H. O., and Venter, J. C. (1995). Whole-genome random sequencing and assembly oi Haemophilus influenzae Rd. Science 269, 496-512. 126. Drlica, K., and Rouviere-Yaniv, J. (1987). Histonelike proteins of bacteria. Microbiol. Rev. 51, 301-319. 127. Rice, P A., Yang, S.-W., Mizuuchi, K., and Nash, H. A. (1996). Cry.stal structure of an IHF-DNA complex: A protein-induced DNA U-turn. Cell 87, 1295-1306. 128. Goosen, N., and van de Putte, P. (1995). The regulation of transcription initiation by integration host factor. Mol. Microbiol. 16, 1-7. 129. Hill, S. A., Samuels, D. S., Carlson, J. H., Wilson, J., Hogan, D., Lubke, L., Belland, R. J. (1997). Integration host factor is a transcriptional cofactor of pilE in Neisseria gonorrhoeae. Mol. Microbiol. 23, 649-656. 130. Porter, M. E., and Dorman, C. J. (1997). Positive regulation of Shigella flexneri virulence genes by integration host factor. J. Bacterioi. 179, 6537-6550. 131. Appleman, J. A., Ross, W., Salomon, J., and Course, R. (1998). Activation of Escherichia coli rRNA transcription by FIS during a growth cycle. J. Bacterioi. 180, 1525-1532.
3.
REGULATION OF VIRULENCE GENE EXF'RESSION IN BACTERIAL PATHOGENS
125
132. Koch, C, Vanderkerck. J., and Kahmann. R. (1988). E. coli host factor for site-specific DNA inversion. Cloning and characterization of the fis gene. Proc. Natl. Acad. Sci. U.S.A. 85, 4237-4241. 133. Nilsson, L., Vanet, A.. Vijgenboom. E.. and Bosch. L. (1990). The role of FIS in trans activation of stable RNA operons of E. coll. EMBO J. 9. 727-734. 134. Wu, H., Tyson, K. L., Cole. J. A., and Busby. S. J. (1998). Regulation of transcription initiation at the Escherichia coll ulr operon promoter: A new mechanism to account for co-dependence on two transcription factors. Mol. Microbiol. 27. 493-505. 135. Xu. J., and Johnson, R. C. (1995). Identification of genes negatively regulated by FIS: FIS and RpoS comodulate growth-phase-dependent gene expression in Escherichia coll. J. Bacterlol. 17, 938-947. 136. Schneider, R.. Travers. A., and Muskhelishvili. G. (1997). FIS modulates growth phase-dependent topological transitions of DNA in Escherichia coll. Mol. Microbiol. 26, 519-530. 137. Calvo, J. M., and Matthews. R. G. (1994). The leucine-responsive regulatory protein, a global regulator of metabolism in Escherichia coll. Microbiol. Rev. 58. 466-490. 138. Drlica, K. (1992). Bacterial topoisomerases and the control of DNA supercoiling. Trends Genet. 6:433-437. 139. Luttinger, A. (1995). The twisted life of DNA in the cell: Bacterial topoisomerases. Mol. Microbiol. 15, 601-606. 140. Schmid, M. B., and Sawitzke. J. A. (1993). Multiple bacterial topoisomerases: Specialization or redundancy? BloEssaxs 15. 445-449. 141. Dorman, C. J., Barr, G. C. Ni Bhriain. N.. and Higgins. C. F (1988). DNA supercoiling and the anaerobic and growth phase regulation of tonB expression. J. Bacterlol. 170. 2816-2826. 142. Goldstein. E., and Drlica. K. (1984). Regulation of bacterial DNA supercoiling: Plasmid linking numbers vary with growth temperature. Proc. Natl. Acad. Scl. U.S.A. 81, 4046-4050. 143. Higgins, C. E, Dorman, C. J.. Stirling. D. A.. Waddell. L.. Booth. I. R.. May, G., and Bremer, E. (1988). A physiological role for DNA supercoiling in the osmotic regulation of gene expression in S. typhlmurlwn and E. coll. Cell 52. 569-584. 144. Hsieh, L. S.. Burger. R. M.. and Drlica. K. (1991). Bacterial DNA supercoiling and [ATP]/[ADP]: Changes associated with a transition to anaerobic growth. J. Mol. Biol. 219, 443-450. 145. Hsieh, L. S.. Rouviere-Yaniv. J., and Drlica. K. (1991). Bacterial DNA supercoiling and [ATP]/[ADP] ratio: Changes associated with salt shock. J. Bacterlol. 173. 3914-3917. 146. Karem, K., and Foster. J. W. (1993). The influence of DNA topology on the environmental regulation of a pH-regulated locus in Salmonella txphunurlwn. Mol. Microbiol. 10, 75-86. 147. van Workum, M., van Dooren. S. J. M.. Oldenburg. N.. Molenaar. D.. Jensen. P. R., Snoep, J. L., and Westerhoff, H. V. (1996). DNA supercoiling depends on the phosphorylation potential in Escherichia coll. Mol. Microbiol. 20. 351-360. 148. Mojica, F. J. M.. and Higgins, C. F. (1997). In vivo supercoiling of plasmid and chromosomal DNA in an Escherichia coll hns mutant. ./. Bacterlol. 179. 3528-3533. 149. Fang, M., and Wu. H.-Y. (1998). A promoter relay mechanism for sequential gene activation. / Bacterlol. 180, 626-633. 150. Liu, L. E, and Wang, J. C. (1987). Supercoiling of the DNA template during transcription. Proc. Natl. Acad. Scl. U.S.A. 84. 7024-7027. 151. Pruss, G. J., and Drlica. K. (1989). DNA supercoiling and prokaryotic transcription. Cell 56, 521-523. 152. Lilley, D. M. J., and Higgins. C. F. (1991). Local DNA topology and gene expression: The case of the leiiSOO promoter. Mol. Microbiol. 5. 779-783.
126
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
153. Cashel, M., Gentry, D. R., Hernandez, V. J., and Vinella, D. (1996). The stringent response. In ''Escherichia coli and Salmonella: Cellular and Molecular Biology" (F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. Brooks Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger, eds.), 2nd ed., pp. 1458-1496. American Society for Microbiology Press, Washington, DC. 154. Figueroa-Bossi, N., Guerin, M., Rahmouni, R., Leng, M., and Bossi, L. (1998). The supercoiling sensitivity of a bacterial tRNA promoter parallels its responsiveness to stringent control. EMBO J. 17, 2359-2367. 155. Wang, J.-Y, and Syvanen, M. (1992). DNA twist as a transcriptional sensor for environmental changes. Mol Microbiol. 6, 1861-1866. 156. Dorman, C. J. (1996). Flexible response: DNA supercoiling, transcription and bacterial adaptation to environmental stress. Trends Microbiol. 4, 214-216. 157. Jordi, B. J. A. M., Owen-Hughes, T A., Hulton, C. S., and Higgins, C. F. (1995). DNA twist, flexibility, and transcription of the osmoregulated proU promoter of Salmonella typhimurium. EMBO J. 14, 5690-5700. 158. Mukerji, M., and Mahadevan, S. (1997). Characterization of the negative elements involved in silencing the bgl operon of Escherichia coli: Possible roles for DNA gyrase, H-NS, and CRP-cAMP in regulation. Mol. Microbiol. 24, 617-627. 159. Matthews, K. S. (1992). DNA looping. Microbiol. Rev. 56, 123-136. 160. Schleif, R. (1992). DNA looping. Anna. Rev. Biochem. 61, 199-223. 161. Palecek, E. (1991). Local supercoil-stabilized structures. CRC Crit. Rev. Biochem. 26, 151-226. 162. Trifonov, E. N. (1985). Curved DNA. CRC Crit. Rev Biochem. 19, 89-106. 163. Nash, H. A. (1990). Bending and supercoiling of DNA at the attachment site of bacteriophage X. Trends Biochem. Sci. 15, 111-111. 164. Dybvig, K. (1993). DNA rearrangements and phenotypic switching in prokaryotes. Mol. Microbiol. 10,465-471. 165. Robertson, B. D., and Meyer, T. F. (1992). Genetic variation in pathogenic bacteria. Trends Genet. 8, 422^27. 166. Abraham, J. M., Freitag, C. S., Clements, J. R., and Eisenstein, B. L (1985). An invertible element of DNA controls phase variation of type I fimbriae of Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 82, 5724-5727. 167. Marrs, C. F, Rozsa, F W., Hackel, M., Stevens, S. P, and Glasgow, A. C. (1990). Identification, cloning and sequencing of piv, a new gene involved in inverting the pilin genes of Moraxella lacunata. J. Bacteriol. 172, 4370-4377. 168. Haas, R., and Meyer, T. F. (1986). The repertoire of silent pilus genes in Neisseria gonorrhoeae: Evidence for gene conversion. Cell 44, 107-115. 169. Murphy, G. L., Connell, T. D., Barritt, D. S., Koomey, M., and Cannon, J. G. (1989). Phase variation of gonococcal protein II: Regulation of gene expression by slipped strand mispairing of a repetitive DNA sequence. Cell 56, 539-547. 170. Stem, A., and Meyer, T. F. (1987). Common mechanism controlling phase variation and antigenic variation in pathogenic Neiserriae. Mol. Microbiol. 1, 5-12. 171. Weiser, J. N., Love, J. M., and Moxon, E. R. (1989). The molecular mechanism of phase variation of H. influenzae lipopolysaccharide. Cell 59, 657-665. 172. van Ham, S. M., van Alphen, L., Mooi, F. R., and Putten, J. P. (1993). Phase variation of H. influenzae fimbriae: Transcriptional control of two divergent genes through a variable combined promoter region. Cell 12^, 1187-1196.
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
127
173. Willems, R., Paul, A., van der Heide, H. G. J., ter Avest. A. R., and Mooi, F. R. (1990). Fimbrial phase variation in Bordetella pertussis: A novel mechanism for transcriptional regulation. EMBO J. 9, 2803-2809. 174. Jonsson, A.-B., Nyberg, G., and Normark, S. (1991). Phase variation of gonococcal pili by frameshift mutation at pilC, a novel gene for pilus assembly. EMBO J. 10, 477-488. 175. Olyhoek, A. J., Sarkari, J., Bopp, M., Morelli, G., and Achtman, M. (1991). Cloning and expression in Escherichia coli of ope, the gene for an unusual class 5 outer membrane protein from Neisseria meningitidis. Microb. Pathogen. 11, 249-257. 176. Stibitz, S., Aaronson, W., Monack, D., and Falkow, S. (1989). Phase variation in Bordetella pertussis by frameshift mutation in a gene for a novel two-component system. Nature 338, 266-269. 177. Belland, R. J. (1991). H-DNA formation by the coding repeat elements of neisserial opa gens. Mol. Microbiol. 5, 2351-2360. 178. Belland, R. J., Morrison, S. G., Carlson, J. H.. and Hogan, D. M. (1997). Promoter strength influences phase variation of neisserial opa genes. Mol. Microbiol. 23, 123-135. 179. Dorman, C. J., and Higgins, C. F. (1987). Fimbrial phase variation in Escherichia coli: Dependence on integration host factor and homologies with other site-specific recombinases. J. Bacteriol. 169, 3840-3843. 180. Eisenstein, B. L, Sweet, D. S., Vaughn, V., and Friedman, D. I. (1987). Integration host factor is required for the DNA inversion that controls phase variation in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 84, 6506-6510. 181. Blomfield, I. C, Kulasekara, D. H., and Eisenstein, B. I. (1997). Integration host factor stimulates both FimB- and FimE-mediated site-specific inversion that controls phase variation of type 1 fimbriae expression in Escherichia coli. Mol. Microbiol. 23, 705-717. 182. Roesch, P. L., and Blomfield, I. C. (1998). Leucine alters the interaction of the leucine-responsive regulatory protein (LRP) with the fim switch to stimulate site-specific recombination in Escherichia coli. Mol. Microbiol. 27, 751-761. 183. Dove, S. L., and Dorman, C. J. (1994). The site-specific recombination system regulating expression of the type 1 fimbrial subunit gene of Escherichia coli is sensitive to changes in DNA supercoiling. Mol. Microbiol. 14, 975-988. 184. Lindberg, F. P., Lund, B., and Normark, S. (1984). Genes of pyelonephritogenic E. coli required for digalactoside-specific agglutination of human cells. EMBO J. 3, 1167-1173. 185. Blyn, L. B., Braaten, B. A., White-Ziegler, C. A., Rolfson, D. H., and Low, D. A. (1989). Phase-variation of pyelonephritis-associated pili in Escherichia coli: Evidence for transcriptional regulation. EMBO J. 8, 613-620. 186. White-Ziegler, C. A., Angus Hill M. L., Braaten, B. A., van der Woude, M., and Low, D. A. (1998). Thermoregulation of Escherichia coli pap transcription: H-NS is a temperature-dependent DNA methylation blocking factor. Mol. Microbiol. 28, 1121-1137. 187. van der Woude, M. W., and Low, D. A. (1994). Leucine-responsive regulatory protein and deoxyadenosine methylase control the phase variation and expression of the sfa and daa pili operons in Escherichia coli. Mol. Microbiol. 11, 605-618. 188. Braaten, B. A., Nou, X., Kaltenbach, L. S., and Low. D. A. (1994). Methylation patterns in pap regulatory DNA control pyelonephritis-associated pili phase variation in E. coli. Cell 74, 577-588. 189. Blyn, L. B., Braaten, B. A., and Low, D. A. (1990). Reguladon of pap pilin phase variadon by a mechanism involving differential Dam methylation states. EMBO J. 9, 4045-^054. 190. Kaltenbach, L. S., Braaten, B. A., and Low, D. A. (1995). Specific binding of Papl to Lrp-pap DNA complexes. / Bacteriol. Ill, 6447-6455.
128
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
191. Nou, X., Skinner, B., Braaten, B., Blyn, B., Hirsh, L., and Low, D. (1993). Regulation of pyelonephritis-associated pili phase variation in Escherichia coli: Binding of the Papl and LRP regulatory proteins is controlled by DNA methylation. Mol. Microbiol. 7, 545-553. 192. van der Woude, M., Kaltenbach, L. S., and Low, D. A. (1995). Leucine-responsive regulatory protein plays dual roles as both an activator and a repressor of the Escherichia coli pap operon. Mol. Microbiol. 17, 303-312. 193. Baga, M., Goransson, M., Nomiark, S., and Uhlin, B. E. (1985). Transcriptional activation of a pap pilus virulence operon from uropathogenic Escherichia coli. EMBO J. 4, 3887-3893. 194. Forsman, K., Goransson, M., and Uhlin, B. E. (1989). Autoregulation and multiple DNA interactions by a transcriptional regulatory protein in E. coli pili biogenesis. EMBO J. 8, 1271-1277. 195. Forsman, K., Sonden, B., Goransson. M., and Uhlin, B. E. (1992). Antirepression function in Escherichia coli for the cAMP-cAMP receptor protein transcriptional activator. Proc. Natl. Acad. Sci. U.S.A. 89, 9880-9884. 196. Goransson, M., Sonden, B., Nilsson, P., Dagberg, B., Forsman, K., Emanuelsson, K., and Uhlin, B. E. (1990). Transcriptional silencing and thermoregulation of gene expression in Escherichia coli. Nature 344, 682-685. 197. Zhang, J. P., and Normark, S. (1996). Induction of gene expression in Escherichia coli after pilus-mediated adherence. Science 273, 1234-1236. 198. Cornelis, G. R., and Wolf-Watz, H. (1997). The Yersinia yop virulon: A bacterial system for subverting eukaryotic cells. Mol. Microbiol. 23, 861-867. 199. Pettersson, J., Nordfelth, R., Dubinina, E., Bergman, T, Gustafsson, M., Magnusson, K. E., and Wolf-Watz, H. (1996). Modulation of virulence factor expression by pathogen target cell contact. Science 273, 1231-1233. 200. Stainier, L, Iriarte, M., and Cornelis, G. R. (1997). YscMl and YscM2, two Yersinia enterocolitica proteins causing downregulation oi yop transcription. Mol. Microbiol. 26, 833-843. 201. Williams, A. W., and Staley, S. C. (1998). YopD of Yersinia pestis plays a role in negative regulation of the low-calcium response in addition to its role in translocation of yops. J. Bacteriol. 180, 350-358. 202. Hughes, K. T., Gillen, K. L., Semon, M. J., and Karlinsey, J. E. (1993). Sensing structural intermediates in bacterial flagellar assembly by export of a negative regulator. Science 161, 1277-1280. 203. Menard, R., Dehio, C , and Sansonetti, P. J. (1996). Bacterial entry into epithelial cells: The paradigm of Shigella. Trends Microbiol. 4, 220-226. 204. Parsot, C , Menard, R., Gounon. P., and Sansonetti, P. J. (1995). Enhanced secretion through the Shigella flexneri Mxi-Spa translocation leads to assembly of extracellular proteins into macromolecular structures. Mol. Microbiol. 16, 291-300. 205. Hale, T. L. (1991). Genetic basis of virulence in Shigella species. Microbiol. Rev. 55, 206-224. 206. Tobe, T., Nagai, S., Okada, N., Adler, B., Yoshikawa, M., and Sasakawa, C. (1991). Temperature-regulated expression of invasion genes in Shigella flexneri is controlled through the transcriptional activation of the virB gene on the large plasmid. Mol. Microbiol. 5, 887-893. 207. Maurelli, A. T, Blackmon, B., and Curtiss III, R. (1984). Temperature-dependent expression of virulence genes in Shigella flexneri. Infect. Immun. 43, 195-201. 208. Nakayama, S.-I., and Watanabe, H. (1995). Involvement of cpxA, a sensor of a two-component regulatory system, in the pH-dependent regulation of expression of Shigella sonnei virE gene. J. Bacteriol. Ill, 5062-5069. 209. Porter, M. E., and Dorman, C. J. (1994). A role for H-NS in the thermo-osmotic regulation of virulence gene expression in Shigella flexneri. J. Bacteriol. 176, 4187^191.
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
129
210. Nakayama, S.-I., and Watanabe, H. (1998). Identification of cp.xR as a positive regulator essential for expression of the Shigella sonnei virF gene. J. Bacterial. 180. 3522-3528. 211. Porter, M. E., and Dorman, C. J. (1997). Differential regulation of the plasmid-encoded genes in the Shigella flexneri virulence regulon. Mol. Gen. Genet. 256. 93-103. 212. Dorman, C. J., Ni Bhriain, N.. and Higgins. C. F. {1990). DNA supercoiling and environmental regulation of virulence gene expression in Shigella flexneri. Nature 344, 789-792. 213. Tobe, T., Yoshikawa, M., and Sasakawa. C. (1995). Thermoregulation of virB transcription in Shigella fle.xneri by sensing of changes in local DNA superhelicity. J. Bactehol. 177, 1094—1097. 214. Bourgerie, S. J., Michan. C. M.. Thomas. M. S.. Busby, S. J. W.. and Hyde, E. I. (1997). DNA binding and DNA bending by the MelR transcription activator protein from Escherichia coli. Nucleic Acids Res. 25, 1685-1693. 215. McNairn, E., Ni Bhriain, N., and Dorman. C. J. (1995). Over-expression of the Shigella fle.xneri genes coding for DNA topoisomerase IV compensates for loss of DNA topoisomerase I: Effect on virulence gene expression. Mol. Microbiol. 15. 507-517. 216. Nf Bhriain, N., and Dorman, C. J. (1993). Isolation and characterization of a topA mutant of Shigella fle.xneri. Mol. Microbiol. 7, 351-358. 217. Free, A., and Dorman, C. J. (1995). Coupling of Escherichia coli hns mRNA levels to DNA synthesis by autoregulation: Implications for growth phase control. Mol. Microbiol. 18, 101-113. 218. Brandi, A., Pon, C. L., and Gualerzi. C. O. (1994). Interaction of the main cold shock protein CS7.4 (CspA) of Escherichia coli with the promoter region of hns. Biochimie 76, 1090-1098. 219. La Teana, A., Brandi, A., Falconi, M., Spurio, R.. Pon, C. L., and Gualerzi, C. O. (1991). Identification of a cold shock transcriptional enhancer of the Escherichia coli gene encoding nucleoid protein H-NS. Proc. Natl. Acad. Sci. U.S.A. 88, 10907-10911. 220. Tobe, T, Yoshikawa, M., Mizuno, T, and Sasakawa, C. (1993). Transcriptional control of the invasion regulatory gene virB of Shigella flexneri: Activation by VirF and repression by H-NS. J. Bacterial. 175, 6142-6149. 221. Durand, J. M. B., Bjork, G. R., Kuwae, A., Yoshikawa, M., and Sasakawa, C. (1997). The modified nucleoside 2-methylthio-A^'-isopentyladenosine in tRNA of Shigella flexneri is required for expression of virulence genes. J. Bacterial. 179, 5777-5782. 222. Durand, J. M., Okada, M., Tobe, T, Watarai. M.. Fukuda, I., Suzuki, T., Nakata, N., Komatsu, K., Yoshikawa, M., and Sasakawa, C. (1994). vacC, a virulence-associated chromosomal locus of Shigella flexneri, is homologous to tgt. a gene encoding tRNA-guanine transglycosylase (Tgt) of Escherichia call K-12. J. Bacterial. 176. 4627-4634. 223. Colonna, B., Casalino, M., Fradiani, P. A.. Zagaglia. C., Naitza. S., Leoni, L., Prosseda, G., Coppo, A., Ghelardini, P., and Nicoletti, M. (1995). H-NS regulation of virulence gene expression in enteroinvasive Escherichia coli harboring the virulence plasmid integrated into the host chromosome. J. Bacterial. 111. 4703^712. 224. Schuch, R., and Maurelli, A. T (1997). Virulence plasmid instability in Shigella fle.xneri 2a is induced by virulence gene expression. Infect. Inunun. 65, 3686-3692. 225. Hurme, R., Berndt, K. D., Normark, S. J., and Rhen. M. (1997). A proteinaceous gene regulatory thermometer in Salmonella. Cell 90, 55-64. 226. Dunny, G. M., and Leonard, B. A. B. (1997). Cell-cell communication in Gram-positive bacteria. Annu. Rev. Microbiol. 51, 527-564. 227. Gray, K. M. (1997). Intercellular communication and group behavior in bacteria. Trends Microbial. 5, 184-188. 228. Swift, S., Throup, J. P, Williams, P, Salmond, G. P C . and Stewart, G. S. A. B. (1996). Quorum sensing: A population-density component in the determination of bacterial phenotype. Trends Biatechnol. 21, 214-219.
130
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
229. Pearson, J. P., Pesci, E. C , and Iglewski, B. H. (1997). Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes, /. Bacteriol 179, 5756-5767. 230. Winson, M. K., Camara, M., Latifi, A., Foglino, M., Chhabra, S. R., Daykin, M., Bally, M., Chapon, V., Salmond, G. P C., Bycroft, B. W., Lazdunski, A., Stewart, G. S. A. B., and Williams, P. (1995). Multiple A^-acyl-L-homoserine lactone signal molecules regulate production of virulence determinants and secondary metabolites in Pseudomonas aeruginosa. Proc. Natl. Acad Sci. U.S.A. 92, 9427-9431. 231. Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., and Greenberg, E. P. (1998). The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280, 295-298. 232. Latiffi, A., Foglino, M., Tanaka, K., Williams, P., and Lazdunski, A. (1996). A hierarchical quorum-sensing cascade in Pseudomonas aeruginosa links the transcriptional activators LasR and RhlR (VsmR) to expression of the stationary-phase sigma factor RpoS. Mol. Microbiol. 21, 1137-1146. 233. Robson, N. D., Cox, A. R. J., McGowan, J., Bycroft, B. W., and Salmond, G. P C. (1997). Bacterial A^-acyl-homoserine-lactone-dependent signalling and its potential biotechnological applications. Trends Biotechnol. 15, 458-464. 234. Balaban, N., Goldhom, T, Nhan, R. T., Dang, L. B., Scott, S., Ridgley, R. M., Rasooly, A., Wright, S. C , Larrick, J. W., Rasooly, R., and Carlson, J. R. (1998). Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 280, 438^40. 235. Cheung, A. L., Koomey, J. M., Butler, C. A., Projan, S. J., and Fischetti, V. A. (1992). Regulation of exoprotein expression in Staphylococcus aureus by a locus {sar) distinct from agr. Proc. Natl. Acad Sci. U.S.A. 89, 6462-6466. 236. Cheung, A. L., and Projan, S. J. (1996). Cloning and sequencing of sar of Staphylococcus aureus, a gene required for the expression of agr. J. Bacteriol. 176, 4168^172. 237. Hart, M. E., Smeltzer, M. S., and landolo, J. J. (1993). The extracellular protein regulator {xpr) affects exoprotein and agr levels in Staphylococcus aureus. J. Bacteriol. 175, 7875-7879. 238. Ji, G. Y, Beavis, R. C , and Novick, R. P (1995). Cell density control of staphylococcal virulence mediated by an octapeptide pheromone. Proc. Natl. Acad. Sci. U.S.A. 92, 1205512059. 239. Morfeldt, E., Tegmark, K., and Arvidson, S. (1996). Transcriptional control of the «gr-dependent gene regulator, RNAIII, in Staphylococcus aureus. Mol. Microbiol. 21, 1227-1237. 240. Morfeldt, E., Taylor, D., von Gabain, A., and Arvidson, S. (1995), Activation of alpha-toxin translation in Staphylococcus aureus by the rraAi^-encoded antisense RNA, RNAIII. EMBO J. 14, 4569-4577. 241. Bridges, B. A. (1997). Hypermutation under stress. Nature 387, 557-558. 242. Foster, P. L. (1993). Adaptive mutation: The uses of adversity. Annu. Rev. Microbiol. 47, 467-504. 243. Torkelson, J., Harris, R. S., Lombardo, M.-J., Nagendran, J., Thulin, C , and Rosenberg, S. M. (1997). Genome-wide hypermutation in a subpopulation of stationary-phase cells underlies recombination-dependent adaptive mutation. EMBO J. 16, 3303-3311. 244. Cairns, J. (1993). Directed mutation. Science 260, 1221-1222. 245. Foster, P. L. (1994). Population dynamics of a Lac- strain of Escherichia coli during selection for lactose utilization. Genetics 138, 253-261. 246. Hall, B. G. (1998). Activation of the bgl operon by adaptive mutation. Mol. Biol. Evol. 15, 1-5. 247. Moxon, E. R., and Thaler, D. S. (1997). The tinkerer's evolving toolbox. Nature 387, 659-662.
3.
REGULATION OF VIRULENCE GENE EXPRESSION IN BACTERIAL PATHOGENS
131
248. LeClerc, J. E., Li, B., Payne, W. L., Cebula, T. A. (1996). High mutation frequencies among Escherichia coli and Scihnonella pathogens. Science 274, 1208-1211. 249. Konigsberg, W., and Godson, G. N. (1983). Evidence for use of rare codons in the dnaG gene and other regulatory genes of Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 80, 687-691. 250. Sharp, P. M., and Li, W.-H. (1986). Codon usage in regulatory genes in Escherichia coli does not reflect selection for rare codons. Nucleic Acids Res. 14, 7737-7749. 251. Kurland, C. G. (1993). Major codon preference in theme and variations. Biochem. Soc. Trans. 21, 841-846. 252. Chen, G. T., and Inouye, M. (1994). Role of AGA/AGG codons, the rarest codons in global gene regulation in Escherichia coli. Genes Dev. 8, 2641-2652. 253. Chen, G. T., and Inouye, M. (1990). Suppression of the negative effect of minor arginine codons on gene expression: Preferential usage of minor codons within the first 25 codons of the Escherichia coli genes. Nucleic Acids Res. 18, 1465-1473. 254. Goldman, E., Rosenberg, A. H., Zubay, G., and Studier, F. W. (1995). Consecutive low-usage leucine codons block translation when near the 5' end of a message in Escherichia coli. J. Mol. Biol. 245, 467-473. 255. Bonekamp, R, and Jensen, K. F. (1988). The AGG codon is translated slowly in E. coli even at very low expression levels. Nucleic Acids Res. 16, 3013-3024. 256. Misra, R., and Reeves, P. (1985). Intermediates in the synthesis of TolC protein include an incomplete peptide stalled at a rare Arg codon. Eur J. Biochem. 152, 151-155. 257. Robinson, M., Lilley, R., Little, S., Emtage, J. S., Yarranton, G., Stephens, R, Millican, A., Eaton, M., and Humphreys, G. (1984). Codon usage can affect translation rate in Escherichia coli. Nucleic Acids Res. 12, 6663-6671. 258. Rosenberg, A. H., Goldman, E., Dunn, J. J., Studier, F W., and Zubay, G. (1993). Effects of consecutive AGG codons on translation in Escherichia coli demonstrated with a versatile codon test system. /. Bacteriol. 175, 716-722. 259. Spanjaard, R. A., and van Duin, J. (1988). Translation of the sequence AGG-AGG yields 50% ribosomal frameshift. Proc. Nad. Acad. Sci. U.S.A. 85, 1961-191 \. 260. Zahn, K., and Landy, A. (1996). Modulation of lambda integrase synthesis by rare arginine tRNA. Mol. Microbiol. 21, 69-76. 261. Ritter, A., Gaily, D., Olsen, P B., Dobrindt, U., Friedrich, A., Klemm, P, and Hacker, J. (1997). The Pai-associated leuX specific tRNA5Leu affects type 1 fimbriation in pathogenic Escherichia coli by control of FimB recombinase expression. Mol. Microbiol. 25, 871-882. 262. Blum, G., Ott, M., Lischewski, A., Ritter, A., Imrich, H., Tschiipe, H., and Hacker, J. (1994). Excision of large DNA regions termed pathogenicity islands from tRNA-specific loci in the chromosome of an Escherichia coli wild-type pathogen. Infect. Immun. 62, 606-614. 263. Colston, M. J., and Davis, E. O. (1994). The ins and outs of protein splicing elements. Mol. Microbiol 12, 359-363. 264. Fsihi, H., Vincent, V, and Cole, S. T. (1996). Homing events in the gyrA gene of some mycobacteria. Proc. Nad. Acad. Sci. U.S.A. 93, 3410-3415. 265. Cooper, A. A., and Steven, T. H. (1995). Protein splicing: Self-splicing of genetically mobile elements at the protein level. Trends Biochem. Sci. 20, 351-356. 266. Derbyshire, V, Wood, D. W., Wu, W., Dansereau, J. T, Dalgaard, J. Z., and Belfort, M. (1997). Genetic definition of a protein-splicing domain: Functional mini-inteins support structure predictions and a model for intein evolution. Proc. Natl. Acad. Sci. U.S.A. 94, 11466-11471. 267. Delihas, N. (1995). Regulation of gene expression by r/T//?.v-encoded antisense RNAs. Mol. Microbiol. 15.411-414.
132
CHARLES J. DORMAN AND STEPHEN G. J. SMITH
268. Wagner, E. G. H., and Simons, R. W. (1994). Antisense RNA control in bacteria, phages, and plasmids. Annu. Rev. Microbiol. 48, 713-742. 269. Okamoto, K., and Freundlich, M. (1986). Mechanism for the autogenous control of the crp operon: Transcriptional inhibition by a divergent RNA transcript. Proc. Natl. Acad. Sci. U.S.A. 83, 5000-5004. 270. Andersen, J., Forst, A., Zhao, K., Inouye, M., and Delihas, N. (1989). The function of micF RNA. J. Biol. Chem. 264, 17961-17970. 271. Strauss, E. J., and Falkow, S. (1997). Microbial pathogenesis: Genomics and beyond. Science 276,707-712. 272. Valdivia, R. H., and Falkow, S. (1997). Fluoresence-based isolation of bacterial genes expressed within host cells. Science 211, 2007-2011. 273. Hoheisel, J. D. (1997). Oligomer-chip technology. Trends Biotechnol. 15, 465-469. 274. Massey, R. C , Rainey, R B., Sheehan, B. J., Keane, O. M., and Dorman, C. J. (1999). Environmentally constrained mutation and adaptive evolution in Salmonella. Cum Biol. 9, 1477-1480.
CHAPTER 4
Strategies to Identify Bacterial Pathogenicity Factors ANDREW CAMILLI D. SCOTT MERRELL JOHN J. MEKALANOS
I. Introduction II. Biochemical Strategies A. Classical Approaches B. Chemical Modification Screens C. Zymography D. Receptor/Ligand Affinity Screens E. Immunological Methods F Subtractive Hybridization G. Differential Display H. Reverse Genetics III. Genetic Screens A. In Vitro Screens B. In VMY; Screens IV. Genetic Selections A. Direct Selections B. Complementation Approaches C. Selection for Nongrowing Bacterial Mutants D. //? V/IY; Expression Technology V. Genomic Approaches A. Genome Walking B. Genomic Analysis and Mapping by /// Vitro Transposition C. Computational Screens D. Transcriptional Profiling and the Use of Microarrays VI. Concluding Remarks References
Principles of Bacterial Pathogenesis Copyright © 2001 by Academic Press AH rights of reproduction in any form reserxed. ISBN 0-12-304220-8
i oo
134 135 135 139 141 143 144 145 147 149 149 150 156 159 160 161 162 163 165 164 166 167 168 169 170
134
ANDREW CAMILLI, D . SCOTT MERRELL, AND JOHN J. MEKALANOS
/. Introduction Since Pasteur, Lister, Koch, and their contemporaries first proved the germ theory of disease in the second half of the nineteenth century, humans have been striving to understand the pathogenic mechanisms of the many reprehensible microbes that plague humans. This desire to understand the microbial causation of many human diseases has led to many epidemiological studies and to increased knowledge of the diverse environmental reservoirs occupied by pathogenic bacteria. The information garnered has been extremely helpful in combating many diseases and has shed light on the persistence of pathogenic bacteria in the absence of a human host. For example, an understanding of the ability of Vibrio cholerae to survive within an aqueous environment led to the development of water treatment strategies that have proven successful in the prevention of cholera and similar diarrheal diseases. Two additional lines of predominantly empirical research—vaccine development and the discovery of antimicrobial compounds—have also had tremendous impact on the prevention and treatment of many bacterial diseases. However, there is now considerable evidence that science has begun to exhaust these empirical lines of research, placing the scientific community at the dawn of an era when detailed knowledge of the cellular and molecular aspects of host-pathogen interactions will seed the future development of novel vaccines and novel antimicrobial compounds. Essential to the establishment of a complete understanding of the host-pathogen interactions that are necessary for the manifestation of disease is the identification and detailed characterization of virulence factors produced by pathogens at each stage of the infection process. The other chapters of this book detail the progression of the understanding of many host-pathogen interactions that have been elucidated during the past century. In contrast, the present chapter focuses on the various biochemical, immunological, and genetic strategies that have been successfully employed by microbiologists to identify these bacterial pathogenicity factors. In addition, speculation on the utilization of several postgenomic strategies that are currently being developed is presented in an attempt to illuminate future methodologies, which should prove useful in further discoveries. A listing of each technique/strategy along with a brief description of some of their advantages and disadvantages is shown in Table I. Bacterial pathogenicity is a multifactorial and dynamic process that requires coordinate production and repression of many bacterial gene products. Though each bacterial pathogen interacts with the human host in a unique way, common events occur in many infections. These common events involve: (1) primary attachment to host cells or tissue, (2) invasion into host cells or tissues (in the case of invasive pathogens) or increased adherence by extracellular pathogens, (3) avoidance of and/or resistance to host immune defenses, (4) acquisition of nutrients, (5) multiplication, and, lasdy, (6) evacuation from the host to either a new host or an environmental reservoir. Invariably, at one or more of these stages.
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
135
bacterial-produced toxins and/or the host immune response result in damage to host tissues or organs and give rise to pathology. Although a tremendous amount of knowledge has been amassed on the identity and function of toxins and other secreted or surface factors produced by bacterial pathogens, it is becoming more and more evident that the investigation of bacterial pathogenicity must be broadened to include an understanding of cytosolic factors that are involved in processes as diverse as production of metabolites, multiplication, and adaptation to dynamic and stressful environments. The reason for this is simple: any factor produced by a pathogen that plays a role in survival or multiplication in the host environment is, a priori, suitable as a target for inclusion in vaccine formulations or for development of antimicrobial drugs. Accordingly, in some sections of this chapter the reader may note the use of a broader definition of "pathogenicity factor" that includes any factor produced by a pathogen that plays a role in its survival, multiplication, or spread to new hosts.
//. Biochemical Strategies A.
Classical Approaches
Prior to the dawn of the recombinant DNA era, microbiologists seeking to identify bacterial pathogenicity factors primarily focused their efforts on the biochemical purification of macromolecules that could be associated with disease symptoms and could be produced by the pathogen during laboratory growth. This classical approach is still utilized today, although usually in conjunction with immunological and/or genetic methods that increase the breadth of the approach. For example. Western blot analysis using human convalescent serum could be used to identify proteins secreted by a pathogen during in vitro growth. Once the protein was identified, it could be purified by two-dimensional gel electrophoresis, an amino-terminal portion of the protein sequenced, degenerate polymerase-chain reaction (PCR) primers synthesized, a portion of the gene amplified by PCR, and the gene encoding the protein identified in the pathogen genome using the PCR product as a probe. This series combines techniques from several sections of this chapter and highlights the value of understanding and utilizing multiple techniques to identify pathogenicity factors. An essential element of the initial, purely biochemical purifications was that an activity had to be associated with the pathogenicity factor to allow its purification. The range of activities of the pathogenicity factors that could be isolated were therefore limited to the presence of enzymatic activity that could be assayed in vitro, or toxic activity that could be assayed using cultured host cells or whole animals. For this reason, many of the first pathogenicity factors
136
Table I
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
Techniques and Strategies for Identifying Pathogenicity Factors"
Technique or strategy
Advantages
Disadvantages
Classical biochemical approaches
Doesn't require genetic manipulation of pathogen. Can identify factors essential for viability.
Requires knowledge of enzymatic activity or function. Can be laborious.
Chemical modification screens
Doesn't require genetic manipulation. Can identify essential factors. Not necessary to know enzymatic activity or function.
Targets only a subset of pathogenicity factors (e.g., those exposed on the outer surface).
Zymography
Doesn't require genetic manipulation. Can identify essential factors. Direct detection of purified or partially purified factor.
Requires knowledge of enzymatic activity for which a substrate is available. Enzymatic activity must be stable and in most cases, renaturable. Can be expensive.
Receptor/ligand affinity screens
Doesn't require genetic manipulation. Direct purification of factor.
Requires knowledge of either ligand or receptor.
Immunological methods
Doesn't require genetic manipulation. Targets factors expressed during infection.
Targets only factors that are immunogenic, many of which may not be pathogenicity factors.
Subtractive hybridization
Doesn't require genetic manipulation. Can identify essential factors. Doe.sn't require knowledge of function.
Lacks sensitivity and can be laborious. Only a subset may encode pathogenicity factors.
Differential display
Doesn't require genetic manipulation. Can identify essential factors.
Lacks sensitivity, and can be laborious. Only a subset may encode pathogenicity factors.
Reverse genetics
Doesn't require genetic manipulation of pathogen. Can identify essential pathogenicity proteins.
Requires some amino acid sequence of protein factor.
Large-scale screenings
Can be comprehensive.
Is usually laborious. Usually requires an in vitro model of infection (e.g., tissue culture). Cannot identify redundant pathogenicity factors.
Targeting exported proteins
Many pathogenicity factors are exported. Simultaneously generates a null mutation in pathogenicity gene.
Only a subset of pathogenicity factors are exported proteins. Some protein-reporter fusions will be toxic.
Coordinate regulation screens
Directly identifies pathogenicity genes coregulated with known ones.
Requires knowledge of in vitro growth conditions that induce expression of pathogenicity genes.
Host mimicry
Directly identifies pathogenicity genes and may point to a role during infection.
Requires knowledge of in vitro conditions that mimic a host parameter(s).
continued
4.
137
STRATEGIES TO IDENTIFY BACTERIAL PATH(XIENICITY FAC TORS
Technique or strategy
Advantages
Disadvantages
Recombinationbased in vivo expression technology
Identifies pathogenicity genes that are transiently induced or induced at a low level in host tissues.
Not all pathogenicity genes are transcriptionally induced in host. Only a subset of infection-induced genes encode pathogenicity factors.
Signature-tagged mutagenesis
Targets pathogenicity genes that play essential roles during infection. Allows multiple mutant strains to be screened per host animal.
Can be laborious. Requires large infectious dose in some disease models. Cannot identify redundant pathogenicity factors.
Direct selections
Directly identifies strains with mutations in pathogenicity genes.
Requires knowledge of a phenotype associated with the pathogenicity factor. For some direct selections only a subset of mutations will be in pathogenicity genes.
Complementation approaches
Directly identifies genes necessary and in some cases sufficient to confer a pathogenic property.
Depending on strategy, requires efficient means of transformation into pathogen, or a simple in vitro model of disease (e.g., adherence to tissue culture cells).
Selection for nongrowing bacterial mutants
Directly identifies genes necessary for multiplication in vitro under host-like conditions (e.g.. within tissue culture cells).
Only a subset of mutations will be in genes specifically required for in vivo growth.
In vivo expression technology
Directly identifies pathogenicity genes that are expressed in host tissues.
Pathogenicity genes that are transiently expressed during infection or are expressed at low levels may not be identified.
Genome walking
Rapid and simple method of identifying pathogenicity genes.
Requires mutagenesis studies to confirm roles in pathogenicity.
Genomic analysis Targets pathogenicity genes that play and mapping essential roles during infection. Allows by in vitro multiple mutant strains to be screened transposition per host animal.
Laborious. Requires prior genome sequence information. Cannot identify redundant pathogenicity factors.
Computational screens
Rapid and simple method of identifying pathogenicity genes.
Requires prior knowledge of pathogenicity factors to serve as query sequences. Requires mutagenesis studies to confirm roles in pathogenicity.
Transcriptional profiling and the use of microarrays
Rapid and comprehensive method of identifying pathogenicity genes.
Requires prior genome sequence information. Expensive. Requires mutagenesis studies to confirm roles in pathogenicity.
"This table is meant to list most of the techniques and strategies discussed in the text and is not all-inclusive. Only a brief description of some of the major advantages and disadvantages of each is given. Please read the text for more detailed discussion, it is up to the reader to thoroughly investigate and carefully weigh the advantages and disadvantages of each technique or strategy before embarking on a study to identify virulence factors.
138
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
identified were bacterial exotoxins that possess dramatic activities whose effects can be easily monitored. For example, the Streptococcus pneumoniae pore-forming protein pneumolysin (Ply) lyses mammalian red blood cells (RBCs), producing clear, hemolytic zones around colonies grown on media containing RBCs. This activity was noted early in this century [72], and it provided a convenient assay to monitor purification of Ply to homogeneity as lysis of RBCs in solution could be easily monitored. A purification strategy that included acetic acid precipitation, ammonium sulfate precipitation, ion-exchange chromatography, gel filtration, and preparative acrylamide gel electrophoresis led to purification of Ply [108]. With purified Ply in hand, researchers were then able to convincingly show that Ply was sufficient to reproduce the toxic lethal effect of 5*. pneumoniae culture filtrates [108]. A second example of a purely biochemical identification of a pathogenicity factor is the isolation of cholera toxin, which built on the prior observations of De [27] and Dutta and colleagues [33] that the profuse watery diarrhea of cholera could be reproduced by enteral administration of sterile culture filtrates to animals. This observation, along with the ability to monitor purification by bioassay in infant rabbits and by immunoassay using polyclonal antiserum, led to the isolation of cholera toxin in a pure form using a purification strategy similar to that described above for Ply [38]. This purification precipitated many elegant studies (reviewed in [37]) that revealed cholera toxin's A-B5 subunit structure, its ganglioside GMj host cell receptor, and its primary mode of action—activation of host cell adenylate cyclase. The application of these purely biochemical approaches to other pathogens has been particularly successful in the identification of factors such as diphtheria toxin, pertussis toxin, and shiga toxin, and unquestionably validates the usefulness of such approaches. The potential for application of biochemical isolations is infinite and is Umited only by the ability of the researcher to measure the specific activity of a factor during purification. Potential applications could utilize prior understanding of enzymatic differences between pathogen and host. For instance, phosphorylated protein tyrosine residues are rare in bacteria, yet prevalent in signaling pathway components in human cells. Therefore, the Yersinia YopH protein, which was in actuality identified by other methods [12], could instead have been identified by a search for protein tyrosine phosphatase activity in whole cell bacterial extracts. The presence of such activity in a bacterial pathogen that is known to possess few examples of protein tyrosine phosphorylation could indicate a potential mode of interaction with the host by modification of host protein phosphorylation patterns. Understanding differences between host and pathogen enzymatic functions has many implications for application of biochemical strategies to isolate bacterial factors that specifically affect the host cell. For instance, though they themselves do not produce actin, many bacterial pathogens utilize host cell F-actin for attachment and intracellular spread. Therefore, one could conceivably design screens for bacterial factors that possess the ability to nucleate host cell G-actin
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
139
or modify F-actin in vitro. Additionally, targeted biochemical screens could be designed to identify factors that proteolytically cleave key host proteins, phosphorylate or dephosphorylate protein serine and/or threonine residues, or covalently modify in other ways certain host proteins. Knowledge of differences between host and pathogen activities can also be used to screen for bacterial factors that alter normal host responses. For example, a recent study found that the Mycobacterium tuberculosis pathogenicity factor, lipoarabinomannan, stimulates the activity of a macrophage tyrosine phosphatase both in vivo and in vitro. This activity possibly inhibits proper macrophage function to provide a means of avoidance of this component of the host immune response [63]. Similar searches for factors that affect host enzymatic functions could also be conducted and could prove beneficial in the elucidation of heretofore undiscovered bacterial pathogenicity factors. Purely biochemical strategies for the discovery of bacterial pathogenicity factors have several advantages: (1) Many pathogenic bacteria are not easily genetically manipulatable and therefore are not easy targets for screens that employ large-scale mutagenesis strategies. Biochemical strategies to identify pathogenicity factors are therefore much more advantageous in these organisms. (2) Some pathogenicity factors are essential for bacterial growth in vitro and thus would never be isolated using genetic strategies that rely on mutagenesis. Therefore, biochemical isolations that do not involve disruption of normal bacterial processes allow isolation of these essential factors. (3) The activities of some pathogenicity factors are known, and this knowledge can facilitate design of strategies specific for the factor responsible for the activity. Despite these strengths, purely biochemical strategies for pathogenicity factor discovery also possess some disadvantages: (1) The advantage presented above as #3 can also serve as a major disadvantage when employing biochemical strategies to look for pathogenicity factors. The isolation and purification of factors that possess unknown functions is impossible since the ability to assay for function is critical to all of the classical biochemical strategies. (2) Biochemical purifications are often laborious as they rely on multiple purification steps that need to be designed or empirically determined to preserve specific activity of the factor one is attempting to isolate. For these reasons, genetic strategies are often more amenable for identification of pathogenicity factors having novel or unknown functions.
B.
Chemical Modification Screens
The first step in bacterial pathogenicity commonly involves adherence of the infectious agent to host cells or tissue. Because most of the host-pathogen interactions that allow this attachment to occur involve intimate contact between the bacteria and host cells, the outer surface of the bacterial cell has served as a
140
ANDREW CAMILLI. D. SCOTT MERRELL, AND JOHN J. MEKALANOS
prime hunting ground for factors involved in this aspect of pathogenicity. This section focuses on a few of the numerous biochemical strategies that have been used to dissect apart the intimate interactions that occur on the outer surface of bacterial pathogens. Although not a biochemical technique per se, direct visualization of bacterial surfaces by microscopy, in conjunction with fixation or biochemical staining procedures, can be used to identify surface-exposed pathogenicity factors. For example, light microscopy of bacterial cells stained with india ink and electron microscopy of polycationic ferritin-stained thin sections of bacterial cells have allowed visual detection of polysaccharide capsules surrounding some pathogens. Although much is already known about the roles of bacterial polysaccharide capsules in pathogenicity [6, 32], application of microscopy techniques and the ability to directly visualize capsule around newly isolated pathogens is useful in that it can provide an immediate advance in one's understanding of the potential pathogenicity of that organism. For example, two reports in 1994 demonstrated that a new epidemic strain of V cholerae, serotype 0139, expressed a polysaccharide capsule. This finding was novel in that the presence of a polysaccharide capsule had never before been seen in epidemic strains [57, 125]. Although the precise role of the capsule in the pathogenicity of this intestinal pathogen is not readily clear, it is possible that the capsule might be involved in adherence to the mucosal layer of the small bowel, or involved in resistance to certain host bactericidal mechanisms such as complement-mediated lysis. To this end, mutants that have lost the ability to express capsule have been shown to be attenuated for pathogenicity in an animal model of cholera [120]. This finding underscores the usefulness of visualization of bacterial surfaces as a means of detection of pathogenic factors. Electron microscopy has many orders of magnitude greater resolving power than light microscopy, and has been used to visualize the very long (0.5-15 |im) and thin (1-11 nm) adhesive fibers, called pili, that extend from the surfaces of many Gram-negative bacteria. Although it should be noted that not all pili expressed by pathogens play a role in human disease (e.g., [112]), the discovery of pili on the surface of a suspected or known pathogen provides a good starting point for further investigation, as some pili have been shown to be essential factors for establishment of infections. Direct application of both electron microscopy and light microscopy are therefore attractive in that they can provide immediate knowledge about surface structures such as pili or capsules. It should be noted, however, that other methods are required to assess the putative roles of these surface structures in pathogenicity. In addition to direct visualization of surface structures, electron microscopy and light microscopy have also proven themselves valuable tools for indirectly monitoring the presence of many bacterial surface adhesins—for example, surface factors involved in such diverse activities as in vitro autoagglutination [113], attachment to cultured host cells [117], and invasion into cultured cells [56]. Once
4.
STRATEGIES TO IDENTIFY BACTERIAL PATH(3GEMCITY FACTORS
141
again, though, other methods are ultimately needed to identify these pathogenicity factors, highlighting the importance of combining multiple techniques to gamer a greater understanding of host-pathogen interactions. Direct chemical modification of bacterial surface macromolecules using reagents that are unable to cross the bacterial outer membrane can facilitate identification of pathogenicity factors. The inability of these reagents to be internalized not only facilitates specific tagging of surface-exposed molecules but also often facilitates the purification and subsequent characterization of surfaceexposed pathogenicity factors. Two frequently used methods of surface modification involve radioiodination and biotinylation of intact cells followed by purification and electrophoretic separation of membrane proteins. Surface molecules that have been radioiodinated can be directly visualized by autoradiography following separation by gel electrophoresis, hi contrast, biotinylated molecules can only be visualized after binding of a secondary molecule such as streptavidin that possesses a high binding affinity for biotin. The secondary molecule is usually visualizable due to the fact that it has been either radiolabeled or conjugated to a colorimetric moiety such as alkaline phosphatase. Though these two surface modification techniques differ chemically, both have proven themselves useful for identification of surface factors involved in pathogenicity. Most recendy, these two labeling methods have been utilized to identify Bartonella henselae surface proteins, and to then further identify the subset of these surface proteins that function as adhesins for human endothelial cells [16]. Biochemical screens for pathogenicity factors that utilize chemical modification have advantages and disadvantages that force the investigator to consider the usefulness of the procedures. A primary advantage of chemical modification is that litde or no information need be known about the pathogenicity factors present on the cell surface other than the fact that they reside there. This allows the investigator to construct broadly based screens, which increases the chances of discovery of important pathogenicity factors. The primary limitations of these types of screens include the fact that many bacterial pathogenicity factors are indeed not expressed on the outer membrane and thus would be missed in screens that exclusively looked at this subset of molecules. In addition, isolation of surface-exposed molecules on a gel generally only provides a starting point for identification of putative pathogenicity factors, and must be followed up by other methodologies. For example, in order to assess a protein's role in pathogenicity, one might wish to mutate the gene encoding the surface protein by using reverse genetics.
C.
Zymography
Since some bacterial pathogenicity factors are enzymes, identification strategies that directly assay for enzymatic activity are useful in that they provide a more
142
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
direct method of identification. For example, many bacterial proteases are involved in cleavage of host cell extracellular matrix proteins or host cellular proteins. Cleavage of these host proteins often assists the pathogen in the establishment of an infection and sometimes aids the bacterium in avoidance of the host cell immune response. One strategy for identification of bacterial enzymatic pathogenicity factors is zymography. This strategy combines electrophoretic separation of bacterial proteins with the subsequent visual detection of enzymatic activity in situ, that is, in the gel itself. The most common zymographs target identification of proteases, as the construction of the substrate matrix is simple. For example, a denaturing acrylamide gel can be embedded with a substrate polypeptide such as casein. This gel would then be loaded with a protein preparation from a pathogen of interest, and electrophoresed to separate the secreted or membrane proteins. The separated proteins would then be renatured by subsequent removal of denaturants from the gel. Next, an incubation period would allow enzymatic proteolysis to occur. Finally, the gel can be stained with coomasie blue, and the presence of a small clearing zone within the casein matrix indicates that the protein species present at that location possesses proteolytic activity. This methodology relies on the fact that the embedded casein molecules do not migrate appreciably during electrophoresis due to their lack of substantial net charge. Candidate proteases can then be purified and further studied biochemically, or purified and subjected to reverse genetics to identify the encoding gene. Various zymography modifications that involve utilization of secondary gels impregnated with additional polypeptide substrates have been made (reviewed in [67]) and then utilized for the study and/or identification of several putative pathogenicity factors from a variety of different pathogens [22, 34, 41]. The usefulness of zymography in identification of pathogenic factors is not limited to proteases. In fact, many other enzymatic activities have also been identified by utilization of zymographic techniques. Examples of the diverse activities and factors that have been identified include a secreted S. sobrinus dextranase inhibitor believed to be involved in colonization of the oral cavity [111], a Staphylococcus aureus murein hydrolase that is under the regulation of the agr and sar pathogenicity gene regulators [44], and a Prevotella melanginogenica hemolysin that is produced by this periodontal pathogen [4]. Indeed, zymography is a method that can be adapted for identification of additional types of enzymes, and is advantageous in that the potential applications for identification of enzymatic factors are as limidess as the imagination of the investigator. It should be noted, however, that limitations to zymography do exist. First, embedding a large gel matrix with some substrates can be very costly. Second, many bacterial enzymes that are involved in pathogenicity may not be produced during normal laboratory growth or may not be present in an active form. Third, bacterial proteases often exhibit high substrate specificity, and the identity of the substrate may not be known. Fourth, detection of an enzymatic
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
143
activity requires that the enzyme be not only stable but renaturable after electrophoretic separation. The latter problem may be solved by running a nondenaturing gel, but then information concerning the molecular weight of the enzyme may be lost. And, fifth, biochemical methods (such as zymography) assume that the activity being pursued is important for pathogenesis; however, this can only be assessed by side-by-side comparison of the corresponding mutant and wild-type strains, or by reproduction of the disease symptoms by the purified protein in the case of toxins.
D. Receptor/Ligand Affinity Screens Intimate interaction between host and pathogen occurs on many levels. Not only do most bacterial pathogens have to adhere to host cells or tissues, but often they produce polypeptides that subsequendy interact with host cell components. These interactions are often key steps in the development and progression of pathogenicity. Because of this, many biochemical screens specifically target pathogenicity factors that show the ability to bind to host molecules with high affinity. Receptor/ligand screens are one such type of screen and have proven beneficial in identification of a number of interacting components. Receptor/ligand screens in the most straightforward form involve the following steps. First, total protein from the pathogen of interest is prepared and then separated on a denaturing acrylamide gel. Following separation, protein constituents are renatured and subsequently transferred and bound to a solid membrane support. This membrane can then be exposed to any radiolabeled host ligand of interest. The immobilized bacterial polypeptide bands that interact with and are bound by the labeled host ligand can then be identified by autoradiography. This type of receptor/ligand screen has been used successfully numerous times. For example, a S. pyogenes adhesin was identified using radiolabeled collagen as a ligand [118]; and in a more recent example, the Enterobacter cloacae mannosesensitive pilus adhesin for human cells was identified from purified pili subunit polypeptides after exposure to mannose-containing biotinylated albumin [92]. In addition to the basic receptor/ligand screen, variations of this technique have been used to study the binding of bacterial proteins to immobilized host ligands (e.g., [129]), and the binding of entire host cells to immobilized bacteria expressing an adhesin (e.g., [70]). Yet another variation of this method combines the expression of individual pathogen proteins on the surface of a surrogate host bacterium (that lacks the binding activity being studied) with affinity binding selection of surrogate host cells expressing the receptor to a ligand matrix. This methodology has been used to identify a Neisseria gonorrhoeae adhesin for the host cell ligand, gangliotetraosylceramide [93]. Affinity binding can often be used as a direct method for the identification of bacterial pathogenicity factors. For instance, both panning and affinity chroma-
144
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
tography utilize immobilized host ligand as a means of purifying bacterial factors that interact with specific host substrates. A more recent innovation in these techniques has been developed, which is called Receptor activity-directed affinity Tagging (ReTagging) [55]. ReTagging is beneficial in that it utilizes a UV light-activatible crosslinker to covalently attach a biotin molecule onto a bacterial receptor when it comes into close contact with the host ligand (Fig. 1, see color plate). The attachment of the biotin molecule then allows direct identification and purification of the bacterial factor to which it is bound using streptavidin-coated magnetic beads (streptavidin possesses high binding affinity for biotinylated compounds). This method was recently utilized to identify the Helicobacter pylori receptor for the Lewis B histo-blood group antigen [55]. This simultaneous identification and purification of the bacterial receptor is a major advantage of the utilization of ReTagging. In addition, the affinity of the receptor-ligand pair enables identification and purification of low-abundance receptors.
E. Immunological Methods Many bacteria disrupt or circumvent the host immune system in order to produce a productive infection. Thus, it is fitting that researchers have developed strategies for discovery of pathogenicity factors that exploit the immunological system. Such strategies are usually based on the ability of antibodies to protect a host or surrogate host from disease. Before application of this strategy, a bank of B-lymphocyte hybridomas that produce monoclonal antibodies (MAbs) directed against antigens exposed on the bacterial surface must first be generated. Subsequently, each individual MAb can then be screened for the ability to protect the host from disease. The inability to cause disease represents a positive result and might indicate that the MAb is binding to and blocking the function of a pathogenicity factor residing on the surface of the pathogen. It should be noted, however, that mere binding of the MAb to the bacterial cell surface can be sufficient to protect the host from disease in that antibodies can act as opsonins for complement deposition and phagocytosis. For this reason, it is necessary to show protection using purified Fab fragments of the MAb, as Fab fragments lack opsonizing activity yet can block the function of the bacterial factor. Of course, studies in surrogate host systems that lack complement and/or phagocytic cells (e.g., cultured mammalian cells grown in medium supplemented with heat-inactivated serum) do not require the Fab control experiment. Once an MAb has been identified that provides protection of the host or surrogate host from disease, the MAb then becomes a powerful tool that can be used to identify the surface molecule to which it binds. Solubilized membrane protein extracts can be used in conjunction with the MAb of interest to direcdy purify the bacterial factor. This methodology has been used to identify many diverse bacterial factors (e.g., [78, 99]). Recently, this method was also used to
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
145
look for factors involved in adherence of Mycobacterium tuberculosis to host cells. In this study an MAb that blocked adherence of M. tuberculosis to cultured mammalian nonprofessional phagocytic cells was identified from a bank of MAb generated against intact M. tuberculosis cells. This MAb was then used to purify and identify a phosphatidylinositol mannoside as the adhesin [52]. Since the production of hybridomas and subsequent screening of many individual MAbs can be very laborious, an often used variation on the immunological approach described above has been developed that uses the host immune system to select for immunogenic bacterial surface antigens during a sublethal infection. In this way, convalescence serum antibodies can then be gathered and used to identify bacterial surface proteins that were expressed during infection. In the most common implementation of this approach, bacterial outer membrane proteins are then electrophoretically separated or prepared as part of a bacteriophage X expression library. These polypeptide species can then be screened using the convalescence serum for the subset that were immunogenic during the course of the infection. Detection of protein species bound by serum antibodies requires binding of a secondary antibody conjugated to a colorimetric moiety. A further subset of these antigenic factors may indeed be pathogenicity factors, and their identification as such requires additional experimentation. This modified immunological approach has been beneficial as sera from lepromatous leprosy patients used to screen a X cosmid expression library of M. leprae genomic DNA [106], and resulted in the identification of a 15-kDa protein that is immunogenic to both B- and T-lymphocytes. The exact role this protein plays in pathogenicity remains as yet to be demonstrated. The application of immunologic strategies is advantageous in that it allows a broad approach to target for identification factors exposed on the bacterial surface. However, three limitations include the fact that these screens can often be quite laborious, many pathogenicity factors are either not exposed on the bacterial surface or are poorly immunogenic and thus would never be found (e.g., shiga toxin), and many highly immunogenic surface antigens are not pathogenicity factors (e.g., S. typhimurium flagella [76]).
F. Subtractive Hybridization The facts that related bacterial strains often have quite different pathogenic abilities and that gene expression patterns of pathogenic bacteria often change dramatically when going from an in vitro to an in vivo environment have led to the development of techniques that seek to identify differential expressed genes. One such technique is nucleic acid subtractive hybridization. In the first case, nucleic acids from two related bacterial strains, one pathogenic and the other nonpathogenic, can be physically compared to identify differentially expressed genes or differences in gene content that may be responsible for the
146
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
pathogenicity difference. In the second situation, the nucleic acids from a single strain grown under a nonhost condition, and a host-like condition can be physically compared to identify differentially expressed genes, with the understanding that some of these may encode pathogenicity factors. The foundation of the subtractive hybridization approach relies on the fact that DNA sequences common to both (denatured) DNA preparations can be subtracted out as doublestranded DNA hybrid duplexes while unique single-stranded sequences remain. The "nonpathogenic" DNA is supplied in molar excess to ensure that complete hybridization of common sequences occur. In addition, the nonpathogenic DNA is typically modified by biotinylation so that subsequent to the annealing reaction the common DNA hybrids can be removed by utilization of a streptavidin matrix. Thus, only the single-stranded fragments of interest are left behind. It should be noted that subtractive hybridization can be performed using either cDNA or genomic DNA derived from the strains of interest. However, differences in gene expression in a single strain grown under in vitro and host-like conditions can only be detected by this method using cDNA. The traditional subtractive hybridization protocols rely simply on subtractive hybridization followed by either cloning of the end products or utilization of the products as probes to identify the genes from genomic libraries (e.g., [15, 95]). A more recent subtractive hybridization protocol has been designed to incorporate modifications that vastly improve the efficiency of the technique. This modified procedure has been called Representational Difference Analysis (RDA) [75]. RDA has been applied to discover bacterial pathogenicity factors. Some examples are the identification of genetic differences between the two closely related pathogens Neisseria meningitidis and A^. gonorrhoeae, which might be responsible for their different etiologies [114], and the recent identification of genetic differences between an emergent epidemic strain of V. cholerae, serogroup 0139, and its progenitor serogroup Ol strain [17]. The RDA method involves initial restriction enzyme digestion of DNA from the virulent strain (called the tester) followed by ligation of a PCR adapter/primer onto the ssDNA overhangs formed by digestion of the tester DNA. Next, the modified tester DNA is amplified by PCR. This amplified tester DNA can then be mixed with a molar excess of digested, but otherwise unmodified, DNA from the nonvirulent strain (the driver), and the mixture is denatured and allowed to anneal. During the course of the annealing reaction, most ssDNA tester fragments anneal with complementary driver ssDNA fragments. These dsDNA hybrids represent sequences common to both the tester and the driver and are thus not of interest. In contrast, though, ssDNA tester fragments that are unique cannot hybridize with driver ssDNA, but instead can only anneal back to the complementary tester ssDNA fragment. This restores the original adapter/primer arms on both ends of the resulting dsDNA fragment. These dsDNA tester fragments can then be reamplified by PCR. The resulting fragments represent unique sequences and can be further enriched by additional rounds of subtractive hybridization and
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
147
amplification. As a final step, the amplified unique tester DNA fragments can be cloned and further analyzed. Despite improvements such as RDA, subtractive hybridization methods are still somewhat laborious and are fairly insensitive, that is, many genetic differences between tester and driver are not identified due to a variety of technical difficulties. A more recent technical improvement to the RDA protocol, however, increases both the efficiency and sensitivity of the method [3]. In the first implementation of this method, which is a slighdy modified version of the Suppressive Subtractive Hybridization (SSH) technique originally developed for use in eukaryotes [28], more than a dozen genomic sequences present in a monkey-isolate of H. pylori (tester) and not present in a human isolate (driver) were identified. Many of the identified sequences were smaller than the limit of detection of tradidonal subtractive hybridization screens, thus validating the improved sensitivity of this technique [3]. The method for SSH is similar to RDA but contains one major procedural difference. Instead of ligating a single adapter/primer onto the ends of the tester DNA restriction fragments, two different adapter/primers are used (Fig. 2, see color plate). First, the digested tester dsDNA is divided into two pools, 1 and 2. Adapter/primer 1 is then ligated onto fragments contained in pool 1, and adapter/primer 2 is ligated to fragments contained in pool 2. Each pool is then subtractively hybridized, separately, to a molar excess of unmodified driver DNA, as described above. After annealing, pools 1 and 2 are mixed together and another molar excess of denatured driver DNA is added. This final mixture is then allowed to undergo additional annealing. During this second annealing reacdon, any remaining common ssDNA from the tester DNA from pools 1 or 2 can anneal to the additional driver ssDNA added to the second annealing reacdon. Likewise, any unique tester ssDNA fragments originally derived from pool 1 sdll remaining after the first annealing reaction can hybridize with a complementary ssDNA tester fragment from pool 2. These latter dsDNA tester fragments will thus contain adapter/primer 1 at one end and adapter/primer 2 at the other. Unique tester dsDNA fragments that contain both adapter/primers 1 and 2 at their two respective ends can then be amplified exponendally in a single PCR reacdon using forward and reverse primers complementary to adapter/primers 1 and 2, respecdvely (Fig. 2, see color plate).
G. Differential Display Since most bacterial pathogens must express different subsets of genes on infecdon of a host, many different methods have been developed that attempt to direcdy analyze these differentially expressed gene products. One approach that is related to, yet distinct from, subtractive hybridizadon, is Differential Display (DD). The DD methodology was originally designed to study differendal gene
148
ANDREW CAMILLI. D. SCOTT MERRELL, AND JOHN J. MEKALANOS
expression in eukaryotes [71] but has been modified to allow for screening of differentially expressed genes between two populations of bacteria [127]. Because of this, DD can be used to identify pathogenicity factors by comparing gene expression either between a pathogenic and a nonpathogenic strain of one species or, between a strain grown in vitro and in vivo. DD allows for differences in gene expression to be visually determined by direct comparison of two sets of randomly primed PCR products, which are generated from the two cDNA pools to be compared. Pools of cDNA are first generated from total RNA purified from each bacterial population. These cDNA pools are made using an arbitrary primer of approximately 18 bases in length. Utilization of an arbitrary primer and low-stringency hybridization allows priming to occur at pseudo-random sites during the reverse transcription reaction. These cDNAs are then PCR amplified in a second reaction, wherein the first amplification cycle uses a low-stringency annealing step that results in products that have the primer sequence at both ends. These double-end primed products are then amplified exponentially in subsequent rounds of the PCR using the arbitrary primer, a stringent annealing temperature, and radioactive deoxynucleotides. After the final PCR amplification, PCR products are separated on an acrylamide gel and visualized by autoradiography to screen for band differences between products derived from the two cell populations. Unique bands represent genes that were differentially expressed between the two cell populations. Finally, these differentially expressed bands can be cut out of the gel and sequenced. DD has been successfully used to identify several bacterial pathogenicity factors. For example, S. typhimurium genes that are stress-induced by exposure to hydrogen peroxide were identified in the study that first reported the DD method modified for use in prokaryotes [127]. More recently, a slightly modified version of this protocol was used to identify a Legionella pneumophila gene that was induced during intracellular infection of macrophages [1]. In this report, cDNAs were made using random hexamer primers, and PCR amplification was done using pairs of arbitrary primers that were 17-23 bases in length. The strengths of DD depend a great deal on a number of experimental parameters. In particular, the length of the arbitrary primer(s) and stringency conditions used directly correspond to the number of bands that one generates per reaction. Generally between 1 and 50 bands are produced per reaction, but since many of these bands are artifactual—for example, corresponding to ribosomal RNA-derived products—it is necessary to screen products generated in several different reactions each using different arbitrary primers. This multipronged screening strategy greatly increases the likelihood of identifying bands that correspond to bona fide differentially expressed genes. Because of these technical limitations, DD is not a comprehensive method by any means and can be quite laborious. However, there are some procedural and theoretical advantages of DD. For example, very little total RNA is needed as starting material, so that DD can be used on relatively small numbers of bacteria recovered after exposure to a wide
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
149
variety of in vitro and in vivo conditions. In addition, DD is reported to be a sensitive method, able to identify genes that are transcribed at very low levels. H. Reverse Genetics Many of the methods described above (II.A-II.E) result in identification of a polypeptide with the potential to play a role in pathogenicity. Although this is a reasonable endpoint for some studies such as those whose goal it is to identify and biochemically characterize a toxin, it is usually of further benefit to proceed with identification of the gene encoding the polypeptide. Not only does this open the door to many additional studies, it can allow for precise determination of the actual role in pathogenicity of the discovered factor. Specifically, after the gene responsible for a putative pathogenicity factor has been identified, it can be mutated and the resulting strain determined to lack the polypeptide of interest. The pathogenicity of the mutant strain can then be compared in side-by-side experiments with that of the isogenic parental strain in, for example, an animal model of disease to assess the relative importance of the putative pathogenicity factor (see III.B.3). In addition to this validation, the gene can then be manipulated to allow purification of large quantities of the polypeptide for additional biochemical, immunological, or structural studies. Although there are several methods by which the gene encoding a polypeptide can be identified, utilization of reverse genetics provides a much more efficient method than, say, random mutagenesis followed by screening for loss of production of the polypeptide. Reverse genetics proceeds by first determining the amino acid sequence of a portion (at least five contiguous residues) of the purified polypeptide by protein microsequencing [65]. Second, the codon usage preference of the bacterial species being studied is used to design and synthesize degenerate DNA oligonucleotides that are predicted to code for the determined amino acid sequence. Third, the degenerate oligonucleotides are used to identify the gene from the bacterial genome. This can be done directly by Southern blot analysis using the oligonucleotides as a probe, or indirectly by PCR amplification of an internal portion of the gene using degenerate oligonucleotides that correspond to two separate parts of the gene, followed by use of the PCR product as a Southern blot probe. This latter methodology requires that the amino acid sequence of two separate parts of the polypeptide be known. Reverse genetics has been used numerous times in both of these manners to identify bacterial genes encoding pathogenicity factors (e.g., [30, 53, 73]).
///. Genetic Screens Coincident with gaining the knowledge that DNA was the genetic material came the realization that DNA also encoded the biosynthetic information for pathogenicity factors [7]. The five and a half decades that have followed this seminal discovery have seen the development of many experimental techniques that have
150
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
potentiated advances in understanding of bacterial pathogens and their ability to cause disease. Techniques such as sequence-specific DNA cleavage, ligation, and transformation, coupled with various mutagenesis protocols, allow scientists to manipulate DNA with amazing power. It is this ease of genetic manipulation that now allows scientists to identify and characterize pathogenicity factors from many organisms. It should be noted, however, that, even though genetic techniques have proven invaluable to culturable and transformable pathogens, many organisms are still unable to be grown in vitro and/or are untransformable. These organisms present a unique challenge to scientists wishing to study them and emphasize the importance of continued advances in molecular techniques. The remainder of this chapter attempts to describe many of the genetic strategies that have been employed throughout the last few decades of the twentieth century to facilitate identification of bacterial pathogenicity factors. Each technique, as described, can result in identification of a bacterial gene that is required for production of a putative pathogenicity factor. In practice, it is evident that the power of genetic techniques is only fully realized when used in combination with immunological or biochemical strategies. By implementation of combinations of strategies and techniques, scientists are able to gain a fuller understanding of the roles of pathogenicity factors in the disease process. Although a large number of genetic screens and selections have been designed to identify pathogenicity factors, only a sampling of these will be covered here for the sake of brevity. Emphasis will be placed on those strategies that have been particularly successful and/or those that introduce an interesting or novel concept.
A. In Vitro Screens 1.
LARGE-SCALE SCREENINGS
Most genetic strategies for identification of pathogenicity factors have in common the need to mutagenize the bacterial genome in a random fashion to generate a bank of mutant strains. Ideally, the mutagenesis is conducted in a manner such that each mutant strain contains a single, unique mutation, and the number of strains in the bank is comprehensive enough to ensure that most genes will have been mutated. The Poisson distribution equation, yV=[ln(l-P)]/[ln(l
-F)l
can be used to calculate the minimum number of strains (AO required to assure (with probability [P]) that any particular gene will be mutated, where F is equal to the average gene size divided by the genome size. For example, given an average gene size of 1 kb in a genome size of 4 Mb, the minimum number of strains in a mutant bank sufficient to assure that 95% of all genes were mutated would be 11,981. After construction of the mutant bank, a screen or a selection
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
151
for strains with changes in pathogenicity is conducted. Intrinsically, a screen is more labor intensive than a selection, as it involves examination of individual strains to find those with the sought-after phenotype. In contrast, a selection is designed to enrich only those strains having the desired phenotype. In this way, the scientist is left with only the strains of interest at the completion of the enrichment. The most laborious yet comprehensive genetic screens are conducted on a large scale, whereby mutagenized strains are individually screened, one at a time, in some assay of pathogenicity chosen by the investigator. This method is powerful in that it allows the investigator the opportunity to assess each individual mutation's effect on the pathogenicity of the organism. In this manner, knowledge concerning each individual gene can, in theory, be gained. A classic example of a large-scale screening is the screening of 9,516 individual transposon insertion strains of 5'. typhimurium for loss of infectivity in microtiter plate wells containing monolayers of cultured murine peritoneal macrophages [36]. The infectivity of each strain was assessed by lysing each monolayer and titering viable bacteria on agar plates. From this screen, 83 strains exhibiting reduced pathogenicity were identified. Although laborious, large-scale screening is advantageous in that, if a large enough bank of mutant strains is screened, it is theoretically more comprehensive than any possible selection. The reason for this comprehensiveness is simple: in a large-scale screen each mutant strain is individually assayed for pathogenicity, whereas in a genetic selection strains that exhibit slightly attenuated pathogenicity are usually lost (or ignored). For example, if one were to search for gene mutations that adversely affected bacterial multiplication in the presence of hydrogen peroxide, a reactive oxygen species produced by host cell macrophages, a mutation that only slightly decreased (or increased) multiplication could be picked up in a screen. However, in a penicillin-based selection, where the penicillin selects for strains that are no longer able to replicate by killing all multiplying cells, a mutant strain that exhibited a slightly reduced multiplication rate would still be killed by the penicillin. Mutants that displayed an enhanced multiplication rate would also be killed in a selection of this type. All genetic selection strategies suffer this type of limitation to some degree. On the other hand, there are several major advantages to the selections discussed below. Because of the different strengths and weaknesses of different genetic strategies, investigators must carefully determine which strategy is most appropriate for isolation of the types of genes being sought after. When conducting genetic screens or selections, it is important that the researcher consider not only the type of screen or selection but also the method utilized for mutagenesis of the bacterial pathogen. As stated above, in most cases a bank of mutant strains containing highly random, single mutations is most desirable. Since the choice of mutagenesis strategy is an important consideration in all types of genetic screens and selections, a brief discussion of the advantages
152
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
and disadvantages of several commonly used methods is included within this section. Physical and chemical methods for generating point mutations, such as UV light and A^-methyl-A^-nitro-A^-nitrosoguanidine, are probably the most frequently utilized types of mutagenesis due to the fact that they are highly random and can generate a tremendous number of different mutant alleles for any gene. The list of possible types of mutant alleles obtainable by utilization of these methods is about as complete as possible in that one can obtain null, partial function, dominant negative, dominant positive, suppressor, promoter-up, promoter-down, polar, or nonpolar mutations. However, a major disadvantage of these methods can be found in that multiple unlinked mutations are commonly introduced into individual cells. The presence of multiple mutations within a single strain gready complicates subsequent identification of the relevant mutation. This problem, however, can be overcome if an efficient means of genetic complementation exists for the pathogen being studied. Another commonly used strategy for mutagenesis involves utilization of transposon insertions. This method is advantageous in that it can be used to make stable, single insertions, and subsequent linkage of the transposon with the mutation greatly facilitates identification of the disrupted gene. Disadvantages of transposon mutagenesis include the fact that even the best of transposons insert only pseudo-randomly, which provides a much more limited spectrum of mutant alleles (relative to chemical mutagenesis), and finally, some pathogens, such as Campylobacter jejuni [64], are not currendy amenable to transposon mutagenesis. An in vitro transposidon protocol using a mariner transposon has been developed [65, 102] that improves generalized transposon mutagenesis in three ways. First, mariner can insert with a high degree of randomness in that it requires only an 5'-AT-3' dinucleotide target site. Second, mariner mini-transposons have been recendy engineered that produce either polar or nonpolar inserdon mutations (B. Akerley, E. Rubin, J. Mekalanos, and A. Camilli, unpublished data). Third, the products of in vitro transposition can be moved into transformable bacterial species followed by double-crossover insertion events, thus obviating the need for transposidon in vivo [2]. Suicide plasmid insertion-duplication mutagenesis is an alternative approach that theoretically can be more random than transposon mutagenesis, provides a linked marker for gene recovery, and can generate both polar or nonpolar mutations in most genes. In this method, random small fragments of the pathogen genome are ligated into a suicide plasmid vector, and the recombinant plasmids are then introduced into the pathogen by transformation, whereupon they integrate into the chromosome by homologous recombination. However, generadng a null allele in small genes can be difficult or impossible given that an internal portion of the gene coding sequence usually needs to be inserted into the suicide vector in order to ensure disrupdon of the gene, and given that the likelihood of proper inserdon (by homologous recombinadon) is limited direcdy by the size of the
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
153
coding sequence contained within the plasmid. Despite the limitations of transposon and suicide plasmid insertion-duplication mutagenesis, both of these methods have the major advantages of: (1) establishing linkage between the observed phenotype and inactivation of a particular locus, and (2) providing a selectable marker tighdy linked to the mutation to allow the mutation to be moved to different genetic backgrounds. 2.
TARGETING EXPORTED PROTEINS
As was discussed in section II.B, many pathogenicity factors are surface-exposed or secreted proteins. A common requirement for all of these proteins is that they be exported across the bacterial cytoplasmic membrane. Several genetic strategies have been designed to target exported proteins for identification and mutagenesis. The most successful and widely used of these is TnphoA mutagenesis. This strategy combines transposon mutagenesis with a series of screens. First, a prescreen to identify strains harboring insertions into genes encoding exported proteins is conducted, and subsequently this subset of strains is screened to identify nonpathogenic mutant strains in a model of disease [113]. This approach relies on the use of TnphoA, which contains at the 5' end of the transposon a truncated/?/zoA gene that lacks a promoter and the DNA region encoding its signal sequence [84]. Because PhoA requires export to the periplasm for disulfide bond formation and subsequent enzymatic activity (as a phosphatase), only those TnphoA insertions occurring into genes encoding extracytoplasmic proteins will result in export of the protein fusion (if the fusion is in the correct reading frame). These exported PhoA translational fusion products are then enzymatically active and can be assayed for colorimetrically by the formation of blue colonies on media containing 5-bromo-4-chloro-3-indolyl-phosphate. This TnphoA mutagenesis strategy has been used to identify many pathogenicity factors such as the V cholerae toxin-coregulated pilus (TCP) pilus [113], Escherichia coli (EPEC) chromosomal and plasmid genes required for adherence to host cells [29], and S. choleraesuis genes required for transcytosis across epithelial cell layers [39]. In addition, other phoA fusion vectors have been constructed and used to identify secreted proteins from other bacterial species in which TnphoA does not function properly [59]. Despite the fact that the TnphoA strategy has been employed so successfully, there are of course limitations to the strategy that must be considered when deciding the appropriateness of the screen. By definition, the techniques described in this section preclude the identification of nonexported pathogenicity factors. Secondly, the expression of some fusion products can be toxic to the host bacterium. Aside from excluding some genes from ever being detected, that is, those whose expression when fused to phoA is deleterious to growth in vitro, this phenomenon poses a problem when assessing the effect of loss of an infectioninduced gene on pathogenicity. Specifically, an attenuated level of pathogenicity may result partially, or totally, from slower /// vivo growth of the bacteria due to
154
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
toxic effects of the fusion product. Methods to alleviate this limitation have centered around the utilization of alternative reporter fusions that are perhaps not as deleterious to the cell. For instance, several other reporter systems have been developed that also identify exported proteins (e.g., p-lactamase [91, 101]), invasin [128], and nuclease [97]). However, as most of these alternative reporters allow for selection of strains expressing an exported fusion product, they will be discussed below under genetic selections. 3.
COORDINATE REGULATION SCREENS
Not only did the original V cholerae study using TnphoA take advantage of the knowledge that exported factors are often pathogenicity factors (III.A.2); it also took advantage of a pre-screen strategy to collect only strains harboring fusions that were coordinately regulated with a previously known pathogenicity factor [113]. Specifically, Tn/7/26>y4-mutagenized V. cholerae strains were grown under two separate in vitro conditions known to downregulate and upregulate, respectively, the expression of cholera toxin. Fusion strains expressing alkaline phosphatase activity only in the upregulatory growth condition could then be said to harbor TnphoA insertions in genes encoding exported polypeptides that are coordinately regulated with cholera toxin. The premise behind this strategy relies on the fact that many pathogenicity factors may often be coordinately regulated with a previously known pathogenicity factor. This premise has now been realized in several other pathogens aside from V cholerae. For instance, both the bvgAS regulon in Bordetella pertussis [40], and the phoPQ regulon in S. typhimurium have been shown to coordinately regulate expression of many pathogenicity factors [89, 110]. There are many other coordinate regulatory screens that have been designed that vary in the choice of reporter gene. Frequently used reporter genes include promoterless lacZ [126] and gfp [115] alleles. In contrast to the TnphoA translational fusion strategy, transcriptional fusions to cytosolic enzymes such as lacZ allow identification of virtually any gene that is coordinately regulated, that is, regardless of whether the gene encodes an exported or cytoplasmic protein. The two primary limitations of coordinate regulatory screens, though, are that, as discussed above, some gene fusions will be toxic to the bacteria, and the in vivo environmental conditions that induce expression of certain pathogenicity gene regulons remain unknown or are difficult to reproduce in the laboratory.
4.
HOST MIMICRY SCREENS
The requirement for bacterial pathogens to differentially regulate expression of genes depending on their environment continues to be a theme that can be exploited by the scientist to attempt to elucidate factors required for pathogenicity.
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
155
In fact, this common theme runs through many of the strategies designed to elucidate pathogenicity factors that have been the most successful throughout the last few decades. Due to the facts that the environmental challenges that a pathogen encounters in its host are often different from one tissue to the next and that host environments are quite complex, screens designed to mimic certain host environmental parameters provide an attractive method for simplification of the process of pathogenicity factor identification. Although numerous mimicry screens have been designed, the most straightforward have proven to be those designed to look for gene fusions to a reporter such as lacZ, which are specifically induced during growth in a laboratory medium that mimics one particular host parameter. Examples of successfully employed screens include the identification of acid-inducible genes from various intestinal pathogens by exposing the bacteria to media having acidic pH values similar to those found in the human stomach or phagosomal microenvironment (e.g., [42]), and identification of high-temperature-inducible genes from facultative pathogens using an in vitro growth temperature equivalent to human body temperature (e.g., [5]). Host mimicry screens have not been limited to utilization of lacZ but have employed other reporter genes such as luciferase, gfp and phoA. In addition, a variety of host mimicking conditions have been employed. Due to the fact that many pathogenicity genes require more than a single signal to induce their expression, it is often advantageous for the investigator to be able to mimic several host signals at one time. It is for this reason that one commonly used in vitro model system is cultured mammalian cells. Cultured mammalian cells often provide many of the signals needed to simulate infection and have thus been used to identify pathogenicity factors produced by both adherent extracellular pathogens (e.g., [49, 94]) and intracellular pathogens (e.g., [61]). A recendy developed strategy combines the use of host macrophages as an inducing environment with Fluorescence-Activated Cell Sorting (FACS). This screen was utilized to search for S. typhimuriiim genes within the SPI-2 pathogenicity island locus, which are induced within the intracellular milieu of macrophages [24]. This study utilized gfp fusions to genes within the SPI-2 locus and resulted in identification of several genes that are transcriptionally induced within host cells and that are required for systemic spread in a mouse model of typhoid. One of the major advantages of host mimicry screens is the fact that there are coundess host-mimicking condidons that can be devised. In addition, most of these screens can be conducted with relative ease due to the fact that they take advantage of in vitro conditions to mimic the often more complex in vivo environment. In pardcular, the GFP/FACS screening strategy is attracdve due to the fact that it should allow near-saturating screens to be performed, as a thousand-fold enrichment of GFP-posidve bacterial cells can be achieved in a short period of dme [116]. However, it should be noted that host mimicry screens do suffer from the limitation that the host conditions required to trigger expression
156
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
of some bacterial factors remain unknown or may be too complex to reproduce in the laboratory. This is less true for tissue culture models of infection than for other in vitro systems, but it applies nonetheless. Because of this limitation, several in vivo screens have been recently developed that utilize the intact host animal to provide a more complete inducing environment (see below).
B. In Vivo Screens 1.
RECOMBINATION-BASED IN VIVO EXPRESSION TECHNOLOGY
Because utilization of large numbers of animals as disease models can be quite costly and trying due to ethical and logistical reasons, scientists have spent a considerable amount of time trying to minimize the necessity to conduct large screens that require intact animals. It is for such reasons that large-scale screens (III.A.l) using animals as hosts can be quite limiting since it is required that each individual strain of interest be screened in a separate animal. Efforts to develop screens that allow multiple mutant strains to be tested per animal have recendy been inspired by the advent of In Vivo Expression Technology (I VET). I VET is a series of genetic selection methods devised to identify bacterial genes that are transcriptionally induced during infection of a host animal (see IV.D). These efforts have resulted in the development of two new screens: RecombinationBased In Vivo Expression Technology (RIVET), and Signature-Tagged Mutagenesis (STM). Each of these screens addresses fundamentally different questions, but both are advantageous in that they allow for utilization of fewer numbers of intact animals to screen for genes of interest. With RIVET, bacterial genes that are transcriptionally induced during infection are identified, while with STM (described in III.B.2) genes that play an essential role in pathogenicity are identified. There are two major obstacles that must be overcome to comprehensively screen for bacterial genes induced during animal infection. First, because traditional gene reporters such as lacZ and phoA encode labile products, a positive signal can be transient and may be lost on recovery of bacterial cells from infected tissues. Second, in order to assay these reporters, a large number of cells is needed. This of course is not possible when screening a library of different strains in an animal. The technique of rapidly screening for GFP-expressing bacterial cells by FACS (described in III.A.4) may largely overcome both of these obstacles for some host-pathogen systems. However, a limitation that applies to all previously used gene reporters including gfp, is that gene fusions that are transiently expressed during infection or that are expressed at very low levels are difficult or impossible to detect. The RIVET strategy overcomes all three of these limitations to some degree. With RIVET, transcriptional gene fusions are made to a promoterless gene encoding a site-specific DNA recombinase, such as the tnpR gene (encoding
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
157
resolvase) of Tn 1000. The resolvase enzyme is able to mediate recombination between two directly repeated copies of a specific target DNA sequence, called resl, which have been inserted flanking a genetic marker within the chromosome of the pathogen of interest. If a particular gtnt-tnpR fusion is transcriptionally induced during infection, even transiently and/or at a low level, the resolvase that is produced will catalyze a heritable change in the bacterium by excising the marker from the chromosome. The resolved strain can then be screened or selected for after recovering the bacteria from host tissues (Fig. 3, see color plate). For example, in the original study describing RIVET, induced resolvase fusions catalyzed the excision of a tetracycline-resistance gene, resulting in conversion of the fusion strain to a tetracycline-sensitive phenotype [18]. The strains harboring induced fusions were then identified by replica-plating colonies onto an agar medium supplemented with tetracycline. In the first implementation of RIVET, over a dozen V cholerae genes were identified whose levels of transcription increased during infection of the small bowel of infant mice, and a few of these genes were shown to play a role in pathogenicity by mutational analysis [19]. In addition to its application to V. cholerae, RIVET has also been used to identify S. aureus pathogenicity genes in a murine renal abscess model of disease [77]. RIVET-based screens suffer from two limitations. First, because the site-specific DNA recombinase acts on only one substrate sequence, a low level of expression of the recombinase gene fusion is sufficient to catalyze the excision event. Although this exquisite sensitivity allows for detection of transient and/or low-level gene induction events, it unfortunately prohibits identification of pathogenicity genes that have high basal levels of transcription during in vitro growth. This is due to the fact that a high basal level of transcription results in a strain that is unable to be constructed in the unrecombined state. However, more recent modifications have largely overcome this limitation. Specifically, a series of tnpR alleles containing "down" mutations in the Shine-Dalgarno sequence have been constructed. These mutations reduce the efficiency of translation over a wide range of transcriptional levels. This modification allows tnpR to be fused to genes that have high basal levels of transcription in vitro, without excising the substrate. If, though, these gene fusions are further transcriptionally induced during infection, the concomitant increase in translation product will result in excision of the marker from the strain [109]. The second limitation of RIVETbased screens, which holds for most other genetic screens and selections, is that only a subset of the genes identified will encode factors whose loss results in attenuation of pathogenicity in models of disease.
2.
SIGNATURE-TAGGED MUTAGENESIS
Signature-Tagged Mutagenesis (STM) is a genetic screen whereby transposon insertion mutant strains that are attenuated for survival and/or growth within the
158
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
host are identified [50]. Specifically, each host animal is infected with an input pool of limited complexity (usually 96 mutants), and the output of mutants recovered from host tissues is compared to the original input pool to identify strains that did not survive within the animal, that is, are missing from the output pool. In the most recent version of STM (Fig. 4, see color plate) [87], the strategy begins by marking each of 96 transposons with a small, unique DNA signature-tag which is inserted into a nonessential site within the transposons. Each of the resulting uniquely tagged transposons is then used to construct an insertion library in the bacterial pathogen. Strains from each of the 96 libraries are subsequently picked sequentially into microliter plate wells (see Fig. 4, see color plate), with each resulting microliter plate representing an input pool. A pooled sample of all 96 strains from each plate is then inoculated into an animal, and after a sufficient period of infection bacteria are recovered from one or more host tissues. The signature-tags are then PCR-amplified from both the input and output pools, and the representation of each strain in the input and output pools is measured by hybridizing the amplified tags to a master dot-blot filter that contains each of the original 96 DNA tags. Any strain present in the input pool, but is missing from the output pool, is attenuated for pathogenicity in the host animal. In the original implementation of STM, a large number of S. typhimurium pathogenicity factors were identified using a murine model of typhoid fever [50]. Since then, numerous STM screens have been successful in identifying pathogenicity factors from a variety of bacterial pathogens, such as V. cholerae [23] and S. pneumoniae [96]. In the first implementation of the modified STM protocol described above, several novel S. aureus pathogenicity factors were identified in a murine model of staphylococcal sepsis [87]. STM is a powerful genetic screen in that it allows many mutant strains to be screened per animal. In addition, the method is designed such that only genes that are essential for survival and pathogenicity in the animal are identified. Another advantage of STM, which is also shared with RIVET (III.B. 1), is that pathogenicity genes that are transiendy expressed, or expressed at low levels during infection, can in theory be identified. Perhaps the most notable limitation of STM, however, is that genes that play subtle roles in pathogenicity or have redundant functions are difficult or impossible to identify. Additional limitations of STM are that: (1) the presence of a colonization bottleneck in many disease models will necessarily reduce the allowable complexity of the input pool, and, relatedly, (2) a large inoculum, which can affect the natural course of the disease, is often needed to ensure adequate representation of all input strains. A significant property of both STM and large-scale screening that can make both methods powerful tools for analysis of potential pathogenicity factors, and which is not true for most other screening or selection strategies, is that a measure of the effect of a gene mutation on pathogenicity is built into the strategy. In contrast, the other strategies end with identification of bacterial factors whose expression levels are known to be increased during infection, or during in vitro
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
159
growth in a host-mimicking condition. As these only lead to the possibility of a role in pathogenicity for such factors, a specific test of this possibility must follow. 3.
VERIFYING A ROLE IN PATHOGENICITY
As has been emphasized throughout this chapter, most genetic screens and selections result in identification of a gene whose role in pathogenicity is implicated, but not proven. Hence, it is usually desirable to fulfill what has been termed a molecular version of Koch's postulates in order to prove that the gene in question does play a role in pathogenicity [34]. The specific postulates are basically as follows: (1) The phenotype or property contributed by the gene should be associated with pathogenic strains. (2) A null mutation in the gene should attenuate pathogenicity in an appropriate model of disease. It should be noted at this point that the type of mutation that is least prone to artifacts is an in-frame deletion of virtually all of the gene coding sequence. For example, a deletion of only part of the gene could result in production of a truncated polypeptide that is toxic to the pathogen during infection. Alternatively, an out-of-frame deletion or insertional mutation might exert a polar effect on a downstream pathogenicity gene. (3) Pathogenicity should be fully restored after adding the gene back to the mutant strain. Such complementation is often best done by either inserting the gene back into the genome in a new location (e.g., [90]) or maintaining it on a low-copy plasmid. Insertion of the gene back into its original location, at the same time removing the mutant allele, does not rule out the possibility that a polar effect was responsible for the reduced level of pathogenicity originally observed. Optimally, the native promoter should be used to drive expression of the gene. However, this is often difficult and can be substituted for by engineering a heterologous promoter upstream of the gene. In practice, complementation of gene mutations usually ranges from easy to near impossible. For example, it is conceivable that some genes may require precisely regulated expression that can only be obtained in their native locations in the genome in order to mediate their effect on pathogenicity. A limitation of the second postulate is that mutations in some genes, which do indeed play roles in pathogenicity, may not result in a substantial decrease in pathogenicity when tested in the disease model. This might result from a limitation of the model of disease being used to measure pathogenicity, or it might result from the presence of another gene with redundant function that is also expressed by the pathogen. In the latter case, it would be ideal to identify and construct a null mutation in the redundant gene(s), and then attempt to fulfill Koch's molecular postulates for the first gene.
IV. Genetic Selections Since screens for pathogenicity factors can often be time consuming, requiring the isolation and analysis of many individual strains, it is of great benefit to the investigator if he/she can select (enrich) for the mutant strains that are being
160
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
sought. Such selection strategies greatly decrease the number of strains that must be analyzed to find a pathogenicity gene. The basis of most genetic selections is that strains harboring mutations that attenuate pathogenicity are selectively amplified to facilitate their isolation and identification. Alternatively, some genetic selections are based on identification of the gene mutations that enhance pathogenicity. The latter type of selection has a built-in enrichment scheme to amplify the strains of interest in that it searches for enhanced survival and/or multiplication in the host. Although the latter type of selection is straightforward, the former is less so, particularly in instances where the only measure of attenuated pathogenicity involves death of the mutant bacterial strain in the host. In this section, several examples of both of these types of genetic selections, which have been successfully employed, will be discussed.
A. Direct Selections There are a number of methods that can be employed for selection purposes, but perhaps the most straightforward enrichment strategy for gene mutations that attenuate pathogenicity is to selectively kill virulent strains, thus enriching avirulent strains. This could be done, for example, by using convalescence serum containing antibodies against a pathogenicity factor(s) exposed on the bacterial cell surface to select strains from a library of mutagenized bacteria that no longer express the pathogenicity factor(s). These strains would be enriched as a direct result of pathogenic bacteria being selected against due to the opsonizing activity of the antibodies. This method has been used, for example, to identify capsular polysaccharide-defective mutants of Klebsiella pneumoniae [9]. It should be noted that this particular method is not generally applicable, as convalescence sera to some pathogens may contain bactericidal antibodies recognizing multiple surface molecules, the losses of which cannot be obtained by the result of a single gene mutation. A second type of direct selection is built on the fact that some pathogenicity factors that reside on the surface of bacterial cells serve as receptors for lytic bacteriophages. This knowledge provides the basis for selection of bacterial mutant strains that have lost expression of the pathogenicity factor and thus are resistant to bacteriophage infection. For example, a major pathogenicity factor of many Gram-negative bacteria, LPS, serves as a receptor for many bacteriophages (e.g., [46]). Therefore, a strain that is deficient in LPS biosynthesis would be resistant to infection and lysis by bacteriophages. In addition to LPS, it has been found that other bacterial surface molecules or structures that are pathogenicity factors can serve as bacteriophage receptors (e.g., V. cholerae TCP [121]). A third type of direct selection takes advantage of growth phenotypes that are associated with the presence or absence of some pathogenicity factors. For example, wild-type L. pneumophila are growth sensitive to high salt concentra-
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
161
tions, but a variety of nonpathogenic derivatives have been noted to be salt resistant. This correlation, which may or may not be relevant to the pathogenesis of this organism, was used as the basis for a selection of transposon mutagenized strains that were salt resistant. This selection was highly successful and resulted in the isolation of multiple strains that were subsequendy shown to be nonpathogenic due to disrupdons in several previously unidentified pathogenicity genes [119]. A limitation of this strategy is, of course, that the presence or absence of most pathogenicity factors cannot be associated with a growth phenotype in vitro, and thus this method is not generally applicable. However, it is likely that some pathogenicity factors, in particular those metabolic factors that assist growth of the pathogen during infecdon, can be identified by similar types of genetic selections. To take a hypothetical example, proton-pump inhibitors that are bactericidal for //. pylori in vitro [109] might be used to select for mutations in the proton-pump encoding genes that in turn encode an essential pathogenicity factor necessary for surviving the low-pH environment of the human stomach.
B.
Complementation Approaches
Many bacterial pathogenicity factors have been identified by complementation selecdon strategies. The most common of these strategies selects for a small fragment of genomic DNA carried on a plasmid, which complements the nonpathogenic phenotype of a strain containing a spontaneous or chemically induced mutadon in an unknown gene. In most cases, the complemendng fragment of DNA contains a functional version of the mutated gene or operon, and thus serves to identify the gene of interest. Three examples of the many pathogenicity factors idendfied by complementation analysis include the inv locus of S. typhimuriwn [46a], the dot/icm genes of L. pneumophila [10], and the phase-variable tcpH gene of V cholerae [21]. It should be noted, however, that it is somedmes possible that the complementing fragment contains a gene or set of genes disdnct from the mutated gene, but which nevertheless can phenotypically complement (i.e., bypass) the mutation. Because complementadon is the most suitable approach to idendfy genes disrupted by chemical mutagenesis, and because chemical mutagenesis produces the widest range of gene mutadons and functions in almost any bacterial species (see III.A.l), this combination of approaches comprises a powerful strategy for idendfying pathogenicity factors. However, it should be noted that complementation strategies are limited to bacterial species for which efficient transformation protocols exist. A second type of complementation strategy expands on the above strategy by searching for a gain of function. This strategy works by selecdng for a small genomic fragment of a pathogen, which when transferred into a nonpathogenic
162
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
Strain or heterologous species bestows some aspect of the pathogenic lifestyle. For example, the invasin protein of Y. pseudotuberculosis, which mediates invasion of nonprofessional phagocytic cells in the host, was identified by transforming a noninvasive E. coli strain with a library of Y. pseudotuberculosis genomic DNA, and then selecting for cells that had gained invasive ability [56]. The invasive strains of E. coli produced were selected for by the addition of an aminoglycoside antibiotic to the tissue culture medium to kill extracellular bacteria but not intracellular ones, as such antibiotics do not equilibrate with the interior of mammalian cells. A major attribute of this second type of complementation strategy is that an expressed genomic library of many pathogenic species, including some that are not genetically manipulatable, can be constructed in a nonpathogenic species that is much more easily manipulatable. However, this approach is limited by the need for relatively simple models of disease for which a single genetic locus can confer the sought-after phenotype on a heterologous bacterial species. As a result of this limitation, this type of approach has been used in the past usually to identify pathogenicity factors that either have enzymatic activities that the host bacterium lacks (e.g., hemolysins [31, 79]) or that complement a metabolic defect in the host bacterium (e.g., iron acquisition [8]). In addition, any factor identified by this method ultimately requires evaluation for a role, if any, in virulence in the original microorganism.
C. Selection for Nongrov^^ing Bacterial Mutants Penicillin selection, which was originally developed to facilitate isolation of auxotrophs, functions by killing growing cells and sparing nongrowing cells [68]. Penicillin selections have been used as the basis for a strategy to isolate nonpathogenic bacterial mutants that fail to grow in host tissues. For example, in the original application of this strategy, transposon insertion mutants of Listeria monocytogenes that failed to multiply within cultured macrophages were selected for after the addition of methicillin, a (3-lactam that is able to freely penetrate into the interior of mammalian cells [20]. Amongst the mutant strains isolated were some that harbored transposon insertions in the gene encoding listeriolysin O, an essential pathogenicity factor that facilitates access to the host cell cytoplasm where multiplication and cell-to-cell spread occur [98]. For a review on the role of listeriolysin O, please refer to the Chapter 16 in this book. An analogous strategy to penicillin selection, termed "thymineless death," was developed to isolate L. pneumophila mutant strains unable to multiply within cultured macrophages [10]. The method is based on the observation that thymine auxotrophs of many bacterial species, including L. pneumophila, die when
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
163
multiplying in the absence of exogenous thymine whereas nonmultiplying cells survive. This allowed an enrichment of nonpathogenic L. pneumophila mutant strains that failed to multiply intracellularly in cultured macrophages. This study identified a multigene locus, called dot (also referred to as icm ([14]), which is required for intracellular multiplication. One of the most important attributes of both penicillin selection and thymineless death strategies that is also shared with STM is that nongrowing mutant strains can be identified direcdy from host tissues or cells. However, in contrast to STM, the former two selection strategies are probably limited to in vitro and tissue culture host model systems, as recovery of a nongrowing mutant strain from an intact animal could be exceedingly difficult. For example, a thymineless death strategy to select for L. monocytogenes mutants that are no longer able to multiply inside macrophages in an animal host would probably fail due to clearance of bacteria by the host immune system. Moreover, an in vivo penicillin selection would require the difficult task of maintaining sufficient antibiotic concentrations at the site of infection in order to select for nongrowing mutant strains. However, the latter technical difficulty would not apply to the thymineless death strategy if used in an intact animal host.
D. In Vivo Expression Technology In Vivo Expression Technology (IVET) is a strategy designed to identify genes that are transcriptionally active only during infection. The premise behind IVET is that some, perhaps many, genes that are transcriptionally active during infection encode pathogenicity factors. The system relies on the enrichment of bacterial strains harboring gene fusions to a marker whose expression is or can be selected for within the intact host animal [80]. In the first implementation of IVET, an S. typhimurium transcriptional gene fusion library iopurA was constructed in a strain background in which the native purA gene had been deleted. Because purine auxotrophs cannot survive during systemic infection of mice, only strains from the library that harbor transcriptional gene fusions to purA that were expressed during infection were complemented and therefore survived and multiplied (Fig. 5, see color plate). This method has been used to identify several genetic loci encoding pathogenicity factors in S. typhimurium [48, 81]. Additionally, IVET has been successfully used to identify pathogenicity factors in other pathogens, such as P. aeruginosa [122, 123]. The above IVET strategy requires prior knowledge of selectable genes, such as purA, whose expression is required for multiplication within the host. It is essential that the chosen selectable gene be required for growth in the same host compartment that the pathogenicity gene (to be identified) is expressed in. Thus, a limitation of IVET strategies that employ complementing genes like purA is that, if the selectable gene is required throughout the entire infectious process.
164
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
then preferential enrichment will occur for strains harboring gene fusions that are constitutively expressed in the host animal. Thus, pathogenicity genes that are expressed at one stage of infection only, or which are transcribed at low levels, may not be identifiable via this approach. A second type of IVET selection is based on enrichment of bacterial strains harboring gene fusions to an antibiotic-resistance gene. In this method, a sufficient concentration of the corresponding antibiotic is maintained in the infected tissues to allow enrichment of strains containing active gene fusions. This method has been used to identify S. typhimurium pathogenicity factors [82]. Clearly, this method is more complicated than the auxotrophy complementation approach mentioned above since suitable antibiotics must be administered and proper concentrations maintained in infected host tissues. However, this property can provide some flexibility in designing the selection. For example, administering the antibiotic at only one stage of infection, or in one host organ, should facilitate identification of pathogenicity factors which may be expressed at only one stage of infection, or in only one host compartment, respectively. Recently, IVET has been combined with a direct selection scheme to identify pathogen genes that are transcriptionally induced during infection and which also encode exported proteins (J. J. Mekalanos and J. W. Tobias, unpublished data). The first component of this method proceeds by isolating pathogen DNA sequences that encode protein export signals, in a manner analogous to the TnphoA strategy (III.A.2). A plasmid library is constructed by ligating genomic fragments immediately upstream of a truncated p-lactamase gene that lacks the signal sequence coding portion required for protein export and subsequent enzymatic activity. The plasmids are moved into an E. coli host, and ampicillin is used to select for plasmids containing genomic fragments that encode protein export signals fused to the p-lactamase. Next, the selected pool of genomic fragments is excised from the plasmids and subcloned into pi VET 1 (see schematic diagram of pIVETl at the top of Fig. 5, see color plate). The resulting pool of pi VET 1 recombinants is then moved into the pathogen genome and subjected to the IVET selection to identify those strains containing infection-induced gene fusions, as described above (Fig. 5, see color plate). In the first implementation of this strategy, several S. typhimurium genes were identified. These included sti, a previously identified gene that encodes a glycosidase that interferes with IL-2 receptor function [85], and /v/-S2, a previously unknown gene whose putative product has a high degree of similarity to AmpD from E. coli, except that /v/-S2 encodes a putative signal sequence (the E. coli AmpD lacks a signal sequence). Roles for sti and ivi-Sl in pathogenicity have not been tested for, as yet. It is likely that this combination strategy will serve as a powerful method to identify additional infection-induced, exported factors from this and other pathogens. However, it should be noted that this combination strategy will be subject to the same limitations that apply to its two component methods.
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
165
V. Genomic Approaches At the time of this writing, the complete genome sequences of 19 bacterial pathogens were publicly available, and another 40 or so were in progress (www.tigr.org). It is likely that within a decade the genomic sequences of almost all clinically important bacterial species will be known. This body of information, accompanied by the many computer algorithms already available for nucleotide and amino acid searching, have made possible a multitude of so-called, postgenomic strategies for identifying pathogenicity factors. In this chapter, several such strategies will be discussed, along with a few genomic strategies that do not require knowledge of a pathogen's genomic sequence. A.
Genome Walking
The past 30 years of molecular genetic research has shown conclusively that the genes encoding pathogenicity factors are more often than not physically linked on chromosomes or on extrachromosomal elements. Genetic linkage is particularly acute for genes that encode the factors necessary for production of complex factors such as pili (e.g., [83]) or type III secretion apparatuses (e.g., [25]). Although some genes encoding pathogenicity factors are not linked in this way (e.g., [47]), it nonetheless remains a fruitful strategy to target one's search for regions adjacent to previously identified pathogenicity genes. This is most easily accomplished by sequencing nearby genes, and analyzing the resulting nucleotide sequence for the presence of putative pathogenicity genes. Any such identified gene would then need to be mutated to assess its role, if any, in pathogenicity. One example of the numerous reports of genome walking is the recent completion of the Y. pestis Pmtl plasmid nucleotide sequence, which revealed the identity of at least seven genes encoding putative pathogenicity factors [54, 74]. A second genome walking strategy involves generating a series of mutations in specific DNA regions that surround a known pathogenicity gene. This strategy is usually accomplished by first cloning the region of interest into a plasmid, mutating the entire plasmid by transposon insertion mutagenesis or by site-directed means such as restriction enzyme-mediated frame-shift or deletion, and finally by moving the mutated plasmids back into the pathogen. The plasmids may then be tested for their ability to complement a complete deletion of the corresponding genomic locus or used to replace the genomic locus by allelic exchange. Strains that are isolated can then be tested for pathogenicity in a model of disease. This genome walking strategy has been used extensively. For example, a cluster of genes required for fimbrial expression in enteroaggregative E. coli, was identified by randomly inserting a transposon into a cloned DNA fragment known to contain genes essential for aggregation [103]. Genome walking has the advantage of discovering pathogenicity genes often with a minimal amount of labor, and it is also useful for identifying genes that function in concert to produce a complex virulence determinant. The only major
166
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
limitation of this strategy is that additional studies need to be done on the putative pathogenicity genes identified to assess their roles in pathogenicity in a model of disease.
B. Genomic Analysis and Mapping by in Vitro Transposition Genomic Analysis and Mapping By In vitro Transposition (GAMBIT) was recently developed primarily as a method to identify genes of bacteria that are essential for in vitro growth [2]. However, GAMBIT can also be used to identify genes that are essential for growth during infection in a host. In this respect, GAMBIT is similar to STM (III.B.2). An essential step in the GAMBIT protocol is the initial PCR-amplification of large segments of the pathogen genome (-15 kb in size). This step, of course, requires knowledge of some, or all, of the genomic sequence of a pathogen in order to allow the design of sets of PCR primer pairs. If the entire genome sequence is known, it would technically be possible to use GAMBIT to identify all essential genes by contiguous amplification and analysis (see below) of 15 kb regions. As shown in Figure 6 (see color plate), when using GAMBIT, each PCR product is subjected to in vitro transposon mutagenesis, which results in random insertions along the length of the fragment. The mutated DNA fragments are then transformed into the pathogen, and strains in which a fragment has integrated by allelic exchange are selected for by the use of the antibiotic resistance marker that is carried on the transposon. Transformant colonies are pooled and subsequently used both to infect a host and to prepare total DNA (the input DNA). After an appropriate period of infection, bacteria are recovered from host tissues, and total bacterial DNA (the output DNA) is prepared. During the course of the infection, strains that harbor transposon insertions in essential pathogenicity genes are selected against. Both the input and output DNAs are used as templates in PCR reactions using one of the primers originally used to amplify the genomic fragment, and a primer that is complementary to a sequence within the inverted repeat present at each end of the transposon. The PCR products are separated on an agarose gel, and their estimated sizes are used in conjunction with the genomic sequence to identify the sites of transposon insertion along the genomic fragment. The patterns of bands derived from the input and output DNA form two "ladders." The two ladders are visually compared to identify gaps (missing bands in one or more regions) in the output-derived ladder that correspond to gene(s) that are essential for survival and/or multiplication in the host (Fig. 6, see color plate). GAMBIT is a new methodology and has not been used to date in a general screen for pathogenicity factors. Nevertheless, a discussion of its advantages and limitations is warranted. Like STM, GAMBIT has the unique advantage of directly identifying genes that are essential for infectivity. However, because GAMBIT is predicted to be more labor intensive than STM when screening the
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
167
entire genome of a pathogen, the former will probably find greater use in analyzing individual loci for the presence of pathogenicity genes. As with most genetic methods, GAMBIT can only be used in pathogens that are readily transformable. Although GAMBIT was originally implemented in two naturally transformable bacterial species, Haemophilus influenzae and S. pneumoniae, it should also be useful for examining small genomic regions in less efficiently transformable species. Finally, GAMBIT has the advantage that near-saturating mutagenesis can be achieved for a locus, thus allowing the essentiality of small regions in any locus to be examined in great detail. For example, in the original GAMBIT study [2], it was found that, although transposon insertions into most of the secA gene of H. influenzae were lethal for growth in vitro, those in the carboxy-terminal coding region were well tolerated. This finding was in accordance with a previous report [100], and it thus serves to demonstrate the ability of GAMBIT to allow detailed analysis of loci of interest.
C. Computational Screens Perhaps the most efficient means of identifying pathogenicity factors using genomic sequence is to search for predicted polypeptides that have amino acid sequence similarity to previously known pathogenicity factors, and which therefore are predicted to function similarly. For example, a recent report identified the prepilin peptidase, PilD, of V. cholerae from genomic sequence analysis. After identification of this gene, the authors then confirmed the requirement of the pilD product for secretion of a number of pathogenicity factors including cholera toxin [45]. Numerous additional similarity search strategies exist. For example, one could search for putative polypeptides with amino acid similarity, and thus possible functional similarity, to host encoded proteins. Such pathogen encoded proteins may function as pathogenicity factors by interfering with or otherwise affecting host cellular functions. Aside from searches based on amino acid similarity, a number of nucleotide search strategies also exist that can be used to identify pathogenicity factors. For example, two characteristics of pathogenicity islands—a different GC content than the overall GC content of the species and the presence of flanking tRNA sequences—have been used to identify previously unknown pathogenicity islands (e.g., [11]). Another strategy could be to search for promoter or coding-sequence elements that are known to be conserved in other pathogenicity genes. For example, most of the pathogenicity genes previously identified in L. monocytogenes are transcriptionally activated by the PrfA protein, which binds to a conserved 14-bp palindrome within their promoters [43]. Thus, after the L. monocytogenes genome sequence (currently in progress; www.pasteur.fr) is completed, it might be fruitful to identify and analyze the subset of genes that contain this palindrome in their promoter regions. Conserved virulence gene
168
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
promoter elements have been defined in a number of other pathogenic species as well, for example, B. pertussis [60, 104]), and thus this approach might be widely applicable. A third potential strategy could be to search for genes that contain small sequence repeats that might undergo slipped-strand mispairing during replication in order to phase-vary the expression of a bacterial factor [51]. For more information on phase variation, please refer to Chapter 14 in this book. Genes that phase-vary are likely to encode proteins that are seen by the host immune system, or that are involved in the biosynthesis or export of such factors, and thus are more likely than not to play a role in pathogenicity (e.g., [58]). As more pathogen genomes are sequenced, pathogenicity gene discovery by computer algorithm searching will become commonplace. Although computational screens are rapid and efficient means of identifying putative pathogenicity genes, it must be understood that these screens are only a starting point, as genes of interest must still be studied by traditional means, such as mutagenesis and complementation to demonstrate a role in pathogenicity.
D.
Transcriptional Profiling and the Use of Microarrays
The advent of extensive microbial and eukaryotic DNA sequence databases has prompted the development of DNA chip and microarray technologies in several commercial and academic laboratories [13, 26, 105, 107, 124]. These methods provide a powerful new way to measure the expression of virtually every gene in a genome by simultaneously measuring the concentration of individual messenger RNAs in an experimental sample. This methodology is referred to as "transcriptional profiling" and has applications in virulence gene identification. In brief, DNA samples that correspond to each individual gene of an organism are spotted by a high-resolution robot (the microarrayer) on the surface of, for example, an appropriately treated glass slide. Each gene has a known location on the microarray, and literally thousands of genes can be arrayed per glass slide. These DNA spots then serve as hybridization targets that will bind complementary nucleic acid labeled with appropriate fluorescent tags. In practice, mRNA is extracted from cell preparations, converted to fluorescently labeled cDNA, and hybridized to the microarray. The resulting hybridization intensities are measured by simply inserting the slide into a special fluorescence confocal microscope (the scanner) that can measure and record the individual fluorescent intensities of each spot in the microarray in a matter of minutes. There are clearly numerous applications for microarray technology. The conceptually easiest applications to envision involve comparisons of various sorts—for example, mutant strain versus parental strain, or bacteria grown in laboratory medium versus those grown in host-derived sample or host cells. In each of these experimental formats, bacteria are grown under a given condition or are allowed to interact with host cells for a defined period of time. Next, RNA
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
169
is extracted and converted to fluorescently labeled DNA probes by reverse transcription. In each case, the comparison of RNA-derived probes from two different sources is made by differentially labeling (e.g., with red and green tags) and then hybridizing the two different probe preparations to the same DNA microarray. Comparison of DNA sequence distribution between different strains or even different culture preparations of a given strain provides an additional application for microarray technology that will fmd use in pathogenicity gene identification. In theory, hybridization to genomic arrays can be used to identify DNA segments that undergo amplification or rearrangement in response to the selective pressure of growth in a mammalian host. Because genetic elements encoding or controlling the expression of pathogenicity genes can undergo amplification [87], inversion [62, 130], or deletion [86], the mapping of any genomic segment that is rearranged in vivo provides a potentially powerful way of identifying genes involved in host-microbe interactions. Variations in sequence content between different clinical isolates might alert investigators to the presence of new pathogenicity-encoding plasmids, phages, and transposons, and pathogenicity islands that have moved horizontally into strains or have been recently lost. Thus, microarray analysis is expected to augment other established methods such as subtractive hybridization and differential display (discussed in II.F and II.G), which have been effectively used to identify genetic differences between closely related clinical isolates. The use of microarrays to define infection-induced genes, or genes coordinately regulated with other pathogenicity genes, will become more common as this technology is explored and improved. Other applications of microarrays will be developed. For example, it is easy to imagine that one could make a custom microarray carrying all oligonucleotide "tags" used to label individual transposons in the STM protocol (III.B.2). Such an array could be hybridized with PCR-derived probe pools derived from transposon mutants before and after animal passage, thus allowing quantification of the relative ratios of various mutants in a mixture without the need to grid mutants out spatially. Thus, like other IVET and STM techniques, microarray technology will eventually provide a new approach to defining which bacterial genes are induced during infection. The primary limitation of microarray technology, currently, is the high cost of manufacturing the microarrays. However, as the utilization of microarrays becomes more commonplace, and as the technology continues to develop, it is likely that the extreme costs associated with this technology will become more affordable.
VL Concluding Remarks As we settle into the postgenomic era, microbiologists will continue to use a combination of biochemical, genetic, and genomic techniques to identify patho-
170
ANDREW CAMILLI, D . SCOTT MERRELL, AND JOHN J. MEKALANOS
genicity factors, although the latter will become a more frequent starting point. In particular, the biggest advances in pathogenicity gene discovery will likely come from large-scale genomic analyses, using either computational methods or DNA microarray technologies. Specifically, these two methods should facilitate identification of sets of pathogenicity genes with related function and/or that are coordinately regulated, many of which may be recalcitrant to discovery by current methods. For example, assessing the roles in pathogenicity of factors that have redundant function is very difficult, because knocking out the expression of one factor may not attenuate pathogenicity in the model of disease being used. However, knowing the identity of the redundant genes would allow a multiple gene knockout strategy to be used to assess their roles. In addition, many pathogenicity genes that are small in size may have eluded identification because they are difficult to mutate by transposon or insertion-duplication mutagenesis. Thus, knowing their locations would allow a site-directed mutagenesis strategy to be used to construct null mutations in them, in order to assess their collective roles in pathogenicity. It is likely that we are at the dawn of new discoveries of pathogenicity factors. With the technical advances of the last few years, in particular the ability to sequence large genomes, it is likely that many of the genes that are involved in pathogenicity will soon be discovered. This jackpot of discovery will more than likely lead to a general slowing of the pace of discovery of new pathogenicity genes within the more well-studied pathogens that are genetically manipulatable. In contrast to this slowing down of gene discovery, though, the scientific community will continue to be faced with a frontier of discovery that is perhaps even more challenging: a true understanding of the actual functions of bacterial pathogenicity factors during infection of the human host.
References Abu Kwaik, Y., and Pederson, L. L. (1996). The use of differential display-PCR to isolate and characterize a Legionella pneumophila locus induced during the intracellular infection of macrophages. Mol. Microbiol. 21(3), 543-556. Akerley, B. J., Rubin, E. J., Camilli, A., Lampe, D. J., Robertson, H. M., and Mekalanos, J. J. (1998). Systematic identification of essential genes by in vitro mariner mutagenesis. Proc. Natl. Acad. Sci. U.S.A. 95(15), 8927-8932. Akopyants, N. S., Fradkov, A., Diatchenko, L., Hill, J. E., Siebert, R D., Lukyanov, S. A., Sverdlov, E. D., and Berg, D. E. (1998). PCR-based subtractive hybridization and differences in gene content among strains of Helicobacter pylori. Proc. Natl. Acad. Sci. U.S.A. 95(22), 13108-13113. Allison, H. E., and Hillman, J. D. (1997). Cloning and characterization of a Prevotella melaninogenica hemolysin. Infect. Immiin. 65(7), 2765-2771. Andrews, G. P., Hromockyj, A. E., Coker, C , and Maurelli, A. T. (1991). Two novel virulence loci, mxiA and mxiB, in Shigella flexneri 2a facilitate excretion of invasion plasmid antigens. Infect. Immun. 59(6), 1997-2005.
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
171
6. Avery, O. T., and Dubos, R. (1931). The protective action of a specific enzyme against type III pneumococcus infections in mice. J. Exp. Med. 54, 73-89. 7. Avery, O. T., MacLeod, C. M., and McCarty, M. (1944). Studies on the chemical nature of the substance inducing transformation of pneumococcal types: Induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. Exp. Med. 79, 137-158. 8. Bearden, S. W., Staggs, T. M., and Perry, R. D. (1998). An ABC transporter system of Yersinia pestis allows utilization of chelated iron by Escherichia coli SABll. J. Bacterial. 180(5), 1135-1147. 9. Benedi, V. J., Ciurana, B., and Tomas, J. M. (1989). Isolation and characterization of Klebsiella pneumoniae unencapsulated mutants. J. Clin. Microbiol. 27(1), 82-87. 10. Berger, K. H., and Isberg, R. R. (1993). Two distinct defects in intracellular growth complemented by a single genetic locus in Legionella pneumophila. Mol. Microbiol. 7(1), 7-19. 11. Blanc-Potard, A. B., and Groisman, E. A. (1997). The Salmonella selC locus contains a pathogenicity island mediating intramacrophage survival. EMBO J. 16(17), 5376-5385. 12. Bliska, J. B., Guan, K. L., Dixon, J. E., and Falkow, S. (1991). Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc. Natl. Acad. Sci. U.S.A. 88(1187), 1187-1191. 13. Bowtell, D. D. (1999). Options available—from start to finish—for obtaining expression data by microarray. Nature Genet. 21(1 Suppl.), 25-32. 14. Brand, B. C , Sadosky, A. B., and Shuman, H. A. (1994). The Legionella pneumophila icm locus: A set of genes required for intracellular multiplication in human macrophages. Mol. Microbiol. 14(4), 797-808. 15. Brown, P. K., and Curtiss III, R. (1996). Unique chromosomal regions associated with virulence of an avian pathogenic Escherichia coli strain. Proc. Natl. Acad. Sci. U.S.A. 93(20), 1114911154. 16. Burgess, A. W,, and Anderson, B. E, (1998). Outer membrane proteins of Bartonella henselae and their interaction with human endothelial cells. Microb. Pathogen. 25(3), 157-164. 17. Calia, K. E., Waldor, M. K., and Calderwood, S. B. (1998). Use of representational difference analysis to identify genomic differences between pathogenic strains of Vibrio cholerae. Infect. Immun. 66(2), 849-852. 18. Camilli, A., Beattie, D., and Mekalanos, J. (1994). Use of genetic recombination as a reporter of gene expression. Proc. Natl. Acad. Sci. U.S.A. 91, 2634-2638. 19. Camilli, A., and Mekalanos, J. J. (1995). Use of recombinase gene fusions to identify Vibrio cholerae genes induced during infection. Mol. Microbiol. 18, 671-683. 20. Camilli, A., Paynton, C. R., and Portnoy, D. A. (1989). Intracellular methicillin selection of Listeria monocytogenes mutants unable to replicate in a macrophage cell line. Proc. Natl. Acad. Sci. U.S.A. 86, 5522-5526. 21. Carroll, P A., Tashima, K. T, Rogers, M. B., DiRita, V. J., and Calderwood, S. B. (1997). Phase variation in tcpH modulates expression of the ToxR regulon in Vibrio cholerae. Mol. Microbiol. 25(6), 1099-1111. 22. Chhatwal, G. S., Walker, M. J., Yan, H., Timmis, K. N., and Guzman, C. A. (1997). Temperature dependent expression of an acid phosphatase by Bordetella bronchiseptica: Role in intracellular survival. Microb. Pathogen. 22(5), 257-264. 23. Chiang, S. L., and Mekalanos, J. J. (1998). Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization. Mol. Microbiol. 27(4), 797-805. 24. Cirillo, D. M., Valdivia, R. H., Monack, D. M., and Falkow, S. (1998). Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Mol. Microbiol. 30(1), 175-188.
172
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
25. Comelis, G. R., Boland, A., Boyd, A. P., Geuijen, C , Iriarte, M., Neyt, C , Sory, M. P., and Stainier, I. (1998). The virulence plasmid of Yersinia, an antihost genome. Microbiol. Mol Biol. Rev. 62(4), 1315-1352. 26. de Saizieu, A., Certa, U., Warrington, J., Gray, C , Keck, W., and Mous, J. (1998). Bacterial transcript imaging by hybridization of total RNA to oligonucleotide arrays [see comments]. Nature Biotechnol. 16( 1), 45-48. 27. De, S. N. (1959). Enterotoxicity of bacteria-free culture-filtrate of Vibrio cholerae. Nature 183, 1533-1534. 28. Diatchenko, L., Lau, Y. R, Campbell, A. P., Chenchik, A., Moqadam, F, Huang, B., Lukyanov, S., Lukyanov, K., and Gurskaya. N. (1996). Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl Acad. Sci. U.S.A. 93(12), 6025-6030. 29. Donnenberg, M. S., Calderwood, S. B., Donohue-Rolfe, A., Keusch, G. T., and Kaper, J. B. (1990). Construction and analysis of TnphoA mutants of enteropathogenic Escherichia coli unable to invade HEp-2 cells. Infect. Immun. 58(6), 1565-1571. 30. Dorrell, N., Li, S. R., Everest, P H., Dougan, G., and Wren, B. W. (1998). Construction and characterisation of a Yersinia enterocolitica 0:8 ompR mutant. FEMS Microbiol. Lett. 165(1), 145-151. 31. Drazek, E. S., Dubois, A., Holmes, R. K., Kersulyte, D., Akopyants, N. S., Berg, D. E., and Warren, R. L. (1995). Cloning and characterization of hemolytic genes from Helicobacter pylori. Infect. Immun. 63(11), 4345-4349. 32. Dubos, R., and Avery, O. T. (1931). Decomposition of the capsular polysaccharide of pneumococcus type III by a bacterial enzyme. J. Exp. Med. 54, 51-71. 33. Dutta, N. K., Pause, M. W., and Kulkarni, D. R. (1959). Role of cholera toxin in experimental cholera. / Bacteriol. 78, 594-595. 34. Engel, L. S., Hobden, J. A., Moreau, J. M., Callegan, M. C, Hill, J. M., and O'Callaghan, R. J. (1997). Pseudomonas deficient in protease IV has significantly reduced corneal virulence. Invest. Ophthalmol. Vis. Sci. 38(8), 1535-1542. 35. Falkow, S. (1988). Molecular Koch's postulates applied to microbial pathogenicity. Rev. Infect. Dis. 10(Suppl. 2), S274-S276. 36. Fields, P I., Swanson, R. V., Haidaris, C. G., and Heffron, F (1986). Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc. Natl. Acad. Sci. U.S.A. 83(14), 5189-5193. 37. Finkelstein, R. A. (1992). History of cholera. In "Cholera" (D. Barua and W. B. Greenough III, eds.), pp. 155-187. Plenum, New York. 38. Finkelstein, R. A., and LoSpalluto, J. J. (1969). Pathogenesis of experimental cholera: Preparation and isolation of choleragen and choleragenoid. J. E.xp. Med. 130(185), 185-202. 39. Finlay, B. B., Starnbach, M. N., Francis, C. L., Stocker, B. A., Chatfield, S., Dougan, G., and Falkow, S. (1988). Identification and characterization of TnphoA mutants of Salmonella that are unable to pass through a polarized MDCK epithelial cell monolayer. Mol. Microbiol. 2(6), 757-766. 40. Finn, T. M., Shahin, R., and Mekalanos, J. J. (1991). Characterization of v/>-activated TnphoA gene fusions in Bordetella pertussis. Infect. Immun. 59(9), 3273-3279. 41. Fletcher, H. M., Schenkein, H. A., and Macrina, F L. (1994). Cloning and characterization of a new protease gene (prtH) from Porphyromonas gingivalis. Infect. Immun. 62(10), 4279-4286. [published erratum appears in Ifjfect. Immun. 1994 62(12), 5707]. 42. Foster, J. W., Park, Y. K., Bang, I. S., Karem, K., Belts, H., Hall, H. K., and Shaw, E. (1994). Regulatory circuits involved with pH-regulated gene expression in Salmonella typhimurium. Microbiology 140(Pt. 2), 341-352.
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
173
43. Freitag, N. E., Youngman, P., and Portnoy, D. A. (1992). Transcriptional activation of the Listeria monocytogenes hemolysin gene in Bacillus siibtilis. J. Bacteriol. 174(4), 1293-1298. 44. Fujimoto, D. F., and Bayles, K. W. (1998). Opposing roles of the Staphylococcus aureus virulence regulators, Agr and Sar, in Triton X-100- and penicillin-induced autolysis. / Bacteriol. 180(14), 3724-3726. 44a. Galan, J. E., and Curtiss, R. (1989). Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc. Natl. Acad. Sci. U.S.A. 86, 6383-6387. 45. Fullner, K. J., and Mekalanos, J. J. (1999). Genetic characterization of a new type IV-A pilus gene cluster found in both classical and El Tor biotypes of Vibrio cholerae. Infect. Immun. 67(3), 1393-1404. 46. Guidolin, A., and Manning, P. A. (1985). Bacteriophage CP-Tl of Vibrio cholerae. Identification of the cell surface receptor. Eur J. Biochem. 153( 1), 89-94. 47. Hardt, W. D., Urlaub, H., and Galan, J. E. (1998). A substrate of the centisome 63 type III protein secretion system of Salmonella typhimurium is encoded by a cryptic bacteriophage. Proc. Natl. Acad. Sci. U.S.A. 95(5), 2574-2579. 48. Heithoff, D. M., Conner, C. P, Hanna, P C, Julio, S. M., Hentschel, U., and Mahan, M. J. (1997). Bacterial infection as assessed by in vivo gene expression. Proc. Natl. Acad. Sci. U.S.A. 94(3), 934-939. 49. Hendrixson, D. R., and St. Geme III, J. W. (1998). The Haemophilus influenzae Hap serine protease promotes adherence and microcolony formation, potentiated by a soluble host protein. Mol. Cell. Biol. 2(6), 841-850. 50. Hensel, M., Shea, J. E., Gleeson, C , Jones, M. D., Dalton, E., and Holden, D. W. (1995). Simultaneous identification of bacterial virulence genes by negative selection. Science 269(5222), 400-403. 51. Hood, D. W., Deadman, M. E., Jennings, M. P., Bisercic, M., Fleischmann, R. D., Venter, J. C, and Moxon, E. R. (1996). DNA repeats identify novel virulence genes in Haemophilus influenzae. Proc. Natl. Acad. Sci. U.S.A. 93(20), 11121-11125. 52. Hoppe, H. C , de Wet, B. J., Cywes, C , Daffe. M., and Ehlers, M. R. (1997). Identification of phosphatidylinositol mannoside as a mycobacterial adhesin mediating both direct and opsonic binding to nonphagocytic mammalian cells. Infect. Immun. 65(9), 3896-3905. 53. Hu, L. T, Pratt, S. D., Perides, G., Katz, L., Rogers, R. A., and Klempner, M. S. (1997). Isolation, cloning, and expression of a 70-kilodalton plasminogen binding protein of Borrelia burgdorferi. Infect. Immun. 65(12), 4989^995. 54. Hu, P, Elliott, J., McCready, P, Skowronski, E., Games, J., Kobayashi, A., Brubaker, R. R., and Garcia, E. (1998). Structural organization of virulence-associated plasmids of Yersinia pestis. J. Bacteriol. 180(19), 5192-5202. 55. liver, D., Arnqvist, A., Ogren, J., Frick, I. M., Kersulyte, D., Incecik, E. T, Berg, D. E., Covacci, A., and Engstrand, L. (1998). Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279(5349), 373-377. 56. Isberg, R. R., and Falcow, S. (1985). A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature 317, 262-264. 57. Johnson, J. A., Salles, C. A., Panigrahi, P, Albert, M. J., Wright, A. C , Johnson, R. J., and Morris, J. G. (1994). Vibrio cholerae 0\39 synonym Bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect. Immun. 62, 2108-2110. 58. Jonsson, A.-B., liver, D., Falk, P., Pepose, J., and Normark, S. (1994). Sequence changes in the pilus subunit lead to tropism variation of Neisseria gonorrhoeae to human tissue. Mol. Microbiol. 13(3), 403-416.
174
ANDREW CAMILLI, D. SCOTT MERRELL, AND JOHN J. MEKALANOS
59. Kahrs, A. F, Bihlmaier, A., Facius, D., and Meyer, T. F. (1994). Generalized transposon shuttle mutagenesis in Neisseria gonorrhoeae: A method for isolating epithelial cell invasion-defective mutants. Mol. Microbiol. 12(5), 819-831. 60. Karimova, G., and UUmann, A. (1997). Characterization of DNA binding sites for the BvgA protein of Bordetella pertussis. J. Bacteriol. 179(11), 3790-3792. 61. Klarsfeld, A. D., Goossens, P. L., and Cossart, P. (1994). Five Listeria monocytogenes genes preferentially expressed in infected mammalian cells: plcA, purH, purD, pyrE and an arginine ABC transporter gene, arpJ. Mol. Microbiol. 13(4), 585-597. 62. Klemm, P. (1986). Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. EMBO J. 5(6), 1389-1393. 63. Knutson, K. L., Hmama, Z., Herrera-Velit, P, Rochford, R., and Reiner, N. E. (1998). Lipoarabinomannan of Mycobacterium tuberculosis promotes protein tyrosine dephosphorylation and inhibition of mitogen-activated protein kinase in human mononuclear phagocytes: Role of the Src homology 2 containing tyrosine phosphatase 1. J. Biol. Chem. 273(1), 645-652. 64. Labigne-Roussel, A., Courcoux, P., and Tompkins, L. (1988). Gene disruption and replacement as a feasible approach for mutagenesis of Campylobacter jejuni. J. Bacteriol. 170(4), 17041708. 65. Lampe, D. J., Churchill, M. E., and Robertson, H. M. (1996). A purified mariner transposase is sufficient to mediate transposition in vitro. EMBO J. 15(19), 5470-5479. [published erratum appears in EMBO J. 1997 16(13), 4153]. 66. Lane, W. S., Galat, A., Harding, M. W., and Schreiber, S. L. (1991). Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus. / Prot. Chem. 10(2), 151-160. 67. Lantz, M. S., and Ciborowski, P. (1994). Zymographic techniques for detection and characterization of microbial proteases. Methods Enzymol. 235, 563-594. 68. Lederberg, J., and Zinder, N. (1948). Concentration of biochemical mutants of bacteria with penicillin. Am. Chem. Soc. J. 70, 4267. 69. Lee, S. H., Hava, D. L., Waldor, M. K., and Camilli, A. (1999). Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection. Cell 99(6), 625-634. 70. Leong, J. M., Moitoso de Vargas, L., and Isberg, R. R. (1992). Binding of cultured mammalian cells to immobilized bacteria. Infect. Immun. 60(2), 683-686. 71. Liang, P., and Pardee, A. B. (1992). Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction [see comments]. Science 257(5072), 961-91 \. 72. Libman, E. (1905). A pneumococcus producing a peculiar form of hemolysis. Proc. N. Y. Pathol. Soc. 5, 168. 73. Lin, B., Hollingshead, S. K., Coligan, J. E., Egan, M. L., Baker, J. R., and Pritchard, D. G. (1994). Cloning and expression of the gene for group B streptococcal hyaluronate lyase. / Biol. Chem. 269(48), 30113-30116. 74. Lindler, L. E., Piano, G. V., Burland, V., Mayhew, G. F, and Blattner, F R. (1998). Complete DNA sequence and detailed analysis of the Yersinia pestis KIM5 plasmid encoding murine toxin and capsular antigen. Infect. Immun. 66(12), 5731-5742. 75. Lisitsyn, N., and Wigler, M. (1993). Cloning the differences between two complex genomes. Science 259(5097), 946-951. 76. Lockman, H. A., and Curtiss, R. (1990). Salmonella typhimurium mutants lacking flagella or motility remain virulent in BALB/c mice. Infect. Immun. 58(137), 137-143. 77. Lowe, A. M., Beattie, D. T, and Deresiewicz, R. L. (1998). Identification of novel staphylococcal virulence genes by in vivo expression technology. Mol. Microbiol. 27(5), 967-976.
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
175
78. Lu, Y. S., Lai, W. C , Pakes, S. P, and Nie, L. C. (1991). A monoclonal antibody against a Pasteurella multocida outer membrane protein protects rabbits and mice against pasteurellosis. Infect. Immun. 59(1), 172-180. 79. Maclnnes, J. I., Kim, J. E., Lian, C. J., and Sokes, G. A. (1990). Actinobacillus pleuropneumoniae hlyX gene homology with the fnr gene oi Escherichia coli. J. Bacterial. 172(8), 4587^592. 80. Mahan, M. J., Slauch, J. M., Hanna, P C , Camilli, A., Tobias, J. W., Waldor, M. K., and Mekalanos, J. J. (1993). Selection for bacterial genes that are specifically induced in host tissues: The hunt for virulence factors (review). Infect. Agents Dis. 2(4), 263-268. 81. Mahan, M. J., Slauch, J. M., and Mekalanos, J. J. (1993). Selection of bacterial virulence genes that are specifically induced in host tissues. Science 259, 686-688. 82. Mahan, M. J., Tobias, J. W., Slauch, J. M., Hanna, P C , Collier, R. J., and Mekalanos, J. J. (1995). Antibiotic-based selection for bacterial genes that are specifically induced during infection of a host. Proc. Natl. Acad. Sci. U.S.A. 92(3), 669-673. 83. Manning, P A. (1997). The tcp gene cluster of Vibrio cholerae. Gene 192(1), 63-70. 84. Manoil, C , and Beckwith, J. (1985). TnphoA: A transposon probe for protein export signals. Proc. Natl. Acad. Sci. U.S.A. 82, 8129-8133. 85. Matsui, K., Nagano, K., Arai, T, Hirono, I., and Aoki, T. (1998). DNA sequencing of the gene encoding Salmonella typhimurium-dQr'wQd T-cell inhibitor (STI) and characterization of the gene product, cloned STI. FEMS Immunol. Med. Microbiol. 22(4), 341-349. 86. Maurelli, A. T, Fernandez, R. E., Bloch, C. A., Rode, C. K., and Fasano, A. (1998). "Black holes" and bacterial pathogenicity: A large genomic deletion that enhances the virulence of Shigella spp., and enteroinvasive Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 95(7), 3943-3948. 87. Mei, J. M., Nourbakhsh, F, Ford, C. W., and Holden, D. W. (1997). Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis. Mol. Microbiol. 26(2), 399-^07. 88. Mekalanos, J. J. (1983). Duplication and amplification of toxin genes in Vibrio cholerae. Cell 35(0,253-263. 89. Miller, S. I., Kukral, A. M., and Mekalanos, J. J. (1989). A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc. Natl. Acad. Sci. U.S.A. 86(13), 5054-5058. 90. Nassif, X., and Sansonetti, P. J. (1986). Correlation of the virulence of Klebsiella pneumoniae Kl and K2 with the presence of a plasmid encoding aerobactin. Infect. Immun. 54(3), 603-608. 91. Odenbreit, S., Till, M., and Haas, R. (1996). Optimized BlaM-transposon shuttle mutagenesis of Helicobacter pylori allows the identification of novel genetic loci involved in bacterial virulence. Mol. Microbiol. 20(2), 361-373. 92. Pan, Y. T, Xu, B., Rice, K., Smith, S., Jackson, R., and Elbein, A. D. (1997). Specificity of the high-mannose recognition site between Enterobacter cloacae pili adhesin and HT-29 cell membranes. Infect. Immun. 65(10), 4199-4206. 93. Paruchuri, D. K., Seifert, H. S., Ajioka, R. S., Karlsson, K. A., and So, M. (1990). Identification and characterization of a Neisseria gonorrhoeae gene encoding a glycolipid-binding adhesin. Proc. Natl. Acad. Sci. U.S.A. 87(1), 333-337. 94. Pichichero, M. E., Loeb, M., Anderson, and Smith, D. H. (1982). Do pili play a role in pathogenicity oi Haemophilus influenzae type B? Lancet 2(8305), 960-962. 95. Plum, G., and Clark-Curtiss, J. E. (1994). Induction oi Mycobacterium avium gene expression following phagocytosis by human macrophages. Infect. Immun. 62(2), 476-483. 96. Polissi, A., Pontiggia, A., Feger, G., Altieri, M., Mottl, H., Ferrari, L., and Simon, D. (1998). Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect. Immun. 66(12), 5620-5629.
176
ANDREW CAMILLI, D . SCOTT MERRELL, AND JOHN J. MEKALANOS
97. Poquet, I., Ehrlich, S. D., and Gruss, A. (1998). An export-specific reporter designed for gram-positive bacteria: Application to Lactococciis lactis. J. Bacterial. 180(7), 1904-1912. [published erratum appears in J. Bactehol. 1998 180(16), 4324]. 98. Portnoy, D. A., Chakraborty, T., Goebel, W., and Cossart, P. (1992). Molecular determinants of Listeria monocytogenes pathogenesis. Infect. Immun. 60(4), 1263-1267. 99. Purven, M., Frisk, A., Lonnroth, I., and Lagergard, T. (1997). Purification and identification of Haemophilus ducreyi cytotoxin by use of a neutralizing monoclonal antibody. Infect. Immun. 65(8), 3496-3499. 100. Rajapandi, T., and Oliver, D. (1994). Carboxy-terminal region of Escherichia coli SecA ATPase is important to promote its protein translocation activity in vivo. Biochem. Biophys. Res. Commun. 200(3), 1477-1483. 101. Reidl, J., and Mekalanos, J. J. (1995). Characterization of Vibrio cholerae bacteriophage K139 and use of a novel mini-transposon to identify a phage-encoded virulence factor. Mol. Microbiol. 18(4), 685-701. 102. Rubin, E. J., Akerley, B. J., Novik, V. N., Lampe, D. J., Husson, R. N., and Mekalanos, J. J. (1999). In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria. Proc. Natl. Acad. Sci. U.S.A. 96(4), 1645-1650. 103. Savarino, S. J., Fox, P., Deng, Y., and Nataro, J. P. (1994). Identification and characterization of a gene cluster mediating enteroaggregative Escherichia coli aggregative adherence fimbria I biogenesis. /. Bacteriol. 176(16), 4949-4957. 104. Scarlato, V., Prugnola, A., Arico, B., and Rappuoli, R. (1991). The bvg-dependent promoters show similar behaviour in different Bordetella species and share sequence homologies. Mol. Microbiol. 5(10), 2493-2498. 105. Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray [see comments]. Science 270(5235), 467-^70. 106. Sela, S., Thole, J. E., Ottenhoff, T H., and Clark-Curtiss, J. E. (1991). Identification of Mycobacterium leprae antigens from a cosmid library: Characterization of a 15-kilodalton antigen that is recognized by both the humoral and cellular immune systems in leprosy patients. Infect. Immun. 59(11), 4117-4124. 107. Shalon, D., Smith, S. J., and Brown, P. O, (1996). A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res. 6(7), 639-645. 108. Shumway, C. N., and Klebanoff, S. J. (1971). Purification of pneumolysin. Infect. Immun. 4(4), 388-392. 109. Sjostrom, J. E., Kuhler, T., and Larsson, H. (1997). Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp. Antimicrob. Agents Chemother 41(8), 1797-1801. 110. Soncini, F C , Garcia Vescovi, E., Solomon, F, and Groisman, E. A. (1996). Molecular basis of the magnesium deprivation response in Salmonella typhimurium: Identification of PhoP-regulated genes. J. Bacteriol. 178(17), 5092-5099. 111. Sun, J. W., Wanda, S. Y., Camilli, A., and Curtiss III, R. (1994). Cloning and DNA sequencing of the dextranase inhibitor gene (del) from Streptococcus sobrinus. J. Bacteriol. 176(23), 7213-7222. 112. Tacket, C. O., Taylor, R. K., Losonsky, G., Lim, Y, Nataro, J. P, Kaper, J. B., and Levine, M. M. (1998). Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae 0139 infection. Infect. Immun. 66(2), 692-695.
4.
STRATEGIES TO IDENTIFY BACTERIAL PATHOGENICITY FACTORS
177
113. Taylor, R. K., Miller, V. L., Furlong, D. B., and Mekalanos, J. J. (1987). Use of p hoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc. Natl Acad. Sci. U.S.A. 84(9), 2833-2837. 114. Tinsley, C. R., and Nassif, X. (1996). Analysis of the genetic differences between Neisseria meningitidis and Neisseria gonorrhoeae: Two closely related bacteria expressing two different pathogenicities. Proc. Natl. Acad. Sci. U.S.A. 93(20), 11109-11114. 115. Valdivia, R. H., and Falkow, S. (1996). Bacterial genetics by flow cytometry: Rapid isolation of Sahnonella typhimuriiim acid-inducible promoters by differential fluorescence induction. Mol. Microbiol. 22(2), 367-378. 116. Valdivia, R. H., Hromockyj, A. E., Monack, D., Ramakrishnan, L., and Falkow, S. (1996). Applications for green fluorescent protein (GFP) in the study of host-pathogen interactions. Gene 173(1), 47-52. 117. van den Berg, B. M., Beekhuizen, H., Willems, R. J., Mooi, F. R., and van Furth, R. (1999). Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract. Infect. Immiin. 67(3), 1056-1062. 118. Visai, L., Bozzini, S., Raucci, G., Toniolo, A., and Speziale, R (1995). Isolation and characterization of a novel collagen-binding protein from Streptococcus pyogenes strain 6414. J. Biol. Chem. 270(1), 347-353. 119. Vogel, J. P., Roy, C, and Isberg, R. R. (1996). Use of salt to isolate Legionella pneumophila mutants unable to replicate in macrophages. Ann. N.Y. Acad. Sci. 191, 271-272. 120. Waldor, M. K., Colwell, R., and Mekalanos, J. J. (1994). The Vibrio cholerae 0139 serogroup antigen includes an 0-antigen capsule and lipopolysaccharide virulence determinants. Proc. Natl. Acad. Sci. U.S.A. 91(24), 11388-11392. 121. Waldor, M. K., and Mekalanos, J. J. (1996). Lysogenic conversion by a filamentous phage encoding cholera toxin [see comments]. Science 272(5270), 1910-1914. 122. Wang, J., Lory, S., Ramphal, R., and Jin, S. (1996). Isolation and characterization of Pseudomonas aeruginosa genes inducible by respiratory mucus derived from cystic fibrosis patients. Mol. Microbiol. 22(5), 1005-1012. 123. Wang, J., Mushegian, A., Lory, S., and Jin, S. (1996). Large-scale isolation of candidate virulence genes of Pseudomonas aeruginosa by in vivo selection. Proc. Natl. Acad. Sci. U.S.A. 93(19), 10434-10439. 124. Wang, K., Gan, L., Jeffery, E., Gayle, M., Gown, A. M., Skelly, M., Nelson, P S., Ng, W. V., Schummer, M. (1999). Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 229{\-2), 101-108. 125. Weintraub, A., Widmalm, G., Jansson, P E., Jansson, M., Hultenby, K., and Albert, M. J. (1994). Vibrio cholerae 0139 Bengal possesses a capsular polysaccharide which may confer increased virulence. Microb. Pathogen. 16(3), 235-241. 126. Weiss, A. A., Melton, A. R., Walker, K. E., Andraos, S. C., and Meidl, J. J. (1989). Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis y/r-regulated genes. Infect. Immun. 57(2674), 2674-2682. 127. Wong, K. K., and McClelland, M. (1994). Stress-inducible gene of Salmonella typhimurium identified by arbitrarily primed PCR of RNA. Proc. Natl. Acad. Sci. U.S.A. 91(2), 639-643. 128. Worley, M. J., Stojiljkovic, I., and Heffron, F. (1998). The identification of exported proteins with gene fusions to invasin. Mol. Microbiol. 29(6), 1471-1480. 129. Yu, J. L., Mansson, R., Flock, J. I., and Ljungh, A. (1997). Fibronectin binding by Propionibacterium acnes. FEMS Immunol. Med. Microbiol. 19(3), 247-253. 130. Zhao, H., Li, X., Johnson, D. E., Blomfield, I., and Mobley, H. L. (1997). In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract. Mol. Microbiol. 23(5), 1009-1019.
This Page Intentionally Left Blank
CHAPTER 5
Mechanisms of Bacterial Pathogenesis in Plants: Familiar Foes in a Foreign Kingdom
JAMES R. ALFANO ALAN COLLMER
I. Introduction II. An Overview of Bacterial Plant Pathogens and Plant Diseases A. Three Types of Gram-Negative Bacterial Pathogens: Tumorigenic, Stealth Necrogenic, and Brute-Force Necrogenic B. The Fate of Nonpathogenic Bacteria in Plants C. The Overriding Importance of Protein Secretion Systems in Pathogenesis III. Tumorigenic Agrobacterium tumefaciens: Using the Type IV Secretion System to Transform the Host into a Factory for Bacterial Nutrients IV. Necrogenic, Stealth Pathogens: Parasites Strongly Dependent on the Hrp (Type III) Protein Secretion System A. The Hypersensitive Response (HR) Plant Defense Syndrome B. Gene-for-Gene (avr-R) Interactions and the Antiparasite Surveillance System of Plants C. hrp and hrc Genes and the Type III Protein Secretion System of Plant Pathogenic Bacteria D. Harpins and Pilins: Proteins Secreted in Culture in Abundance by the Hrp System E. Avr Proteins as Injected, Interchangeable Effectors of Parasitism V. Necrogenic, Brute-Force Pathogens: Soft-Rotters Dependent on Type II Secretion of Pectic Enzymes VI. Other Virulence Factors of Gram-Negative Plant Pathogens Compared with Those of Animal Pathogens A. Attachment Factors: Important in Agrobacterium but Role Unclear in Necrogenic Pathogens B. EPS: A Special Role in Wilt Diseases of Plants
Principles of Bacterial Pathogenesis Copyright © 2001 by Academic Press All rights of reproduction in any form reserved. ISBN 0-12-304220-8
i '7Q
180 181 181 184 185 186 189 189 190 191 194 196 200 201 201 202
180
JAMES R. ALFANO AND ALAN COLLMER
VII. VIII. IX. X.
C. Toxins: Some Similarities, but Differently Defined D. Iron Uptake Mechanisms: Common Strategies for Overcoming a General Eukaryote Defense E. Resistance to Host Antimicrobial Peptides: Related Mechanisms Underlying Bacterial Virulence in Mouse and Potato F. Regulation of Virulence: A Potpourri of Common Components, Strategies, and Signals Host Innate Immune Systems: Common Components in Pathogen Recognition and Defense Signaling The R Gene Surveillance System: An Innate Immune System with Elaborate Recognition Specificity Pseudomonas aeruginosa: Dual-Kingdom Pathogenesis Conclusions References
202 203 204 205 206 207 209 210 211
/. Introduction With vast areas of their surface bearing perforations large enough to admit most bacteria, and without an adaptive immune system, plants would seem easy targets for hungry prokaryotes. But, surprisingly, plants are relatively resistant to bacterial attack, and most of the bacterial diseases that do afflict them are caused by strains in a handful of species. When the interactions between these successful pathogens and plants are viewed from the perspective of animal pathogenic microbiology, we find a mix of the familiar and the alien. The plant pathogens use familiar, conserved regulatory components and secretion systems to deploy key virulence proteins, and the attacked plant cells often respond defensively with familiar factors like oxidative bursts, nitric oxide synthesis, and programmed cell death. However, the virulence proteins themselves and the antiparasite surveillance systems that trigger these defenses are significantly different. Both the familiar and alien features are becoming more relevant to students of animal pathogenesis. Aspects of conserved virulence systems are sometimes more experimentally accessible in the plant pathogens, and the prevalence of horizontally transferred pathogenicity islands highlights the universal nature and potential interchangeability of these systems. Food safety concerns encourage more attention to the association of many animal pathogenic bacteria with fruits and vegetables and the possible interactions of these bacteria with plant pathogens. And the development of a model system involving a Pseudomonas aeruginosa strain pathogenic to both plants and animals suggests that novel genes involved in animal pathogenesis may be efficiendy identified using a plant system. The purpose of this chapter is to provide an introduction to the world of bacterial plant pathogenesis that is accessible to students of animal pathogens. We will delineate the conserved and
5.
BACTERIAL PLANT PATHOGENS
181
unique mechanisms and emphasize those features that will contribute most to a broader understanding of mechanisms of bacterial pathogenesis.
//. An Overview of Bacterial Plant Pattiogens and Plant Diseases The most important prokaryotic pathogens of plants are Gram-negative bacteria in the genera Agrobacterium, Envinia, Pseudomonas, Xanthomonas, Ralstonia, and Xylella, Gram-positive bacteria in the genera Clavibacter and Streptomyces, and Mollicutes in the genus Spiroplasma and the Candidatus genus Phytoplasma. The Mollicutes and Xylella are fastidious parasites that are typically delivered by insects into the vascular system of plants. The other bacterial pathogens are generally facultative parasites that colonize the intercellular spaces between plant cells (or the nonliving xylem cells that conduct water up from the roots). Thus, most bacterial plant pathogens colonize a microniche in the host that is separated from the host cytoplasm not only by a plasma membrane, but also by a cell wall that is ca. 200 nm thick and comprised of a matrix of polysaccharide and protein thought to exclude macromolecules with a Stokes radius >4.6 nm [1].
A.
Three Types of Gram-Negative Bacterial Pathogens: Tumorigenic, Stealth Necrogenic, and Brute-Force Necrogenic
Most of what we know about pathogenic mechanisms is based on work with the Gram-negative bacteria, and in subsequent sections we will distinguish three types of pathogens within this group (Table I). Agrobacterium tumefaciens represents the first type, which is distinguished by its tumorigenicity. The pathogen transforms plant cells with bacterial DNA, producing tumors, but generally not necrosis, in the host (Fig. 1). In contrast, bacteria in the genera Erwinia, Pseudomonas, Xanthomonas, and Ralstonia are necrogenic. That is, they have a characteristic ability to elicit plant cell death. Pseudomonas syringae is representative of a subgroup of the necrogenic pathogens and of the second pathogen type we will discuss in that it is host specific and triggers host cell death only after prolonged "stealthy" parasitic multiplication. Eminia carotovora, on the other hand, is representative of another subgroup of the necrogenic pathogens and of the third pathogen type we will discuss in that it is relatively host promiscuous and kills host tissues rapidly during *'brute-force" pathogenesis. We will use the descriptive terms "stealth" and "brute-force" here instead of the formal terms
182 Table I
JAMES R. ALFANO AND ALAN COLLMER
Model Gram-Negative Plant Pathogens
Pathogentype/ representative species
Model hosts
Typical disease symptoms
Major virulence factor secretion pathway"
Key virulence factors secreted
tobacco, carrot. and other dicots
crown gall tumors
Type IV
T-DNA
Pseudomonas syringae pvs.
tomato, Arabidopsis, legumes
necrotic lesions. often with chlorotic halos on leaves and fruit
Type III
Avr proteins^
Xanthomonas campestris pvs.
pepper, tomato. brassicas, rice
necrotic lesions on leaves and fruit
Type III
Avr proteins^
Erwinia amyiovora
apple and pear
fire blight
Type III
harpins, DspE (and other Avrlike proteins?)
Ralstonia solanacearum
tomato, tobacco. banana
wilt and necrosis of whole plant
Type III
Avr proteins?
potato, Saintpaulia, and many other plants with fleshy tissues
maceration "softrof' of fleshy plant organs
Type II
pectic enzymes
Tumorigenic Agrobacterium tumefaciens Necrogenic: host-specific ("stealth")
Necrogenic: host-promiscuous ("brute-force") Erwinia carotovora and E. chrysanthemi
^Note that plant cell-wall-degrading enzymes secreted by the type II pathway also contribute to the virulence of X. campestris and R. solanacearum and that the type III pathway contributes to the ability of E. chrysanthemi to initiate infections at low levels of inoculum [27, 77]. As discussed in the text, the known Avr proteins are thought to represent a larger class of effector proteins injected into host cells by the type III pathway.
biotroph and necrotroph, respectively, which denote the feeding relationship of the parasite with host cells [2]. The necrogenic pathogens produce a wide array of symptoms in plants (Fig. 1). For example, P. syringae typically causes small necrotic lesions, often surrounded by a toxin-induced yellow halo, on leaves. Ralstonia solanacearum colonizes the xylem cells in the water-supplying vascular system and causes plants to wilt. Erwinia amyiovora attacks blossoms and then vascular tissues in
5.
BACTERIAL PLANT PATHOGENS
183
Fig. 1 Representative disease symptoms and plant responses caused by Gram-negative plant pathogens. (A) Crown gall of cherry caused by A. tumefaciens; note the massive gall exposed after removing soil. Reprinted through the courtesy of Wayne A. Sinclair. (B) Brown spot of bean caused by P. syringae pv. syringae; note the necrotic lesion (arrow) that has developed after several days of symptomless bacterial multiplication. Reprinted through the courtesy of Susan S. Hirano [269]. (C) Southern bacterial wilt of tomato caused by R. solanacearum; note the wilted plant on the right, which was grown in infested soil. Reprinted through the courtesy of H. David Thurston. (D) Fire blight of pear; note the blackened, collapsed stem and white strands of extruded bacterial ooze. Reprinted through the courtesy of Steven V. Beer. (E) Bacterial soft rot of potato caused by E. carotovora; note the sharply demarcated zone of macerated tissue in this close-up of a sectioned, infected potato tuber. (F) The hypersensitive response (HR) elicited in tobacco following infiltration with P. syringae pv. tomato at a concentration of 1 x 10^ cells/ml; note the infiltrated panel (arrow) has collapsed 24 hr after infiltration.
184
JAMES R. ALFANO AND ALAN COLLMER
the shoots of apple trees, causing aptly named "fire blight" symptoms. And E. carotovora macerates fleshy plant tissues, producing "soft rots" in organs such as potato tubers. Beyond these major differences, there is another level of more subtle variation in plant diseases. For example, a field of tobacco attacked by P. syringae may have a dynamic mixture of strains that differ only in their ability to produce a toxin: those producing the toxin will cause "wildfire" symptoms with massive yellow halos around lesions, whereas the others will produce more limited "angular leaf spot" symptoms [3]. As will be discussed below, pathogenesis by the necrogenic pathogens is a highly multifactorial process involving much apparent redundancy and subtle variation in virulence factors. Because of this and the diversity of susceptible plants, a small handful of pathogen species using highly conserved virulence factor delivery systems can cause hundreds of different diseases. Host specificity is a key part of this pathogen variability and is well defined at the pathovar and race level. That is, P. syringae is divided into over 40 pathovars based primarily on specificity for different plant species. For example, many strains off! syringae pv. syringae are virulent on bean but "avirulent" on tobacco, whereas strains of P. syringae pv. tabaci have the opposite specificity. Over 100 pathovars similarly have been defined for Xanthomonas campestris (although taxonomic studies support the redefinition of some pathovar groups as new species [4]). Races can be distinguished within many pathovars off! syringae and X. campestris based on host range among cultivars of the host species. For example, P. syringae pv. glycinea is pathogenic to soybean, but race 6 is avirulent on Harosoy and a few other cultivars of soybean, where it triggers a strong defense syndrome known as the hypersensitive response (HR). The search for the basis of this specificity and the strong defenses elicited in resistant cultivars has driven major advances in our understanding of how these bacteria attack plants.
B. The Fate of Nonpathogenic Bacteria in Plants When nonpathogenic bacteria, such as Escherichia coli and Pseudomonas fluorescens, or disarmed pathogen mutants are introduced into the intercellular spaces of a plant leaf, they neither grow nor trigger the strong defense reactions associated with avirulent pathogens [5, 6]. However, they do trigger several weak, transient, localized defense responses, including an oxidative burst, plant cell wall papilla deposition, and increased expression of the phenylpropanoid pathway (which leads to phenolics involved in wall fortification, defense signaling, and pathogen inhibition) [7-9]. These responses may also be triggered nonspecifically by two common bacterial surface features, LPS and flagella. LPS isolated from a variety of bacteria can elicit weak defenses [10-12], and plants also respond to flagellins or a 20-amino-acid domain that is conserved in the N terminus of flagellins from bacteria as diverse as Escherichia and BaciUus spp. [13]. Virulent
5.
BACTERIAL PLANT PATHOGENS
185
necrogenic stealth pathogens, such as P. syringae, suppress these defense responses [8]. What actually accounts for the stasis of nonpathogenic bacteria in plant leaves (or what enables pathogens to grow) remains a puzzle. It is likely that pathogens, in addition to suppressing defenses, also possess active mechanisms to trigger the release of nutrients to the surface of plant cells. This has been established for tumorigenic A. tumefaciens and for necrogenic brute-force pathogens (which lyse host cells) [14, 15]. However, the relative importance of defense suppression and nutrient acquisition in the success of the necrogenic stealth pathogens is unknown. Interestingly, mixed inoculations of these bacteria and nonpathogens result in growth of the nonpathogens [16], which indicates that pathogen-induced changes in host metabolism render plants broadly susceptible to bacteria. This issue has direct implications for human health given the contamination of many horticultural products with fecal coliforms and the finding that Salmonella grows better in vegetable tissues that are diseased [17]. In this regard, it is also noteworthy that in some situations (e.g., in the commercial production of alfalfa sprouts) human pathogens like Salmonella can grow significantly on the surface of plant tissues [18].
C. The Overriding Importance of Protein Secretion Systems in Pathogenesis The primary determinants of pathogenicity in the Gram-negative plant pathogens are T-DNA for tumorigenic Agrobacterium and secreted proteins for the necrogenic pathogens in Pseudomonas, Xanthomonas, Envinia, and Ralstonia. Other factors, such as peptide toxins and extracellular polysaccharides, appear to have a secondary role and are discussed later. Typically, necrogenic pathogen mutants altered in the production of a single virulence protein are only partially reduced in virulence. Redundancy among such proteins seems to be the rule. In contrast, mutants deficient in protein secretion pathways are generally nonpathogenic. This is true for the type IV pathway in Agrobacterium, the type III pathway in stealth necrogenic pathogens, and the type II pathway in brute-force necrogenic pathogens [15, 19]. Indeed, screens for random mutants that have lost pathogenicity generally yield deficiencies in the respective secretion systems [19]. The pathogenic personality of the three types of pathogens is largely determined by the unique capabilities of the dominant secretion pathway, which are to deliver a nucleoprotein complex into plant cells (type IV), to inject effector proteins into plant cells (type III), or to efficiently secrete massive quantities of degradative enzymes to the bacterial milieu and the surface of plant cells (type II). The type IV secretion system is also described as "conjugation-like" and is used by Bordetella pertussis to secrete pertussis toxin, as discussed below. The type III secretion system is also referred to as the "Hrp system" in plant pathogens and
186
JAMES R. ALFANO AND ALAN COLLMER
the "contact-dependent" secretion system in animal pathogenic Yersinia, Salmonella, and Shigella because of its stimulation by contact with host cells [20]. And, the type II secretion system is also known as the "main terminal branch of the general secretory pathway" [21]. Aspects of the operation of these pathways that are particularly relevant to pathogenesis will be treated in subsequent sections, and an earlier chapter in this book is devoted to protein secretion systems (see Chapter 2 by Harper and Silhavy).
///. Tumorigenic Agrobacterium tumefaciens; Using the Type IV Secretion System to Transform ttie Host into a Factory for Bacteriai Nutrients Central to the pathogenesis of A. tumefaciens is the Ti (tumor inducing) plasmid and the transfer of a DNA segment (T-DNA) from the plasmid to the cytoplasm of the plant cell, where it is imported into the nucleus and integrated into the plant genome. The T-DNA encodes enzymes that synthesize plant growth hormones, thereby producing neoplastic growths, "crown galls," which develop at the crown of the plant just below the soil line. T-DNA also encodes opines and amino acid or sugar derivatives that provide a specialized food source for Ti-plasmid-bearing A. tumefaciens in the surrounding soil. This interkingdom DNA transfer system has aspects of both conjugation and protein secretion systems [22, 23]. For example, T-DNA borders are similar to the origin of transfer region oriT sites; in some plasmids, T-DNA is transferred in a single-stranded form, and components of the translocation apparatus are similar [22]. However, both T-DNA transfer and bacterial conjugation systems transfer both DNA and proteins, and, as discussed below, the VirE2 protein is probably transferred independently of T-DNA [23,24]. Thus, these conjugal transport systems can also be thought of as protein secretion systems. Further supporting this concept is the finding that these systems (encoded by virB genes in Agrobacterium and trb genes in conjugation systems) share extensive similarity with the Ptl secretion system present in the animal pathogen B. pertussis, which is dedicated to the secretion of the pertussis protein toxin [23, 25, 26]. These systems are presently being referred to as type IV protein secretion systems [27]. Agrobacterium pathogenesis and the associated type IV secretion system are summarized below and illustrated in Figure 2. A more detailed description can be found in several recent reviews that focus on different aspects of this phenomenon [15, 28, 29]. Agrobacteria in the soil are attracted to plant roots by a variety of signals, including monocyclic phenolics and monosaccharides associated with plant cell wall repair [15]. (The subsequent attachment to plant cells is discussed below.) The signals are thought to be released from plant wounds at the root-shoot
5.
187
BACTERIAL PLANT PATHOGENS
Hormone prodyction
Fig. 2 Overview of the type IV secretion system of Agrobacterium and key events in the development of crown gall disease. Signals from wounded plant cells (white hexagons) induce the expression of vir genes via the VirA/VirG two-component regulatory system. The type IV secretion apparatus (encoded by the virB operon) delivers single-stranded (ss) T-DNA (squiggled line) across both the inner membrane (IM) and the outer membrane (OM) of the bacterial cell, and the cell wall (CW) and plasma membrane (PM) of the plant cell. T-DNA bound covalently to VirD2 (white trapezoids) at the 5'-phosphoryl end of the T-DNA may be transferred separately from the ssDNA-binding protein, VirE2 (hatched circles). Inside the plant cell, the T-DNA becomes coated with VirE2 and is targeted by the nuclear localization signals contained in both VirD2 and VirE2 to enter the nucleus through a nuclear pore (NP), whence it integrates into the plant genome. The transformed plant cell then produces tumor-promoting growth hormones and also opines, which support bacterial growth and induce tra genes directing conjugational spread of the Ti plasmid.
188
JAMES R. ALFANO AND ALAN COLLMER
interface and are perceived by a two-component regulatory system comprised of the VirA and VirG proteins, which in turn activates virulence (vir) gene expression [30]. The vir genes are carried on the Ti plasmid within a 35-kb region that is made up of at least 6 operons involved in different aspects of tumorigenesis. With the exception of 11 chromosomal genes, some of which are known to be involved in bacterial attachment or sugar perception, the Ti plasmid carries all of the genetic information necessary to transfer T-DNA complexes from the bacterial cell to the plant nucleus. The T-DNA carries the information for tumor formation and opine production in the plant, whereas opine utilization by the bacterium is directed by genes carried on the Ti plasmid outside of the T-DNA region [28]. Since the ability to utilize these compounds is rare in nature, this trait gives plasmid-bearing strains a competitive advantage over other neighboring soil bacteria. Furthermore, opines stimulate a conjugational transfer system encoded by the Ti plasmid, resulting in transfer of the plasmid to Agwbacteriiim strains lacking it. Hence, the prime beneficiary of this curious disease is the ca. 200-kb Ti plasmid. The T-DNA complex translocation apparatus is encoded primarily by the virB operon. A current focus of research involves localization of different VirB proteins and determining specific protein-protein interactions occurring among components of the translocation apparatus [29]. Since most of these proteins are localized to the inner and outer bacterial membranes, the VirB proteins likely assemble to form a pore through both bacterial membranes, permitting one-step secretion of T-DNA complexes from the bacterial cell. It is important to note that the type IV (Ptl) system in B. pertussis secretes pertussis toxin subunits to the periplasmic space by using an export system similar to the E. coli Sec system. The subunits are assembled into the mature toxin in the periplasm and secreted to the extracellular milieu via the type IV secretion system. Thus, it appears that in different bacteria type IV secretion systems can secrete dissimilar macromolecules and initiate the secretion of these molecules from either the bacterial cytoplasm or the periplasmic space [23]. The substrate that travels the type IV pathway in Agrobacterium, the T-DNA complex, is a single-stranded DNA molecule containing the VirD2 protein attached at the 5'-end. The T-DNA molecule itself apparently provides no secretion signals targeting it for the type IV pathway; therefore, all of the information that enables DNA to be delivered into the plant cell apparently resides in the protein component of the complex. VirD2 (along with VirDl) nicks the T-DNA and attaches to the 5' end of the released single-stranded DNA [31, 32]. The binding of VirE2 to the T-DNA is not needed in the bacterium but is essential in the plant, and VirE2 is likely to be secreted independendy of the T-DNA. That is, the T-DNA complex can be translocated into the plant cell without VirE2 as long as VirE2 is supplied by another Agrobacterium strain (producing VirE2 but not T-DNA) or by expression of VirE2 in transgenic plants [33, 34]. VirD2 and VirE2 contain functional nuclear localization signals, implicating both proteins in transporting the T-DNA to the nucleus [28, 34, 35]. The T-DNA is randomly and
5. BACTERIAL PLANT PATHOGENS
189
Stably inserted into the plant genome. Plant molecular biologists have exploited the Agrobacterium system by replacing T-DNA genes with desired genes and a selectable marker, and then infecting germinal tissues or somatic cells capable of regenerating whole plants to construct transgenic plants expressing foreign genes. The recent discovery of type IV secretion systems in the animal pathogens Legionella pneumophila and Helicobacter pylori indicates that type IV secretion systems may be widely important in bacterial pathogenicity [36-38]. Because of the well-studied potential of the Agrobacterium type IV system to transfer both protein and DNA into host cells, it will be interesting to learn what macromolecules are transferred by these novel systems.
IV. Necrogenic, Stealth Pattiogens: Parasites Strongly Dependent on ttie Hrp (Type III) Protein Secretion System The stealth pathogens can trigger strong plant defenses in nonhost plants, or even in host plants in the latter stages of pathogenesis (e.g., in the common leaf spot diseases where lesions typically are limited). The capacity to trigger these defenses is intimately linked with the ability of the bacteria to be pathogenic, and the defense reactions (specifically the HR) have traditionally provided more convenient assays for this basic bacterial ability [39]. Hence, we will start with a general overview of plant defenses and a description of the antiparasite surveillance system of plants before moving on to the all-important bacterial type III (Hrp) protein secretion system and its parasite-promoting protein traffic.
A. The Hypersensitive Response (HR) Plant Defense Syndrome At the heart of plant resistance against most necrogenic, stealth pathogens is the HR, a defense-associated, rapid (usually within 24 hr), programmed death of plant cells in contact with an "incompatible" pathogen (i.e., an avirulent bacterium that is virulent on some other plant) [39, 39a]. Single bacterial cells can trigger the HR death of single plant cells in a one-to-one manner [40], and if bacteria are infiltrated into leaf intercellular spaces at a level higher than 5x10^ cells/ml, then usually enough plant cells die to produce a readily assayed macroscopic tissue collapse (Fig. 1). The HR is elicited in nature only by plant pathogens (including bacteria, fungi, viruses, and nematodes), and the gene-for-gene interactions and signals underlying this phenomenon are discussed in the next section. Paradoxically, plant cell death itself does not appear necessary for effective resistance
190
JAMES R. ALFANO AND ALAN COLLMER
against P. syringae [41]. However, the HR syndrome includes a panoply of antimicrobial responses, and exploring these has revealed much about plant defense systems. The ability to respond with the HR is not restricted to any specialized cell types but is a general property of plant cells that enables defense anywhere in the plant to be immediate and localized. Many of the defense responses are further localized to the plant cell wall at the site of contact with the pathogen. These are early responses occurring within the first few hours of pathogen contact and include an oxidative burst [42, 43], dityrosine crosslinking of tyrosine-rich proteins in the wall [44], increased levels of phenolic compounds associated with wall fortification [45], callose synthesis and deposition of a callose-rich papilla between the cell wall and the plasma membrane [46], and redistribution of phospholipase D in the plasma membrane to the site of contact [47]. The affected plant cell and its neighbors then produce phytoalexins (low-molecular-weight antimicrobial compounds produced in response to microbes) [48], and a variety of "pathogenesisrelated" (PR) proteins that are secreted into the cell wall and intercellular fluids or into the vacuole (from which they are released if the cell dies) [49]. If enough plant cells in the region detect pathogen, then a signal for systemic acquired resistance (SAR) is sent throughout the plant, leading to induction of a subset of PR proteins, known as SAR proteins, in distal tissues. SAR development takes several days, and it confers increased (but often not complete) resistance against a broad array of pathogens for several weeks [49]. Salicylic acid is involved in SAR signaling, although it may not be the long-distance signal [50, 51]. (Serendipitously, because of the defense-inducing effects of salicylates, the standard medical prescription for two aspirins and a phone call in the morning is not entirely off the mark with plants.) There is litde evidence that these HR-associated defense responses are tailored to the potential invader. Many of them are also triggered (but more weakly and without host cell death) by nonpathogenic bacteria, and an SAR that is triggered by a bacterium, a fungus, or a virus is equally (usually partially) effective against members of all three groups of pathogens [49].
B.
Gene-for-Gene (avr-R) Interactions and the Antiparasite Surveillance System of Plants
We now know that the HR is triggered when a bacterial avirulence (avr) gene product interacts with the product of a cognate plant resistance (R) gene in a "gene-for-gene" manner [52]. Figure 3 depicts the dynamic nature of gene-forgene interactions. It is such interactions that control race-cultivar specificity within various pathovars off! syringae andX. campestris as well as similar highly host-specific interactions of plants with many fungi, viruses, and nematodes. It is also likely that avr-R gene interactions are important in host-range determination
5.
BACTERIAL PLANT PATHOGENS
191
at the level of pathogen pathovar and host species. For example, R syringae pv. tomato carries several avr genes that interact with R genes in soybean, thereby contributing to the avirulence of this tomato pathogen on soybean [53]. Thus, the R gene products form the antennae of a surveillance system that is constitutively arrayed against a broad array of stealth parasites. We will further discuss the R gene system below in the section on innate immunity. Interestingly, most (but not all) of the known R genes recognizing bacteria encode cytoplasmic plant proteins [54]. Thus, the recognition event that betrays unsuccessful stealth parasites appears to occur most commonly inside of plant cells.
C. hrp and hrc Genes and the Type III Protein Secretion System of Plant Pathogenic Bacteria The hrp genes were discovered in P. syringae and so named because mutants lose their ability to elicit the HR in nonhosts or to be pathogenic in hosts [6, 55]. hrp gene clusters have now been at least partially characterized in several other Gram-negative plant pathogens, including X. campestris pv. campestris (black rot of crucifer), X. campestris pv. vesicatoria (bacterial spot of pepper), R. solanacearum (Southern bacterial wilt of tomato), E. amylovora (fire blight of apple), Pantoea (Erwinia) stewartii (Stewart's wilt of com), E. chrysanthemi (soft rot), E. carotovora (soft rot), and Erwinia herbicola pv. gypsophilae (gypsophila gall) [56]. Thus, they appear to be universal among the necrogenic pathogens, although they are not essential for the virulence of the brute-force pathogens. They have not been reported for A. tumefaciens. hrp genes are always clustered and appear to be flanked by genes encoding Avr proteins, harpins, and other potential virulence factors in apparent pathogenicity islands [57-60]. In P. syringae and E. amylovora, the Hrp pathogenicity islands have integrase and tRNA sequences at one border [60a] (J. F. Kim and S. V. Beer, unpublished results), which is typical of pathogenicity islands [61, 62]. hrp genes encode the type III protein secretion pathway, and nine of the hrp genes have been renamed ''hrc'' (HR and conserved) to indicate that they encode conserved components that are also present in the type III secretion systems of Yersinia, Shigella, and Salmonella [63]. The hrc genes were given the last letter designation of their Yersinia ysc homolog. With the availability of more DNA sequences for comparison, it now appears that there are hrp homologs of yscD and yscL, and these can be conceptually included among the hrc genes [56], thus bringing the total to 11. Ten of these widely conserved genes have homologs involved in flagellum biogenesis and flagellar-specific secretion, whereas hrcC encodes a "secretin," an outer membrane protein with homologs involved in type II and filamentous phage secretion [64]. Secretins are thought to multimerize and form a channel through the outer membrane [65]. Thus, the hrc genes appear to
192
JAMES R . ALFANO AND ALAN COLLMER
Round
Wild relatives
Host
J
Cuitivar 0
"i
"2
Pothogen
Outcome
Disease
Race 0
"3"' Resistance
Race 0
Disease
Cuitivar 1
Race 1
Resistance
Cuitivar 2
Race 1
Disease
Cuitivar 2
Race 2
Fig. 3 Gene-for-gene interactions of plants and stealth parasites. Panel A depicts the gene-for-gene concept portrayed in terms of a "game" played between plant breeders and the parasite. Round 1 depicts a highly inbred cuitivar of a crop species being attacked by a stealth parasite (e.g.. P. syringae, X. campestris, a rust fungus, etc.) that presumably has many adaptations for parasitism, but the only relevant features depicted are two molecules, encoded by the avrl and avr2 genes, that have the potential to be recognized by the host. In round 1, however, the plant lacks the factor(s) needed to detect race 0, and disease ensues. In round 2. recognition of the parasite is achieved by introgressing into the crop a major resistance gene {R\) derived from a wild relative. The interaction between the products of/?i and avr\ betrays the parasite, and strong. HR-associated defenses are triggered. Thus, the introduction of a single gene into the plant produces a new. resistant cuitivar. In round 3, the wide planting of cuitivar 1 has put strong selection pressure on the emergence of a new race of the parasite that lacks a functional avr\. There may be a fitness cost to this avr loss, but it is often slight or undetectable. The R\ gene in cuitivar 1 has now been ""defeated." and the crop is susceptible to this new race. In round 4, the plant breeder introgresses a second R gene, which is effective against both races 1 and 0. The resultant cuitivar 2 is widely planted, which leads to round 5. when a new race arises that lacks avn_ function. The game can go on for many more rounds because stealth parasites appear to carry a great number oi avr genes and wild relatives of the crop (typically in the geographic origin of the crop where complex host and parasite populations are in equilibrium) have a similarly large supply of/? genes.
5.
193
BACTERIAL PLANT PATHOGENS
B.
HR Test cultivar
Avirulent donor race
D" [ «
Test cultivar
Virulent recipient race Cosmid library
\
Avirulent transconjugant
C.
Tomato {Pto)
m
Pepper (Bs3j
P. syringae pv. tomato
^\r
f< ovrBsS
^
X.campe8trls pv. voslcatorta
Fig. 3 (cont'd) Panel B depicts the universal strategy established by Staskawicz and Keen and their coworkers [53, 255, 270] for cloning bacterial ovr genes. The process requires a test cultivar that is resistant to the donor race and susceptible to the recipient race. A cosmid library of donor DNA is constructed in E. coli and then conjugated into the recipient race. Random transconjugants are inoculated into the test cultivar, and those that have acquired the avr gene are identified on the basis of their avirulence phenotype. That is, they elicit the HR instead of multiplying to high levels and causing disease. Note that the donor can also be another pathovar that is virulent in some other plant species and avirulent on all cultivars of the test species. Panel C clarifies the location of Avr-R protein interactions, which was schematically depicted at the spatial interface between the host and parasite in panels A and B, but for several bacterial Avr proteins appears to occur inside the plant cell. For example, as discussed in the text, there is convincing evidence that recognition of AvrPto and AvrBs3 occurs in the plant cytoplasm and nucleus, respectively.
194
JAMES R. ALFANO AND ALAN COLLMER
have been recruited from two different protein secretion systems and to direct the translocation of proteins across the bacterial envelope. The Hrp systems of plant pathogens have been exploited to advance our understanding of some universal type III secretion system functions. For example, the Yersinia pestis LcrD and Bacillus subtilis FlhA proteins, which are homologs of HrcV, were initially thought to be regulatory proteins [66, 67]. However, the unambiguous secretion phenotype of an E. amylovora hrcV mutant provided evidence for the function of this protein family in secretion [68]. Similarly, the HrcC protein of Z. campestris pv. vesicatoria was the first type III secretin shown to induce the phage shock protein operon in E. coli, thus providing evidence that it forms a multimeric channel in the outer membrane [69]. Also, the observation that P. syringae pv. syringae hrcC mutants accumulate HrpZ (a type Ill-secreted harpin protein discussed below) in the periplasm, whereas mutants deficient in hrcU or several other hrc genes accumulated HrpZ only in the cytoplasm, provided the first direct evidence that the flagellar homologs specifically directed secretion across the inner membrane in a ^^c-independent manner [70]. The primary function of the type III protein secretion system is to deliver effector proteins into host cells (as will be discussed below). Thus, there are likely to be additional components of Hrp systems that function outside of the bacterial cell to enable effector proteins to cross the plant cell wall and plasma membrane. These components may be quite different between plant and animal pathogens because of the fundamental differences in the surfaces of the host cells. The hrp gene clusters of various plant pathogens can be divided into two groups based on protein similarities, gene arrangements, and regulatory components (discussed below) [71]. The hrp clusters oiR syringae and Erwinia spp. are in group I, those of X. campestris and R. solanacearum are in group II. Interestingly, the 11 /zrc-class genes are the only genes that are obviously conserved between the two groups. Although this may reflect the fact that extracellular components of the type III secretion system are more variable than those contained within the bacterial envelope [72], it is also possible that there are significant differences in the way these two groups of pathogens translocate proteins across the host cell wall.
D.
Harpins and Pilins: Proteins Secreted in Culture in Abundance by the Hrp System
It is important to note at the outset that there are conceptual discrepancies between the biological activities of isolated harpins and the phenotypes of harpin mutants, and this leaves the function of these proteins somewhat enigmatic. Harpins are defined as glycine-rich proteins that lack cysteine, are secreted by the Hrp system, and possess heat-stable HR elicitor activity when infiltrated into the intercellular spaces of leaves of tobacco and several other plants [19]. The first harpin was
5.
BACTERIAL PLANT PATHOGENS
195
discovered in culture supematants of an E. coli transformant strongly expressing a functional E. amylovora hrp cluster [73]. Mutations in the encoding hrpN gene in E. amylovora essentially abolished the ability of the bacterium to elicit the HR in nonhost tobacco or to be pathogenic in susceptible immature pear fruit [73]. That is, hrpN mutants had a strong Hrp phenotype. These observations suggested that the HrpN harpin protein was the long sought bacterial elicitor of the HR. Genes encoding proteins with similar properties were subsequently found in R syringae [74, 75], R. solanacearum [76], E. chrysanthemi [77], and other plant pathogens, including the highly virulent strain CFBP1430 of £". amylovora [78]. No significant sequence similarity was found between the harpin genes in different bacterial genera, although the encoded proteins all had the properties that defined them as harpins (the PopA protein of R. solanacearum is unique in selectively triggering the HR in plants in which the bacterium is avirulent). Unexpectedly, with the exception of E. chrysanthemi, harpin gene mutations had little or no effect on the ability of the bacteria to elicit the HR. These observations suggested that harpins are not generally responsible for bacterial HR elicitation or that each bacterium has redundant harpin genes. Observations with the HrpZ harpin for P. syringae pv. syringae highlight the puzzling nature of harpins. The hrpZ gene is conserved in divergent P. syringae pathovars [75], and the isolated protein elicits an apparent programmed cell death in plants that is indistinguishable from the HR elicited by living bacteria [74]. Furthermore, a functional cluster of cloned R syringae pv. syringae hrp genes is greatly reduced in its ability to direct HR elicitation in E. coli when hrpZ is deleted [79]. However, mutation of hrmA [80, 81], which is in a variable region flanking the conserved hrp cluster in the cloned genes, has the paradoxical effect of abolishing the ability of this heterologous system to direct HR elicitation in tobacco without diminishing HrpZ synthesis or secretion [79]. Thus, isolated HrpZ is sufficient to elicit an HR in tobacco leaves, but HrpZ produced by bacteria in plants is not. hrmA has several properties of an avr gene (explained in Fig. 3 and below) that interacts with an unknown R gene in tobacco [82], and these observations suggest that the HrmA protein is the actual elicitor of the HR in this particular system and that HrpZ has a secondary or supporting activity in HR elicitation. Genes encoding HrpW, a second harpin, have recently been found near the hrp gene clusters of E. amylovora and P. syringae [59, 60]. In both bacteria, the N-terminal half of HrpW has general characteristics of harpins, whereas the C-terminal half is homologous to a newly defined class of pectate lyases found in fungal and bacterial plant pathogens. The harpin domain has elicitor activity, but neither the whole protein nor the pectate lyase domain possesses detectable pectolytic activity. As will be discussed in a later section, pectate lyases are major virulence factors in the brute-force pathogenesis of soft-rot Erwinia spp. because they efficiendy destroy plant cell wall structure. Furthermore, the a-l,4-linked galacturonide (pectic) polymers they attack are thought to control the porosity of plant cell walls [1]. Thus, it is intriguing that the R syringae pv. syringae HrpW pectate lyase domain binds specifically to calcium pectate [60]. The R syringae
196
JAMES R. ALFANO AND ALAN COLLMER
HrpZ harpin binds to plant cell walls and has biological activity only with walled cells [83]. Thus, the current evidence points to plant cell walls as the site of harpin activity, but the function of these proteins remains a puzzle. One of the most abundant proteins secreted by the P. syringae Hrp system in culture is the HrpA pilin [84, 85]. HrpA is the subunit of a pilus that is formed on bacteria in an Hrp-dependent manner and is required for pathogenicity and elicitation of the HR. The Hrp pilus is 6-8 nm in diameter, and thus similar to the pilus required by A. tumefaciens for T-DNA transfer [85, 86]. E. Avr Proteins as Injected, Interchangeable Effectors of Parasitism Avr proteins are so named because of the avirulence phenotype they can confer to pathogenic bacteria, as depicted in Figure 3A. Over 30 bacterial avr genes have been cloned on the basis of this phenotype, as described in Figure 3B [87, 88]. Unlike harpins, no bacterial Avr protein has shown HR elicitor activity when infiltrated into the intercellular spaces of test plant leaves. There are several lines of evidence that typical Avr proteins act inside plant cells following injection by the Hrp system. These lines of evidence also highlight several experimental tools that are unique to plant pathosystems: (1) Cloned hrp gene clusters functioning heterologously in nonpathogenic bacteria, like E. coli, can direct elicitation of an <3vr-/?-dependent HR if the appropriate avr gene is expressed in the bacterium and the set ofhrplhrc genes is intact [89, 90]. That is, the type III secretion system is both sufficient and necessary for bacterial delivery of Avr signals, even though the Avr proteins typically do not appear to be secreted to the bacterial milieu, and the proteins do not have elicitor activity when exogenously delivered to the surface of plant cells (which argues by default for targets in the plant cell interior). (2) Similarly, avr genes can trigger an R gene-dependent HR if expressed inside plant cells following delivery by biolistics or A. tumefaciens-mtdxdiitd transformation or transient expression systems [90-94]. (3) The R gene products expected to interact with known bacterial Avr proteins are predicted to reside in the plant cytoplasm [54]. (4) The bacterial AvrPto and the plant Pto proteins interact in the yeast 2-hybrid system, and mutations that affect this physical interaction also affect biological activity [91, 92]. (5) The AvrBs3 protein and homologs carry nuclear localization signals, AvrBs3 is localized to the plant nucleus in transient expression assays, and these targeting signals (or heterologous replacements) are required for HR elicitation [94, 95]. However, transfer of an Avr protein from a bacterium to a plant cell has not been observed directly, and it is likely that relatively small amounts of Avr proteins are actually transferred into host cells. These observations suggest that the central event in the pathogenesis of the stealth necrogenic bacteria is the Hrp-mediated delivery of Avr proteins into plant cells, as depicted in Figure 4. That is, the primary function of Avr proteins is in virulence, even though their avirulence activity is epistatic in plants carrying a cognate R gene. There are two main lines of evidence that Avr proteins (meaning injected effector proteins; an alternative term, ''Hop," for Hrp-dependent outer protein, has also been proposed [71]) are important to parasitism. First, mutations
5.
197
BACTERIAL PLANT PATHOGENS
Hypervarlabia rtgion wttfn B¥rgenes Conserved hrp/hrc cluster Conserve<J reglop with avr and harpin genes
HrpW Jk HrpZ HutrmntB pH Increiss Water
- ^ \ X Type ill 0«r^ apparatus
Avr proteins
Hrc/Hrp
o Reactive oxygen intermecilates Cell wall fortification Antimicrobial peptideslprot#lns Phytoaleiclns
^^M^^M^^^^^^^^M^^WPW^^WM^^ff
Avr proteins
PARASITISM Avr proteins collectively promote parasitism by: ^suppressing defenses? -promoting nutrient release?
HR and DEFENSE Any Avr protein can betray pattiogen if appropriate R protein is present, thereby triggering strong defense
Fig. 4 Model of stealth, necrogenic pathogenesis based on Hrp (type III secretion)-mediated delivery of Avr-like proteins into plant cells, avr genes are shown in an Hrp pathogenicity island and on a plasmid, and are likely exchanged among plant pathogens via various mobile genetic elements. The machinery translocating Avr proteins into the host cytoplasm is shown in three parts, which direct translocation across the bacterial inner membrane (IM), outer membrane (OM), plant cell wall (CW), and plasma membrane (PM), although the process is likely continuous. Whether the HrpA pilus penetrates the plant cell wall and is a conduit for protein transfer is uncertain. The HrpZ and HrpW harpins are proposed to interact with the plant cell wall, possibly to foster Avr transfer, but this also is uncertain. Inside plant cells, the Avr proteins may collectively promote parasitism via interaction with unknown susceptibility targets. However, if any one of them is recognized by the /?-gene surveillance system, the HR is triggered and a panoply of defenses are mounted.
198
JAMES R. ALFANO AND ALAN COLLMER
in the Hrp secretion genes abolish the parasitic ability of pathogens like P. syringae, suggesting that injected proteins are collectively required for this ability. It is also possible that harpins and possibly other proteins secreted by the Hrp system operate outside of plant cells to direcdy promote parasidsm. Unfortunately, no mutant has been reported in a plant pathogen that allows secretion of harpins but not injection of Avr proteins. Such a mutant would permit testing of the relative contribution to virulence of "inside" and hypothetical "outside" (of the host cell) effector proteins. yopD mutants represent such a class in Yersinia [96]. Perhaps in plant pathogens the extracellular components are more integral to secretion across the bacterial envelope than they are in Yersinia. Regardless, our working hypothesis is that injected proteins are the primary effectors of parasitism, and all other proteins are secondary or support the delivery of these Avr-like proteins. The second line of evidence for the role of Avr proteins in parasitism is that approximately one-third of the avr mutants studied to date are quantitatively reduced in their ability to grow in planta or to produce full symptoms in susceptible plants [87]. For example, AvrBs2 homologs are widespread in the X campestris group, and avrBs2 mutants are significantiy reduced in their ability to grow in host tissues [97]. AvrBs3 homologs appear to be similarly widespread, and in X. campestris pv. malvacearum (angular leaf spot of cotton) multiple AvrBs3 homologs contribute quantitatively to the water-soaked lesions associated with the disease [98]. Experiments involving heterologous expression of avr genes inside plant cells suggest that Avr proteins can be deleterious even in the absence of a known cognate R gene if expressed too strongly [90, 99]. Whether this results from excessive interaction with susceptibility targets in the host is unknown. What Avr proteins do inside host cells to promote the growth of bacteria on the surface of the cell remains a puzzle. The known Avr proteins represent a menagerie with respect to sequence and physical properties, and comparisons with sequences in the databases generally have not been informative. Only one Avr protein has an observed biochemical activity: AvrD directs the synthesis of syringolides (low-molecular-weight C-glycosides) that elicit the HR in soybean in an /?pg4-dependent manner [102, 103]. One Avr protein has a sequence suggesting a biochemical activity: AvrBs2 shows similarity with agrocinopine synthase (opine production in tumors) of A. tumefaciens, which suggests a direct role in nutrition of the pathogen [101]. And one Avr protein, AvrRxv from X. campestris pv. vesicatoria, has a homolog among the effector proteins of animal pathogens, namely, YopJ/P of Yersinia and AvrA of Salmonella (discussed further below) [100]. Finally, members of the AvrBs3 family are unique in possessing 13.5-17.5 direct 34 amino-acid repeats that control Avr specificity, and, as discussed above, these proteins appear to function inside plant nuclei [87, 104, 105]. Studies of the localization of Avr proteins in P. syringae and X. campestris have failed to detect secretion out of the bacterial cytoplasm either in culture or in
5. BACTERIAL PLANT PATHOGENS
199
planta [106-108]. However, a cluster of hrplhrc genes from E. chrysanthemi, functioning heterologously in E. coli, can secrete the P. syringae AvrB and AvrPto proteins in culture and trigger an avr-dependent HR in appropriate test plants [109]. One interpretation is that Avr protein secretion is dependent on contact with host cells in P. syringae and X. campestris, but this regulation is less stringent in the Hrp system of the brute-force pathogen E. chrysanthemi. This heterologous secretion system opens new avenues for research. Genes encoding effector proteins traveling the Hrp pathway can now be screened on the basis of a protein secretion phenotype in culture without the need for test plants that happen to carry cognate R genes, and targeting signals in Avr proteins and putative plant signals triggering Avr secretion can now be explored more efficiently. The discovery of this system also suggests that a stage in brute-force pathogenesis involves the injection of Avr proteins into host cells and that avr genes can be swapped among diverse plant pathogenic bacteria without loss of the ability of their products to be substrates for the Hrp system. This observation is consistent with the previously reported functional conservation of the translocation machinery for virulence proteins of Yersinia, Salmonella, and Shigella [110]. One question raised by the broad specificity of type III secretion systems is whether animal and plant pathogens can reciprocally deliver heterologous effector proteins into their respective host cells. The E. amylovora dspE and P. syringae pv. tomato avrE genes provide a case study for the functional interchangeability of Avr-like genes between different genera of plant pathogenic bacteria [111]. dspE (disease specific; also known as dspA in strain CFBP1430) is required for E. amylovora to cause disease in pear and apple hosts but not to elicit the HR in nonhost tobacco (presumably because other avr products trigger defenses in tobacco) [111,112]. avrE, on the other hand, was found through its ability to confer avirulence to P. syringae pv. glycinea by the method depicted in Figure 3B [53]. avrE mutation partially reduces the parasitic fitness of one strain of P. syringae pv. tomato [113]. DspE and AvrE are homologs sharing 30% identity, and they appear to be functionally similar: expression of dspE in P. syringae pv. glycinea causes it to become avirulent on soybean, and avrE can restore at least partial virulence to an E. amylovora dspE mutant [111]. Whether the site of DspE and AvrE action is inside of plant cells is unknown. However, DspE does travel the type III pathway, as it is secreted in an Hrp-dependent manner by E. amylovora in culture [112, 114]. The targeting signals in Avr proteins appear to be recognized by the Hrp systems of diverse bacteria, which suggests that avr genes may be readily swapped among these bacteria. Indeed, there is growing evidence that avr genes are quite mobile. Many are carried on plasmids. Most of the known P. syringae avr genes are associated with mobile genetic elements or are linked to the hrp gene cluster in loci possessing different avr genes in different strains [58, 60a, 115]. Also, avr genes may be inactivated at a high frequency by insertion elements, thus permitting the pathogen to evade recognition by the host [87, 116].
200
JAMES R. ALFANO AND ALAN COLLMER
V, Necrogenic, Brute-Force Pathogens: Soft-Rotters Dependent on Type II Secretion of Pectic Enzymes These bacteria attack a wide range of plants, particularly those with fleshy tissues. Bacterial soft rot of potato tuber is a representative disease commonly encountered when a potato that looks healthy on the outside is squeezed and found to be liquefied, or macerated, inside. The soft-rot erwinias, E. carotovora and E. chrysanthemi, also cause systemic, persistent infections and vascular necroses in vegetatively propagated ornamental plants, such as African violet (Saintpaulia) and chrysanthemum [117]. The many diseases caused by these pathogens differ in three fundamental ways from those caused by the stealth pathogens in that pathogenesis is: (1) usually dependent on bruising, wetness, hypoxia, or other environmental conditions that compromise the host; (2) not determined by gene-for-gene interactions but rather by the quantitative balance of multiple pathogen and host factors; and (3) driven by pectic enzymes secreted by the pathogen (via the type II secretion pathway). Pectic enzymes are produced by many bacteria, including some human pathogens, like Yersinia pseudotuberculosis [118], but their involvement in virulence appears unique to plant pathogens [14]. Pectic enzymes cleave a-1,4galacturonosyl linkages in plant cell wall polymers by p-elimination (pectate or pectin lyases) or by hydrolysis (polygalacturonases) [14]. The primary (unlignified) walls of plants contain a variety of structural polysaccharides, including pectic polymers, hemicelluloses, and cellulose [119]. In dicots and some monocots, the pectic polymers are particularly important because they are both structurally critical and enzymatically accessible in both the cell wall and the middle lamella (which glues the walls together to form a tissue) [120, 121]. Application of a purified E. chrysanthemi pectate lyase to potato tuber tissue causes the middle lamellae to disintegrate and the cell walls to fail to retain turgid protoplasts [122]. That is, a single pectic enzyme can produce the major symptoms—tissue maceration and cell killing—that are characteristic of the disease. E. chrysanthemi secretes an arsenal of pectic enzymes that modify (two pectin methylesterases and a pectin acetyl esterase), nibble (exo-poly-a-D-galacturonosidase and exo-polygalacturonate lyase), and chop (one pectin lyase and at least eight pectate lyase isozymes) pectic polymers [14, 123-126]. Mutagenesis has revealed that none of these enzymes is essential for pathogenesis, although the pectate lyases with very alkaline isoelectric points are particularly active in maceration [14]. Also, mutations in individual pectate lyase pel genes have different effects on virulence in different hosts, which suggests that isozyme multiplicity contributes to the wide host range of these bacteria [127]. And, of course, mutations in the type II secretion pathway through which all of these enzymes pass (except for the SOS-inducible pectin lyase) virtually abolish virulence [14].
5.
BACTERIAL PLANT PATHOGENS
201
Pectic enzymes and their products can also elicit plant defenses. Specifically, oligogalacturonates that have between 10 and 15 galacturonosyl residues induce genes encoding the phenylpropanoid pathway and the synthesis of phytoalexins and PR proteins (but not the HR) [ 128]. These defense responses are also triggered by pectolytic culture fluids of E. carotovora, and are diminished by combinations of pectic enzymes that prevent the accumulation of elicitor-active oligomers [129-131]. E. chrysanthemi pectate lyase isozyme Pell is processed by E. chrysanthemi extracellular proteases to a smaller form that is highly active in eliciting necrosis and phytoalexin production [132]. Whether this defense elicitation is acting through enzyme products is uncertain. If tobacco seedlings are pretreated with low levels of pectic enzymes from soft-rot erwinias, they become resistant to subsequent attack by a variety of bacterial pathogens, so it appears that the soft-rotter's main weapon also has the potential to foil pathogenesis [129, 130, 133]. As will be discussed below, E. carotovora has a regulatory mechanism for apparently delaying pectic enzyme production until the bacterium has a "quorum" population that is able to overwhelm these host defenses.
W. other Virulence Factors of Gram-Negative Plant Pathiogens Compared witli Ttiose of Animal Pathiogens A. Attachment Factors: Important in Agrobacterium but Role Unclear in Necrogenic Pathogens A stage in bacterial pathogenesis of both plant and animals that would seem intuitively important is attachment to host cells, and the essential role of attachment factors in many animal pathogens has been extensively studied [134]. Factors involved in attaching to plant surfaces have also been investigated; they are considered essential for the virulence of Agrobacterium but not for the necrogenic pathogens [135]. In Agrobacterium, attachment to plant cells occurs in two steps. Initially, agrobacteria in the soil loosely bind to plant cells [136]. Afterward, cellulose filaments are produced, resulting in a tight association with the plant cell [137]. The binding to the plant cell appears to involve specific receptors located on the plant cell surface because it is possible to saturate the number of bacteria that can bind. In animals, one component of the cellular matrix is vitronectin, and there are several examples of animal pathogens attaching to vitronectin or other components of the cellular matrix [138, 139]. Vitronectin-like proteins have been isolated from a number of plant species, and these proteins may act as receptors iov Agrobacterium [140]. Attachment of Agrobacterium to carrot cells is reduced in the presence of anti-vitronectin antibodies [141]. Several Agrobacterium mutants have been isolated that are reduced in their ability to attach to plant cells and are defective in their ability to synthesize or secrete cellulose, p-l,2-glucans.
202
JAMES R. ALFANO AND ALAN COLLMER
or acidic polysaccharides that are associated with the bacterial envelope or surface [142-145]. Another class of attachment-defective mutants involves proteins with homology to ABC transport systems [146]. Carrot cell binding is restored to these mutants by a conditioned medium in which wild-type bacteria and plant cells had been grown, suggesting that the defect is in secretion of a bacterial factor promoting attachment or in uptake of a plant signal [146]. Many plant pathogenic bacteria produce pili and fimbriae, but these appendages generally are not required for pathogenicity [135], and instead they appear to aid the attachment of bacterial cells to microniches on the epidermis during epiphytic growth. Pili are also produced by the type IV and type III secretion systems of plant pathogenic bacteria, and they have been shown to be essential for the virulence of A. tumefaciens and P. syringae, respectively, as discussed above [85, 86]. Since both of these secretion systems are capable of transferring macromolecules through the plant cell wall and plasma membrane, it is possible that these dedicated pili have a primary role as conduits rather than as attachment factors. B. EPS: A Special Role in Wilt Diseases of Plants Many bacterial species, including pathogens of animals and plants, can produce copious amounts of exopolysaccharides (EPSs) as secreted capsular material or as a loose slime. In animal pathogens, capsular material is thought to help the pathogen evade the inflammatory response of the host [147], and EPSs may help the pathogen colonize certain niches in the animal. For example, alginate made by P. aeruginosa has been implicated in the ability of the bacterium to persist in the lungs of patients suffering from cystic fibrosis [148]. In plant pathogens, EPS acts as a virulence factor in those pathogens that produce wilt and extensive water-soaking symptoms, although it is generally not absolutely required for pathogenesis [149]. The regulation and biosynthesis of EPS has been most extensively studied in the plant pathogens R. solanacearum [150, 151], £". amylovora [152, 153], P. stewartii [154], and X. campestris [155, 156]. EPS is thought to act in pathogenesis by restricting water flow in the xylem (causing the plant to wilt), producing a hydrophilic gel in leaf intercellular spaces (promoting water-soaking), or by altering the accessibility of antimicrobial compounds and defense-related signals [149]. Since EPS is also made by nonpathogens, it is important to note that these compounds may have a role in protection against general environmental stresses (e.g., desiccation) away from the host. C. Toxins: Some Similarities, but Differently Defined Unlike bacterial exotoxins of animal pathogens, which often appear central to pathogenicity, toxins of plant pathogenic bacteria (phytotoxins) generally function as supporting virulence factors [134, 157]. Most of the known phytotoxins from Gram-negative plant pathogens have been discovered in different P syringae
5. BACTERIAL PLANT PATHOGENS
203
pathovars. These are secondary metabolites that show no host specificity, typically do not contribute to bacterial multiplication, and are highly diffusible in plant tissue [157]. Bacterial phytotoxins can be broadly classified into two groups based on the type of symptoms they cause: necrosis-inducing toxins that kill plant cells and produce necrotic lesions, and chlorosis-inducing toxins, which cause yellowing of plant tissue, usually due to the destruction of chloroplasts. The actual role of phytotoxins in pathogenesis is somewhat unclear. Toxins are produced in nonpathogenic strains [158], and R syringae pathogenic strains that have spontaneously deleted tabtoxin biosynthetic genes retain pathogenicity [3]. Furthermore, many toxins have antimicrobial activity, which suggests that their primary targets may be other plant-associated microorganisms [157]. However, several phytotoxins appear to affect signaling processes within plant cells, which suggests that their targets are in the host. For example, the related necrosis-inducing toxins syringomycin and syringopeptin have pore-forming activity in membrane bilayers and cause rapid ion fluxes across membranes [159-161]. It is postulated that by permitting Ca^"*^ influx into plant cells these toxins activate various cellular signahng pathways [161], and, indeed, syringomycin induces kinase-mediated phosphorylation of plant proteins [162]. In their pore-forming activity, the syringomycin-like phytotoxins are functionally similar to a large group of exotoxins from animal pathogens that range from iturins, which are small peptides, to the RTX toxins, which are larger proteins [163-166]. The syringomycin-like phytotoxins appear to cause similar host cell responses in plant cells [160, 161]. Moreover, syringomycin, like many RTX toxins, is secreted via a type I secretion pathway [167]. Whereas all phytotoxins are secondary metabolites (mostly small peptides), many animal pathogen exotoxins are proteins, which may be grouped as A-B enzyme toxins, pore-forming toxins that disrupt membranes, proteolytic toxins that block the vertebrate central nervous system, or a number of other toxins that do not fit in any of these groups [134]. Some of the proteins that are delivered to animal cells via type III systems are considered A-B exotoxins [168, 169], and it will be interesting to see if a more complete inventory of proteins traveling the type III pathway in plant pathogens includes any homologs of these proteins.
D.
Iron Uptake Mechanisms: Common Strategies for Overcoming a General Eukaryote Defense
Iron presents two potential threats to pathogens of both plants and animals. On the one hand, the levels of iron not sequestered by the host are usually too low to support the essential iron needs of the invading bacterium. On the other hand, free iron can catalyze the production of highly reactive hydroxide radicals that may enhance localized, oxidative defenses mounted by the host. Microbial iron uptake systems may ameliorate both problems, and siderophore systems are prevalent in
204
JAMES R. ALFANO AND ALAN COLLMER
pathogens of both plants and animals [ 170, 171]. The role of siderophores in plant pathogenesis has been extensively explored in E. chrysanthemi 3937, particularly in the context of the ability of the bacterium to systemically invade African violet plants by moving through the vascular system [170]. E. chrysanthemi produces two siderophores, the catechol-type chrysobactin and achromobactin (which lacks both catechol and hydroxamate). The former is expressed in the plant and is important for systemic invasion but not localized maceration; the latter is expressed at high basal levels in the presence of mineral iron [172-174]. Plants do not produce transferrin-like proteins, but polyphenols possessing multiple 6>-dihydroxyphenyl groups may contribute to the nutritionally restrictive levels of free iron observed in plant fluids [172, 175]. Interestingly, chrysobactin is produced in such high levels in infected plants that it appears to reduce the amount of iron available to host cells [172].
E.
Resistance to Host Antimicrobial Peptides: Related Mechanisms Underlying Bacterial Virulence in Mouse and Potato
Antimicrobial peptides are effectors of innate immunity in vertebrates and insects [176]. Plants also produce several classes of antimicrobial peptides, including thionins, defensins, and lipid transfer proteins, all of which contain 4, 6, or 8 cysteines [177]. Plant antimicrobial peptides are constitutively abundant in many storage organs and are induced in other tissues upon pathogen attack. At the subcellular level, they accumulate in either the vacuole or the intercellular spaces between plant cells [177]. Transgenic overexpression in tobacco of barley genes encoding either an a-thionin or a lipid transfer protein resulted in plants with increased resistance to P. synngae pv. tabaci (wild-fire of tobacco), which suggests that these two antimicrobial peptides may have a role in plant defense against bacteria [178, 179]. This notion is further supported by the observation that R. solanaceamm mutants with altered LPS structures lose resistance to these two antimicrobial peptides and virulence to the same degree [180]. There is growing evidence that mechanisms enabling pathogens to resist antimicrobial peptides are widely important for bacterial virulence [181]. For example, in S. typhimurium, the sapA-F (sensitivity to antimicrobial peptides) operon confers resistance to the antimicrobial peptides protamine and melittin, and sap mutants lose this resistance and virulence in a mouse model [182, 183]. Because of the similarities of SapA to solute-binding proteins and other Sap proteins to ABC transporters, the Sap system was proposed to act by transporting antimicrobial peptides away from membrane targets and into the bacterial cell, possibly for degradation [183]. E. chrysanthemi also carries the sapA-F operon, which confers resistance to snakin-1 and a-thionin, two antimicrobial peptides found in potato, and a sap mutant has reduced virulence in potato tuber tissue [184]. The sap operons in the two bacteria are colinear in arrangement, and their
5. BACTERIAL PLANT PATHOGENS
205
products share between 69 and 78% sequence identity [184]. Thus, although adapted for the antimicrobial peptides of their respective hosts, homologous Sap systems are required for the virulence of bacteria attacking different kingdoms.
F.
Regulation of Virulence: A Potpourri of Common Components, Strategies, and Signals
The regulation of virulence factors in plant pathogens is mediated by proteins that belong to many of the same families that regulate virulence and other bacterial functions in animal pathogens [185, 186]. For example, HrpL is a member of the ECF (extracytoplasmic factor) family of sigma factors and activates the transcription of hrp genes in the group I Hrp systems of P. syringae and E. amylovora [187-189]. The expression of hrpL is dependent on two regulatory proteins, HrpR and HrpS, that have similarity with known a^'^-dependent promoter-enhancerbinding proteins [187, 190, 191]. In addition, the Hrp system of R syringae is negatively regulated by HrpV, which has no known homologs, and appears to act upstream of HrpR/S in the regulatory hierarchy [192]. In contrast to the group I Hrp systems, a homolog of the AraC family of positive activators is required to activate the group II Hrp systems of X. campestris and R. solanaceamm [193195]. Two upstream activators have been identified for these systems: HrpG in X. campestris is homologous to two-component response regulators [196], and PrhA shows homology to several TonB-dependent outer membrane siderophore receptors (although it is not regulated by iron levels), and is further noteworthy in being specifically required for induction of hrp genes in the presence of plant cells [197]. Virulence in plant pathogens, as in animal pathogens, is controlled by complex regulatory networks. For example, the battery of pectic enzymes produced by E. chrysanthemi is controlled by a regulatory system that involves at least three regulatory proteins (KdgR, PecS, and PecT) responding to a plethora of environmental cues (reviewed in [123]). In E. carotovora, both pectic enzyme and hrp gene transcripts are regulated at the level of mRNA stability by the RsmA/B system [198]. In R. solanacearum, the production of EPS and several extracellular virulence proteins is controlled by a hierarchy of regulatory proteins that involves at least three two-component regulatory systems, an LysR-type transcriptional regulator, and a volatile factor that may function analogously to an autoinducer [199-201]. The expression of virulence in X. campestris pv. campestris is also dependent on a diffusible signal molecule, but this factor is distinct from the R. solanacearum volatile factor and the E. carotovora acyl-homoserine lactone autoinducer, which is discussed below [202]. Plant and animal pathogens also share several global regulators of virulence. For example, in P. syringae, the LemA/GacA two-component regulatory system controls the production of syringomycin, tabtoxin, protease activity, and, in
206
JAMES R. ALFANO AND ALAN COLLMER
certain pathovars, lesion formation. The GacA protein is also required for P. aeruginosa virulence in mouse [203-205]. The sigma factor RpoS, which is involved in regulation of many genes during stationary phase, also is required for expression of virulence genes in both Salmonella spp. and E. carotovora [206208]. Cyclic-AMP receptor protein (CRP) homologs are required for the virulence of X. campestris, E. chrysanthemi, and P. aeruginosa [209-211]. And, finally, many different bacteria monitor their population density with a quorum-sensing regulation (LuxR-LuxI type) system based on production of a diffusible acyl-homoserine lactone autoinducer [212, 213]. Long thought to be limited to Photobacterium (Vibrio) fischeri, this system was subsequendy found in the pathogens E. carotovora and P aeruginosa, and then in a variety of other bacteria [214-217]. It is postulated that the production of pectic enzymes by E. carotovora occurs only when the bacterial population in the infection site is high enough to permit the destructive effects of the enzymes to overpower their side-effects of eliciting host defenses [216, 217]. Although regulatory systems based on diffusible signals appear important to the virulence of many plant pathogens, the signals and circuitry vary. For example, the LuxR homolog (EsaR) in P stewartii is unusual in acting as a negative regulator that is inactivated by the autoinducer [218], and, although E. chrysanthemi has homologs of Luxl and LuxR, neither is required for pectic enzyme production or virulence [219]. Environmental signals such as temperature, iron availability, nitrogen, and pH are also important signals for pathogenicity in both plant and animal pathogens [220-223].
VIL Host Innate Immune Systems: Common Components in Pattiogen Recognition and Defense Signaling The receptor-based plant surveillance system, consisting in part of resistance (R) gene products, represents an ancient defense mechanism that appears related to innate immune systems in vertebrates and insects [54, 224, 225]. For example, the tobacco A^ gene, an R gene conferring resistance to tobacco mosaic virus, encodes a protein with a domain that is similar to the Drosophila Toll protein and the mammalian interleukin-1 (IL-1) receptor [226, 227]. The TIR (Joll-IL-l region) domain is likely involved in downstream defense-signaling events. In tobacco plants resistant to TM V, the N protein recognizes a TM V Avr determinant, the TMV replicase protein [228], thereby triggering the HR [225]. In adult Drosophila, the pathway initiated by Toll results in production of the antifungal peptide drosomycin [229]. In mammals, the IL-1 receptor is activated by IL-1 and initiates a signaling cascade that results in the Rel-related transcriptional activator NF-KB being transported to the nucleus, where it activates transcription of many genes encoding acute phase and proinflammatory proteins [230]. Several additional human receptors with Toll homology have been identified [231], and one
5. BACTERIAL PLANT PATHOGENS
207
has been shown to activate production of antimicrobial peptides and cytokines, thereby also implicating it in stimulation of acquired immunity [232]. Among the limited set of R proteins characterized so far, those containing the TIR domain confer resistance against fungi (and TMV) but not bacteria [54]. Also, there are at least three genetically distinguishable signaling pathways downstream of different R genes [233-234]. However, there does not appear to be a set of R proteins or defense responses dedicated to any class of pathogens. The cloned R genes that recognize bacterial pathogens fall into three classes. The tomato Pto gene encodes a serine/threonine kinase [235]. The RPS2 and RPMl genes from Arabidopsis encode intracellular proteins that, like the N protein (and many R proteins), possess an internal nucleotide-binding site (NBS) and a leucine-rich repeat (LRR) domain; but, unlike the N protein, they have a leucine zipper instead of a TIR domain near the N terminus [236, 237]. The rice Xa-21 gene encodes a putative membrane-spanning protein with an extracellular LRR domain and a cytoplasmic kinase domain [238]. Interacting avr genes have been identified for all of these R genes except Xa-21. There are several additional indications of the similarity of the innate immune systems of plants, insects, and mammals. (1) The tomato Pto kinase and the rice Xa21 kinase have similarity to kinases involved in innate immunity pathways in insects {Drosophila pelle kinase) and mammals (human IRAK kinase) [235, 238-240]. (2) The NPRl/NIMl protein, which acts downstream of at least some R genes in Arabidopsis, contains ankyrin repeats and other regions similar to those in the IKB and Cactus proteins from mammals and Drosophila, respectively [241, 242]. These proteins inhibit the Rel-related transcription factors NF-KB and Dorsal present in their respective systems. The similarities between NPRl/NIMl, IKB, and Cactus suggest that NPRl/NIMl may be acting in a similar way in plants. (3) In plants, reactive oxygen species function in defense signaling, wall fortification, and possibly in pathogen killing, and they are generated by an NADPH oxidase similar to that in neutrophils [42]: both NADPH oxidases are inhibited by diphenylene iodonium [243], antibodies to the neutrophil p47 and p67 proteins crossreact with plant proteins of the same size [244], and plant homologs of the gp91P*^°^ subunit gene have been identified [245, 246]. (4) Similarly, as in animals [247], nitric oxide is involved in redox-mediated defense gene induction, with cyclic GMP and cyclic ADP-ribose apparently functioning as second messengers [248, 249].
VIIL The R Gene Surveillance System: An Innate Immune System with Elaborate Recognition Specificity The ability of the plant R gene surveillance system to specifically recognize a vast array of subspecific groups (e.g., pathovars and races) among potential pathogens distinguishes it from the innate immune system of animals. That is, in addition to the system that recognizes general features of bacteria and their activities in the
208
JAMES R. ALFANO AND ALAN COLLMER
cell wall (e.g., LPS and pectic fragments), plants have evolved a more elaborate germline-encoded system that recognizes specific virulence proteins of pathogens. This second recognition system bears resemblance to the adaptive immune system in vertebrates in its specificity and strong responsiveness. However, there appear to be three fundamental differences in the development of pathogen recognition by the R gene surveillance and adaptive immune systems: (1) In plants, the reservoir for recognitional capacity resides in the germlines of different individuals in complex populations, not in somatically varying cells (lymphocytes) within a given individual. (2) In vertebrates, recognition of a pathogen by the adaptive immune system appears to be dependent on costimulatory instruction by the innate immune system [224, 250], whereas the selective advantage of defensive recognition of individual parasite proteins appears sufficient to drive the evolution of R genes. (3) In vertebrates, recognitional diversity is generated by somatic gene rearrangement, whereas in plants it is generated typically by meiotic recombination involving R genes in complex loci. Although some R genes are found in simple loci or in allelic series, most exist in complex loci containing tandemly repeated members of R gene families, with plant genomes containing many of these loci [54]. This arrangement of R genes fosters duplications, deletions, and sequence exchanges, with polymorphism in intergenic regions suppressing sequence homogenization among members [251, 252]. Furthermore, comparisons of the sequences of tomato Cf genes and homologs, which are R genes conferring resistance to the fungus Cladosporium fulvum, reveal that solvent-exposed residues in LRR domains are hypervariable, suggesting a role in recognition specificity [251 ]. The finding of more nonsynonymous than synonymous nucleotide substitutions in the LRR domains of rice Xa21 homologs further supports the concept that these domains are subject to adaptive selection for pathogen recognition [253]. The possibility that animals also have an R gene surveillance system, such that naive individuals can specifically recognize a parasite protein and trigger defenses, has been raised by Galan in a provocative commentary addressing the homology between the X. campestris pv. vesicatoria AvrRxv, Yersinia spp. YopJ/P, and Salmonella enterica AvrA proteins [254]. The R gene that corresponds to avrRxv has not yet been isolated; however, AvrRxv induces an HR on resistant plants that is likely due to an R gene interaction, as indicated by cultivar-differential effects [255]. YopJ/P induces apoptosis in macrophage cell lines [256, 257], which raises the possibility that this is mediated by an R protein analog in mammalian cells. There are additional similarities between these proteins: (1) they are dispensable for virulence; (2) the sporadic distribution oiavrA resembles that of many avr genes in plant pathogens [100]; and (3) AvrA, YopJ/P, and probably AvrRxv are secreted via the type III system [100, 256, 257]. IpaB, which is secreted via the type III system of Shigella flexneri, also induces apoptosis in macrophages [258, 259]. Unlike the HR in plants, which is clearly a defense response, the function of programmed cell death of macrophages in response to these proteins is uncertain. In one scenario, apoptotic macrophages release IL-1,
5. BACTERIAL PLANT PATHOGENS
209
which induces a proinflammatory response as part of a defense. Alternatively, the removal of bactericidal cells, which results in inflammation-induced tissue damage, could promote further bacterial invasion [258]. Comparative investigations of the innate immune systems of plants and animals will help resolve these questions.
IX. Pseudomonas aeruginosa; Dual-Kingdom Pathogenesis The numerous similarities between plant and animal pathogens described in the preceding sections invite the question of whether some bacteria can attack both plants and animals. The potential hazard of several plant-associated bacteria to immunodeficient or otherwise compromised human patients has long been known [260]. Burkholderia {Pseudomonas) cepacia and P. aeruginosa present two important examples of dual-kingdom pathogens, and each yields different lessons. B. cepacia causes sour skin of onion, a rot of the outer, fleshy scales of the bulb [261], and it is also a prevalent pathogen of the human respiratory tract, particularly in patients with cystic fibrosis [148]. Bacteria classified as B. cepacia are remarkably diverse in their genome size and metabolic abilities, and some strains proliferate in the rhizosphere around plant roots and suppress fungal diseases. These strains are being exploited as biological control antagonists (see, e.g., [262]). However, because of the apparently extreme plasticity of the B. cepacia genome and the uncertain taxonomic distinction between "environmental" and "clinical" isolates, the wisdom of such agricultural use of ^. cepacia is now being debated [263, 264]. In contrast, P. aeruginosa UCBPP-PA14 provides an example of a single bacterial strain that has been established to cause disease in both plant (Arabidopsis and lettuce) and animal (mouse) models, and it is being used to find novel virulence factors [205, 265]. P. aeruginosa has been described as a "quasi-pathogen" of plants [266], and as the "quintessential opportunist" pathogen of humans [147]. Nevertheless, strain UCBPP-PA14 causes soft-rotting in leaves of the model plant Arabidopsis in an ecotype-specific manner (a characteristic of many true pathogens), and it causes a high level of mortality in a mouse full-thickness thermal burn assay [205]. Furthermore, experiments with strain UCBPP-PA14 are yielding important insights into P aeruginosa virulence mechanisms in both hosts. Directed mutations in the toxA, plcS, and gacA genes, which were previously implicated in bacterial virulence in one of the hosts, revealed these factors to be essential for virulence in both hosts [205]. Subsequently, a collection of mutants (ca. 25% genome saturation) carrying random TnphoA insertions was screened in the plant (lettuce) assay system for loss of virulence, thereby yielding
210
JAMES R. ALFANO AND ALAN COLLMER
dsbA and seven novel genes that are also needed for virulence in the animal model [265]. Thus, both individual effectors (exotoxin A and phospholipase C) and global regulatory or putative deployment factors (GacA two-component responseregulator and DsbA disulfide bond oxidoreductase) are important in both hosts, and the available (but still incomplete) genetic evidence suggests that the mechanisms for virulence in the two host kingdoms are congruent. Finally, the basic validity of this system is supported by the finding that homologs of both GacA and DsbA are required for the virulence of highly virulent, dedicated pathogens of each host kingdom [265].
X. Conclusions Gram-negative bacteria have evolved at least three distinct strategies for parasitizing plants. The Agrobacterium strategy of transforming the host has no known counterpart among animal pathogenic bacteria. In contrast, similarities are extensive between plant and animal "stealth and interdiction" [267] pathogens like P. syringae and K enterocolitica, which inject major virulence proteins into their hosts via the type III pathway, and they are similarly extensive for brute-force pathogens like E. carotovora and P. aeruginosa, which secrete tissue-degrading enzymes via the type II pathway on achieving quorum populations for attacking their hosts. Similarly, plant defense and innate immunity systems in animals have a growing list of homologous components. These similarities are not surprising. For example, a system that injects virulence proteins into host cells and is encoded by horizontally transferred pathogenicity islands would be expected to support the evolution, "by quantum leaps" [61], of virulence in a wide range of bacterium-eukaryote pathosystems. Similarly, evolving multicellular eukaryotes would be expected to retain at least some ancient signaling components and defense factors like oxidative bursts and antimicrobial peptides. However, there are three unique features of plant pathosystems and the experimental approaches they afford that warrant highlighting. The first unique feature is the plant cell wall, which provides the common meeting ground for all plant-bacterium interactions. Wall fortification is the function of several of the most rapidly deployed plant defenses, and wall destruction is the main virulence strategy of the brute-force pathogens. The second unique feature is the /?-gene surveillance system, whose evolutionary elaboration appears to have driven an arms race involving avr-gene proliferation and exchange among the stealth pathogens. The third unique feature is the experimental advantages afforded by Arabidopsis and other plant genetic systems, the Agrobacterium transformation system, and a suite of tools that permits rapid and rigorous evaluation of disease factors in plant-bacterium pathosystems. For example, tens of thousands of Arabidopsis plants can easily be screened for mutants with altered susceptibility, and Agrobacterium-mtdisLied transient-expression and transformation systems allow facile screening for the effects of pathogen proteins inside plant cells [91,
5.
BACTERIAL PLANT PATHOGENS
211
92, 99, 268]. Similarly, plant pathogen-derived type III secretion cassettes, functioning in nonpathogens like E. coli, facilitate the study of naturally delivered, individual effector proteins [89, 90, 109]. If some of the many plant pathogen effector proteins are indeed suppressors of plant defense signaling pathways, they may provide novel tools for exploring innate immunity in general. The availability of well-developed experimental systems on both sides of the interaction makes plant-bacterium pathosystems ideal for exploring common defenses of multicellular eukaryotes and the virulence mechanisms bacteria use to overcome them.
Acknowledgments We thank Kent E. Loeffler for photography and Terrence P. Delaney and Jihyun F. Kim for critical review of portions of this manuscript before submission in December 1998. Work in the authors' laboratories was supported by grants MCB-9631530 (AC) from the National Science Foundation and 97-35303-4488 (AC) and 98-35303-6464 (JRA) from the National Research Initiative Competitive Grants Program, U.S. Department of Agriculture.
References 1. Baron-Epel, O., Gharyal, P. K., and Schindler, M. (1988). Pectins as mediators of wall porosity in soybean cells. Planta 175, 389-395. 2. Thrower, L. B. (1966). Terminology for plant parasites. Phytopathol. Z. 56, 258-259. 3. Willis, D. K., Barta, T. M., and Kinscherf, T. G. (1991). Genetics of toxin production and resistance in phytopathogenic bacteria. Experientia 47, 765-771. 4. Van den Mooter, M., and Swings, J. (1990). Numerical analysis of 295 phenotypic features of 266 Xanthomonas strains and related strains and an improved taxonomy of the genus. Int. J. Syst. Bacteriol 40, 348-369. 5. Klement, Z., Farkas, G. L., and Lovrekovich, L. (1964). Hypersensitive reaction induced by phytopathogenic bacteria in the tobacco leaf. Phytopathology 54, 474^77. 6. Lindgren, P. B., Peet, R. C , and Panopoulos, N. J. (1986). Gene cluster of Pseudomonas syringae pv. ''phaseolicola' controls pathogenicity of bean plants and hypersensitivity on nonhost plants. J. Bacteriol. 168, 512-522. 7. Baker, C. J., and Orlandi, E. W. (1995). Active oxygen in plant pathogenesis. Annu. Rev. Phytopathol. 33, 299-321. 8. Jakobek, J. L., Smith, J. A., and Lindgren, P. B. (1993). Suppression of bean defense responses by Pseudomonas syringae. Plant Cell 5, 57-63. 9. Bestwick, C. S., Bennett, M. H., and Mansfield, J. W. (1995). hrp mutant of Pseudomonas syringae pv. phaseolicola induces cell wall alterations but not membrane damage leading to the hypersensitive reaction in lettuce. Plant Physiol. 108, 503-516. 10. Graham, T. L., Sequeira, L., and Huang, T. R. (1977). Bacterial lipopolysaccharides as inducers of disease resistance in tobacco. Appl. Environ. Microbiol. 34, 424-32. 11. Barton-Willis, P A., Wang, M. C , Holliday, M. J., Long, M. R., and Keen, N. T. (1984). Purification and composition of lipopolysaccharides from Pseudomonas syringae pv. glycinea. Physiol. Plant Pathol. IS, 387-398. 12. Newman, M.-A., Daniels, M. J,, and Dow, J. M. (1995). Lipopolysaccharide from Xanthomonas campestris induces defense-related gene expression in Brassica campestris. Mol. Plant-Microbe Interact. 8, 778-780.
212
JAMES R. ALFANO AND ALAN COLLMER
13. Boiler, T., and Felix, G. (1996). Olfaction in plants: Specific perception of common microbial molecules. In "Biology of Plant-Microbe Interactions" (G. Stacey, B. Mullin, and P. M. Greshoff, eds.), pp. 1-8. ISMPMI, St. Paul. 14. Barras, F., Van Gijsegem, F., and Chatterjee, A. K. (1994). Extracellular enzymes and pathogenesis of soft-rot Erwinia. Anmi. Rev. Phytopathol. 32, 201-234. 15. Winans, S. C., Kalogeraki, V., Jafri, S., Akakura, R., and Xia, Q. (1999). Diverse roles of Agrobacterium Ti plasmid-encoded genes in the formation and colonization of plant tumors. In "Pathogenicity Islands" (J. B. Kaper and J. Hacker, eds.), pp. 289-308. ASM Press, Washington, DC. 16. Young, J. M. (1974). Development of bacterial populations in vivo in relation to plant pathogenicity. N.Z. J. Agric. Res. 17, 105-113. 17. Wells, J. M., and Butterfield, J. E. (1997). Salmonella contamination associated with bacterial soft rot of fresh fruits and vegetables in the marketplace. Plant Dis. 81, 867-872. 18. Jaquette, C. B., Beuchat, L. R., and Mahon, B. E. (1996). Efficacy of chlorine and heat treatment in killing Salmonella Stanley inoculated onto alfalfa seeds and growth and survival of the pathogen during sprouting and storage. Appl. Environ. Microbiol. 62, 2212-2215. 19. Alfano, J. R., and Collmer, A. (1996). Bacterial pathogens in plants: Life up against the wall. Plant Cell %, 1683-1698. 20. Comelis, G. R. (1997). Contact with eukaryotic cells: A new signal triggering bacterial gene expression. Trends Microbiol. 5, 43-45. 21. Pugsley, A. P. (1993). The complete general protein secretory pathway in gram-negative bacteria. Microbiol. Rev. SI, 50-108. 22. Lessl, M., and Lanka, E. (1994). Common mechanisms in bacterial conjugation and Ti-mediated T-DNA transfer to plant cells. Cell 11, 321-324. 23. Winans, S. C , Bums, D. L., and Christie, P. J. (1996). Adaptation of a conjugal transfer system for export of pathogen macromolecules. Trends Microbiol. 4, 64-68. 24. Sundberg, C , Meek, L., Carroll, K., Das, A., and Ream, W. (1996). VirEl protein mediates export of the single-stranded DNA-binding protein VirE2 from Agrobacterium tumefaciens into plant cells. J. Bacteriol. 178, 1207-1212. 25. Farizo, K. M., Cafarella, T. G., and Burns, D. L. (1996). Evidence for a ninth gene, /?///, in the locus encoding the pertussis toxin secretion system of Bordetella pertussis and formation of a Ptll-PdF complex. J. Biol. Chem. Ill, 31643-31649. 26. Weiss, A. A., Johnson, F. D., and Bums, D. L. (1993). Molecular characterization of an operon required for pertussis toxin secretion. Proc. Natl. Acad. Sci. U.S.A. 90, 2970-2974. 27. Salmond, G. P. C. (1994). Secretion of extracellular virulence factors by plant pathogenic bacteria. AA2«W. Rev. Phytopathol. 32, 181-200. 28. Zupan, J., and Zambryski, P. (1997). The Agrobacterium DNA transfer complex. Crit. Rev. Plant Sci. 16, 279-295. 29. Christie, P. J. (1997). Agrobacterium tumefaciens T-complex transport apparatus: A paradigm for a new family of multifunctional transporters in Eubacteria. J. Bacteriol. 179, 3085-3094. 30. Winans, S. C. (1992). Two-way chemical signaling in Agrobacterium-^\dini interactions. Microbiol. Mol Biol. Rev. 56, 12-31. 31. Wang, K., Stachel, S. E., Timmerman, B., Van Montagu, M., and Zambryski, P (1987). Site-specific nick occurs within the 25 bp transfer promoting border sequence following induction of vir gene expression in Agrobacteium tumefaciens. Science 235, 587-591. 32. Herrera-Estrella, A., Chen, Z., Van Montagu, M., and Wang, K. (1988). VirD proteins of Agrobacterium tumefaciens are required for the formation of a covalent DNA protein complex at the 5' terminus of T-strand molecules. EMBO J. 7, 4055^062.
5.
BACTERIAL PLANT PATHOGENS
213
33. Otten, L., De Greve, H., Leemans, J., Hain, R., Hooykaas, P., and Schell, J. (1984). Restoration of virulence of Vir region mutants of Agrobacterium tumefaciens strain B6S3 by coinfection with normal and mui?iX\i Agrobacterium strains. Mol. Gen. Genet. 195, 159-163. 34. Citovsky, V., Zupan, J., Wamick, D., and Zambryski, P. (1992). Nuclear localization of Agrobacterium VirE2 protein in plant cells. Science 256, 1802-1805. 35. Howard, E., Zupan, J., Citovsky, V., and Zambryski, P (1992). The VirD2 protein of A. tumefaciens contains a C-terminal bipartite nuclear localization signal: Implications for nuclear uptake of DNA in plant cells. Cell 68, 109-118. 36. Tummuru, M. K. R., Sharma, S. A., and Blaser, M. J. (1995). Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein. Mol. Microbiol. 18, 867-876. 37. Segal, G., and Shuman, H. A. (1997). Characterization of a new region required for macrophage killing by Legionella pneumophila. Infect. Immun. 65, 5057-5066. 38. Vogel, J. P, Andrews, H. L., Wong, S. K., and Isberg, R. R. (1998). Conjugative transfer by the virulence system of Legionella pneumophila. Science 279, 873-876. 39. Klement, Z. (1982). Hypersensitivity. In "Phytopathogenic Prokaryotes," Vol. 2 (M. S. Mount and G. H. Lacy, eds.), pp. 149-177. Academic Press, New York. 39a. Pennell, R. I., and Lamb, C. (1997). Programmed cell death in plants. Plant Cell 9, 1157-1168. 40. Turner, J. G., and Novacky, A. (1974). The quantitative relation between plant and bacterial cells involved in the hypersensitive reaction. Phytopathology 64, 885-890. 41. Yu, L C , Parker, J., and Bent, A. F. (1998). Gene-for-gene disease resistance without the hypersensitive response in Arabidopsis dndl mutant. Proc. Natl. Acad. Sci. U.S.A. 95, 7819-7824. 42. Lamb, C , and Dixon, R. A. (1997). The oxidative burst in plant disease resistance. Annu. Rev. Plant Physiol. Mol. Biol. 48, 251-275. 43. Bestwick, C. S., Brown, L R., Bennett, M. H. R., and Mansfield, J. W. (1997). Localization of hydrogen peroxide accumulation during the hypersensitive reaction of lettuce cells to Pseudomonas syringae pv phaseolicola. Plant Cell 9, 209-221. 44. Bradley, D. J., Kjelvom, P., and Lamb, C. J. (1992). Elicitor- and wound-induced oxidative cross-linking of a proline-rich plant cell wall protein: A novel, rapid defense response. Cell 70, 21-30. 45. Nicholson, R. L., and Hammerschmidt, R. (1992). Phenolic compounds and their role in disease resistance. Annu. Rev. Phytopathol. 30, 369-389. 46. Brown, I., Trethowan, J., Kerry, M., Mansfield, J., and Bolwell, G. P. (1998). Localization of components of the oxidative cross-linking of glycoproteins and of callose synthesis in papillae formed during the interaction between non-pathogenic strains of Xanthomonas campestris and French bean mesophyll cells. Plant J. 15, 333-343. 47. Young, S. A., Wang, X., and Leach, J. E. (1996). Changes in the plasma membrane distribution of rice phospholipase D during resistant interactions with Xanthomonas oryzae pv oryzae. Plant Cells, 1079-1090. 48. Smith, C. J. (1998). Accumulation of phytoalexins: Defense mechanism and stimulus response system. New Phytol. 132, 1-45. 49. Ryals, J. L., Neuenschwander, U. H., Willits, M. C , Molina, A., Steiner, H.-Y, and Hunt, M. D. (1996). Systemic acquired resistance. Plant Cell 8, 1809-1819. 50. Delaney, T. P. (1997). Genetic dissection of acquired resistance to disease. Plant Physiol. 113, 5-12. 51. Dong, X. (1998). SA, JA, ethylene, and disease resistance in plants. Curr Opin. Plant Biol. 1, 316-323.
214
JAMES R. ALFANO AND ALAN COLLMER
52. Keen, N. T. (1990). Gene-for-gene complementarity in plant-pathogen interactions. Annu. Rev. Genet. 24, 447^63. 53. Kobayashi, D. Y., Tamaki, S. J., and Keen, N. T. (1989). Cloned avirulence genes from the tomato pathogen Pseudomonas syringae pv. tomato confer cultivar specificity on soybean. Proc. Natl. Acad. Sci. U.S.A. 86, 157-161. 54. Hammond-Kosack, K. E., and Jones, J. D. G. (1997). Plant disease resistance genes. Annu. Rev. Plant Physiol. Mol. Biol. 48, 575-607. 55. Niepold, F., Anderson, D., and Mills, D. (1985). Cloning determinants of pathogenesis from Pseudomonas syringae pathovar syringae. Proc. Natl. Acad. Sci. U.S.A. 82, 406-410. 56. Hueck, C. J. (1998). Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev 62, 379-433. 57. Lorang, J. M., and Keen, N. T. (1995). Characterization of avrE from Pseudomonas syringae pv. tomato: An hrp-Vinked avirulence locus consisting of at least two transcriptional units. Mol. Plant-Microbe Interact. 8, 49-57. 58. Mansfield, J., Jenner, C , Hockenhull, R., Bennett, M. A., and Stewart, R. (1994). Characterization of avrPphE, a gene for cultivar-specific avirulence from Pseudomonas syringae pv. phaseolicola which is physically linked to hrpY, a new hrp gene identified in the halo-blight bacterium. Mol. Plant-Microbe Interact. 7, 726-739. 59. Kim, J. F., and Beer, S. V. (1998). HrpW of Erwinia amylovora, a new harpin that contains a domain homologous to pectate lyases of a distinct class. / Bacteriol. 180, 5203-5210. 60. Charkowski, A. O., Alfano, J. R., Preston, G., Yuan, J., He, S. Y, and Collmer, A. (1998). The Pseudomonas syringae pv. tomato HrpW protein has domains similar to harpins and pectate lyases and can elicit the plant hypersensitive response and bind to pectate. / Bacteriol. 180, 5211-5217. 60a. Alfano, J. R., Charkowski, A. O., Deng, W.-L., Badel, J. L., Petnicki-Ocwieja, T, van Dijk, K., and Collmer, A. (2000). The Pseudomonas syringae Hrp pathogenicity island has a tripartite mosaic structure composed of a cluster of type III secretion genes bounded by exchangeable effector and conserved effector loci that contribute to parasitic fitness and pathogenicity in plants. Proc. Natl. Acad. Sci. U.S.A. 97, 4856-4861. 61. Groisman, E. A., and Ochman, H. (1996). Pathogenicity islands: Bacterial evolution in quantum leaps, a / / 8 7 , 791-794. 62. Hacker, J., Blum-Oehler, G., Muhldorfer, I., and Tschape, H. (1997). Pathogenicity islands of virulent bacteria: Structure, function and impact on microbial evolution. Mol. Microbiol. 23, 1089-1097. 63. Bogdanove, A. J., Beer, S. V., Bonas, U., Boucher, C. A., Collmer, A., Coplin, D. L., Comelis, G. R., Huang, H.-C, Hutcheson, S. W., Panopoulos, N. J., and Van Gijsegem, E (1996). Unified nomenclature for broadly conserved hrp genes of phytopathogenic bacteria. Mol. Microbiol. 20, 681-683. 64. Russel, M. (1994). Phage assembly: A paradigm for bacterial virulence factor export? Science 265,612-614. 65. Kazmierczak, B. I., Mielke, D. L., Russel, M., and Model, P. (1994). pIV, a filamentous phage protein that mediates phage export across the bacterial cell envelope, forms a multimer. J. Mol. Biol. 238, 187-198. 66. Carpenter, P. B., and Ordal, G. W. (1993). Bacillus subtilis FlhA: A flagellar protein related to a new family of signal-transducing receptors. Mol. Microbiol. 7, 735-743. 67. Piano, G. V., Barve, S. S., and Straley, S. C. (1991). LcrD, a membrane-bound regulator of the Yersinia pestis low-calcium response. J. Bacteriol. 173, 7293-7303.
5.
BACTERIAL PLANT PATHOGENS
215
68. Wei, Z.-M., and Beer, S. V. (1993). HrpI of Erwinia amylovora functions in secretion of harpin and is a member of a new protein family. J. Bacterioi 175, 7958-7967. 69. Wengelnik, K., Marie, C , Russel, M., and Bonas, U. (1996). Expression and localization of HrpAl, a protein of Xanthomonas campesths pv. vesicatoria essential for pathogenicity and induction of the hypersensitive response. J. Bacterioi. 178, 1061-1069. 70. Charkowski, A. O., Huang, H.-C, and CoUmer, A. (1997). Altered localization of HrpZ in Pseudomonas syringae pv. syringae hrp mutants suggests that different components of the type III secretion pathway control protein translocation across the inner and outer membranes of Gram-negative bacteria. J. Bacterioi. 179, 3866-3874. 71. Alfano, J. R., and Collmer, A. (1997). The type III (Hrp) secretion pathway of plant pathogenic bacteria: Trafficking harpins, Avr proteins, and death. J. Bacterioi. 179, 5655-5662. 72. Li, J., Ochman, H., Groisman, E. A., Boyd, E. P., Solomon, P., Nelson, K., and Selander, R. K. (1995). Relationship between evolutionary rate and cellular location among the Inv/Spa invasion proteins of Salmonella enterica. Proc. Natl. Acad. Sci. U.S.A. 92, 7252-7256. 73. Wei, Z.-M., Laby, R. J., Zumoff, C. H., Bauer, D. W., He, S. Y, Collmer, A., and Beer, S. V. (1992). Harpin, elicitor of the hypersensitive response produced by the plant pathogen Erwinia amylovora. Science 257, 85-88. 74. He, S. Y., Huang, H.-C, and Collmer, A. (1993). Pseudomonas syringae pv. syringae harpiup,,: A protein that is secreted via the Hrp pathway and elicits the hypersensitive response in plants. C^//73, 1255-1266. 75. Preston, G., Huang, H.-C, He, S. Y, and Collmer, A. (1995). The HrpZ proteins of Pseudomonas syringae pvs. syringae, glycinea, and tomato are encoded by an operon containing Yersinia ysc homologs and elicit the hypersensitive response in tomato but not soybean. Mol. Plant-Microbe Interact. H, 111-132. 76. Arlat, M., Van Gijsegem, P, Huet, J. C , Pemollet, J. C , and Boucher, C A. (1994). PopAl, a protein which induces a hypersensitive-like response on specific Petunia genotypes, is secreted via the Hrp pathway of Pseudomonas solanacearum. EMBO J. 13, 543-553. 77. Bauer, D. W., Wei, Z.-M., Beer, S. V., and Collmer, A. (1995). Erwinia chrysanthemi harpiuEch: An elicitor of the hypersensitive response that contributes to soft-rot pathogenesis. Mol. Plant-Microbe Interact. 8, 484-491. 78. Bamy, M.-A. (1995). Erwinia amylovora hrpN mutants, blocked in harpin synthesis, express a reduced virulence on host plants and elicit variable hypersensitive reactions on tobacco. Eur J. Plant Pathol. 101, 333-340. 79. Alfano, J. R., Bauer, D. W., Milos, T. M., and Collmer, A. (1996). Analysis of the role of the Pseudomonas syringae pv. syringae HrpZ harpin in elicitation of the hypersensitive response in tobacco using functionally nonpolar deletion mutations, truncated HrpZ fragments, and hrmA mutations. Mol. Microbiol. 19, 715-728. 80. Huang, H.-C, Hutcheson, S. W., and Collmer, A. (1991). Characterization of the hrp cluster from Pseudomonas syringae pv. syringae 61 and Tnp/zoA tagging of genes encoding exported or membrane-spanning Hrp proteins. Mol. Plant-Microbe Interact. 4, 469-476. 81. Heu, S., and Hutcheson, S. W. (1993). Nucleotide sequence and properties of the hrmA locus associated with the Pseudomonas syringae pv. syringae 61 hrp gene cluster. Mol. Plant-Microbe Interact. 6, 553-564. 82. Alfano, J. R., Kim, H.-S., Delaney, T. P, and Collmer, A. (1997). Evidence that the Pseudomonas syringae pv. syringae /zr/?-linked hrmA gene encodes an Avr-like protein that acts in an /zr/7-dependent manner within tobacco cells. Mol. Plant-Microbe Interact. 10, 580-588. 83. Hoyos, M. E., Stanley, C M., He, S. Y, Pike, S., Pu, X.-A., and Novacky, A. (1996). The interaction of Harpiup,, with plant cell walls. Mol. Plant-Microbe Interact. 9, 608-616.
216
JAMES R. ALFANO AND ALAN COLLMER
84. Yuan, J., and He, S. Y. (1996). The Pseudomonas syhngae Hrp regulation and secretion system controls the production and secretion of multiple extracellular proteins. J. Bacteriol. 178, 6399-6402. 85. Roine, E., Wei, W., Yuan, J., Nurmiaho-Lassila, E.-L., Kalkkinen, N., Romantschuk, M., and He, S. Y. (1997). Hrp pilus: An /7r/7-dependent bacterial surface appendage produced by Pseudomonas syringae pv. tomato DC3000. Proc. Natl. Acad. Sci. U.S.A. 94, 3459-3464. 86. Fullner, K. J., Lara, J. C, and Nester, E. W. (1996). Pilus assembly by Agrobacterium T-DNA transfer genes. Science 213, 1107-1109. 87. Leach, J. E., and White, F. F. (1996). Bacterial avirulence genes. Anmi. Rev. Phytopathol. 34, 153-179. 88. Vivian, A., Gibbon, M. J., and Murillo, J. (1997). The molecular genetics of specificity determinants in plant pathogenic bacteria. In "The Gene-for-Gene Relationship" (L R. Crute, E. B. Holub, and J. J. Burdon, eds.), pp. 293-328. CAB International, Wallingford. 89. Pirhonen, M. U., Lidell, M. C , Rowley, D. L., Lee, S. W., Jin, S., Liang, Y, Silverstone, S., Keen, N. T, and Hutcheson, S. W. (1996). Phenotypic expression of Pseudomonas syringae avr genes in E. coli is linked to the activities of the /ir/;-encoded secretion system. Mol. Plant-Microbe Interact. 9, 252-260. 90. Gopalan, S., Bauer, D. W., Alfano, J. R., Loniello, A. O., He, S. Y, and Collmer, A. (1996). Expression of the Pseudomonas syringae avirulence protein AvrB in plant cells alleviates its dependence on the hypersensitive response and pathogenicity (Hrp) secretion system in eliciting genotype-specific hypersensitive cell death. Plant Cell 8, 1095-1105. 91. Tang, X., Frederick, R. D., Zhou, J., Halterman, D. A., Jia, Y, and Martin, G. B. (1996). Initiation of plant disease resistance by physical interaction of AvrPto and Pto kinase. Science 274, 2060-2062. 92. Scofield, S. R., Tobias, C. M., Rathjen, J. P, Chang, J. H., Lavelle, D. T, Michelmore, R. W., and Staskawicz, B. J. (1996). Molecular basis of gene-for-gene specificity in bacterial speck disease of tomato. Science 114, 2063-2065. 93. Leister, R. T, Ausubel, F M., and Katagiri, F (1996). Molecular recognition of pathogen attack occurs inside of plant cells in plant disease resistance specified by the Arabidopsis genes RPS2 and RPMl. Proc. Natl. Acad. Sci. U.S.A. 93, 15497-15502. 94. Van den Ackerveken, G., Marois, E., and Bonas, U. (1996). Recognition of the bacterial avirulence protein AvrBs3 occurs inside the host plant cell. Cell 87, 1307-1316. 95. Yang, Y, and Gabriel, D. W. (1995). Xanthomonas avirulence/pathogenicity gene family encodes functional plant nuclear targeting signals. Mol. Plant-Microbe Interact. 8, 627-631. 96. Comelis, G. R., and Wolf-Watz, H. (1997). The Yersinia Yop regulon: A bacterial system for subverting eukaryotic cells. Mol. Microbiol. 23, 861-867. 97. Kearney, B., and Staskawicz, B. J. (1990). Widespread distribution and fitness contribution of Xanthomonas campestris avirulence gene avrBsl. Nature 346, 385-386. 98. Yang, Y, Yuan, Q., and Gabriel, D. W. (1996). Water-soaking function(s) of XcmH1005 are redundantly encoded by members of the Xanthomonas avr/pth gene family. Mol. Plant-Microbe Interact. 9, 105-113. 99. McNeills, T. W, Mudgett, M. B., Li, K., Aoyama, T, Horvath, D., Chua, N.-H., and Staskawicz, B. J. (1998). Glucocorticoid-inducible expression of a bacterial avirulence gene in transgenic Arabidopsis induces hypersensitive cell death. Plant J. 14, 247-257. 100. Hardt, W. E., and Galan, J. E. (1997). A secreted Salmonella protein with homology to an avirulence determinant of plant pathogenic bacteria. Proc. Natl. Acad. Sci. U.S.A. 94, 98879892.
5.
BACTERIAL PLANT PATHOGENS
217
101. Swords, K. M. M., Dahlbeck, D., Kearney, B., Roy, M., and Staskawicz, B. J. (1996). Spontaneous and induced mutations in a single open reading frame alters both virulence and avirulence in Xanthomonas campestris pv. vesicatoria avrBs2. J. Bacteriol. 178, 4661-4669. 102. Keen, N. T., Tamaki, S., Kobayashi, D., Gerhold, D., Stayton, M., Shen, H., Gold, S., Lorang, J., Thordal-Christensen, H., Dahlbeck, D., and Staskawicz, B. (1990). Bacteria expressing avirulence gene D produce a specific elicitor of the soybean hypersensitive reaction. Mol. Plant-Microbe Interact. 3, 112-121. 103. Midland, S. L., Keen, N. T., Sims, J. J., Midland, M. M., Stayton, M. M., Burton, V., Smith, M. J., Mazzola, E. P., Graham, K. J., and Clardy, J. (1993). The structures of syringolides 1 and 2: Novel C glycosidic elicitors from Pseudomonas syringae pv. tomato. J. Org. Chem. 58, 2940-2945. 104. Bonas, U., and Van den Ackerveken, G. (1997). Recognition of bacterial avirulence proteins occurs inside the plant cell: A general phenomenon in resistance to bacterial diseases? Plant J. 12, 1-7. 105. Gabriel, D. W. (1997). Targeting of protein signals from Xanthomonas to the plant nucleus. Trends Plant Set. 2, 204-206. 106. Brown, I., Mansfield, J., Irlam, I., Conrads-Strauch, J., and Bonas, U. (1993). Ultrastructure of interactions between Xanthomonas campestris pv. vesicatoria and pepper, including immunocytochemical localization of extracellular polysaccharides and the AvrBs3 protein. Mol. Plant-Microbe Interact. 6, 376-386. 107. Young, S. A., White, F. F., Hopkins, C. M., and Leach, J. E. (1994). AvrXalO protein is in the cytoplasm of Xanthomonas oryzae pv. oryzae. Mol. Plant-Microbe Interact. 7, 799-804. 108. Puri, N., Jenner, C., Bennet, M., Stewart, R., Mansfield, J., Lyons, N., and Taylor, J. (1997). Expression of avrPphB, an avirulence gene from Pseudomonas syringae pv. phaseolicola, and the delivery of signals causing the hypersensitive reaction in bean. Mol. Plant-Microbe Interact. 10, 247-256. 109. Ham, J. H., Bauer, D. W., and Collmer, A. (1998). A cloned Erwinia chrysanthemi Hrp (type III protein secretion) system functions in Escherichia coli to deliver Pseudomonas syringae Avr signals to plant cells and to secrete Avr proteins in culture. Proc. Nad. Acad. Sci. U.S.A. 95, 10206-10211. 110. Rosqvist, R., Hakansson, S., Forsberg, A., and Wolf-Watz, H. (1995). Functional conservation of the secretion and translocation machinery for virulence proteins of yersiniae, salmonellae and shigellae. EMBO J. 14, 4187-4195. 111. Bogdanove, A. J., Kim, J. F, Wei, Z., Kolchinsky, P, Charkowski, A. O., Conlin, A. K., Collmer, A., and Beer, S. V. (1998). Homology and functional similarity of an hrp-Ymked pathogenicity locus, dspEF, of Erwinia amylovora and the avirulence locus avrE of Pseudomonas syringae pathovar tomato. Proc. Natl. Acad. Sci. U.S.A. 95, 1325-1330. 112. Gaudriault, S., Malandrin, L., Paulin, J.-P., and Barny, M.-A. (1997). DspA, an essential pathogenicity factor of Erwinia amylovora showing homology with AvrE of Pseudomonas syringae, is secreted via the Hrp secretion pathway in a DspB-dependent way. Mol. Microbiol. 26, 1057-1069. 113. Lorang, J. M., Shen, H., Kobayashi, D., Cooksey, D., and Keen, N. T. (1994). avrA and avrE in Pseudomonas syringae pv. tomato PT23 play a role in virulence on tomato plants. Mol. Plant-Microbe Interact. 7, 508-515. 114. Bogdanove, A. J., Bauer, D. W., and Beer, S. V. (1998). Erwinia amylovora secretes DspE, a pathogenicity factor and functional AvrE homolog, through the Hrp (type III secretion) pathway. J. Bacteriol. 180, 2244-2247.
218
JAMES R. ALFANO AND ALAN COLLMER
115. Kim, J. F, Charkowski, A. O., Alfano, J. R., Collmer, A., and Beer, S. V. (1998). Sequences related to transposable elements and bacteriophages flank avirulence genes of Pseudomonas syringae. Mol. Plant-Microbe Interact. 11, 1247-1252. 116. Kearney, B., Ronald, R C , Dahlbeck, D., and Staskawicz, B. J. (1988). Molecular basis for evasion of plant host defense in bacterial spot of pepper. Nature 332, 541-543. 117. Perombelon, M. C. M., and Kelman, A. (1980). Ecology of the soft rot erwinias. Annu. Rev. Phytopathol. 18,361-387. 118. Manulis, S., Kobayashi, D. Y., and Keen, N. T. (1988). Molecular cloning and sequencing of a pectate lyase gene from Yersinia pseudotuberculosis. J. Bacteriol. 170, 1825-1830. 119. Cosgrove, D. J. (1997). Relaxation in a high-stress environment: The molecular bases of extensible cell walls and cell enlargement. Plant Cell 9, 1031-1041. 120. Collmer, A., and Keen, N. T. (1986). The role of pectic enzymes in plant pathogenesis. Annu. Rev. Phytopathol. 24, 383-409. 121. McNeil, M., Darvill, A. G., Fry, S. C , and Albersheim, R (1984). Structure and function of the primary cell walls of plants. Annu. Rev. Biochem. 53, 625-663. 122. Basham, H. G., and Bateman, D. F. (1975). Relationship of cell death in plant tissue treated with a homogeneous endopectate lyase to cell wall degradation. Physiol. Plant Pathol. 5, 249-261. 123. Hugouvieux-Cotte-Pattat, N., Condemine, G., Nasser, W., and Reverchon, S. (1996). Regulation of pectinolysis in Erwinia chrysanthemi. Annu. Rev. Microbiol. 50, 213-257. 124. Shevchik, V., and Hugouvieux-Cotte-Pattat, N. (1997). Identification of a bacterial pectin acetyl esterase in Erwinia chrysanthemi. Mol. Microbiol. 24, 1285-1301. 125. Shevchik, V., Robert-Baudouy, J., and Hugouvieux-Cotte-Pattat, N. (1997). Pectate lyase Pell oi Erwinia chrysanthemi 3937 belongs to a new family. J. Bacteriol. 179, 7321-7330. 126. Pissavin, C , Robert-Baudouy, J., and Hugouvieux-Cotte-Pattat, N. (1996). Regulation of pelZ, a gene of the pelBC cluster encoding a new pectate lyase in Erwinia chrysanthemi 3937. J. Bacteriol. 178,7187-7196. 127. Beaulieu, C , Boccara, M., and Van Gijsegem, F. (1993). Pathogenic behavior of pectinase-defective Erwinia chrysanthemi mutants on different plants. Mol. Plant-Microbe Interact. 6, 197-202. 128. Hahn, M. G., Bucheli, P, Cervone, F, Doares, S. H., O'Neill, R. A., Darvill, A., and Albersheim, P. (1988). The roles of cell wall constituents in plant-pathogen interactions. In "Plant-Microbe Interactions, Molecular and Genetic Perspectives," Vol. 3 (E. Nester and T. Kosuge, eds.), pp. 131-181. Macmillan, New York. 129. Palva, T. K., Holmstrom, K.-O., Heino, P, and Palva, E. T. (1993). Induction of plant defense response by exoenzymes of Erwinia carotovora subsp. carotovora. Mol. Plant-Microbe Interact. 6, 190-196. 130. Vidal, S., Eriksson, A. R. B., Montesano, M., Denecke, J., and Palva, E. T. (1998). Cell wall-degrading enzymes from Erwinia carotovora cooperate in the salicylic acid-independent induction of a plant defense response. Mol. Plant-Microbe Interact. 11, 23-32. 131. Yang, Z., Cramer, C. L., and Lacy, G. H. (1992). Erwinia carotovora subsp. carotovora pectic enzymes: In planta gene activation and roles in soft-rot pathogenesis. Mol. Plant-Microbe Interact. 5, 104-112. 132. Shevchik, V. E., Boccara, M., Vedel, R., and Hugouvieux-Cotte-Pattat, N. (1998). Processing of the pectate lyase Pell by extracellular proteases of Erwinia chrysanthemi 3937. Mol. Microbiol. 29, 1459-1469. 133. Baker, C. J., Atkinson, M. M., Roy, M. A., and Collmer, A. (1986). Inhibition of the hypersensitive response in tobacco by pectate lyase. Physiol. Mol. Plant Pathol. 29, 217-225.
5.
BACTERIAL PLANT PATHOGENS
219
134. Finlay, B., and Falkow, S. (1997). Common themes in microbial pathogenicity revisited. Microbiol. MoL Biol. Rev. 61, 136-169. 135. Romantschuk, M. (1992). Attachment of plant pathogenic bacteria to plant surfaces. Annu. Rev. Phytopathol. 30, 225-243. 136. Lippincott, J. A., and Lippincott, B. B. (1969). Bacterial attachment to a specific wound site as an essential stage in tumor induction by Agrobacteriiim tumefaciens. J. Bacteriol. 97, 620-628. 137. Matthysse, A. G. (1986). Initial interactions of Agrobacterium tumefaciens with plant host cells. CRC Crit. Rev Microbiol. 13, 281-307. 138. Westerlund, B., and Korhonen, T. K. (1993). Bacterial proteins binding to mammalian extracellular matrix. Mol. Microbiol. 9, 687-694. 139. Paulsson, M., and Wadstrom, T. (1990). Vitronectin and type-1 collagen binding by Staphyloccus aureus and coagulase-negative streptococci. FEMS Microbiol. Immunol. 65, 55-62. 140. Sanders, L., Wang, C.-O., Walling, W. L., and Lord, E. (1991). A homolog of the substrate adhesion molecule vitronectin occurs in four species of flowering plants. Plant Cell 3, 629-635. 141. Wagner, V. T., and Matthysse, A. G. (1992). Involvement of a vitronectin-like protein in attachment of Agrobacterium tumefaciens to carrot suspension culture cells. J. Bacteriol. 174, 5999-6003. 142. Matthysse, A. G. (1987). Characterization of nonattaching mutants of Agrobacterium tumefaciens. J. Bacteriol. 169, 313-323. 143. Matthysse, A. G., and McMahan, S. (1998). Root colonization by Agrobacterium tumefaciens is reduced in eel, attB, attD, and attR mutants. Appl. Environ. Microbiol. 64, 2341-2345. 144. Thomashow, M. F, Karlinsky, J. E., Marks, J. R., and Hurlburt, R. E. (1987). Identification of a new virulence locus in Agrobacterium tumefaciens that affects polysaccharide composition and plant cell attachment. J. Bacteriol. 169, 3209-3216. 145. Puvanesarajah, V., Schell, F M., Stacey, G., Douglas, C. J., and Nester, E. (1985). Role of 2-linked-P-D-glucan in the virulence of Agrobacterium tumefaciens. J. Bacteriol. 164, 102-106. 146. Matthysse, A. G., Yarnall, H. A., and Young, N. (1996). Requirement for genes with homology to ABC transport systems for attachment and virulence of Agrobacterium tumefaciens. J. Bacteriol. 178, 5302-5308. 147. Salyers, A. A., and Whitt, D. D. (1994). "Bacterial Pathogenesis: A Molecular Approach." ASM Press, Washington, DC. 148. Govan, J. R. W., and Deretic, V. (1996). Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbial. Rev. 60, 539-574. 149. Denny, T. P. (1995). Involvement of bacterial polysaccharide in plant pathogenesis. Annu. Rev. Phytopathol. 33, 173-197. 150. Denny, T. P., and Back, S.-R. (1991). Genetic evidence that extracellular polysaccharide is a virulence factor of Pseudomonas solanacearum. Mol. Plant-Microbe Interact. 4, 198-206. 151. Kao, C. C , Barlow, E., and Sequeira, L. (1992). Extracellular polysaccharide is required for wild-type virulence of Pseudomonas solanacearum. J. Bacteriol. 174, 1068-1071. 152. Steinberger, E. M., and Beer, S, V. (1988). Creation and complementation of pathogenicity mutants of Erwinia amylovora. Mol. Plant-Microbe Interact. 1, 135-144. 153. Bernhard, T., Coplin, D. L., and Geider, K. (1993). A gene cluster for amylovoran synthesis in Erwinia amylovora: Characterization and relation to cps genes in Erwinia stewartii. Mol. Gen. Genet. 239, 158-168. 154. Coplin, D. L., and Majerczak, D. R. (1990). Extracellular polysaccharide genes in Erwinia stewartii: Directed mutagenesis and complementation analysis. Mol. Plant-Microbe Int. 5, 286-292.
220
JAMES R. ALFANO AND ALAN COLLMER
155. Tang, J. L., Feng, J. X., Li, Q. Q., Wen, H. X., Zhou, D. L., Greer Wilson, T. J., Dow, J. M., Ma, Q. S., and Daniels, M. J. (1996). Cloning and characterization of the rpfC gene of Xanthomonas oryzae pv. oryzae: Involvement in exopolysaccharide production and virulence to rice. Mol. Plant-Microbe Interact. 9, 664-666. 156. Katzen, F, Ferreiro, D. U., Oddo, C. G., lelmini, V., Becker, A., Puhler, A., and lelpi, L. (1998). Xanthomonas campestris pv. campestris gum mutants: Effects on xanthum biosynthesis and plant virulence. J. Bacteriol. 180, 1607-1617. 157. Gross, D. C. (1991). Molecular and genetic analysis of toxin production by pathovars of Pseudomonas syringae. Anmi. Rev. Phytopathol. 29, 247-278. 158. Adetuyi, F. €., Isogai, A., Di Giorgio, D., Ballio, A., and Takemoto, J. Y. (1995). Saprophytic Pseudomonas syringae strain Ml of wheat produces cyclic lipodepsipeptides. FEMS Microbiol. Lett. 131, 63-67. 159. Takemoto, J. Y. (1992). Bacterial phytotoxin syringomycin and its interaction with host membranes. In "Molecular Signals in Plant-Microbe Communications" (D. P. S. Verma, eds.), pp. 247-260. CRC, Boca Raton, FL. 160. Hutchison, M. L., Tester, M. A., and Gross, D. C. (1995). Role of biosurfactant and ion channel-forming activities of syringomycin in transmembrane ion flux: A model for the mechanism of action in the plant-pathogen interaction. Mol. Plant-Microbe Interact. 8, 610-620. 161. Hutchison, M. L., and Gross, D. C. (1997). Lipopeptide phytotoxins produced by Pseudomonas syringae pv. syringae: Comparison of the biosurfactant and ion channel-forming activities of syringopeptin and syringomycin. Mol. Plant-Microbe Interact. 10, 347-354. 162. Bidwai, A. P., and Takemoto, J. Y. (1987). Bacterial phytotoxin, syringomycin, induces a protein kinase-mediated phosphorylation of red beet plasma membrane polypeptides. Proc. Natl. Acad. Sci. U.S.A. 84, 6755-6759. 163. Bhakdi, S., and Tranum-Jensen, J. (1987). Damage to mammalian cells by proteins that form transmembrane pores. Rev. Physiol. Biochem. Pharmacol. 107, 147-223. 164. Menestrina, G., Moser, C , Pellet, S., and Welch, R. (1994). Pore-formation by Escherichia coli hemolysin (HlyA) and other members of the RTX toxins family. Toxicology 87, 249-267. 165. Braun, V., and Focareta, T. (1991). Pore-forming bacterial protein hemolysins (cytolysins). Crit. Rev. Microbiol. 18, 115-158. 166. Stanley, P., Koronakis, V., and Hughes, C. (1998). Acylation o^ Escherichia coli Hemolysin: A unique protein lipidation mechanism underlying toxin function. Microbiol. Mol. Biol. Rev. 62, 309-333. 167. Quigley, N. G., Mo, Y.-Y, and Gross, D. C. (1993). syrD is required for syringomycin production by Pseudomonas syringae pathovar syringae and is related to a family of ATP-binding secretion proteins. Mol. Microbiol. 9, 787-801. 168. Yahr, T. L., Goranson, J., and Frank, D. W. (1996). Exoenzyme S oi Pseudomonas aeruginosa is secreted by a type III pathway. Mol. Microbiol. 22, 991-1003. 169. Michiels, T, Wattiau, P, Brasseur, R., Ruysschaert, J.-M., and Comelis, G. (1990). Secretion of Yop proteins by Yersiniae. Infect. Immun. 58, 2840-2849. 170. Expert, D., Enard, C , and Masclaux, C. (1996). The role of iron in plant host-pathogen interactions. Trends Microbiol. 4, 232-237. 171. Wooldridge, K. G., and Williams, P. H. (1993). Iron uptake mechanisms of pathogenic bacteria. FEMS Microbiol. Rev. 12, 325-348. 172. Neema, C, Laulhere, J.-P., and Expert, D. (1993). Iron deficiency induced by chrysobactin in Saintpaulia leaves inoculated with Erwinia chrysanthemi. Plant Physiol. 102, 967-973. 173. Enard, C , Diolez, A., and Expert, D. (1988). Systemic virulence of Erwinia chrysanthemi 3937 requires a functional iron assimilation system. J. Bacteriol. 170, 2419-2426.
5.
BACTERIAL PLANT PATHOGENS
221
174. Mahe, B., Masclaux, C , Rauscher, L., Enard, C, and Expert, D. (1995). Differential expression of two siderophore-dependent iron-acquisition pathways in Erwinia chrysanthemi 3937: Characterization of a novel ferrisiderophore permease of the ABC transporter family. Mol. Microbiol. 18, 3 3 ^ 3 . 175. Mila, I., Scalbert, A., and Expert, D. (1996). Iron withholding by plant polyphenols and resistance to pathogens and rots. Phytochemistry 42, 1551-1555. 176. Bowman, H. G. (1995). Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 13, 61-92. 177. Broekaert, W. R, Cammue, B. P A., De Bolle, M. R C , Thevissen, K., De Samblanx, G. W., and Osborn, R. W. (1997). Antimicrobial peptides from plants. Cht. Rev. Plant Sci. 16, 297-323. 178. Carmona, M. J., Molina, A., Pernandez, J. A., Lopez-Fando, J. J., and Garcia-Olmeda, R (1993). Expression of the a-thionin gene from barley in tobacco confers enhanced resistance to bacterial pathogens. Plant J. 3, 457-462. 179. Molina, A., and Garcia-Olmedo, P. (1997). Enhanced tolerance to bacterial pathogens caused by the transgenic expression of barley lipid transfer protein LTP2. Plant J. 12, 669-675. 180. Titarenko, E., Lopez-Solanilla, E., Garcia-Olmedo, P., and Rodriguez-Palenzuela, P. (1997). Mutants of Ralstonia (Pseudomonas) solanaceanim sensitive to antimicrobial peptides are altered in their lipopolysaccharide structure and are avirulent in tobacco. J. Bacteriol. 179, 6699-6704. 181. Groisman, E. A. (1994). How bacteria resist killing by host-defense peptides. Trends Microbiol. 2, 444-449. 182. Groisman, E. A., Parra-Lopez, C , Salcedo, M., Lipps, C. J., and Heffron, P. (1992). Resistance to host antimicrobial peptides is necessary for Salmonella virulence. Proc. Natl. Acad. Sci. U.S.A. 89, 11939-11943. 183. Parra-Lopez, C , Baer, M. T., and Groisman, E. A. (1993). Molecular genetic analysis of a locus required for resistance to antimicrobial peptides in Salmonella typhimurium. EMBO J. 12, 4053-4062. 184. Lopez-Solanilla, E., Garcia-Olmedo, P., and Rodriguez-Palenzuela, P. (1998). Inactivation of the sapA to sapF locus of Erwinia chrysanthemi reveals common features in plant and animal bacterial pathogenesis. Plant Cell 10, 917-924. 185. Wharam, S. D., Mulholland, V., and Salmond, G. P C. (1995). Conserved virulence factor regulation and secretion systems in bacterial pathogens of plants and animals. Eur J. Plant Pathol. 101, 1-13. 186. Dziejman, M., and Mekalanos, J. J. (1995). Two-component signal transduction and its role in the expression of bacterial virulence factors. In "Two-Component Signal Transduction" (J. A. Hoch and T. J. Silhavy, eds.), pp. 305-317. ASM Press, Washington, DC. 187. Xiao, Y., Heu, S., Yi, J., Lu, Y, and Hutcheson, S. W. (1994). Identification of a putative alternate sigma factor and characterization of a multicomponent regulatory cascade controlling the expression of Pseudomonas syringae pv. syringae Pss61 hrp and hrmA genes. J. Bacteriol. 176, 1025-1036. 188. Xiao, Y, and Hutcheson, S. (1994). A single promoter sequence recognized by a newly identified alternate sigma factor directs expression of pathogenicity and host range determinants in Pseudomonas syringae. J. Bacteriol. 176, 3089-3091 [author's correction, 176, 6158]. 189. Wei, Z.-M., and Beer, S. V. (1995). hrpL activates Erwinia amylovora hrp gene transcription and is a member of the ECF subfamily of a factors. / Bacteriol. Ill, 6201-6210. 190. Grimm, C, and Panopoulos, N. J. (1989). The predicted protein product of a pathogenicity locus from Pseudomonas syringae pv. phaseolicola is homologous to a highly conserved domain of several procaryotic regulatory proteins. J. Bacteriol. Ill, 5031-5038.
222
JAMES R. ALFANO AND ALAN COLLMER
191. Grimm, C , Aufsatz, W., and Panopoulos, N. J. (1995). The hrpRS locus of Pseudomonas syringae pv. phaseolicola constitutes a complex regulatory unit. Mol. Microbiol. 15, 155-165. 192. Preston, G., Deng, W.-L., Huang, H.-C, and Collmer, A. (1998). Negative regulation of hrp genes in Pseudomonas syringae by HrpV. J. Bacteriol. 180, 4532-4537. 193. Genin, S., Gough, C. L., Zischek, C., and Boucher, C. A. (1992). Evidence that the hrpB gene encodes a positive regulator of pathogenicity genes from Pseudomonas solanacearum. Mol. Microbiol 6, 3065-3076. 194. Oku, T., Alvarez, A. M., and Kado, C. I. (1995). Conservation of the hypersensitivity-pathogenicity regulatory gene hrpX of Xanthomonas campestris and X. oryzae. DNA Seq. 5, 245-249. 195. Wengelnik, K., and Bonas, U. (1996). HrpXv, an AraC-type regulator, activates expression of five of the six loci in the hrp cluster of Xanthomonas campestris pv. vesicatoria. / Bacteriol. 178, 3462-3469. 196. Wengelnik, K., Van den Ackerveken, G., and Bonas, U. (1996). HrpG, a key hrp regulatory protein of Xanthomonas campestris pv. vesicatoria is homologous to two-component response regulators. Mol. Plant-Microbe Interact. 9, 704-712. 197. Marenda, M., Brito, B., Callard, D., Genin, S., Barberis, P., Boucher, C , and Arlat, M. (1998). PrhA controls a novel regulatory pathway required for the specific induction of Ralstonia solanacearum hrp genes in the presence of plant cells. Mol. Microbiol. 27, 437^53. 198. Liu, Y, Cui, Y., Mukherjee, A., and Chatterjee, A. K. (1998). Characterization of a novel RNA regulator of Erwinia carotovora ssp. carotovora that controls production of extracellular enzymes and secondary metabolites. Mol. Microbiol. 29, 219-234. 199. Chapmen, M. R., and Kao, C. C. (1998). EpsR modulates production of extracellular polysaccharides in the bacterial wilt pathogen Ralstonia (Pseudomonas) solanacearum. J. Bacteriol. 180, 27-34. 200. Clough, S. J., Lee, K.-E., Schell, M. A., and Denny, T. P (1997). A two-component system in Ralstonia (Pseudomonas) solanacearum modulates production of Phc-regulated virulence factors in response to 3-hydroxypalmitic acid methyl ester. J. Bacteriol. 179, 3639-3648. 201. Huang, J., Yindeeyoungyeon, W., Garg, R. P, Denny, T. P, and Schell, M. A. (1998). Joint transcriptional control of xpsR, the unusual signal integrator of the Ralstonia solanacearum virulence gene regulatory network, by a response regulator and a LysR-type transcriptional activator. J. Bacteriol. 180, 2736-2743. 202. Barber, C. E., Tang, J. L., Feng, J. X., Pan, M. Q., Wilson, T J. G., Slater, H., Dow, J. M., Williams, P., and Daniels, M. J. (1997). A novel regulatory system required for pathogenicity of Xanthomonas campestris is mediated by a small diffusible signal molecule. Mol. Microbiol. 24, 555-566. 203. Hrabak, E. M., and Willis, D. K. (1993). Involvement of the lemA gene in production of syringomycin and protease by Pseudomonas syringae pv. syringae. Mol. Plant-Microbe Interact. 6, 368-375. 204. Rich, J. J., Kinscherf, T G., Kitten, T, and Willis, D. K. (1994). Genetic evidence that the gacA gene encodes the cognate response regulator for the lemA sensor in Pseudomonas syringae. J. Bacteriol. 176, 7468-7475. 205. Rahme, L. G., Stevens, E. J., Wolfort, S. P., Shao, J., Tompkins, R. G., and Ausubel, E M. (1995). Common virulence factors for bacterial pathogenicity in plants and animals. Science 268, 1899-1902. 206. Fang, F. C , Libby, S. J., Buchmeier, N. A., Loewen, P. C , Switala, J., Harwood, J., and Guiney, D. G. (1992). The alternative a factor KatF (RpoS) regulates Salmonella virulence. Proc. Natl. Acad Sci. U.S.A 89, 11978-11982.
5.
BACTERIAL PLANT PATHOGENS
223
207. Hengge-Aronis, R. (1996). Regulation of gene expression during entry into stationary phase. In ''Escherichia coli and Salmonella: Cellular and Molecular Biology" (F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger, eds.), pp. 1497-1512. ASM Press, Washington, DC. 208. Mukherjee, A., Cui, Y, Ma, Y, Liu, Y, Ishihama, A., Eisenstark, A., and Chatterjee, A. K. (1998). RpoS (sigma-S) controls the expression of rsmA, a global regulator of secondary metabolites, Harpin and extracellular proteins in Erwinia carotovora. J. Bacteriol 180, 3629-3634. 209. De Crecy-Lagard, V., Glaser, P., Lejeune, P., Sismeiro, O., Barber, C. E., Daniels, M. J., and Danchin, A. (1990). A Xanthomonas campestris pv. campestris protein similar to catabolite activation factor is involved in regulation of phytopathogenicity. J. Bacteriol. 112, 5877-5883. 210. Reverchon, S., Expert, D., Robert-Baudouy, J., and Nasser, W. (1997). The cyclic AMP receptor protein is the main activator of the pectinolysis genes in Erwinia chrysanthemi. J. Bacteriol. 179, 3500-3508. 211. West, S. E., Sample, A. K., and Runyen-Janecky, L. J. (1994). The vfr gene product, required for Pseudomonas aeruginosa exotoxin A and protease production, belongs to the cyclic AMP receptor protein family. J. Bacteriol. 176, 7532-7542. 212. Fuqua, C , Winans, S. C , and Greenberg, E. P. (1996). Census and consensus in bacterial ecosystems: The LuxR-LuxI family of quorum-sensing transcriptional regulators. Annu. Rev. Microbiol. 50,727-751. 213. Swift, S., Throup, J. P, Williams, P, Salmond, G. R, and Stewart, G. S. A. B. (1996). Quorum sensing: A population-density component in the determination of bacterial phenotype. Trends Biochem. Sci. 21,214-219. 214. Engebrecht, J., Nealson, K., and Silverman, M. (1983). Bacterial bioluminescence: Isolation and genetic analysis of functions from Vibrio fischeri. Cell 32, 773-781. 215. Bainton, N. J., Stead, P, Chhabra, S. R., Bycroft, B. W., Salmond, G. P C , Stewart, G. S. A. B., and Williams, P. (1992). A^-3 oxohexanoyl-L-homoserine lactone regulates carbapenem antibiotic production in Erwinia carotovora. Biochem. J. 288, 997-1004. 216. Jones, S., Yu, B., Bainton, N. J., Birdsall, M., Bycroft, B. W., Chhabra, S. R., Cox, A. J. R., Golby, P, Reeves, P J., Stephens, S., Winson, M. K., Salmond, G. P C , Stewart, G. S. A. B., and Williams, P. (1993). The lux autoinducer regulates the production of exoenzyme virulence determinants in Erwinia carotovora and Pseudomonas aeruginosa. EMBO J. 12, 2477-2482. 217. Pirhonen, M., Flego, D., Heikinheimo, R., and Palva, E. T (1993). A small diffusible signal molecule is responsible for the global control of virulence and exoenzyme production in the plant pathogen Erwinia carotovora. EMBO J. 12, 2467-2476. 218. Beck von Bodman, S., Majerczak, D. R., and Coplin, D. L. (1998). A negative regulator mediates quorum-sensing control of exopolysaccharide production in Pantoea stewartii subsp. stewartii. Proc. Natl. Acad. Sci. U.S.A. 95, 7687-7692. 219. Nasser, W., Bouillant, M. L., Salmond, G., and Reverchon, S. (1998). Characterization of the Erwinia chrysanthemi expl-expR locus directing the synthesis of two A^-acyl-homoserine lactone signal molecules. Mol. Microbiol. 29, 1391-1405. 220. Budde, I. P, Rohde, B. H., Bender, C. L., and Ullrich, M. S. (1998). Growth phase and temperature influence promoter activity, transcript abundance, and protein stability during biosynthesis of the Pseudomonas syringae phytotoxin coronatine. J. Bacteriol. 180, 1360-1367. 221. Sauvage, C , and Expert, D. (1994). Differential regulation by iron of Erwinia chrysanthemi pectate lyases: Pathogenicity of iron transport regulatory {cbr) mutants. Mol. Plant-Microbe Interact. 7, 71-77. 222. Huynh, T. V., Dahlbeck, D., and Staskawicz, B. J. (1989). Bacterial blight of soybean: Regulation of a pathogen gene determining host cultivar specificity. Science 245, 1374-1377.
224
JAMES R. ALFANO AND ALAN COLLMER
223. Mahan, M. J., Slauch, J. M., and Mekalanos, J. J. (1996). Environmental regulation of virulence gene expression in Escherichia, Salmonella, and Shigella spp. In ''Escherichia coli and Salmonella: Cellular and Molecular Biology" (F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger, eds.), pp. 2803-2815. ASM Press, Washington, DC. 224. Medzhitov, R., and Janeway Jr., C. A. (1997). Innate Immunity: The virtues of a nonclonal system of recognition. Cell 91, 295-298. 225. Baker, B., Zambryski, R, Staskawicz, B., and Dinesh-Kumar, S. P. (1997). Recognition and signaling in plant-microbe interactions. Science 216, 726-733. 226. Hashimoto, C , Gertula, S., and Anderson, K. V. (1988). The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane receptor. Cell 52, 269-279. 227. Whitham, S., Dinesh-Kumar, S. P, Choi, D., Hehl, R., Corr, C, and Baker, B. (1994). The product of the tobacco mosaic virus resistance gene A^: Similarity to toll and interleukin-1 receptor. Celll^, 1101-1 lj5. 228. Padgett, H. S., Watanabe, Y., and Beachy, R. N. (1997). Identification of the TMV replicase sequence that activates the N gene-mediated hypersensitive response. Mol. Plant-Microbe Interact. 10,709-715. 229. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.-M., and Hoffmann, J. A. (1996). The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973-983. 230. Siebenlist, U., Franzoso, G., and Brown, K. (1994). Structure, regulation and function of NF-KB. Annu. Rev. Cell Biol 10, 405^55. 231. Rock, K L., Hardiman, G., Timans, J. C , Kastelein, R. A., and Bazan, J. F. (1998). A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U.S.A. 95, 588-593. 232. Medzhitov, R., Preston-Hurlburt, P., and Janeway Jr., C. A. (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397. 233. Aarts, N., Metz, M., Holub, E., Staskawicz, B. J., Daniels, M. J., and Parker, J. E. (1998). Different requirements for EDSl and NDRI by disease resistance genes define at least two R gene-mediated signaling pathways in Arahidopsis. Proc. Natl. Acad. Sci. U.S.A. 95, 1030610311. 234. Zhou, J., Tang, X., and Martin, G. B. (1997). The Pto kinase conferring resistance to tomato bacterial speck disease interacts with proteins that bind a c/.v-element of pathogenesis-related genes. EMBO J. 16, 3207-3218. 235. Martin, G. B., Brommonschenkel, S. H., Chunwongse, J., Frary, A., Ganal, M. W., Spivey, R., Wu, T, Earle, E. D., and Tanksley, S. D. (1993). Map-based cloning of a protein kinase gene conferring disease resistance in tomato. Science 262, 1432-1436. 236. Bent, A. F, Kunkel, B. N., Dahlbeck, D., Brown, K. L., Schmidt, R., Giraudat, J., Leung, J., and Staskawicz, B. J. (1994). RPS2 of Arahidopsis thaliana: A leucine-rich repeat class of plant disease resistance genes. Science 265, 1856-1860. 237. Mindrinos, M., Katagiri, F, Yu, G.-L., and Ausubel, F M. (1994). The A. thaliana disease resistance gene RPS2 encodes a protein containing a nucleotide-binding site and leucine-rich repeats. Cell 7H, 1089-1099. 238. Song, W.-Y, Wan, G.-L., Chen, L.-L., Kim, H.-S., Pi, L.-Y, Holsten, T, Gardner, J., Wang, B., Qhai, W.-X., Zhu, L.-H., Fauquet, C , and Ronald, P. (1995). A receptor kinase-like protein encoded by the rice disease resistance gene, Xa2I. Science 270, 1804-1806. 239. Cao, Z. O., Henzel, W. J., and Gao, X. O. (1993). IRAK: A kinase associated with the interleukin-1 receptor. Science 271, 1128-1131.
5.
BACTERIAL PLANT PATHOGENS
225
240. Shelton, C. A., and Wasserman, S. A. (1993). pelle encodes a protein kinase required to establish dorsoventral polarity in the Drosophila embryo. Cell 12, 515-525. 241. Ryals, J., Weymann, K., Lawton, K., Friedrich, L., Ellis, D., Steiner, H.-Y, Johnson, J., Delaney, T. P., Jesse, T., Vos, P., and Uknes, S. (1997). The Arabidopsis NIM] protein shows homology to the mammalian transcription factor inhibitor IKB. Plant Cell 9, 425-439. 242. Cao, H., Glazebrook, J., Clarke, J. D., Volko, S., and Dong, X. (1997). The Arabidopsis NPRl gene that controls systemic acquired resistance encodes a novel protein containing ankyrin repeats. Cell 88, 57-63. 243. Levine, A., Tehhaken, R., Dixon, R., and Lamb, C. (1994). H2O2 from the oxidative burst orchestrates the plant hypersensitive disease resistance response. Cell 79, 583-593. 244. Dwyer, S. C , Legendre, L., Low, P. S., and Leto, T. L. (1996). Plant and human neutrophil oxidative burst complexes contain immunologically related proteins. Biochim. Biophys. Acta 1289,231-237. 245. Groom, Q. J., Torres, M. A., Fordham-Skelton, A. P., Hammond-Kosack, K. E., Robinson, N. J., and Jones, J. D. (1996). rhohA, a rice homologue of the mammalian gp91P''°'' respiratory burst oxidase gene. Plant J. 10, 515-522. 246. Keller, T, Damude, H. G., Werner, D., Doerner, P, Dixon, R. A., and Lamb, C. (1998). A plant homolog of the neutrophil NADPH oxidase gp91P^"^ subunit gene encodes a plasma membrane protein with Ca^^ binding motifs. Plant Cell 10, 255-266. 247. Nathan, C. (1995). Natural resistance and nitric oxide. Cell 82, 873-876. 248. Dumer, J., Wendehenne, D., and Klessig, D. F. (1998). Defense gene induction in tobacco by nitric oxide, cyclic GMP, and cyclic ADP-ribose. Proc. Natl. Acad. Sci. U.S.A. 95, 10328-10333. 249. Delledonne, M., Xia, Y., Dixon, R. A., and Lamb, C. (1998). Nitric oxide functions as a signal in plant disease resistance. Nature 394, 585-588. 250. Fearon, D. T., and Locksley, R. M. (1996). The instructive role of innate immunity in the acquired immune response. Science 272, 50-53. 251. Pamiske, M., Hammond-Kosack, K. E., Golstein, C., Thomas, C. M., Jones, D. A., Harrison, K., Wulff, B. B., and Jones, J. D. (1997). Novel disease resistance specificities result from sequence exchange between tandemly repeated genes at the Cf-4/9 locus of tomato. Cell 91, 821-832. 252. Ronald, P C. (1998). Resistance gene evolution. Cum Opin. Plant Biol. 1, 294-298. 253. Wang, G. L., Ruan, D. L., Song, W. Y, Sideris, S., Chen, L., Pi, L. Y, Zhang, S., Zhang, Z., Fauquet, C , Gaut, B. S., Whalen, M. C, and Ronald, P C. (1998). Xa2lD encodes a receptor-like molecule with a leucine-rich repeat domain that determines race-specific recognition and is subject to adaptive evolution. Plant Cell 10, 765-79. 254. Galan, J. E. (1998). "Avirulence genes" in animal pathogens? Trends Microbiol. 6, 3-6. 255. Whalen, M. C , Stall, R. E., and Staskawicz, B. J. (1988). Characterization of a gene from a tomato pathogen determining hypersensitive resistance in non-host species and genetic analysis of this resistance in bean. Proc. Natl. Acad. Sci. U.S.A. 85, 6743-6747. 256. Mills, S. D., Boland, A., Sory, M.-P, Van Der Smissen, P, Kerbourch, C , Finlay, B. B., and Cornells, G. R. (1997). Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein. Proc. Natl. Acad. Sci. U.S.A. 94, 12638-12643. 257. Monack, D. M., Mecsas, J., Ghori, N., and Falkow, S. (1997). Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc. Natl. Acad. Sci. U.S.A. 94, 10385-10390. 258. Zychlinsky, A., and Sansonetti, P. J. (1997). Apoptosis as a proinflammatory event: What can we learn from bacteria-induced cell death? Trends Microbiol. 5, 201-204.
226
JAMES R. ALFANO AND ALAN COLLMER
259. Chen, Y., Smith, M. R., Thirumalai, K., and ZychUnsky, A. (1996). A bacterial invasin induces macrophage apoptosis by binding directly to ICE. EMBO J. 15, 3853-3860. 260. Starr, M. R (1981). Prokaryotes as plant pathogens. In "The Prokaryotes" (M. P Starr, H. Stolp, H. G. Truper, A. Balows, and H. G. Schlegel, eds.), pp. 123-134. Springer-Verlag, New York. 261. Burkholder, W. H. (1950). Sour skin, a bacterial rot of onion bulbs. Phytopathology 40, 115-117. 262. Mao, W., Lumsden, R. D., Lewis, J. A., and Hebbar, P K. (1998). Seed treatment using pre-infiltration and biocontrol agents to reduce damping-off of corn caused by species of Pythium and Fusarium. Plant Dis. 82, 294-299. 263. Govan, J. R. W., and Vandamme, P. (1998). Agricultural and medical microbiology: A time for bridging the gaps. Microbiology 144, 2373-2375. 264. Holmes, A., Govan, J., and Goldstein, R. (1998). Agricultural use of Burkholderia (Pseudomonas) cepacia: A threat to human health? Emerg. Infect. Dis. 4, 221-227. 265. Rahme, L. G., Tan, M. W., Le, L., Wong, S. M., Tompkins, R. G., Calderwood, S. B., and Ausubel, F. M. (1997). Use of model plant hosts to identify Pseudomonas aeruginosa virulence factors. Proc. Natl. Acad. Sci. U.S.A. 94, 13245-13250. 266. Cho, J. J., Schroth, M. N., Kominos, S. D., and Green, S. K. (1975). Ornamental plants as carriers of Pseudomonas aeruginosa. Phytopathology 65, 425^31. 267. Bliska, J. B., Galan, J. E., and Falkow, S. (1993). Signal transduction in the mammalian cell during bacterial attachment and entry. Cell 73, 903-920. 268. Glazebrook, J., Rogers, E. E., and Ausubel, F. M. (1996). Isolation of Arabidopsis mutants with enhanced disease susceptibility by direct screening. Genetics 143, 973-982. 269. Hirano, S. S., Rouse, D. I., Clayton, M. K., and Upper, C. D. (1995). Pseudomonas syringae pv. syringae and bacterial brown spot of snap bean: A study of epiphytic phytopathogenic bacteria and associated disease. Plant Dis. 79, 1085-1093. 270. Staskawicz, B. J., Dahlbeck, D., and Keen, N. T (1984). Cloned avirulence gene oi Pseudomonas syringae pv. glycinea determines race specific incompatibility on Glycine max (L.) Merr. Proc. Natl. Acad. Sci. U.S.A. 81. 6024-6028.
CHAPTER 6
Yersinia AoiFE P. BOYD GUY R . CORNELIS
I. Introduction A. Course of Yersinia Infection B. Avoidance of Phagocytosis C. Control of Cytokine Production and Release D. Virulence Factors II. The Adhesive Factors A. Invasin B. Ail C. Myf/pH 6 Antigen D. YadA E. Conclusion III. Iron Acquisition IV. Pathogenicity Islands V. Yst Enterotoxin VI. The Yersinia Virulence Plasmid A. Role of the Virulence Plasmid B. Ysc Secretion System C. Yops D. Regulation of Transcription of the Virulon Genes E. Syc Cytosolic Chaperones F Translocation of Effector Yops across the Eukaryotic Cell Plasma Membrane G. The Yop Effectors and Their Targets VII. Conclusion References
Principles of Bacterial Pathogenesis Copyright © 2001 by Academic Press All rights of" reproduction in any form reserved. ISBN 0-12-304220-8
997
228 228 230 230 231 231 231 233 234 235 235 236 237 238 238 238 240 242 244 245 246 249 252 253
228
AoiFE P. BOYD AND GUY R. CORNELIS
/. INTRODUCTION A.
Course of Yersinia Infection
Yersinia spp. are Gram-negative bacilli belonging to the Enterobacteriaceae family. Based on differentiating biochemical characteristics, 11 species have been identified and further divided into biogroups. Serotypes have been established based on the reaction of antibodies to different lipopolysaccharide structures. The serotypes are linked to geographical distribution, severity of human disease, and animal reservoir. Of the 11 species in the Yersinia genus, only three are human pathogens: Y. pestis, Y. pseudotuberculosis, and K enterocolitica. Y pestis is the agent of bubonic plague, which is best known as the black death of the Middle Ages that killed millions of people. More recently, there has been an increase in cases of Y pestis seen in the United States, and isolated outbreaks have also occurred in India [1]. K enterocolitica, which is the most prevalent in humans, and Y pseudotuberculosis cause a broad range of gastrointestinal syndromes, ranging from acute gastroenteritis to mesenteric lymphadenitis and, on rare occasions, they can even provoke systemic infections such as septicaemia and meningitis [2]. Humans generally become infected with Y pestis via a bite of a flea that has acquired K pestis from a blood meal on an infected animal, such as a rat (Fig. 1). In the flea, infection is limited to the alimentary tract, which becomes so blocked with bacteria that Y. pestis is regurgitated into the next animal the flea feeds on. In humans and other animals, K pestis spreads from the site of the flea bite into the regional lymph nodes and the characteristic buboes (swollen lymph nodes) of bubonic plague form. The bacteria may then spread into the bloodstream to cause septicaemia, and also to the spleen, liver, and lungs. Pneumonic plague is transmitted by respiratory droplets from the lungs of an infected individual and causes an overwhelming pneumonia. K pestis is an obligate parasite, and this is in contrast to K enterocolitica and K pseudotuberculosis, which can survive outside animal hosts and are foodbome pathogens. Y enterocolitica infection occurs mainly by ingestion of contaminated food or water, and pork meat is a frequent source of this pathogen [3]. Because of its ability to grow at low temperatures, K enterocolitica can multiply in refrigerated stored blood bags, which can lead to severe posttransfusional septic shock [4]. Once ingested, K pseudotuberculosis and K enterocolitica attach to the intestinal mucus and intestinal cells, and Y. enterocolitica produces an enterotoxin that induces diarrhoea (Fig. 1). Y enterocolitica and Y pseudotuberculosis are able to cross the gut epithelium and proliferate locally in the underlying tissue. The bacteria selectively enter via the M (microfold) cells, and reach the intestinal lymphoid aggregates known as Peyer's patches [5-7]. M cells are specialized epithelial cells that carry out transcytosis; they take up small quantities of the intestinal contents and release them at their basolateral side into the Peyer's patches. Entry into the Peyer's patches leads to an enormous recruitment of phagocytic polymorphonuclear leukocytes (PMNs), formation of microabcesses comprising extracellular Yersinia, appearance of dead apoptotic cells and, even-
6.
229
YERSINIA
K pestis 1
Respiratory droplets
Y. pestis
Y, enterocolitica Y. pseudotuberculosis
Fig. 1 Infection routes of the three pathogenic Yersinia species. K pestis enters the body from a flea bite and moves to the lymphatic nodes, where it forms buboes. From the lymphatic system it can reach the bloodstream and eventually the lungs, to cause pneumonic plague, which can be transmitted by respiratory droplets. Y. enterocolitica and Y. pseudotuberculosis are food-borne pathogens that enter the body via the intestinal tract and pass through the M cells of the Peyer's patches to reach the lymph system. Y. pseudotuberculosis can also pass into the bloodstream.
230
AoiFE p. BOYD AND GUY R. CORNELIS
tually, complete destruction of the cytoarchitecture of the Peyer's patches [5, 7]. Monocytes infiltrate the Peyer's patches and mature into inflammatory macrophages to produce cytokines such as interleukin-12 (IL-12), gamma interferon (IFNy), and tumor necrosis factor alpha (TNF-a), which aid in development of the immune response [8-10]. Professional phagocytes severely restrict the rate at which Yersinia multiplies in the host tissues, thereby allowing the host to develop a specific protective immunity. However, Yersinia can fight back by impairing phagocytosis, inhibiting phagocytic killing, triggering apoptosis, and suppressing the normal release of TNF-a and other cytokines. Once established in the Peyer's patches, the bacteria can disseminate to the mesenteric lymph nodes and eventually to the liver and spleen [7, 11].
B. Avoidance of Phagocytosis The alterations in tissue morphology that occur after Yersinia infection result from both the virulence properties of the bacteria and the defense features of the immune system of the host and, hence, reflect the fragile equilibrium between these two factors. In spite of their different infection routes, all three Yersinia spp. share a common tropism for lymphoid tissues and a common capacity to resist the nonspecific immune response. All the histological and microscopic studies confirm the affinity of Yersinia for lymphoid tissue and the reticuloendothelial system, and have also provided evidence for a predominantly extracellular multiplication of Yersinia in the lymphatic organs [5, 12]. Once the bacteria have passed through the M cells to the Peyer's patches, it seems that the majority remain extracellular. However, one cannot exclude an intracellular state of Yersinia at later stages of the infection, especially when the bacteria transmigrate from the Peyer's patches to deeper tissues. In accordance with these in vivo observations. Yersinia spp. are resistant to phagocytosis by macrophages [13, 14] and PMNs [15-17] in vitro. Thus, Yersinia spp. are predominantly extracellular pathogens, and their survival strategy strongly relies on their ability to escape phagocytosis.
C. Control of Cytokine Production and Release Cytokines play a major role in limiting and eliminating bacterial infection. One of their most important effects is to cause cells of the immune system to become activated, proliferate and differentiate, and so drive the development of the immune and inflammatory responses against the infection. The major cytokines released in response to bacterial infection are interleukin 1 (IL-1), interleukin 2 (IL-2), interleukin 6 (IL-6), tumor necrosis factor (TNF), and prostaglandins. TNF-a, which is mainly released by macrophages, plays an essential role in the
6.
YERSINIA
231
local host defense mechanism against Yersinia in intestinal tissues, possibly by activating phagocytes [9]. Epithelial cells also participate in modulation of the immune response against infection by Yersinia via the release of proinflammatory cytokines such as IL-1, IL-6, IL-8, TNF-a, monocyte chemotactic protein-1 (MCP-1), granulocyte-macrophage colony-stimulating factor (GM-CSF), and melanoma growth-stimulating activity (MGSA) [18-20]. These cytokines play a role in the initiation or amplification of the inflammatory response: IL-8 and MCP-1 act as potent chemoattractants and activators of neutrophils and monocytes, respectively; TNF-a activates neutrophils and mononuclear phagocytes, while GM-CSF prolongs the survival of neutrophils and monocytes and increases the response of those cells to other proinflammatory stimuli, which can further amplify the inflammatory response. Epithelial cells thus appear to be programmed to provide a set of chemotactic and activating signals to adjacent and underlying immune and inflammatory cells in the earliest phases after microbial infection. However, as we will discuss later in this chapter, cytokine release is inhibited by pathogenic Yersinia spp., potentially providing a powerful survival mechanism. D. Virulence Factors A number of virulence factors are encoded in the chromosome of Yersinia spp., including the invasin InvA, the adhesive factors Myf/pH 6 antigen and Ail, the enterotoxin Yst, and iron acquisition proteins (Table I). In addition, all three pathogenic Yersinia spp. harbor a common 70-kb virulence plasmid that encodes an array of tightly regulated and sophisticated antihost factors.
//. The Adhesive Factors A pathogen must be able to cope with and subvert the host immune responses. The strategies used by Yersinia to establish an infection are to resist phagocytosis by macrophages and PMNs, to inhibit cytokine production, and to induce apoptosis [21]. To achieve these effects. Yersinia adheres to receptors on the surface of host cells and injects toxic proteins inside the host cell cytosol, thereby inducing dysregulation of signal transduction pathways (see below). Yersinia spp. possess a number of adhesion factors that mediate bacterial attachment to eukaryotic cells, including Inv, YadA, Ail, and Myf/pH 6 antigen. A.
Invasin
Invasin (Inv) is a chromosomally encoded outer membrane protein that is expressed in both Y enterocolitica and Y pseudotuberculosis [22-25]. Nonpathogenic strains of these two species often lack a functional Inv and are missing other virulence determinants [26]. Surprisingly, the Y pestis inv gene is inactivated by an insertion sequence [27]. Inv promotes both attachment to and invasion into eukaryotic cells, including nonphagocytic cells, by Yersinia spp. [22-24, 28].
232 Table I
AoiFE P. BOYD AND GUY R. CORNELIS
Adhesion Molecules and Chromosomal Virulence Factors Required for virulence
Protein
Function
Inv
Adherence and invasion
K pseudotuberculosis and pathogenic K enterocolitica strains
Not absolutely; enhances Peyer's patches colonization
Ail
Adherence and invasion
K pseudotuberculosis and pathogenic K enterocolitica strains
No for Y enterocolitica; unknown for Y pseudotuberculosis
YadA
Adherence and invasion
Y. pseudotuberculosis and pathogenic K enterocolitica strains
Yes for Y enterocolitica; no for Y pseudotuberculosis
Myf/pH 6 antigen
Adherence
Y. pestis, Y. pseudotuberculosis, and pathogenic K enterocolitica strains
Yes for Y pestis; others unknown
Yst
Enterotoxin
Pathogenic K enterocolitica strains
Required for diarrhea
FyuA/ Psn-Irp
Iron acquisition
K pestis, Y. pseudotuberculosis and highly pathogenic Y enterocolitica strains
Yes for Y pestis and Y enterocolitica; unknown for Y pseudotuberculosis
Present in
Introduction of the inv gene into other bacterial species, such as Escherichia coli, confers the capacity to invade eukaryotic cells upon these bacteria [24, 25]. Inv is not required for virulence in Y. pseudotuberculosis or Y. enterocolitica, but it does favor efficient translocation of the bacteria from the intestinal tract into the Peyer's patches and so to the underlying tissues [29-31]. As Inv is important at this initial stage of infection, it could be advantageous for the ingested Yersinia to have the adhesin already present on its surface to direct the bacterium to the M cells, and indeed Inv is maximally produced at 23°C [32]. However, the addition of sodium and a reduction in the pH to 5.5 allows production of Inv at 37°C at levels that are equal to those observed at 23°C [33]. It thus seems that Inv expression is possible inside the host animal at 37°C with the appropriate environmental conditions, and, in agreement with these results, Inv can be detected on Yersinia in Peyer's patches 2 days after infection [33]. Inv expression is maximal when bacteria enter stationary phase, and SspA (a stationary phase regulator) is required for optimal Inv expression [34]. The inv gene is located in the middle of a gene cluster encoding the flagella proteins [35]. Interestingly, the expression of Inv is inversely related to that of flagella, (i.e., the
6.
YERSINIA
233
environmental conditions and regulatory proteins that enhance Inv expression decrease expression of flagellin [34]). It makes sense that these two factors would be regulated in this way, as motile bacteria would not be able to move freely if they were attached to a surface and attachment would not be favored by bacteria trying to swim away all the time! The Inv receptor on eukaryotic cells is (31 integrin [36]. Integrins are able to couple extracellular adhesion events to numerous signaling pathways within the mammalian cell, some of which allow association of the pi chain to cytoskeletal-associated proteins. Once attached, multiple points of contact are established between the cell and bacterium, and the bacterium is taken up into an endocytic vacuole by what is called a zipper mechanism [37]. Uptake is accompanied by cytoskeletal rearrangements with accumulation of actin, filamin, talin, and (31 integrins around the incoming bacteria. Invasion can be inhibited by cytochalasin D, which disorganizes actin filaments, and this property has been used to study the effects on host cells of externally located bacteria [38, 39]. It has also been shown that tyrosine protein kinases are involved in the invasion event [40]. The (31 integrin-binding domain is located in the 192 C-terminal amino acids of the 986-aa Inv protein and incorporates a 76-aa disulfide loop [41,42]. An RGD motif is important for the binding of fibronectin to (31 integrins, and attachment of Yersinia to cells via the Inv protein is inhibited by RGD-containing peptides. However, Inv does not contain an RGD sequence. Instead, amino acids around residue D911 are critical for binding, and residues around D811 are important for high-affinity binding [43, 44].
B. Ail Ail is the second chromosomally encoded, membrane-associated protein that promotes attachment to and subsequent invasion of eukaryotic cells by Yersinia spp. [23]. Like Inv, Ail is expressed in virulent strains of Y pseudotuberculosis and Y enterocolitica but is lacking in Y. pestis due to an insertion sequence. Also, Hke Inv, Ail confers invasion properties on E. coli [23, 45, 46]. Ail is a less powerful adhesin than Inv [46], but it does have the additional ability of rendering Yersinia spp. resistant to killing by serum complement [47, 48]. Ail is expressed by Yersinia during infection; but, nevertheless. Ail is not required for virulence in Y enterocolitica—neither to establish infection nor to cause systemic infection [49, 50]. Unlike Inv, Ail is preferentially expressed at 37°C under aerobic conditions in the stationary phase [48]. In an as-yet-uncharacterized manner, ClpP protease seems to play a role in negative transcriptional regulation of Ail at lower temperatures [51]. A number of Ail homologs have been identified in other pathogenic bacteria. Structural models for these proteins predict the presence of eight membrane-span-
234
AoiFE P. BOYD AND GUY R. CORNELIS
ning domains alternating with hydrophilic inner and outer loops. The Rck protein of Salmonella typhimurium promotes resistance to complement killing and cellular invasion [52]; PagC, also in S. typhimurium, is essential for full virulence in mice and survival within macrophages [53]; Lom of bacteriophage lambda is expressed in the outer membranes of E. coli lysogens [54]; and OmpX of E. coli is required for a^ activity [55]. Rck and Ail promote serum resistance and eukaryotic cell invasion, properties not shared by PagC, E. coli OmpX, and Lom [54]. However, the Ail homolog Tia of enterotoxigenic E. coli (ETEC) does promote adhesion and invasion [56], as do OmpX of Enterobacter cloacae [57] and lalB of Bartonella bacilliformis, the agent of human Oroya fever [58].
C. Myf/pH 6 Antigen Myf (mucoid Yersinia factor) in K enterocolitica and its homolog pH 6 antigen in Y. pestis and Y, pseudotuberculosis are chromosomally encoded proteins that form a fibrillar structure of strands, bundles, and aggregates of 15-kDa subunits surrounding the bacteria [59-61]. Like Inv and Ail, expression of these proteins is restricted to pathogenic strains [61]. They enhance thermoinducible binding of Yersinia spp. to eukaryotic cells and can bind intestinal luminal mucus [31, 62]. pH 6 antigen binds specifically to (31-linked galactosyl residues in glycosphingolipids [63]. In addition, synthesis of this antigen has been found to be induced inside macrophages, suggesting it may also play a role in intracellular survival [60]. Most interestingly, pH 6 antigen is required for full virulence of Y pestis [59], and this distinguishes it from Inv and Ail, which are genetically inactivated in Y pestis. Myf/pH 6 antigen is produced from a locus of five genes, one of which, myfA/psaA, encodes the main fibrillar subunit [59-61, 64]. myfBlpsaB and myfClpsaC are required for transport of the subunit across the bacterial membrane and assembly of the subunit into fibrillae [59, 61]. MyfB/PsaB is a member of the PapD family of periplasmic chaperones and could act as a chaperone for MyfA/PsaA, while MyfC/PsaC could act as an usher in the outer membrane. The two inner membrane proteins, MyfE/PsaE and MyfF/PsaF, are required for transcription of myfA/psaA [59, 64, 65]. The C termini of MyfE/PsaE and MyfF/PsaF are periplasmic, while the cytoplasmic N terminus of MyfE/PsaE has similarity to the DNA-binding domain of transcription regulators of two component regulatory systems. This suggests that together these two proteins can sense environmental signals and transduce these signals to the interior of the bacterium. myfE/psaE and myfFlpsaE are transcribed constitutively while transcription of the myfA/psaA operon occurs at 37°C in an acidic medium—hence, the name pH 6 antigen in Y pestis.
6.
YERSINIA
235
D. YadA The virulence plasmids of Y. enterocolitica and K pseudotuberculosis encode an outer membrane protein called YadA [66-68]. The yadA gene of Y. pestis has a single basepair deletion that results in a reading frame shift and an mRNA with a reduced half-life, so that the YadA protein is not produced in this species [69]. YadA can bind a variety of eukaryotic extracellular and cell surface molecules, including collagens, fibronectin, and laminins [70-73], and can also mediate internalization of the bacteria into eukaryotic cells, a process in which interaction with pl-integrins plays a role [74, 75]. In addition, YadA contributes to the protection of Y. enterocolitica against killing by the antimicrobial polypeptides from the cytoplasmic granules of PMNs that are normally released into the phagolysosome containing the phagocytosed Yersinia [76]. YadA can also protect against killing by human serum [66, 77] due to binding of factor H by YadA, which leads to inactivation of C3b and a subsequent decrease in the deposition of membrane attack complexes on the bacterial surface [78, 79]. This reduction of complement-mediated opsonization could be involved in the resistance of Yersinia to phagocytosis [80]. There is a major difference between K enterocolitica and K pseudotuberculosis regarding the role of the yadA gene in virulence in mice. A Y. enterocolitica yadA mutant is attenuated for virulence [49, 81-83], as YadA is required for survival and multiplication in the Peyer's patches, and perhaps for dissemination of the bacteria from the Peyer's patches to other sites in the body [49, 81]. In contrast, a Y. pseudotuberculosis yadA mutant is just as virulent as the wild type and can colonize the Peyer's patches just as efficiently [30, 68, 84]. An inv yadA double mutant strain maintained the same virulence as the parental strain, demonstrating that neither Inv nor YadA plays an important role during Y. pseudotuberculosis infection [30]. The differences between the Yersinia species with regard to the role of YadA in virulence probably results from the interplay of multiple adhesion factors of varying importance. Structure-function studies have revealed a number of functional domains in the YadA protein. The N terminus of YadA comprises a typical secretion signal sequence [85] and is followed by amino acids 29-81, which are required for adherence to PMNs [82]. Residues 83-101 compose one of the hydrophobic domains of YadA and are required for autoagglutination, and binding to collagen and laminin [83, 86]. Histidines 156 and 159, which are also important for collagen and laminin binding, are needed for binding to fibronectin and to epithelial cells [81]. Finally, the hydrophobic C-terminal amino acids of YadA are involved in surface exposure of the protein and polymer formation [83]. E.
Conclusion
To summarize, four Yersinia spp. adhesins have been identified—Inv, Ail, YadA, and Myf/pH 6 antigen. Expression of each of these adhesins can be induced at 37°C in the appropriate conditions, but expression is restricted to virulent strains
236
AoiFE P. BOYD AND GUY R. CORNELIS
only. K pestis does not express Inv, Ail, or YadA. These adhesive factors may not be necessary in Y, pestis, as it enters the body by a different route than Y. pseudotuberculosis and Y. entewcolitica. Alternatively, Y. pestis could possess additional adhesion factors, such as the Fraction 1 capsule or the Pla protease (plasminogen activator) which can bind weakly to collagen [1]. YadA is required for virulence in K entewcolitica, and pH 6 antigen for virulence in Y. pestis, but none of the four adhesins has been shown to be absolutely necessary for virulence in all three Yersinia species. This suggests that there is probably a combination of bacterial adhesins and eukaryotic cell receptors that mediate pathogenicity and that there is a certain amount of redundancy in their functions, and/or that these adhesins play a second role in Yersinia lifestyle other than attachment to eukaryotic cells (e.g., YadA and Ail are both involved in resistance to killing by serum).
///. Iron Acquisition Iron is an essential nutrient for Yersinia spp., but, in the host, iron is chelated by mammalian proteins, making it less available to the bacteria. To overcome this problem. Yersinia spp. possess a number of iron acquisition systems. In Y enterocolitica the presence of iron acquisition systems makes a significant difference between low- and high-pathogenicity strains [87, 88]. The importance of iron during infection is demonstrated by Y. enterocolitica bacteremia, which occurs under conditions that make iron more available to the bacteria (e.g., in patients that are overloaded with iron and/or are treated with desferrioxamine, an iron-chelator that Yersinia spp. can readily utilize). The highly pathogenic strains Y pestis, Y pseudotuberculosis 0:01, and Y. enterocolitica biotype 1B share a common iron uptake system called FyuA/PsnIrp [89-91]. This system uses yersiniabactin, a siderophore that can remove iron from a number of mammalian proteins, due to its extremely high affinity for ferric iron [92]. Functional yersiniabactin production and uptake are required for growth at 37°C in iron-depleted media and for virulence [89, 93-95]. Seven genes— called irpl, irp2, irpS, irp4, irp5,fyuA/psn and ybtA—have been identified at this locus so far [94, 96]. irpl encodes HMWPl (high molecular weight protein 1), which is a cytosolic 385-kD protein required for yersiniabactin synthesis. irp2 encodes HMWP2—a 228-kD protein also required for yersiniabactin synthesis. The N terminus of HMWPl resembles polyketide synthases and the C terminus resembles HMWP2. irpS encodes a 41-kD protein of unknown function and irp4 encodes a 30-kD protein (YbtT) that resembles thioesterases. The 56-kD YbtE encoded by irp5 resembles dihydroxybenzoic acid activators and is also required for yersiniabactin synthesis. The proteins encoded by these five genes are presumably the yersiniabactin synthesizing enzymes. The sixth gene in this locus encodes the highly specific yersiniabactin receptor called FyuA in K enterocolitica and Psn is Y pestis. This 74-kD outer membrane protein also serves as a receptor for pesticin—a bacteriocin produced by Y. pestis.
6.
YERSINIA
237
Energy-dependent transport of inorganic iron is induced by iron-deficient conditions in all three pathogenic species of Yersinia. Under iron-replete conditions, iron transport is repressed and excess iron is stored inside the bacteria. Over 30 Y. pestis proteins have been shown to be regulated by iron [97]. This regulation is mediated to a large extent by Fur [98, 99], a cytosolic protein that on binding ferrous iron changes conformation and binds DNA in front of Fur-regulated genes at a specific site called a Fur box, thus preventing transcription. In the presence of iron. Fur downregulates transcription of fyuA/psn, irp2 and most, but not all, other iron-regulated proteins [89]. Under these conditions, yersiniabactin production and uptake is repressed due to transcriptional repression of irp2 andfyuA/psn by Fur. In the absence of iron, Fur cannot bind DNA and transcription proceeds, and Ybt and its receptor are produced. Ybt chelates iron from the environment, then attaches it to Psn/FyuA, and the iron is transported inside the bacteria. Other factors are also involved in iron regulation: YbtA is an AraC-like regulator that is required for transcription of fyuA/psn and irp2, and it is encoded by a gene located upstream of irp2 [100]. Ybt A also acts to control the system as it downregulates its own transcription. In addition, yersiniabactin is itself required for upregulation of genes involved in its own production and uptake, including irp2 andfyuA/psn [94, 96]. Thus, there is autoregulation of genes involved in the synthesis and uptake of yersiniabactin. A number of other iron acquisition systems and iron-regulated proteins have been identified. For instance, in K enterocolitica the exogenous siderophore desferrioxamine B is bound and taken up by the 77-kD outer membrane protein Fox A [101]. This explains why septicaemia with low-virulence Y. enterocolitica is sometimes observed in patients who receive desferrioxamine B to treat iron overload caused by multiple blood transfusions. Still to be investigated is the conservation of these systems among the Yersinia species, the specific role of each system, the function of the components within each system, and the importance of each system in virulence.
IV. Pathogenicity islands The fyuAlpsn-irp region has many characteristics of pathogenicity islands: it carries genes necessary for a high-pathogenicity phenotype, it is present only in pathogenic strains, it is greater than 35 kb long (45 kb total), it is bordered by a tRNA gene at one side {asn tRNA), it contains insertion sequences, it has a GC content different from that of the rest of the chromosome (60% versus 47-50%), and it is not found in other bacterial species {E. coli) [102-104]. As this region determines the level of pathogenicity in Y. enterocolitica between strains of high virulence (e.g., serotypes 0:8 and 0:21) and those of low virulence (e.g., serotypes 0:9 and 0:3), it has been called an HPI (high-pathogenicity island). In Y. pestis, the fyuAlpsn-irp region is linked to a haemin storage (hms"^) and pigmentation (pgm"^) locus to form a complete 102-kb region [104]. The haemin storage locus allows Y pestis to use haem and haem-protein complexes—for example, myoglobin or haemoglobin—as a source of iron. When grown in the
238
AoiFE P. BOYD AND GUY R. CORNELIS
presence of haemin or Congo red, bacteria harboring this locus give rise to pigmented colonies, and so these are given the phenotype pgm"^. This large region is conserved among different strains, but in the lab it is easily lost, most probably due to recombination between insertion sequences located at the extremities of the 102 kb [105]. It is maintained under natural conditions, as it is essential for in vivo survival (iron acquisition) and transmission to new hosts via flea vectors (haemin storage system) [106].
V. Yst Enterotoxin Pathogenic strains of Y. enterocolitica produce a heat-stable enterotoxin called Yst, which is responsible for the diarrhoea associated with Yersinia infection [107, 108]. Yst is homologous to the STI toxin of E. coli and to rat guanylin, an endogenous activator of the intestinal guanylate cyclase [109]. Like STI, Yst stimulates cGMP synthesis in the intestinal brush border, leading to an overall effect of fluid loss and lack of fluid absorption [110-112]. The STI toxin is very tissue specific, and receptors for it are apparently present only in the intestine. Yst is synthesized as a 71-aa pre-pro-Yst nascent protein, of which the 18 N-terminal amino acids comprise a signal sequence that is cleaved off during secretion [107, 113]. A further 23 central amino acids are removed during or after secretion, and the mature active peptide thus contains just 30 amino acids. Yst is produced during the stationary phase at 30°C, but increased osmolarity and pH at 37°C also induce high expression of this protein [114]. Accordingly, yst transcription is controlled by the stationary phase sigma factor RpoS and by two proteins that affect DNA supercoiling—the YmoA histone-like protein and Yrp, which is homologous to E. coli host factor 1 [114-116].
VL The Yersinia Virulence Plosmid A. Role of the Virulence Plasmid The virulence plasmid, referred to as the pYV plasmid in K enterocolitica, encodes the Yop virulon—an integrated virulence apparatus (Fig. 2) [117a-c]. Experimental infection of mice with laboratory-constructed derivatives lacking the virulence plasmid showed that numerous bacteria were located intracellularly in vacuoles of PMNs and mononuclear cells but were unable to cause infection. In contrast, virulence plasmid-carrying bacteria were not phagocytosed and
239
6. YERSINIA
repBA
oriR
yopO
arsCBR/^'^
yadA
yopl\/l
pYVeO:9
yscM2
yopD ^ yopB Hi sycD g j^^^
intracellular delivery
69.5 kb
IcrG spyAB
plasmid partition
secretion secretion and its control
effectors and chaperones
secretion
secretion yscM
regulation
s > yscuj'x^
yopH
virC
p
o/T
/ f ,^,R
//
^ ^ yscV(lcrD) _ tyeA yopN
virB
virF y^*^^ ^"^ (virG)
Fig. 2 Map of the pYV plasmid of K enterocolitica. The genes encoded by the pYV plasmid and the functions of their protein product. Adapted with permission from Iriarte and Cornelis (1998) [175].
remained extracellular, even though they were surrounded by inflammatory cells [118]. Thus, virulence plasmid-encoded proteins are involved in the resistance of Yersinia to phagocytosis by PMNs and macrophages. These proteins are also involved in inhibition of the PMN oxidative burst [119], in induction of programmed cell death in macrophages [120-122], and in inhibition of the cytokine release that is normally induced by Yersinia infection [19, 20, 123], so limiting the host's inflammatory response to the infection. The cell types that are the actual targets of these Yersinia proteins in vivo are presently not known, and, although macrophages and PMNs are obvious in vivo targets, epithelial cells of the gastrointestinal tract and endothelial cells may also be relevant targets. Epithelial cells not only constitute a barrier against bacterial invasion, but they also synthesize and secrete a number of cytokines, while endothelial cells have an important role in development of the immune and inflammatory responses by recruiting PMNs through the increased surface expression of adhesion molecules.
240
AoiFE p. BOYD AND GUY R. CORNELIS
The Yop virulon includes a set of secreted proteins (the Yop proteins), the Yop-specific chaperones (the Syc proteins), a Yop-dedicated secretion system (the Ysc system), and a regulatory network. Some of the secreted Yop proteins are required for the translocation across the eukaryotic cell membrane of other Yops that interfere with normal cellular processes in the cytosol of the eukaryotic cell.
B. Ysc Secretion System The virulence plasmid encodes a set of proteins that are involved in establishing and building a Yop-specific secretion apparatus through the bacterial membranes of Yersinia spp. Homologous secretion systems are also present in a number of other bacteria, all of which interact with eukaryotic cells. These include animal pathogens—Salmonella spp.. Shigella flexneri, enteropathogenic and enterohaemorraghic E. coli (EPEC and EHEC), Pseudomonas aeruginosa. Chlamydia psittaci, and Bordetella spp.—and plant pathogens that elicit the hypersensitive response and pathogenesis—Erxvinia amylovora, Pseudomonas syringae, Xanthomonas campestris, and Ralstonia solanacearum [21, 124-126]. This system is also involved in the nodulation of legumes by the symbiotic nitrogen-fixing Rhizobium sp. NGR234 [127]. The Ysc system belongs to the family of type III secretion systems, which are called contact-dependent because intimate contact between the eukaryotic cell and bacteria triggers secretion and allows delivery of bacterial proteins inside eukaryotic cells. In Yersinia, 29 ysc secretion genes have been identified within four contiguous loci, and, although a mutation in almost any one of these genes causes a lack of secretion, little is known about the exact function of the various encoded components. Four proteins—LcrD, YscD, YscR, and YscU—span the inner membrane (Fig. 3) [128-132], while YscC is an outer membrane protein that belongs to the family of secretins, a group of outer membrane proteins involved in the transport of various macromolecules and filamentous phages across the outer membrane [130, 133, 134]. The VirG lipoprotein is required for efficient targeting of this YscC complex to the outer membrane [133], where it forms a ring-shaped pore structure with an external diameter of about 200 A and an apparent central pore of 50 A. YscN contains ATP-binding motifs (Walker boxes A and B) resembling the p catalytic subunit of FQEI proton translocase and related ATPases, and presumably energizes the secretion of Yops [135]. Four }^5c-encoded proteins are secreted: YopR, encoded by yscH, YscO, YscP and YscM/LcrQ [136-139]. YopR is not required for secretion of the other Yops, but it is involved in pathogenesis since the LD50 of the yscH mutant is 10-fold higher than that of the wild-type strain [138]. YscM/LcrQ is involved in the feedback control of Yop synthesis (see §VI.D.2) [138-141]. The type III Ysc secretion proteins are thought to form a structure similar to that of the apparatus involved in flagellar assembly [142, 143].
6.
241
YERSINIA
f^ Aimm 1
fiPfliiniiniiiifioM
mm
Mumu
MUM
ii IM O5 GOO
folding or association
Yop
y
'g
Fig. 3 Model of the Ysc secretion apparatus. The Syc chaperones bind to their newly synthesized partner Yops to prevent Yop misfolding, inappropriate protein-protein interactions and/or degradation. The Yops associate with the secretion apparatus, pass through, and are then released from the bacterium. The Ysc machinery comprises the YscN ATPase, the inner membrane proteins YscR, YscU, and YscD, the lipoproteins VirG and YscJ, the proteins YscS, LcrD, and YscT, and, in the outer membrane, the secretin YscC. Reprinted with permission from Cornells et al. (1998) [21].
242
AoiFE P. BOYD AND GUY R. CORNELIS
C. Yops The Ysc system is required for the specific secretion of the virulence plasmid-encoded Yop proteins [144, 145]. 14 Yops have been identified so far, and they seem to be very well conserved among the Yersinia species (Table II, Fig. 4). Most of the Yop proteins are essential for virulence [146-151]. The information necessary for Yop secretion is contained in the N terminus [39, 144], and the shortest region Table II
Yops Secreted by Y. entewcolitica W22703
Yop
Size: predicted and apparent (kDa)
Secretion signal (N-terminal amino acids)
Translocation signal (N-terminal amino acids)
Required for virulence
YopO/ YpkA
82, 84
77
77
Yes
YscP YopH
50, 66 51, 51
ND" 17
N/A^ 71
ND Yes
YopM YopB LcrV YopD
42, 42, 37, 33,
48 44 41 37
40 ND ND ND
100 N/A ND ND
Yes Yes Yes Yes
YopT
36, 36
124
124
No
YopN YopP/YopJ
33, 35 33, 30
15 43
N/A 99
ND No
YopE
23, 25
11
50
Yes
YopQ/YopK
21, 20
ND
N/A
Yes
YopR YscMl
18, 17 12, 12
ND ND
N/A N/A
Yes ND
"ND = not determined.
N/A = not applicable.
Function Effector—serine/ threonine kinase Unknown Effector—tyrosine phosphatase of FAK and pHO'^^'; prevents phagocytosis and phagocytic killing Effector? Translocator Translocator effector? Translocator; negative regulator of secretion; effector? Effector—depolymerizes actin; causes cytotoxicity Controls Yop secretion Effector—inhibits NFkB activation; IkB is possible target Induces apoptosis; prevents cytokine induction Effector—depolymerizes actin; causes cytotoxicity; prevents phagocytosis Controls size of translocator pore Unknown Negative regulator of secretion
6.
243
YERSINIA
-Ca"" +Ca2*
YopO
S '
YSCP
Y o p M •"wW'"*™*
67
43
30
YopE
YopQ
igi 20
YopR
14
Fig. 4 The secreted proteins of K entewcolitica. Acrylamide gel separation of the proteins secreted by K entewcolitica grown in calcium deficient media (-Ca^"^) and in media containing calcium (+Ca +). The names of the Yops are shown on the left-hand side of the figure and the molecular weight standards in kD on the right-hand side.
244
AoiFE P. BOYD AND GUY R. CORNELIS
shown to be sufficient for secretion of a Yop was 15 amino acids for YopE [152, 153]. However, unlike proteins secreted by the type II system, there is no cleavage of this secretion signal during export from the bacteria [145, 154, 155]. There is no similarity between the secretion domains of the Yops with respect to amino-acid sequence, hydrophobicity profile, distribution of charged residues, or prediction of secondary structure, which suggests that a conformational structure is important for secretion. It has also been suggested that there may be a signal in the yopE mRNA that directs the nascent polypeptide to the secretion apparatus [156]. A second, and weaker, secretion signal corresponding to the chaperonebinding site (see further) has also been described for YopE [157]. D.
Regulation of Transcription of the Virulon Genes
In vitro, Yop secretion only occurs at 37°C in the absence of Ca^"^. This secretion correlates with growth arrest, a phenomenon known for a long time as "Ca^"^ dependency." There seem to be two different regulatory networks. The first permits full expression of all the virulence plasmid-encoded virulence functions when the environment is ideal and the temperature reaches 37°C, while the second only prevents Yop production in the presence of 2.5 mM Ca^"^ ions. 1.
EFFECT OF TEMPERATURE ON YOP VIRULON TRANSCRIPTION
Transcription of many virulence plasmid genes—including all the yop genes, sycE, yadA and the virC operon—is dependent on VirE/LcrF, a member of the AraC family of regulators [134, 158-160]. On the other hand, VirF/LcrF seems to be dispensable or less important for transcription of the virA and virB operons encoding the Ysc secretion apparatus [161], and of several other genes like sycH [162]. VirF binds to a 40-bp region localized immediately upstream from the RNA polymerase-binding site. These VirF-binding sequences are located in an AT-rich region, appear either isolated or repeated in opposite orientation and contain the 13-bp consensus sequence TTTTaGYcTtTat (in which nucleotides conserved in >60% of the sequences are in uppercase letters and Y indicates C or T) [163]. As VirF/LcrF expression is regulated by temperature at both transcriptional and posttranscriptional levels, this explains in part the temperature regulation of these genes. YmoA, a histone-like protein, is involved in inhibiting transcription at lower temperatures [164]. It has been hypothesized that temperature could dislodge the YmoA transcriptional inhibitor from the promoter regions of VirF/LcrF-sensitive genes, so VirF/LcrF could bind and transcription could proceed [165]. 2.
EFFECT OF CA^^ ON YOP VIRULON TRANSCRIPTION
While Ca^"^ has little effect on transcription of the ysc machinery loci, it has a very clear inhibitory effect on yop expression [166, 167]. Thus, the presence of Ca^"^ ions blocks not only the secretion of Yops but also their synthesis. This
6.
YERSINIA
245
secretion blockage by Ca^"^ probably occurs at the bacterial surface, such that when secretion is compromised a feedback inhibition mechanism blocks transcription of yop genes. This hypothesis is reinforced by the fact that mutations in v/M, virB and virC loci, which encode the Ysc secretion apparatus, severely downregulate expression of iht yop genes [128-131, 135, 158]. Three proteins are involved in the control of Yop release: YopN [154, 168], LcrG [169, 170] and TyeA [168]. yopN, IcrG, and tyeA mutants express and secrete Yops in the presence and absence of Ca^"^ (see later) [154, 169, 170]. The fact that these mutants are derepressed for Yop expression even in repressive conditions (presence of Ca^"^ ions) leads to the idea that feedback regulation operates via a negative regulator. By analogy with the secreted antisigma factor involved in the regulation of flagellum synthesis, Rimpilainen et al [140] suggested that feedback inhibition could be mediated by a negative regulator called LcrQ/YscM that is normally expelled via the Yop secretion machinery. Overproduction of LcrQ abolishes Yop production, and, in the absence of secretion (presence of Ca^+ or mutation in the genes coding for the secretion machinery), an IcrQ mutant indeed synthesizes more Yops than the wild type. In the presence of Ca^"*", this mutant secretes YopD and LcrV. LcrQ is rapidly secreted when bacteria are shifted from a medium containing 2.5 mM Cd?^ (nonpermissive conditions for Yop secretion) to a medium containing a Ca^+ chelator (permissive for Yop secretion), which fits quite well with the "secreted negative regulator" hypothesis [141]. In K enterocolitica, two different YscM proteins—YscMl and YscM2—fulfill the role of LcrQ in Y. pseudotuberculosis [139]. LcrQ/YscM is probably not a transcriptional repressor and one or more other virulence plasmidencoded proteins, including YopD, are required to act with this protein in the feedback inhibition mechanism [171, 172]. E.
Syc Cytosolic Chaperones
Syc chaperones (specific Yop chaperones) are present in Yersinia to aid in secretion of specific Yops. The genes encoding these chaperones are generally situated beside the genes encoding the Yops they aid. Several Syc chaperones have been described, including SycE/YerA for YopE, SycH for YopH, SycN for YopN, SycT for YopT, and SycD/LcrH for both YopB and YopD [162, 163, 173-177]. The Sycs are required for efficient secretion of their corresponding Yops but not for their synthesis. In addition, they bind specifically to their Yop. YopE and YopH have discrete domains (residues 15-50 for YopE and residues 20-70 for YopH) that bind their cognate chaperones, while SycD binds to several domains on YopB [177, 178]. Surprisingly, the chaperone-binding domain of YopE and YopH is not the secretion domain, but rather the translocation domain (see§VI.Rl). Although the Syc chaperones seem to have a common role in protein secretion, they are only weakly related in terms of primary amino acid sequence. However, they do share some common features: (1) an acidic pi; (2) a size in the range of 15 to 19 kD, and (3) a C-terminal amphiphilic a-helix. SycE, SycH, and SycT
246
AoiFE P.
BOYD AND GUY R. CORNELIS
possess a conserved "leucine-repeat" motif (LLWXRXPLXXXXXXXLXXXLEXLVXXAEXL) in this a-helix, where most of the hydrophobic residues, essentially leucines, are present on the same side of the helix [179]. Sycs strongly enhance, but are not required for, secretion of the Yops, as residual secretion of YopE or YopH was still observed in the absence of SycE or SycH, respectively [162, 163]. It was also shown that Yops deleted of their chaperone-binding domains are normally secreted in the absence of their chaperones, in contrast to wild-type Yops, which are much less secreted in the absence of the chaperone [178]. As the amount of a Yop is generally decreased inside Yersinia in the absence of the cognate Syc as compared to in its presence [162, 177], Sycs could have a protective role for their respective Yops. In support of this idea, SycD protects E. coli from cell lysis due to overexpression of YopB [177]. Thus, there are three possibilities (which are not necessarily mutually exclusive) for the role of the Syc chaperones and the chaperone-binding domains: (1) the chaperone-binding domain binds another protein that interferes with secretion, and binding by Syc inhibits this interaction; (2) the chaperone-binding domain inhibits interaction with the Ysc secretion machinery, perhaps as a result of misfolding, and binding by Syc overcomes this inhibition; and (3) the chaperone-binding domain is a site for a protease, and binding by Syc protects against degradation of the Yop.
F.
Translocation of Effector Yops across the Eukaryotic Cell Plasma Membrane 1.
DISCOVERY OF TRANSLOCATION
The secreted Yops include translocators and effectors. The translocators (YopB, YopD and LcrV) presumably form a pore in the eukaryotic cell membrane through which the effector Yops (YopE, YopH, YopP, YopO, YopT, YopM) enter the cytosol of the host cell (Fig. 5). A domain important for translocation of the Yop effectors has been shown to reside in their N-terminal domain, immediately following the secretion domain [152, 153]. This translocation domain is also the chaperone-binding domain, raising the possibility that the Syc chaperones play a role in the translocation of Yops, as well as in their secretion [178]. The translocation event is carried out by extracellular bacteria adhering to the eukaryotic cell surface [39, 180]. Contact between the bacteria and the cell is necessary for translocation of the Yops inside the eukaryotic cell, as neither Yops produced by nonadherent bacteria nor purified secreted Yops have the ability to enter eukaryotic cells [39, 180, 181]. The adhesins primarily involved in enhancing attachment of K pseudotuberculosis and Y. enterocolitica to allow Yop translocation are YadA and Inv [39, 180-182]. For Y. pestis, which lacks Inv and YadA, other adherence factors must fulfill this role (e.g., pH 6 antigen).
6.
247
YERSINIA
EUKARYOTIC CELL depolymerization of actin
phosphorylation
apoptosis & ^ inhibition of cytokine release
Ca2+ dephosphorylation ^^^J of signal transduction ^ > ^ ^ proteins _^€^^.w*
depolymerization of actin
Ca 2+
ftmmnfliiiin Inner MMM^^ membrane JJil^UUJili] [OPEN
Ca2+
.^
Ca2+
nnnnnnnnnn uuuuuuuuuu ICONTACTI
BACTERIAL CELL Fig. 5 Model of the process of Yop translocation into eukaryotic cells in the presence of calcium (right-hand side). The secretion channel, which is composed of Ysc proteins, is closed by YopN, LcrG, and TyeA. On contact with a eukaryotic cell, the channel is opened and YopB, YopD, and LcrV are released to aid in formation of a pore in the eukaryotic cell membrane. YopE, YopH, YopM, YopO/YpkA, YopP/YopJ, and YopT are translocated through this pore into the eukaryotic cell cytosol, where they disrupt normal cellular processes. Adapted with permission from Cornells and Wolf-Watz (1997) [209].
YopE was the first Yop to be shown directly to enter into eukaryotic cells. Earlier experiments had indicated that cellular cytotoxicity was induced by internalized YopE and that the internalization was dependent on other virulence plasmid-encoded proteins, including YopD [181]. The direct translocation of YopE into eukaryotic cells was shown by fractionating the cells after Yersinia infection and by using confocal immunofluorescence [180]. In addition, Sory and Comelis created a plasmid construct that fused the N terminal of the yopE gene to the cya gene and showed that infection of eukaryotic cells by Y. enterocolitica producing the YopE-Cya hybrid resulted in an increase in intracellular cAMP levels which demonstrated that YopE-Cya had been translocated into the cytosol of the eukaryotic cells [39] {cya codes for the catalytic domain of adenylate cyclase from Bordetella pertussis; this enzyme catalyzes the conversion of ATP to cAMP only in the presence of calmodulin, which is present in eukaryotic cells but not in bacteria). Using similar methods, the YopOAfpkA, YopH, YopT, YopM, and YopPAbpJ proteins have also been shown to be translocated into eukaryotic cells [19, 152, 168, 175, 183-185].
248
AoiFE P. BOYD AND GUY R. CORNELIS
2.
THE DELIVERY APPARATUS
The translocation apparatus composed of the YopB, YopD, and LcrV proteins is required for translocation of all the Yops across the eukaryotic cell membrane [19, 152, 168, 171, 175, 183-187]. Analysis of YopD and YopB suggests the presence of domains that could form coiled coils—structures commonly involved in protein-protein interactions—and suggests the presence of hydrophobic domains, thus implying they could be transmembrane proteins [155]. YopB has a moderate level of similarity with proteins of the RTX family of a-hemolysins and leukotoxins that disrupt the membranes of eukaryotic cells by forming pores, suggesting that the translocation apparatus could be some kind of a pore, where YopB would be the main element. In support of this hypothesis, purified YopB has the ability to disrupt lipid bilayers and Yersinia spp. have a YopB- and contact-dependent lytic activity on sheep erythrocytes. Protection experiments with sugars of various molecular weights suggest that the hypothetical pore has an inner diameter between 12 and 35 A [186]. YopB and YopD appear to be associated with one another in the bacterium prior to their secretion, suggesting that YopB and YopD could insert together into the eukaryotic membrane to make the translocation pore [177]. Alternatively, as YopD has been shown to be itself translocated, it has been proposed that YopD could act to guide effector Yops into the eukaryotic cytosol [171]. Other proteins are also involved in the translocation process. LcrV is involved in the process of secretion of YopB and/or YopD [187, 188]; LcrG, a protein encoded by the same operon as YopB, YopD, and LcrV, is needed for efficient translocation of the Yop effectors, but this has only been observed in K enterocolitica [169]. The degree of translocation can be controlled by changing the size of the pore, a mechanism in which YopK/YopQ is involved [189]. Some proteins have a more specific control of Yop translocation, such as TyeA, which is required for translocation of YopE and YopH but not of the effector Yops [168]. Thus, the translocation apparatus is thought to be composed of a pore formed by YopB, with essential (YopD and LcrV) and ancillary (LcrG, YopK/YopQ, TyeA) proteins also playing important roles. 3.
CONTROL OF YOP RELEASE DURING TRANSLOCATION
As described above. Yersinia spp. only secrete Yops in the absence of Ca^"^ and at 37°C. However, contact between the bacterium and the eukaryotic cell is the signal inducing Yop secretion in vivo. Transcription of the yopE gene is induced in bacteria attached to eukaryotic cells, but not in bacteria attached to glass [141]. When Yop secretion is triggered by eukaryotic cells, it is "directional" in the sense that the majority of the Yop effector molecules produced are directed into the cytosol of the eukaryotic cell and not to the external milieu [180, 185].
6.
YERSINIA
249
As described in section VLD.2, three genes are involved in the control of Yop release: yopN, IcrG, and tyeA. Bacteria carrying mutations in any one of these genes are deregulated for Yop secretion in the sense that they secrete Yops even in the presence of Ca^+ in lab media (i.e., they are calcium blind), and they secrete a large percentage of Yops into the culture media when grown in contact with cells (i.e., Yop secretion becomes nondirectional) [154, 168-170, 180, 183, 185, 187, 190]. These three proteins could form a complex on the bacterial surface that functions as a sensor and a stop valve controlling Yop secretion. YopN and TyeA are present and associated on the bacterial surface, while LcrG is primarily cytosolic, with small quantities found in the membrane and extracellular media [154, 168, 170, 191]. LcrG has been shown to bind to LcrV [188, 191], and it has been suggested that the negative effect of LcrG on secretion is counteracted by LcrV. After contact with a receptor on the eukaryotic cell, the three-member sensor would be opened to allow Yop secretion and delivery to the target cell. LcrG binds HeLa cells by interacting with heparan sulfate proteoglycans [192]. Proteoglycans are glycosaminoglycan-containing proteins found on the surface of practically all types of eukaryotic cells, and they have been shown to be receptors for a variety of microorganisms via the glycosaminoglycan moieties. Addition of exogenous heparin or treatment with heparitinase decreased the level of YopE translocation into HeLa cells. As the addition of heparin was unable to completely abolish translocation, another bacterial-eukaryotic cell interaction could also be involved. Thus, the heparan sulfate-LcrG interaction can be viewed as maximizing the efficiency of LcrG in the translocation process but may not be absolutely essential. Although Yersinia carrying mutations in yopN, tyeA, or IcrG have a similar deregulated secretion phenotype, their Yop translocation phenotypes are all different. yopN mutant Yersinia can still deliver all the Yops into the cytosol of the target cell [141, 168, 175, 185]. However, a tyeA mutant is impaired in translocation of YopE and YopH, but surprisingly not of YopM, YopO, YopP, and YopT [168, 175]. Finally, LcrG is required for efficient translocation of all the Yop effectors into eukaryotic cells [169]. These results suggest that these three proteins could form a complex at the exterior tip of the secretion apparatus that controls the passage of Yops through the translocation pore.
G. The Yop Effectors and Their Targets 1.
YOPE
YopE induces disruption of the actin microfilament structure of the host cell [181]. The host cell rounds up and detaches from the extracellular matrix, a phenomenon referred to as cytotoxicity [148, 193]. Actin is responsible for maintaining the shape of cells, and disruption of actin thus leads to cellular amorphism and the rounding up. As the actin is linked to surface-located cellular
250
AoiFE p. BOYD AND GUY R. CORNELIS
adhesion factors, there would also be subsequent detachment of cells. The actin disruption contributes to the ability of Yersinia to resist phagocytosis [181, 194]. The actual enzyme activity and the target of YopE within the eukaryotic cell remain to be identified. In addition to YopE, three other Yops have a cytotoxic effect on cultured epithelial cells, namely, YopH, YopO, and YopT (see further). 2.
YOPH
YopH is a protein tyrosine phosphatase [195-197]. Protein tyrosine phosphorylation processes form part of the signal transduction pathways that control many cellular functions, including mitogenesis and cell division. YopH inhibits phagocytosis mediated by either complement receptors or Fc receptors, and also inhibits Inv-mediated invasion [14, 17, 198]. The Yersinia antiphagocytic effect thus involves blocking of a broad-specificity phagocytic mechanism and is not restricted to the uptake of Yersinia themselves [14, 194]. YopH is able to interfere with early tyrosine phosphorylation signals that occur in the cell during phagocytosis, including phosphorylation of paxillin, focal adhesion kinase (FAK), and plSQC^^ [198-200]. YopH interacts direcdy with FAK and plSO^^^ within focal adhesions, and their subsequent dephosphorylation leads to disruption of peripheral focal complexes and impaired ability of the target cell to carry out phagocytosis by macrophages or the invasin-mediated internalization of the bacteria by nonphagocytic cells [198, 200]. YopE and YopH thus act in concert to enable Yersinia to inhibit their own uptake by macrophages and hence to be able to proliferate in the Peyer's patches as extracellular microcolonies. Integrinmediated adhesion of phagocytes to endothelia or extracellular matrix proteins plays an important role during inflammation. Interference with this process due to YopH-mediated dephosphorylation of plSO^^"^ might have an important impHcation for PMN function during a Yersinia infection. It has also been suggested that YopH is responsible for the capacity of Y pseudotuberculosis to inhibit the respiratory burst [201, 202]. 3.
YOPM
Purified YopM has thrombin-binding activity and competitively inhibits thrombin-induced platelet activation in vitro, suggesting that YopM is an extracellular effector [146, 203]. However, YopM is delivered inside eukaryotic cells [185], indicating that YopM is rather an intracellular Yop effector. YopM contains a succession of leucine-rich repeats (LRR), which are motifs for protein-protein interactions [204], but the intracellular target of YopM is as yet unknown. No effect of intracellular YopM on eukaryotic cells has yet been documented. 4.
YOPOA'PKA
YopO/YpkA is a serine/threonine kinase that induces morphological alterations in epithelial cells causing the cells to round up, but, unlike YopE or YopH, the
6.
YERSINIA
251
cells do not detach from the extracellular matrix [151, 184, 205]. Inside the host cells, the YopOAfpkA protein is targeted to the inner surface of the plasma membrane. No target protein of YopOAfpkA has been identified yet. 5.
YOPP/YOPJ
YopPAfopJ induces apoptosis (programmed cell death) in murine macrophages [19, 120, 121, 206]. By using the mechanism of apoptosis during the infection process. Yersinia might eliminate macrophages without inducing an inflammatory response, thereby promoting Yersinia proliferation in lymphoid tissues. YopPAbpJ also inhibits the ERK2, JNK, and p38 mitogen-activated protein kinase (MAPK) activities in infected macrophages [123, 207, 208], as well as inhibiting activation of the transcription factor NF-KB [19, 206]. MAPKs and NF-KB usually become activated in response to lipopolysaccharide. YopP/YopJ inhibits NF-KB activation by preventing the phosphorylation and subsequent degradation of the NF-KB-inhibitor protein IKB, and there is a striking correlation between the abilities to inhibit NF-KB activation and to trigger apoptosis [19, 206]. These results suggest that Yersinia could trigger apoptosis by suppressing the cellular activation of N F - K B , which normally acts to help cell survival. Suppression of NF-KB activation also leads to suppression of the transcription of a number of cytokines, including the proinflammatory cytokines TNF-a, IL-8, and IL-1, and melanoma growth-stimulating activity (MGSA) [19, 123, 206]. It is easily conceivable that this effect favors Yersinia, especially during the early phase of infection, by delaying the attraction of PMNs to the site of infection. YopP activity requires a region resembling an src homology domain 2 (SH2), which is found in several eukaryotic signaling proteins [19]. Thus, YopP could interact directly with signaling proteins involved in inductive cytokine expression. 6.
YOPT
YopT induces a cytotoxic effect in eukaryotic cells that consists of disruption of the actin filaments and alteration of the cell cytoskeleton [175]. YopT does not seem to be functional in Y pseudotuberculosis, as a yopE single mutant, which would presumably still produce YopT, is not cytotoxic [181]. However, in Y enterocolitica, YopT-induced cytotoxicity is just as strong as that of YopE [175]. 7.
SUMMARY
The effector Yops cause disruption of normal cell processes. These disruptions can be visualized by morphological alterations in the target cell—cytotoxic rounding up or apoptosis. Two Yop effectors—YopE and YopT—cause disruption of the cytoskeleton, which leads, at least in the case of YopE, to inhibition of phagocytosis. YopH also inhibits phagocytosis, but in this case by dephosphory-
252
AoiFE p. BOYD AND GUY R. CORNELIS
lating key signaling proteins including pHO^^*^ and FAK. In contrast to the dephosphorylating YopH, YopO phosphorylates proteins, but it presumably also interferes with signaling pathways in the cell. YopP disrupts transcriptional signaling in the cell via N F - K B , leading to apoptosis and a lack of induction of cytokine release. This multipronged attack is a terribly efficient way of killing a cell. But why do Yersinia spp. produce so many effectors, when one would probably be sufficient to do the job? Perhaps the different effectors are delivered to, or are active on, different cell types. Or perhaps it is an attack strategy, with defensive Yop effectors first entering to inactivate the cell and so protecting the bacteria, and later offensive Yops entering to kill the cell.
VIL Conclusion Yersinia spp. have a number of virulence factors that contribute to their ability to establish an infection in their mammalian host. First, the two pathogens that enter via the gastrointestinal route, Y pseudotuberculosis and Y enterocolitica, must adhere to and invade M cells in the intestinal tract, a process in which Inv is particularly important but other adhesion molecules also play a role. While in the intestine, the Yst enterotoxin is released by Y. enterocolitica to cause diarrhoea. Once the three Yersinia spp., Y pestis included, have reached the reticuloendothelial system, which is their preferred niche in the body, iron acquisition becomes crucial for survival, and siderophore production and the receptor system ifyuAlpsn-irp system) are very important in this regard. The capacity of the Yersinia spp. to cause infection also depends on their ability to evade and inhibit the immune and inflammatory responses of the host, a capacity that requires the presence of the Yersinia virulence plasmid. The virulence plasmid encodes a set of secreted Yop proteins, their dedicated Ysc type III secretion system, and a regulatory network. The Yersinia first adhere to the host cells by a number of adhesion molecules. Inv and YadA are the most important, but Ail and Myf/pH 6 antigen could also be involved. This attachment induces Yop production and secretion. Several Yops (YopB, YopD, LcrV, YopK/YopQ) are involved in the formation and functioning of a pore for translocation of the effector Yops into the eukaryotic cells. The Yop effectors (YopE, YopH, YopP/YopJ, YopO/YpkA, YopM, YopT) enter into the eukaryotic cell, where, among other things, they interfere with the signaling cascades of the host cell. This Yop system allows Yersinia spp. to inhibit phagocytosis and killing by macrophages and PMNs, to reduce the inflammatory response by inhibiting the release of proinflammatory cytokines, and to induce apoptosis of macrophages.
6.
YERSINIA
253
Acknowledgments A. P. B. was funded in part by an H. and A. Brenninkmeijer ICP fellowship and by EU TMR Programme Research Network Contract FMRX-CT98-0164. The Yersinia project is supported by the Belgian "Fonds National de la Recherche Scientifique Medicale" (Convention 3.4595.97), the "Direction generale de la Recherche Scientifique-Communaute Frangaise de Belgique" ("Action de Recherche Concertee" 94/99-172), and by the "Interuniversity Poles of Attraction Program, Belgian State, Prime Minister's Office, Federal Office for Scientific, Technical and Cultural affairs" (PAI4/03).
References 1. Perry, R. D., and Fetherston, J. D. (1997). Yersinia pestis: Etiologic agent of plague. Clin. Microbiol Rev. 10, 35-66. 2. Cover, T. L., and Aber, R. C. (1989). Yersinia enterocolitica. New Engl. J. Med. 321, 16-24. 3. Tauxe, R. V., Vandepitte, J., Wauters, G., Martin, S. M., Goossens, V., De Mol, P., Van Noyen, R., and Thiers, G. (1987). Yersinia enterocolitica infections and pork: The missing link. Lancet ii, 1129-1132. 4. Tipple, M. A., Bland, L. A., Murphy, J. J., Arduino, M. J., Panlilio, A. L., Farmer III, J. J., Tourault, M. A., Macpherson, C. R., Menitove, J. E., and Grindon, A. J. (1990). Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica. Transfusion 30,207-213. 5. Hanski, C , Kutschka, U., Schmoranzer, H. P., Naumann, M., Stallmach, A., Hahn, H., Menge, H., and Riecken, E. O. (1989). Immunohistochemical and electron microscopic study of interaction of Yersinia enterocolitica serotype 0:8 with intestinal mucosa during experimental enteritis. Infect. Immiin. 57, 673-678. 6. Grutzkau, A., Hanski, C , Hahn, H., and Riecken, E. O. (1990). Involvement of M cells in the bacterial invasion of Peyer's patches: A common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria. Gut 31, 1011-1015. 7. Autenrieth, I. B., and Firsching, R. (1996). Penetration of M cells and destruction of Peyer's patches by Yersinia enterocolitica: An ultrastructural and histological study. J. Med. Microbiol. 44, 285-294. 8. Autenrieth, I. B., Beer, M., Bohn, E., Kaufmann, S. H., and Heesemann, J. (1994). Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: An essential role for gamma interferon. Infect. Immun. 62, 2590-2599. 9. Autenrieth, I. B., Kempf, V., Sprinz, T., Preger, S., and Schnell, A. (1996). Defense mechanisms in Peyer's patches and mesenteric lymph nodes against Yersinia enterocolitica involve integrins and cytokines. Infect. Immun. 64, 1357-1368. 10. Bohn, E., and Autenrieth, I. B. (1996). IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN~ production in NK cells and CD4^ T cells. J. Immunol. 156, 1458-1468. 11. Carter, P. B. (1975). Pathogenicity of Yersinia enterocolitica for mice. Infect. Immun. 11, 164-170. 12. Simonet, M., Richard, S., and Berche, P. (1990). Electron microscopic evidence for in vivo extracellular localization of Yersinia pseudotuberculosis harboring the pYV plasmid. Infect. Immun. 58, 841-845. 13. Rosqvist, R., Bolin, L, and Wolf-Watz, H. (1988). Inhibition of phagocytosis in Yersinia pseudotuberculosis: A virulence plasmid-encoded ability involving the Yop2b protein. Infect. Immun. 56.2139-2143.
254
AoiFE P. BOYD AND GUY R. CORNELIS
14. Fallman, M., Andersson, K., Hakansson, S., Magnusson, K. E., Stendahl, O., and Wolf-Watz, H. (1995). Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells. Infect. Immun. 63, 3117-3124. 15. Burrows, T. W., and Bacon, G. A. (1956). The basis of virulence in Pasteurella pestis: An antigen determining virulence. Br J. Exp. Pathol. 37, 481-493. 16. Visser, L. G., Annema, A., and van Furth, R. (1995). Role of Yops in inhibition of phagocytosis and killing of opsonized Yersinia enterocolitica by human granulocytes. Infect. Immun. 63, 2570-2575. 17. Ruckdeschel, K., Roggenkamp, A., Schubert, S., and Heesemann, J. (1996). Differential contribution of Yersinia enterocolitica virulence factors to evasion of microbicidal action of neutrophils. Infect. Immun. 64, 724-733. 18. Arnold, R., Scheffer, J., Konig, B., and Konig, W. (1993). Effects of Listeria monocytogenes and Yersinia enterocolitica on cytokine gene expression and release from human polymorphonuclear granulocytes and epithelial (HEp-2) cells. Infect. Immun. 61, 2545-2552. 19. Schesser, K., Spiik, A. K., Dukuzumuremyi, J. M., Neurath, M. F, Pettersson, S., and WolfWatz, H. (1998). The 3^0/77 locus is required for y^r^m/fl-mediated inhibition of NF-KB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol. Microbiol. 28, 1067-1079. 20. Schulte, R., Wattiau, R, Hartland, E. L., Robins-Browne, R. M., and Cornelis, G. R. (1996). Differential secretion of interleukin-8 by human epithelial cell lines upon entry of virulent or nonvirulent Yersinia enterocolitica. Infect. Immun. 64, 2106-2113. 21. Cornelis, G. R., Boland, A., Boyd, A. P, Geuijen, C , Iriarte, M., Neyt, C , Sory, M.-P, and Stainier, I. (1998). The virulence plasmid of Yersinia, an antihost genome. Microbiol. Mol. Biol. Rev. 62, 1315-1352. 22. Isberg, R. R., Voorhis, D. L., and Falkow, S. (1987). Identification of invasin: A protein that allows enteric bacteria to penetrate cultured mammalian cells. Cell 50, 769-778. 23. Miller, V. L., and Falkow, S. (1988). Evidence for two genetic loci from Yersinia enterocolitica that can promote invasion of epithelial cells. Infect. Immun. 56, 1242-1248. 24. Pepe, J. C , and Miller, V. L. (1990). The Yersinia enterocolitica inv gene product is an outer membrane protein that shares epitopes with Yersinia pseudotuberculosis invasin. J. Bacteriol. 172, 3780-3789. 25. Young, V. B., Miller, V. L., Falkow, S., and Schoolnik, G. K. (1990). Sequence, localization and function of the invasin protein of Yersinia enterocolitica. Mol. Microbiol. 4, 1119-1128. 26. Pierson, D. E., and Falkow, S. (1990). Nonpathogenic isolates of Yersinia enterocolitica do not contain functional inv-homologous sequences. Infect. Immun. 58, 1059-1064. 27. Simonet, M., Riot, B., Fortineau, N., and Berche, P. (1996). Invasin production by Yersinia pestis is abolished by insertion of an IS200-like element within the inv gene. Infect. Immun. 64, 375-379. 28. Isberg, R. R., and Leong, J. M. (1988). Cultured mammalian cells attach to the invasin protein of Yersinia pseudotuberculosis. Proc. Natl. Acad. Sci. U.S.A. 85, 6682-6686. 29. Pepe, J. C , and Miller, V. L. (1993). Yersinia enterocolitica invasin: A primary role in the initiation of infection. Proc. Natl. Acad. Sci. U.S.A. 90, 6473-6477. 30. Han, Y. W, and Miller, V. L. (1997). Reevaluation of the virulence phenotype of the inv yadA double mutants of Yersinia pseudotuberculosis. Infect. Immun. 65, 327-330. 31. Marra, A., and Isberg, R. R. (1997). Invasin-dependent and invasin-independent pathways for translocation of Yersinia pseudotuberculosis across the Peyer's patch intestinal epithelium. Infect. Immun. 65, 3412-3421. 32. Isberg, R. R., Swain, A., and Falkow, S. (1988). Analysis of expression and thermoregulation of the Yersinia pseudotuberculosis inv gene with hybrid proteins. Infect. Immun. 56, 2133-2138.
6.
YERSINIA
255
33. Pepe, J. C , Badger, J. L., and Miller, V. L. (1994). Growth phase and low pH affect the thermal regulation of the Yersinia enterocolitica inv gene. Mol Microbiol 11, 123-135. 34. Badger, J. L., and Miller, V. L. (1998). Expression of invasin and motility are coordinately regulated in Yersinia enterocolitica. 7. Bacteriol 180, 793-800. 35. Fauconnier, A., Allaoui, A., Campos, A., Van Elsen, A., Comelis, G. R., and Bollen, A. (1997). Flagellar flhA, flhB and flhE genes, organized in an operon, cluster upstream form the inv locus in Yersinia enterocolitica. Microbiology 143, 3461-3471. 36. Isberg, R. R., and Leong, J. M. (1990). Multiple p, chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 60, 861-871. 37. Young, V. B., Falkow, S., and Schoolnik, G. K, (1992). The invasin protein of Yersinia enterocolitica: Internalization of invasin-bearing bacteria by eukaryotic cells is associated with reorganization of the cytoskeleton. J. Cell Biol. 116, 197-202. 38. Finlay, B. B., and Falkow, S. (1988). Comparison of the invasion strategies used by Salmonella choleraesuis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: Endosome acidification is not required for bacterial invasion or intracellular replication. Biochimie 70, 1089-1099. 39. Sory, M. R, and Comelis, G. R. (1994). Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol. Microbiol. 14, 583-594. 40. Rossenshine, I., Duronio, V., and Finlay, B. B. (1992). Tyrosine protein kinase inhibitors block invasin-promoted bacterial uptake by epithelial cells. Infect. Immun. 60, 2211-2217. 41. Leong, J. M., Foumier, R. S., and Isberg, R. R. (1990). Identification of the integrin binding domain of the Yersinia pseudotuberculosis invasin protein. EMBO J. 9, 1979-1989. 42. Leong, J. M., Morrissey, P. E., and Isberg, R. R. (1993). A 76-amino acid disulfide loop in the Yersinia peudotuberculosis invasin protein is required for integrin receptor recognition. / Biol. Chem. 268, 20524-20532. 43. Leong, J. M., Morrissey, P. E., Marra, A., and Isberg, R. R. (1995). An aspartate residue of the Yersinia pseudotuberculosis invasin protein that is critical for integrin binding. EMBO J. 14, 422-431. 44. Saltman, L. H., Lu, Y, Zaharias, E. M., and Isberg, R. R. (1996). A region of the Yersinia pseudotuberculosis invasin protein that contributes to high-affinity binding to integrin receptors. J. Biol. Chem. Ill, 23438-23444. 45. Miller, V. L., Farmer, J. J., Hill, W. E., and Falkow, S. (1989). The ail locus is found uniquely in Yersinia enterocolitica serotypes commonly associated with disease. Infect. Immun. 57, 121-131. 46. Miller, V. L., BHska, J. B., and Falkow, S. (1990). Nucleotide sequence of the Yersinia enterocolitica ail gene and characterization of the Ail protein product. J. Bacteriol. 172, 1062-1069. 47. Bliska, J. B., and Falkow, S. (1992). Bacterial resistance to complement killing mediated by the Ail protein of Yersinia enterocolitica. Proc. Natl. Acad. Sci. U.S.A. 89, 3561-3565. 48. Pierson, D. E., and Falkow, S. (1993). The ail gene of Yersinia enterocolitica has a role in the ability of the organism to survive serum killing. Infect. Immun. 61, 1846-1852. 49. Pepe, J. C , Wachtel, M. R., Wagar, E., and Miller, V. L. (1995). Pathogenesis of defined invasion mutants of Yersinia enterocolitica in a BALB/c mouse model of infection. Infect. Immun. 63, 4837-4848. 50. Wachtel, M. R., and Miller, V. L. (1995). In vitro and in vivo characterization of an ail mutant of Yersinia enterocolitica. Infect. Immun. 63, 2541-2548. 51. Pederson, K. J., Carlson, S., and Pierson, D. E. (1997). The ClpP protein, a subunit of the ClpP protease, modulates ail gene expression in Yersinia enterocolitica. Mol. Microbiol. 26, 99-107.
256
AoiFE P. BOYD AND GUY R. CORNELIS
52. Heffeman, E. J., Harwood, J., Fierer, J., and Guiney, D. (1992). The Salmonella typhimurium virulence plasmid complement resistance gene rck is homologous to a family of virulence-related outer membrane protein genes, including pagC and ail. J. Bacterial. 174, 84-91 53. Pulkkinen, W. S., and Miller, S. I. (1991). A Salmonella typhimurium virulence protein is similar to a Yersinia enterocolitica invasion protein and a bacteriophage lambda outer membrane protein. J. Bacteriol. 173, 86-93. 54. Heffernan, E. J., Wu, L., Louie, J., Okamoto, S., Fierer, J., and Guiney. D. G. (1994). Specificity of the complement resistance and cell association phenotypes encoded by the outer membrane protein genes rck from Salmonella typhimurium and ail from Yersinia enterocolitica. Infect. Immun. 62,5183-5186. 55. Mecsas, J., Welch, R., Erickson, J. W., and Gross, C. A. (1995). Identification and characterization of an outer membrane protein, OmpX, in Escherichia coli that is homologous to a family of outer membrane proteins including Ail of Yersinia enterocolitica. J. Bacteriol. 177, 799-804. 56. Fleckenstein, J. M., Kopecko, D. J., Warren, R. L.. and Elsinghorst, E. A. (1996). Molecular characterization of the tia invasion locus from enterotoxigenic Escherichia coli. Infect. Immun. 64, 2256-65. 57. de Kort, G., Bolton, A., Martin, G., Stephen, J., van de Klundert, J. A. (1994), Invasion of rabbit ileal tissue by Enterohacter cloacae varies with the concentration of OmpX in the outer membrane. Infect. Immun. 62, 4722-4726 58. Mitchell, S. J., and Minnick. M. F. (1995). Characterization of a two-gene locus from Bartonella hacilliformis associated with the ability to invade human erythrocytes. Infect. Immun. 63, 1552-1562. 59. Lindler, L. E., Klempner, M. S., and Straley, S. C. (1990). Yersinia pestis pH 6 antigen: Genetic, biochemical, and virulence characterization of a protein involved in pathogenesis in bubonic plague. Infect. Immun. 58, 2569-2577. 60. Lindler, L. E., and Tall, B. D. (1993). Yersinia pestis pH 6 antigens forms fimbriae and is induced by intracellular association with macrophages. Mol. Microbiol. 8, 311-324. 61. Iriarte, M., Vanooteghem, J.-C., Delor, I., Diaz, R., Knutton, S., and Cornelis, G. R. (1993). The Myf fibrillae of Yersinia enterocolitica. Mol. Microbiol. 9, 507-520. 62. Yang, Y., Merriam, J. J., Mueller, J. P., and Isberg. R. R. (1996). The psa locus is responsible for thermoinducible binding of Yersinia pseudotuberculosis to cultured cells. Infect. Immun. 64, 2483-2489. 63. Payne, D., Tatham, D., Williamson, E. D.. and Titball. R. E. (1988). The pH 6 antigen of Yersinia pestis binds to pi-linked galoctosyl residues in glycosphingolipids. Infect. Immun. 66, 45454548. 64. Yang, Y, and Isberg, R. R. (1997). Transcriptional regulation of the Yersinia pseudotuberculosis pH 6 antigen adhesin by two envelope-associated components. Mol. Microbiol. 24, 499-510. 65. Iriarte, M., and Cornelis, G. R. (1995). MyfF. an element of the network regulating the synthesis of fibrillae in Yersinia enterocolitica. J. Bacteriol. Ill, 738-744. 66. Balligand, G., Laroche, Y, and Cornelis, G. (1985). Genetic analysis of virulence plasmid from a serogroup 9 Yersinia enterocolitica strain: Role of outer membrane protein PI in resistance to human serum and autoagglutination. Infect. Immun. 48, 782-786. 67. Bolin, I., Norlander, L., and Wolf-Watz, H. (1982). Temperature-inducible outer membrane protein of Yersinia pseudotuberculosis and Yersinia enterocolitica is associated with the virulence plasmid. Infect. Immun. 37. 506-512. 68. Bolin, I., and Wolf-Watz, H. (1984). Molecular cloning of the temperature-inducible outer membrane protein 1 of Yersinia pseudotuberculosis. Infect. Immun. 43, 72-78.
6.
YERSINIA
257
69. Rosqvist, R., Skumik, M., and Wolf-Watz, H. (1988). Increased virulence of Yersinia pseudotuberculosis by two independent mutations. Nature 334, 522-525. 70. Flugel, A., Schulze-Koops, H., Heesemann, J., Kiihn, K., Sorokin, L., Burkhardt, H., von der Mark, K., and Emmrich, F. (1994). Interaction of enteropathogenic Yersinia enterocolitica with complex basement membranes and the extracellular matrix proteins collagen type IV, laminin-1 and -2, and nidogen/entactin. J. Biol. Chem. 269, 29732-29738. 71. Schulze-Koops, H., Burkhardt, H., Heesemann, J., Kirsch, T., Swoboda, B., Bull, C , Goodman, S., and Emmrich, F. (1993). Outer membrane protein YadA of enteropathogenic Yersiniae mediates specific binding to cellular but not plasma fibronectin. Infect. Imniun. 61, 2513-2519. 72. Schulze-Koops, H., Burkhardt, H., Heesemann, J., von der Mark, K., and Emmrich, F. (1992). Plasmid-encoded outer membrane protein YadA mediates specific binding of enteropathogenic Yersiniae to various types of collagen. Infect. Immun. 60, 2153-2159. 73. Tertti, R., Skurnik, M., Vartio, T., and Kuusela, R (1992). Adhesion protein YadA of Yersinia species mediates binding of bacteria to fibronectin. Infect. Immun. 60, 3021-3024. 74. Bliska, J. B., Copass, M. C , and Falkow, S. (1993). The Yersinia pseudotuberculosis adhesin YadA mediates intimate bacterial attachment to and entry into HEp-2 cells. Infect. Immun. 61, 3914-3921. 75. Yang, Y, and Isberg, R. R. (1993). Cellular internalization in the absence of invasin expression is promoted by the Yersinia pseudotuberculosis yadA product. Infect. Immun. 61, 3907-3913. 76. Visser, L. G., Hiemstra, R S., van den Barselaar, M. T., Ballieux, P. A., and van Furth, R. (1996). Role of YadA in resistance to killing of Yersinia enterocolitica by antimicrobial polypeptides of human granulocytes. Infect. Immun. 64, 1653-1658. 77. Martinez, R. J. (1989). Thermoregulation-dependent expression of Yersinia enterocolitica protein 1 imparts serum resistance to Escherichia coli K-12. J. Bacteriol. 171, 3732-3739. 78. Pilz, D., Vocke, T., Heesemann, J., and Brade, V. (1992). Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype 0 3 . Infect. Immun. 60, 189-195. 79. China, B., Sory, M.-P, N'Guyen, B. T., de Bruyere, M., and Cornelis, G. R. (1993). Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules. Infect. Immun. 61,3129-3136. 80. China, B., N'Guyen, B. T., de Bruyere, M., and Cornelis, G. R. (1994). Role of YadA in resistance of Yersinia enterocolitica to phagocytosis by human polymorphonuclear leukocytes. Infect. Immun. 62, 1275-1281. 81. Roggenkamp, A., Neuberger, H.-R., Flugel, A., Schmoll, T., and Heesemann, J. (1995). Substitution of two histidine residues in YadA protein of Yersinia enterocolitica abrogates collagen binding, cell adherence and mouse virulence. Mol. Microbiol. 16, 1207-1219. 82. Roggenkamp, A., Ruckdeschel, K., Leitritz, L., Schmitt, R., and Heesemann J. (1996). Deletion of amino acids 29 to 81 in adhesion protein YadA of Yersinia enterocolitica serotype 0:8 results in selective abrogation of adherence to neutrophils. Infect. Immun. 64, 2506-2514. 83. Tamm, A., Tarkkanen, A. M., Korhonen, T. K., Kuusela, P., Toivanen, P., and Skurnik, M. (1993). Hydrophobic domains affect the collagen-binding specificity and surface polymerization as well as the virulence potential of the YadA protein of Yersinia enterocolitica. Mol. Microbiol. 10, 995-1011. 84. Rosqvist, R., and Wolf-Watz, H. (1986). Virulence plasmid-associated HeLa cell induced cytotoxicity of Yersinia pseudotuberculosis. Microh. Pathogen. 1, 229-240. 85. Skurnik, M., and Wolf-Watz, H. (1989). Analysis of the yopA gene encoding the Yopl virulence determinants of Yersinia spp. Mol. Microbiol. 3, 517-529. 86. Skurnik, M., el Tahir, Y, Saarinen, M., Jalkanen, S., and Toivanen, P. (1994). YadA mediates specific binding of enteropathogenic Yersinia enterocolitica to human intestinal submucosa. Infect. Immun. 62, 1252-1261.
258
AoiFE P. BOYD AND GUY R. CORNELIS
87. Robins-Browne, R. M., and Prpic, J. K. (1985). Effects of iron and desferrioxamine on infections with Yersinia enterocolitica. Infect. Immun. 47, 774-779. 88. Boelart, J. R., van Landuyt, H. W., Valcke, Y. J., Cantinieaux, B., Lomoy, W. F, Vanherweghem, J. L., Moreillon, R, and Vandepitte, J. M. (1987). The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients. / Infect. Dis. 156, 384-387. 89. Camiel, E., Guiyoule, A., Guilvout, I., and Mercereau-Puijalon, O. (1992). Molecular cloning, iron-regulation and mutagenesis of the irp2 gene encoding HMWP2, a protein specific for the highly pathogenic Yersinia. Mol. Microbiol. 6, 379-388. 90. Chambers, C. E., and Sokol, P. A. (1994). Comparison of siderophore production and utilization in pathogenic and environmental isolates of Yersinia enterocolitica. J. Clin. Microbiol. 32, 32-39. 91. de Almeida, A. M., Guiyoule, A., Guilvout, I., Iteman, I., Baranton, G., and Camiel, E. (1993). Chromosomal irp2 gene in Yersinia: Distribution, expression, deletion and impact on virulence. Microb. Pathogen. 14, 9-21. 92. Haag, H., Hantke, K., Drechsel, H., Stojilijkovic, I., Jung, G., and Zahner, H. (1993). Purification of yersiniabactin: A siderophore and possible virulence factor of Yersinia enterocolitica. J. Gen. Microbiol. 139, 2159-2165. 93. Heesemann, J., Hantke, K., Vocke, T., Saken, E., Rakin, A., Stojilijkovic, I., and Berner, R. (1993). Virulence of Yersinia enterocolitica is closely associated with siderophore production, expression of an iron-repressible outer membrane polypeptide of 65,000 Da and pesticin sensitivity. Mol. Microbiol. 8, 397-408. 94. Bearden, S. W., Fetherston, J. D., and Perry, R. D. (1997). Genetic organization of the yersiniabactin biosynthetic region and construction of avirulenty mutants in Yersinia pestis. Infect. Immun. 65, 1659-1668. 95. Rakin, A., Saken, E., Harmsen, D., and Heesemann, J. (1994). The pesticin receptor of Yersinia enterocolitica: A novel virulence factor with dual function. Mol. Microbiol. 13, 253-263. 96. Pelludat, C , Rakin, A., Jacobi, C. A., Schubert, S., and Heesemann, J. (1998). The yersiniabactin biosynthetic gene cluster of Yersinia enterocolitica: Organization and siderophore-dependent regulation. J. Bacteriol. 180, 538-546. 97. Lucier, T. S., Fetherson, J. D., Brubaker, R. R., and Perry, R. D. (1996). Iron uptake and iron-repressible polypeptides in Yersinia pestis. Infect. Immun. 64, 3023-3031. 98. Staggs, T. M., Fetherson, J. D., and Perry, R. D. (1994). Pleiotropic effects of a Yersinia pestis. J. Bacteriol. 176, 7614-7624. 99. Staggs, T. M., and Perry, R. D. (1992). Fur regulation in Yersinia species. Mol. Microbiol. 6, 2507-2516. 100. Fetherston, J. D., Bearden, S. W., and Perry, R. D. (1996). YbtA, an AraC-type regulator of the Yersinia pestis pesticin/yersiniabactin receptor. Mol. Microbiol. 22, 315-325. 101. Baumler, A. J., and Hantke, K. (1992). Ferrioxamine uptake in Yersinia enterocolitica: Characterization of the receptor protein Fox A. Mol. Microbiol. 6, 1309-1321. 102. Schubert, S., Rakin, A., Karch, H., Camiel, E., and Heesemann, J. (1998). Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans. Infect. Immun. 66, 480-485. 103. Camiel, E., Guilvout, I., and Prentice, M. (1996). Characterization of a large chromosomal "high-pathogenicity island" in biotype IB Yersinia enterocolitica. J. Bacteriol. 178, 6743-6751. 104. Buchrieser, C , Prentice, M., and Camiel, E. (1998). The 102-kb unstable region of Yersinia pestis comprises a high-pathogenicity island linked to a pigmentation segment which undergoes intemal rearrangement. J. Bacteriol. 180, 2321-2329.
6.
YERSINIA
259
105. Fetherston, J. D., Schuetze, P., and Perry, R. D. (1992). Loss of the pigmentation phenotype in Yersinia pestis is due to the spontaneous deletion of 102 kb of chromosomal DNA which is flanked by a repetitive element. Mol. Microbiol. 6, 2693-2704. 106. Hinnebusch, B. J., Perry, R. D., and Schwan, T. G. (1996). Role of the Yersinia pestis hemin storgae {hms) locus in the transmission of plague by fleas. Science 213, 367-370. 107. Delor, I., Kaeckenbeeck, A., Wauters, G., and Comelis, G. R. (1990). Nucleotide sequence of yst, the Yersinia enterocolitica gene encoding the heat-stable enterotoxin, and prevalence of the gene among pathogenic and nonpathogenic yersiniae. Infect. Immun. 58, 2983-2988. 108. Delor, I., and Comelis, G. R. (1992). Role of Yersinia enterocolitica Yst toxin in experimental infection of young rabbits. Infect. Immun. 60, 4269^277. 109. Currie, M. G., Fok, K. P., Kato, J., Moore, R. J., Hamra, F K., Duffm, K. L., and Smith, C. E. (1992). Guanylin: An endogenous activator of intestinal guanylate cyclase. Proc. Natl. Natl. Sci. U.S.A. 89,947-951. 110. Rao, M. C., Guandalini, S., Laird, W. J., and Field, M. (1979). Effects of heat-stable enterotoxin of Yersinia enterocolitica on ion transport and cyclic guanosine 3',5'-monophosphate metabolism in rabbit ileum. Infect. Immun. 26, 875-878. 111. Robins-Browne, R. M., Still, C. S., Miliotis, M. D., and Koomhof, H. J. (1979). Mechanism of action of Yersinia enterocolitica enterotoxin. Infect. Immun. 25, 680-684. 112. Inoue, T., Okamoto, K., Moriyama, T., Takahashi, T., Shimizu, K., and Miyama, A. (1983). Effect of Yersinia enterocolitica ST on cycHc guanosine 3',5'-monophosphate levels in mouse intestines and cultured cells. Microbiol. Immunol. 27, 159-166. 113. Takao, T., Yominaga, N., Shimonishi, Y., Hara, S., Inoue, T., and Miyama, A. (1984). Primary structure of the heat-stable enterotoxin produced by Yersinia enterocolitica. Biochem. Biophys. Res. Commun. 125, 845-851. 114. Mikulskis, A. V., Delor, L, Thi, V. H., and Comelis, G. R. (1994). Regulation of the Yersinia enterocolitica Yst gene. Influence of growth phase, temperature, osmolarity, pH and bacterial host factors. Mol. Microbiol. 14, 905-915. 115. Iriarte, M., Stainier, I., and Comelis, G. R. (1995). The rpoS gene from Yersinia enterocolitica and its influence on expression of virulence factors. Infect. Immun. 63, 1840-1847. 116. Nakao, H., Watanabe, H,. Nakayama, S., and Takeda, T. (1995). yst gene expression in Yersinia enterocolitica is positively regulated by a chromosomal region that is highly homologous to Escherichia coli host factor 1 gene {hfq). Mol. Microbiol. 18, 859-865. 117a . 117b .
Iriarte, M., Lambermont, I., Kerbourch, C , and Comelis, G. R. (1998). Complete sequence of the pYVe227 plasmid of Yersinia enterocolitica serotype 0:9. Genbank accession AFl02990. Hu, P., Elliot, J., McCready, P., Skowronski, E., Games, J., Kobayashi, A., Carrano, A. V., Brubaker, R., and Garcia, E. (1998). Yersinia pestis plasmid pCDl, complete plasmid sequence. Genbank accession AF053946. 117c Perry, R. D., Straley, S. C , Fetherston, J. D., Rose, D. J., Gregor, J., and Blattner, K R. (1998). . DNA sequencing and analysis of the low-Ca^^ response plasmid pCDl of Yersinia pestis KIM5. Infect. Immun. 66,4611^623. 118. Lian, C. J., Hwang, W. S., and Pai, C. H. (1987). Plasmid-mediated resistance to phagocytosis in Yersinia enterocolitica. Infect. Immun. 55, 1176-1183. 119. Lian, C. J., and Pai, C. H. (1985). Inhibition of human neutrophil chemiluminescence by plasmid-mediated outer membrane proteins of Yersinia enterocolitica. Infect. Immun. 49, 145-151. 120. Mills, S. D., Boland, A., Sory, M.-P, Van der Smissen, P, Kerbourch, C , Finlay, B. B., and Comelis, G. R. (1997). Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein. Proc. Natl. Acad. Sci. U.S.A. 94, 12638-12643.
260
AoiFE p. BOYD AND GUY R. CORNELIS
121. Monack, D. M., Mecsas, J., Ghori, N., and Falkow, S. (1997). Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc. Natl. Acad. Sci. U.S.A. 94, 10385-10390. 122. Ruckdeschel, K., Roggenkamp, A., Lafont, V., Mangeat, R, Heesemann, J., and Rouot, B. (1997). Interaction of Yersinia enterocolitica with macrophages leads to macrophage cell death through apoptosis. Infect. Immun. 65, 4813-4821. 123. Boland, A., and Cornelis, G. R. (1998). Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection. Infect. Immun. 66, 1878-1884. 124. Alfano, J. R., and Collmer, A. (1997). The type III (Hrp) secretion pathway of plant pathogenic bacteria: Trafficking harpins, Avr proteins, and death. J. Bacterial. 179, 5655-5662. 125. Hueck, C. J. (1998). Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62, 379^33. 126. Yuk, M. H., Harvill, E. T, and Miller, J. F. (1998). The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica. Mol. Microbiol. 28, 945-959. 127. Viprey, V., Greco, A. D., Golinowski, W., Broughton, W. J., and Ferret, X. (1998). Symbiotic implications of type III protein secretion machinery in Rhizobium. Mol. Microbiol. 28, 1381-1389. 128. Piano, G. V., Barve, S. S., and Straley, S. C. (1991). LcrD, a membrane-bound regulator of the Yersinia pestis low-calcium response. / Bacterial. 173, 7293-7303. 129. Piano, G. V., and Straley, S. C. (1993). Multiple effects of IcrD mutations in Yersinia pestis. J. Bacterial 175, 3536-3545. 130. Piano, G. V., and Straley, S. C. (1995). Mutations in wscC, yscD, and yscG prevent high-level expression and secretion of V antigen and Yops in Yersinia pestis. J. Bacterial. Ill, 3843-3854. 131. Allaoui, A., Woestyn, S., Sluiters, C., and Cornelis, G. R. (1994). YscU, a Yersinia enterocolitica inner membrane protein involved in Yop secretion. J. Bacterial. 176, 4534^542. 132. Fields, K. A., Piano, G. V., and Straley, S. C. (1994). A low-Ca-^ response (LCR) secretion {ysc) locus lies within the IcrB region of the LCR plasmid in Yersinia pestis. J. Bacterial. 176, 569-579. 133. Koster, M., Bitter, W., de Cock, H., Allaoui, A., Cornelis, G. R., and Tommassen, J. (1997). The outer membrane component, YscC, of the Yop secretion machinery of Yersinia enterocolitica forms a ring-shaped multimeric complex. Mol. Microbial. 26, 789-798. 134. Michiels, T, Vanooteghem, J. C , Lambert de Rouvroit, C. L., China, B., Gustin, A., Boudry, P., and Cornelis, G. R. (1991). Analysis of virC, an operon involved in the secretion of Yop proteins by Yersinia enterocolitica. J. Bacterial. 173, 4994-5009. 135. Woestyn, S., Allaoui, A., Wattiau, P., and Cornelis, G. R. (1994). YscN, the putative energizer of the Yersinia Yop secretion machinery. J. Bacterial. 176, 1561-1569. 136. Payne, P. L., and Straley, S. C. (1998). YscO of Yersinia pestis is a mobile core component of the Yop secretion system. J. Bacterial. 180, 3882-3890.. 137. Stainier, I., Karmani, L., and Cornelis, G. R. Unpublished data. 138. Allaoui, A., Schulte, R., and Cornelis, G. R. (1995). Mutational analysis of the Yersinia enterocaliticia v/rC operon: Characterization ofyscE, F, G, I, J, and AT required for Yop secretion and yscH encoding YopR. Mol. Microbiol. 18, 343-355. 139. Stainier, I., Iriarte, M., and Cornelis, G. R. (1997). YscMl and YscM2, two Yersinia enterocolitica proteins causing down regulation of yop transcription. Mol. Microbiol. 26, 833-843. 140. Rimpilainen, M., Forsberg, A., and Wolf-Watz, H. (1992). A novel protein, LcrQ, involved in the low-calcium response of Yersinia pseudotuberculosis shows extensive homology to YopH. J. Bacterial. 174, 3355-3363.
6.
YERSINIA
261
141. Pettersson, J., Nordfelth, R., Dubinina, E., Bergman, T., Gustafsson, M., Magnusson, K. E., and Wolf-Watz, H. (1996). Modulation of virulence factor expression by pathogen target cell contact. Science 273, 1231-1233. 142. Lee, C. A. (1997). Type III secretion systems: Machines to deliver bacterial proteins into eukaryotic cells? Trends. Microbiol. 5, 148-156. 143. Kubori, T., Matsushima, Y., Nakamura, D., Uralil, J., Lara-Tejero, M., Sukhan, A., Galan, J. E., and Aizawa, S.-I. (1998). Supramolecular structure of the Salmonella typhimiirium type III protein secretion system. Science 280, 602-605. 144. Michiels, T., and Cornelis, G. R. (1991). Secretion of hybrid proteins by the Yersinia Yop export system. J. Bacteriol 173, 1677-1685. 145. Michiels, T., Wattiau, P., Brasseur, R., Ruysschaert, J. M., and Cornelis, G. (1990). Secretion of Yop proteins by Yersiniae. Infect. Immim. 58, 2840-2849. 146. Leung, K. Y, Reisner, B. S., and Straley, S. C. (1990). YopM inhibits platelet aggregation and is necessary for virulence of Yersinia pestis in mice. Infect. Immiin. 58, 3262-3271. 147. Mulder, B., Michiels, T., Simonet, M., Sory, M.-P, and Cornelis, G. (1989). Identification of additional virulence determinants on the pYV plasmid of Yersinia enterocolitica W227. Infect. Immun. 57,2534-2541. 148. Rosqvist, R., Forsberg, A., Rimpilainen, M., Bergman, T, and Wolf-Watz, H. (1990). The cytotoxic protein YopE of Yersinia obstructs the primary host defence. Mol. Microbiol. 4, 657-667. 149. Straley, S. C , and Bowmer, W. S. (1986). Virulence genes regulated at the transcriptional level by Ca-+ in Yersinia pestis include structural genes for outer membrane proteins. Infect. Immun. 51, 445-454. 150. Bolin, I., and Wolf-Watz, H. (1988). The plasmid encoded Yop2b protein of Yersinia pseudotuberculosis is a virulence determinant regulated by calcium and temperature at the level of transcription. Mol. Microbiol. 2, 237-245. 151. Galyov, E. E., Hakansson, S., Forsberg, A., and Wolf-Watz, H. (1993). A secreted protein kinase of Yersinia pseudotuberculosis is an indispensable virulence determinant. Nature 361, 730-732. 152. Sory, M.-P, Boland, A., Lambermont, I., and Cornelis, G. R. (1995). Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach. Proc. Natl. Acad. Sci. U.S.A. 92, 11998-12002. 153. Schesser, K., Frithz-Lindsten, E., and Wolf-Watz, H. (1996). Delineation and mutational analysis of the Yersinia pseudotuberculosis YopE domains which mediate translocation across bacterial and eukaryotic cellular membranes. J. Bacteriol. 178, 7227-7233. 154. Forsberg, A., Viitanen, A. M., Skurnik, M., and Wolf-Watz, H. (1991). The surface-located YopN protein is involved in calcium signal transduction in Yersinia pseudotuberculosis. Mol. Microbiol. 5, 977-986. 155. Hakansson, S., Bergman, T, Vanooteghem, J.-C, Cornelis, G., and Wolf-Watz, H. (1993). YopB and YopD constitute a novel class of Yersinia Yop proteins. Infect. Immun. 61, 71-80. 156. Anderson, D. M., and Schneewind, O. (1997). An mRNA signal for the type III secretion of Yop proteins by Yersinia enterocolitica. Science 278, 1140-1143. 157. Cheng, L. W., Anderson, D. M., and Schneewind, O. (1997). Two independent type III secretion mechanisms for YopE in Yersinia enterocolitica. Mol. Microbiol. 24, 757-765. 158. Cornelis, G. R., Sluiters, C , Lambert de Rouvroit, C. L., and Michiels, T. (1989). Homology between virF, the transcriptional activator of the Yersinia virulence regulon, and AraC, the Escherichia coli arabinose operon regulator. J. Bacteriol. 171, 254—262. 159. Skurnik, M., and Toivanen, P. (1992). LcrF is the temperature-regulated activator of the yadA gene of Yersinia enterocolitica and Yersinia pseudotuberculosis. J. Bacteriol. 174, 2047-2051.
262
AoiFE P. BOYD AND GUY R. CORNELIS
160. Wattiau, P., and Cornells, G. R. (1993). SycE, a chaperone-like protein of Yersinia enterocolitica involved in the secretion of YopE. Mol. Microbiol. 8, 123-131. 161. Lambert de Rouvroit, C. L., Sluiters, C., and Cornelis, G. R. (1992). Role of the transcriptional activator, VirF, and temperature in the expression of the pYV plasmid genes of Yersinia enterocolitica. Mol. Microbiol. 6, 395-409. 162. Wattiau, P, Bemier, B., Deslee, P, Michiels, T., and ComeHs, G. R. (1994). Individual chaperones required for Yop secretion by Yersinia. Proc. Natl. Acad. Sci. U.S.A. 91, 1049310497. 163. Wattiau, P., and Cornelis, G. R. (1994). Identification of DNA sequences recognized by VirF, the transcriptional activator of the Yersinia yop regulon. J. Bacteriol. 176, 3878-3884. 164. Cornelis, G. R., Sluiters, C , Delor, I., Geib, D., Kaniga, K., Lambert de Rouvroit, C. L., Sory, M.-P, Vanooteghem, J.-C, and Michiels, T. (1991). ymoA, a Yersinia enterocolitica chromosomal gene modulating the expression of virulence functions. Mol. Microbiol. 5, 1023-1034. 165. Rohde, J. R., Fox, J. M., and Minnich, S. A. (1994). Thermoregulation in Yersinia enterocolitica is coincident with changes in DNA supercoiling. Mol. Microbiol. 12, 187-199. 166. Bolin, I., Forsberg, A., Norlander, L., Skumik, M., and Wolf-Watz, H. (1988). Identification and mapping of the temperature-inducible, plasmid-encoded proteins of Yersinia spp. Infect. Immun. 56, 343-348. 167. Forsberg, A., and Wolf-Watz, H. (1988). The virulence protein Yop5 of Yersinia pseudotuberculosis is regulated at transcriptional level by plasmid-plBl-encoded trans-diCimg elements controlled by temperature and calcium. Mol. Microbiol. 2, 121-133. 168. Iriarte, M., Sory, M.-P, Boland, A., Boyd, A. P., Mills, S. D., Lambermont, I., and Cornelis, G. R. (1998). TyeA, a protein involved in control of Yop release and in translocation of Yersinia Yop effectors. EMBO J. 17, 1907-1918 169. Sarker, M. R., Sory, M.-P, Boyd, A. P, Iriarte, M., and Cornelis, G. R. (1998). LcrG controls translocation of Yersinia Yop effector proteins into eukaryotic cells. Infect. Immun. 66, 2976-2979. 170. Skrzypek, E., and Straley, S. C. (1993). LcrG, a secreted protein involved in negative regulation of the low-calcium response in Yersinia pestis. J. Bacteriol. 175, 3520-3528. 171. Francis, M. S., and Wolf-Watz, H. (1998). YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: Evidence of a structural domain necessary for translocation. Mol. Microbiol. 29, 799-813. 172. Williams, A. W, and Straley, S. C. (1998). YopD of Yersinia pestis plays a role in negative regulation of the low-calcium response in addition to its role in translocation of Yops. / Bacteriol. 180, 350-358. 173. Frithz-Lindsten, E., Rosqvist, R., Johansson, L., and Forsberg, A. (1995). The chaperone-like protein YerA of Yersinia pseudotuberculosis stabilizes YopE in the cytoplasm but is dispensible for targeting to the secretion loci. Mol. Microbiol. 16, 635-647. 174. Forsberg, A., and Wolf-Watz, H. (1990). Genetic analysis of the yopE region of Yersinia spp.: Identification of a novel conserved locus, yerA, regulating yopE expression. / Bacteriol. Ill, 1547-1555. 175. Iriarte, M., and Cornells, G. R. (1998). YopT, a new Yersinia Yop effector protein, affects the cytoskeleton of host cells. Mol. Microbiol. 29, 915-929. 176. Iriarte, M., and Cornells, G. R. (1999). Identification of SycN, YscX, and YscY, three new elements of the Yersinia Yop virulon. J. Bacteriol. 181, 675-680. 177. Neyt, C, and Cornells, G. R. (1999). Role of SycD, the chaperone of the Yersinia Yop translocators YopB and YopD. Mol. Microbiol. 31, 143-156.
6.
YERSINIA
263
178. Woestyn, S., Sory, M.-R, Boland, A., Lequenne, O., and Comelis, G. R. (1996). The cytosolic SycE and SycH chaperones of Yersinia protect the region of YopE and YopH involved in translocation across eukaryotic cell membranes. Mol. Microbiol. 20, 1261-1271. 179. Wattiau, P., Woestyn, S., and Comelis, G. R. (1996). Customized secretion chaperones in pathogenic bacteria. Mol. Microbiol. 20, 255-262. 180. Rosqvist, R., Magnusson, K.-E., and Wolf-Watz, H. (1994). Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J. 13, 964-972. 181. Rosqvist, R., Forsberg, A., and Wolf-Watz, H. (1991). Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect. Immun. 59, 4562-4569. 182. Boyd, A. R, and Comelis, G. R. Unpublished data. 183. Persson, C , Nordfelth, R., Holmstrom, A., Hakansson, S., Rosqvist, R., and Wolf-Watz, H. (1995). Cell-surface-bound Yersinia translocate the protein tyrosine phosphatase YopH by a polarized mechanism into the target cell. Mol. Microbiol. 18, 135-150. 184. Hakansson, S., Galyov, E. E., Rosqvist, R., and Wolf-Watz, H. (1996). The Yersinia YpkA Ser/Thr kinase is translocated and subsequently targeted to the inner surface of the HeLa cell plasma membrane. Mol. Microbiol. 20, 593-603. 185. Boland, A., Sory, M.-P, Iriarte, M., Kerbourch, C , Wattiau, P, and Comelis, G. R. (1996). Status of YopM and YopN in the Yersinia Yop vimlon: YopM of K enterocolitica is intemalized inside the cytosol of PU5-1.8 macrophages by the YopB, D, N delivery apparatus. EMBO J. 15, 5191-5201. 186. Hakansson, S., Schesser, K., Persson, C , Galyov, E. E., Rosqvist, R., Homble, F., and Wolf-Watz, H. (1996). The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. EMBO J. 15, 5812-5823. 187. Nilles, M. L., Fields, K. A., and Straley, S. C. (1998). The V antigen of Yersinia pestis regulates Yops vectorial targeting as well as Yops secretion through effects on YopB and LcrG. J. Bacteriol. 180, 3410-3420. 188. Sarker, M. R., Neyt, C , Stainier, I., and Comelis, G. R. (1998). The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD. J. Bacteriol. 180, 1207-1214. 189. Holmstrom, A., Pettersson, J., Rosqvist, R., Hakansson, S., Tafazoli, F., Fallman, M., Magnusson, K. E., Wolf-Watz, H., and Forsberg, A. (1997). YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane. Mol. Microbiol. 24, 73-91. 190. Forsberg, A., Rosqvist, R., and Wolf-Watz, H. (1994). Regulation and polarized transfer of the Yersinia outer proteins (Yops) involved in antiphagocytosis. Trends. Microbiol. 2, 14-19. 191. Nilles, M. L., Williams, A. W., Skrzypek, E., and Straley, S. C. (1997). Yersinia pestis LcrV forms a stable complex with LcrG and may have a secretion-related regulatory role in the low-Ca2+ response. J. Bacteriol. 179, 1307-1316. 192. Boyd, A. P, Sory, M.-P, Iriarte, M., and Comelis, G. R. (1998). Heparin interferes with translocation of Yop proteins into HeLa cells and binds to LcrG, a regulatory component of the Yersinia Yop apparatus. Mol. Microbiol. 27, 425-436. 193. Goguen, J. D., Walker, W. S., Hatch, T. P, and Yother, J. (1986). Plasmid-determined cytotoxicity in Yersinia pestis and Yersinia pseudotuberculosis. Infect. Immun. 51, 788-794. 194. Mecsas, J., Raupach, B., and Falkow, S. (1998). The Yersinia Yops inhibit invasion of Listeria, Shigella, and Edwardsiella but not Salmonella into epithelial cells. Mol. Microbiol. 28, 1269-1281.
264
AoiFE P. BOYD AND GUY R. CORNELIS
195. Guan, K. L., and Dixon, J. E. (1990). Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science 249, 553-556. 196. Bliska, J. B., Guan, K. L., Dixon, J. E., and Falkow, S. (1991). Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc. Natl. Acad. Sci. U.S.A. 88, 1187-1191. 197. Bliska, J. B., Clemens, J. C., Dixon, J. E., and Falkow, S. (1992). The Yersinia tyrosine phosphatase: Specificity of a bacterial virulence determinant for phosphoproteins in the ill Ah. 1 macrophage. / Exp. Med. 176, 1625-1630. 198. Persson, C., Carballeira, N., Wolf-Watz, H., and Fiillman, M. (1997). The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of pi30^"' and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. EMBO J. 16. 2307-2318. 199. Andersson, K., Carballeira, N., Magnusson, K. E., Persson, C , Stendahl, O., Wolf-Watz, H., and Fallman, M. (1996). YopH of Yersinia pseudotuberculosis interrupts early phosphotyrosine signaling associated with phagocytosis. Mol. Microbiol. 20, 1057-1069. 200. Black, D. S., and Bliska, J. B. (1997). Identification of pi30^^"^ as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions. EMBO J. 16, 2730-2744. 201. Bliska, J. B., and Black, D. S. (1995). Inhibition of the Fc receptor-mediated oxidative burst in macrophages by the Yersinia pseudotuberculosis tyrosine phosphatase. Infect. Inmnin. 63, 681-685. 202. Green, S. P, Hartland, E. L.. Robins Browne, R. M.. and Phillips. W. A. (1995). Role of YopH in the suppression of tyrosine phosphorylation and respiratory burst activity in murine macrophages infected with Yersinia enterocolitica. J. Leukoc. Biol. 57, 972-977. 203. Reisner, B. S., and Straley, S. C. (1992). Yersinia pestis YopM: Thrombin binding and overexpression. Infect. Immun. 60, 5242-5252. 204. Leung, K. Y, and Straley, S. C. (1989). The yopM gene of Yersinia pestis encodes a released protein having homology with the human platelet surface protein GPIb. J. Bacteriol. 171, 4623-4632. 205. Galyov, E. E., Hakansson, S., and Wolf-Watz, H. (1994). Characterization of the operon encoding the YpkA Ser/Thr protein kinase and the YopJ protein of Yersinia pseudotuberculosis. J. Bacteriol. 176, 4543-4548. 206. Ruckdeschel, K., Harb, S., Roggenkamp, A., Hornef, M., Zumbihl, R., Kohler, S., Heesemann, J., and Rouot, B. (1998). Yersinia enterocolitica impairs activation of transcription factor NF-KB: Involvement in the induction of programmed cell death and in the suppression of the macrophage TNF-oc production. J. Exp. Med. 187, 1069-1079. 207. Palmer, L. E., Hobbie, S., Galan, J. E., and Bliska, J. B. (1998). YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNFa production and downregulation of the MAP kinases p38 and JNK. Mol. Microbiol. 11, 953-965. 208. Ruckdeschel, K., Machold, J., Roggenkamps, A., Schubert, S., Pierre, J., Zumbihl, R., Liautard, J. P., Heesemann, J., and Rouot, B. (1997). Yersinia enterocolitica promotes deactivation of macrophage mitogen-activated protein kinases extracellular signal-regulated kinase-1/2, p38, and c-Jun NH.-terminal kinase. / Biol. Chem. 272, 15920-15927. 209. Cornelis, G. R., and Wolf-Watz, H. (1997). The Yersinia Yop virulon: A bacterial system for subverting eukaryotic cells. Mol. Microbiol. 23, 861-867.
CHAPTER 7
Molecular Pathogenesis of Salmonellae CHRISTINA A. SCHERER SAMUEL I. MILLER
I. II. III. IV.
V.
VI.
VII.
VIII.
IX.
Introduction History Taxonomy Epidemiology and Clinical Disease A. Enteric Fever B. Gastroenteritis C. Bacteremia and Other Complications of Nontyphoidal Salmonellosis D. Chronic Carrier State Clinical Course and Basic Immunology A. Disease Course B. Inbred Mouse Enteric Fever Model C. Immunology of Salmonella Infections In Vitro Models of Salmonella Virulence A. Modeling Interactions with Macrophages B. Modeling Salmonella Interactions with Epithelial Cells Virulence Factors A. Major Transcriptional Regulators B. Factors Required for the Invasion of Epithelial Cells C. Factors Required for Systemic Infection D. Salmonella Toxins E. Virulence Plasmids Antibiotic-Resistant Salmonellae A. Multi-Antibiotic Resistant Salmonellae B. Development of New Antibiotics Salmonella-Based Wsicc'mes A. Development of More Effective Typhoid Vaccines B. Salmonellae as Multivalent Vaccine Strains C. Salmonella-Based Cancer Therapy References
Principles of Bacterial Pathogenesis Copyright © 2001 by Academic Press All rights of reproduction in any form reserved. ISBN 0-12-304220-8
9^S
266 266 267 268 268 269 271 271 272 272 274 276 280 280 286 290 290 302 308 310 310 312 312 313 314 314 315 316 316
266
CHRISTINA A. SCHERER AND SAMUEL I. MILLER
/. Introduction The Salmonellae are Gram-negative bacilli that cause enteric (typhoid) fever and gastroenteritis. Over 2000 serotypes of Salmonella infect humans and virtually all known wild and domestic animals, including birds, reptiles, and insects. These infections result in significant morbidity and mortality. Typhoid fever, caused by the exclusively human pathogens S. typhi and S. paratyphi, was a major cause of death throughout the world in the nineteenth and early twentieth centuries. Due to improvements in sanitation, the incidence of typhoid fever has dropped dramatically in developed nations; however, it remains a significant problem in the developing world. In contrast, human gastroenteritis caused by nontyphoidal Salmonellae is globally increasing because of zoonotic contamination of food, whose distribution and processing is now more centralized. Antibiotic resistance of both typhoidal and nontyphoidal serotypes is increasing and has magnified the public health problem of Salmonellae infections. In this chapter, the epidemiology, general disease course, and pathogenesis of Salmonella infections will be discussed. Pathogenesis involves an interaction between both host and bacterial factors. Although our understanding of the diverse and resourceful Salmonellae is far from complete, significant progress has been made in elucidating molecular mechanisms of Salmonella pathogenesis. Much of the information on the molecular mechanisms of pathogenesis has been derived from the study of tissue culture and small animal infection models. These models may not always reflect natural infection, but they do reveal important mechanisms and principles of pathogenesis. After detailed discussion of host and bacterial factors that are implicated in disease pathogenesis, this chapter considers the potential for applying pathogenic knowledge to the development of new vaccines and antibiotics.
//. History Before the nineteenth century, human enteric or typhoid fever was often confused with typhus, a rickettsial disease. The two diseases were pathologically distinguished by P. Ch. A. Louis in France (1829) and William Jenner in the United States (1850). The typhoid bacillus was first isolated in 1884, when the German microbiologist Gaffkey obtained S. typhi from human spleens. S. choleraesuis was subsequently isolated from the intestines of pigs infected with hog cholera in 1885 by the veterinary pathologist Daniel Salmon, for whom the Salmonellae are named. In 1896, Pfeiffer and Kalle introduced the first heat-killed bacterial typhoid vaccine. In the same year, Widal determined that S. typhi could be agglutinated by convalescent patient sera. This technique provided a clinical tool for the identification of Salmonellae and was used extensively by Kauffman and White in the 1920s and 1930s for classification of over 2000 serotypes. The modem era of antibiotic treatment of typhoid fever was initiated in 1948, when Woodward and colleagues successfully treated the disease with chloramphenicol.
7.
MOLECULAR PATHOGENESIS OF SALMONELLAE
267
A small animal model for typhoid fever was developed in the early 1950s, when animal experiments illustrated the susceptibility of inbred mouse strains to infection by S. typhimurium. Early experiments showed that bacterial strains auxotrophic for aromatic amino acids and purines were attenuated for virulence. The discovery by Zinder and Lederberg in 1952 that S. typhimurium could be transduced by P22 bacteriophage led to the development of S. typhimurium as a model system for genetic studies [1]. The combination of a convenient animal model and the powerful genetic techniques available for study of S. typhimurium has resulted in widespread study of this model system of Salmonellae pathogenesis.
///. Taxonomy The genus Salmonella is a member of the family Enterobacteriaceae. The Salmonellae are Gram-negative bacilli, approximately 2-3 x 0.4-0.6 |Lim in size. Molecular characterization of the genus has resulted in the grouping of Salmonellae into a single species, Salmonella choleraesuis. Alternatively, to prevent confusion with the serovar choleraesuis, the species is commonly referred to as Salmonella enterica. Based on genetic similarity and host range, the species has been divided into six subspecies (ssp.): choleraesuis (or enterica, Group 1), salamae (Group 2), arizonae (Group 3a), diarizonae (Group 3b), houtenae (Group 4), and indica (Group 6). S. bongori, which was initially categorized as subspecies 5, is generally considered a separate species due to its divergence from the other Salmonellae [2]. Group 1 (enterica) includes many of the serotypes pathogenic for humans, including S. typhi and S. typhimurium. As the correct taxonomic classification for Salmonella subspecies is rather unwieldy, the common species name that prevailed before reclassification of the species is still widely used. Thus, Salmonella choleraesuis ssp. choleraesuis (or Group 1), serovar typhi, is referred to by its common name, S. typhi. Salmonellae have been grouped into over 2200 serotypes [3] according to three major antigenic determinants: the flagellar H antigen, the somatic O antigen, and the Vi antigen. The Vi antigen, a homopolymer of yV-acetylgalactosaminouronic acid, is predominantly found on S. typhi, and is considered an identifying feature of this serotype. Nontyphoidal serogroups are identified based on differential agglutination by specific antibodies to O antigen. O antigen is a polysaccharide structural component of bacterial lipopolysaccharide (LPS), the major component of the outer leaflet of the bacterial membrane. Agglutination by antibodies specific for the various O antigens is used to group Salmonellae into 6 serogroups: A, B, CI, C2, D, and E. Although these groupings can help identify pathogenic bacteria as Salmonella, crossreactivity between groups does not allow for definitive identification of the serotype. For instance, both S. enteritidis and S. typhi express O antigens of Group D. Further classification of serotypes is based on the antigenicity of the flagellar H antigen and other more specific genetic and molecular methods, such as bacteriophage typing, pulsed field gel electrophoresis, and restriction fragment length polymorphism (RFLP) analysis.
268
CHRISTINA A. SCHERER AND SAMUEL I. MILLER
IV, Epidemiology and Clinical Disease The two major clinical syndromes that result from Salmonella infection are typhoid (enteric) fever and gastroenteritis. Focal infections of the vasculature (endocarditis), bone (osteomyelitis), and joints (arthritis) as well as a variety of other organs can occur but are much less common and are often associated with specific immune defects. Serotypes that exhibit strict human species specificity cause enteric fever. Other serotypes are associated with specific animal populations, such as S. dublin (cattle) and S. choleraesuis (swine), but also cause disease in humans. The two predominant agents of human gastroenteritis, S. typhimurium and S. enteritidis, infect a wide range of zoonotic hosts, including poultry, catde, sheep, pigs, horses, rodents and primates. A list of common serotypes and their characteristics is provided in Table I [4-13]. A. Enteric Fever Typhoid fever is a severe systemic illness characterized by high fever, gastrointestinal symptoms, including diarrhea and constipation, and sometimes a charac-
Table I
Major Salmonella Serotypes
Serotype
Primary host
Disease in humans
Year and references of recent outbreaks (source)
5". arizonae